Index,PatientID,Sex,IBD_Type,Biologic_Type,Steroid_Medication,ASA,Immunomodulators,NC_Value,NC_Seroconversion,RBD_Value,RBD_Seroconversion,Age_COVIDpos,Age_Group,DX_sero_days,DX_secsero_days,Vaccine_Status,Serology_Date,Group,Days_since_pv1,Days_since_pv2,Days_since_pv3,pv4,pv1,pv2,pv3,dbv1v2,dbv2v3,ln_rbdvalue,CDdistribution,CDbehaviour,UCdistribution,IleostomyPouchitis,patienttype,serologyindication,baselinebiologicother,variant1,COVID2,variant2,COVIDrapidtest,ncpositive,pv1,v1type,v1biologic,v1biologicother,v1steroid,v1ASA,v1immunomodulator,pv2,v2type,v2biologic,v2biologicother,v2steroid,v2ASA,v2immunomodulator,pv3,v3type,v3biologic,v3biologicother,v3steroid,v3ASA,v3immunomodulator,pv4,v4type,v4biologic,v4biologicother,v4steroid,v4ASA,v4immunomodulator,post1st,post1to2,post2to8,post1to8,post8to18,post18plus,post8plus,post2nd,post3rd,post4th,COVID1,covhis,male,agevax,agecollection,baseantitnf,basevedo,baseuste,basejak,basesteroid,baseasa,baseimmuno,baseclass,v1antitnf,v1vedo,v1uste,v1jak,v1steroidyn,v1asayn,v1immyn,v1class,v2antitnf,v2vedo,v2uste,v2jak,v2steroidyn,v2asayn,v2immyn,v2class,v3antitnf,v3vedo,v3uste,v3jak,v3steroidyn,v3asayn,v3immyn,v3class,days1,days2,timebw,sched,DuplicateType,DuplicateNote,logrbd,age65,crohn,vcategory,v1mRNA,v2mRNA,days3,v1nomed,v3nomed,v2nomed,covdate,breakthrough,weeks1,weeks2,weeks3,Index2,decadecoll,decaderange
18,,Female,CD,Ustekinumab,none,none,none,0.05,Negative,431,Positive,,Adult,,,Post-1st,28-May-21,baseline,53,,,,05-Apr-21,30-May-21,,55,,6.066340082,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-05,Pfizer,Ustekinumab,.,none,none,none,2021-05-30,Pfizer,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,19,19,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,53,,55,0,,,6,0,1,Post-1st Dose,1,1,,0,0,0,,,8,,,7,1,18-29
70,,Female,CD,Inflectra,none,none,none,0.07,Negative,16622,Positive,,Adult,,,Post-3rd,28-Oct-21,baseline,,,36,,24-Apr-21,10-Jun-21,22-Sep-21,47,104,9.718506462,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-24,Moderna,Inflectra,.,none,none,none,2021-06-10,Moderna,Inflectra,.,none,none,none,2021-09-22,Moderna,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,26,26,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,47,0,,,10,0,1,Post-3rd Dose,1,1,36,0,0,0,,3,,,5,822,1,18-29
71,,Female,CD,Inflectra,none,none,none,,,18891,Positive,,Adult,,,Post-2nd,05-Jul-21,baseline,,25,,,24-Apr-21,10-Jun-21,22-Sep-21,47,104,9.846435604,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-24,Moderna,Inflectra,.,none,none,none,2021-06-10,Moderna,Inflectra,.,none,none,none,2021-09-22,Moderna,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,26,26,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,25,47,0,,,10,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,823,1,18-29
118,,Male,CD,Infliximab,none,none,none,,,4990,Positive,,Adult,,,Post-2nd,06-Jul-21,baseline,,24,,,09-Apr-21,12-Jun-21,06-Sep-21,64,86,8.515131067,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-09,Pfizer,Infliximab,.,none,none,none,2021-06-12,Pfizer,Infliximab,.,none,none,none,2021-09-06,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,29,29,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,24,64,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,767,1,18-29
119,,Male,CD,Infliximab,none,none,none,0.05,Negative,308,Positive,,Adult,,,Post-1st,15-May-21,baseline,36,,,,09-Apr-21,12-Jun-21,06-Sep-21,64,86,5.729125282,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-09,Pfizer,Infliximab,.,none,none,none,2021-06-12,Pfizer,Infliximab,.,none,none,none,2021-09-06,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,29,29,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,36,,64,0,,,6,0,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,768,1,18-29
124,,Male,CD,Adalimumab,none,none,none,0.09,Negative,13359,Positive,,Adult,,,Post-3rd,19-Oct-21,baseline,,,23,,12-Apr-21,25-May-21,26-Sep-21,43,124,9.499908165,colonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-12,Moderna,Adalimumab,.,none,none,none,2021-05-25,Moderna,Adalimumab,.,none,none,none,2021-09-26,Moderna,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,20,21,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,43,0,,,9,0,1,Post-3rd Dose,1,1,23,0,0,0,,3,,,3,102,1,18-29
125,,Male,CD,Adalimumab,none,none,none,0.02,Negative,7692,Positive,,Adult,,,Post-2nd,17-Jun-21,baseline,,23,,,12-Apr-21,25-May-21,26-Sep-21,43,124,8.947975108,colonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-12,Moderna,Adalimumab,.,none,none,none,2021-05-25,Moderna,Adalimumab,.,none,none,none,2021-09-26,Moderna,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,20,20,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,23,43,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,103,1,18-29
149,,Male,CD,Inflectra,none,none,none,0.2,Negative,2012,Positive,,Adult,,,Post-2nd,30-Aug-21,baseline,,77,,,03-Apr-21,14-Jun-21,,72,,7.606884531,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,Inflectra,.,none,none,none,2021-06-14,Pfizer,Inflectra,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,21,22,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,77,72,0,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,11,,310,1,18-29
154,,Male,CD,Renflexis/IFX,none,none,none,0.04,Negative,85,Positive,,Adult,,,Post-1st,20-May-21,baseline,36,,,,14-Apr-21,14-Jun-21,,61,,4.439115602,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-14,Pfizer,Renflexis/IFX,Ustekinumab,none,none,none,2021-06-14,Pfizer,Renflexis/IFX,Ustekinumab,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,24,24,1,0,0,0,0,0,0,Anti-TNF Only,1,0,1,0,0,0,0,Combination Therapy,1,0,1,0,0,0,0,Combination Therapy,0,0,0,0,0,0,0,,36,,61,0,,,4,0,1,Post-1st Dose,1,1,,0,0,0,,,5,,,123,1,18-29
169,,Male,CD,Ustekinumab,none,none,none,0.03,Negative,1061,Positive,,Adult,,,Post-1st,15-Jun-21,baseline,43,,,,03-May-21,02-Jul-21,,60,,6.966778619,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-03,Pfizer,Ustekinumab,.,none,none,none,2021-07-02,Pfizer,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,22,23,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,43,,60,0,,,7,0,1,Post-1st Dose,1,1,,0,0,0,,,6,,,945,1,18-29
205,,Male,IBD-U,Vedolizumab,none,none,Azathioprine/Immuran,0.02,Negative,478,Positive,,Adult,,,Post-1st,03-Jun-21,baseline,36,,,,28-Apr-21,25-Jul-21,,88,,6.16898292,N/A,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-04-28,Pfizer,Vedolizumab,.,none,none,Azathioprine/Immuran,2021-07-25,Pfizer,Vedolizumab,.,none,none,Azathioprine/Immuran,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,20,20,0,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,1,Combination Therapy,0,0,0,0,0,0,0,,36,,88,0,,,6,0,0,Post-1st Dose,1,1,,0,0,0,,,5,,,861,1,18-29
212,,Female,CD,Adalimumab,none,none,Methotrexate,0.11,Negative,9128,Positive,,Adult,,,Post-3rd,17-Nov-21,baseline,,,18,,01-May-21,25-Jun-21,30-Oct-21,55,127,9.119145712,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-01,Pfizer,Ustekinumab,.,none,none,Methotrexate,2021-06-25,Pfizer,Ustekinumab,.,none,none,Methotrexate,2021-10-30,Pfizer,Ustekinumab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,26,26,1,0,0,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,,,55,0,,,9,0,1,Post-3rd Dose,1,1,18,0,0,0,,3,,,3,678,1,18-29
213,,Female,CD,Adalimumab,none,none,Methotrexate,,,5556,Positive,,Adult,,,Post-2nd,29-Jul-21,baseline,,34,,,01-May-21,25-Jun-21,30-Oct-21,55,127,8.622543707,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-01,Pfizer,Ustekinumab,.,none,none,Methotrexate,2021-06-25,Pfizer,Ustekinumab,.,none,none,Methotrexate,2021-10-30,Pfizer,Ustekinumab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,26,26,1,0,0,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,,34,55,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,5,,679,1,18-29
214,,Female,CD,Adalimumab,none,none,Methotrexate,0.06,Negative,25,Negative,,Adult,,,Post-1st,15-Jun-21,baseline,45,,,,01-May-21,25-Jun-21,30-Oct-21,55,127,3.218875825,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-01,Pfizer,Ustekinumab,.,none,none,Methotrexate,2021-06-25,Pfizer,Ustekinumab,.,none,none,Methotrexate,2021-10-30,Pfizer,Ustekinumab,.,none,none,Methotrexate,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,26,26,1,0,0,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,45,,55,0,,,3,0,1,Post-1st Dose,1,1,,0,0,0,,3,6,,,680,1,18-29
227,,Female,CD,Adalimumab,none,none,Azathioprine/Immuran,0.33,Negative,4902,Positive,,Adult,31,,Post-1st,08-Jun-21,covid,17,,,,22-May-21,25-Aug-21,,95,,8.497378164,ileal,Stricturing,N/A,,Outpatient,Confirmed COVID,,,,,,,2021-05-22,Pfizer,Adalimumab,.,none,none,Azathioprine/Immuran,2021-08-25,Pfizer,Adalimumab,.,none,none,Azathioprine/Immuran,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,2021-05-08,1,Female,18,18,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,0,0,0,0,0,0,0,,17,,95,0,,,8,0,1,Post-1st Dose,1,1,,0,0,0,2021-05-08,,2,,,41,1,18-29
262,,Male,UC,Infliximab,none,none,none,,,7789,Positive,,Adult,,,Post-2nd,06-Jul-21,baseline,,17,,,11-Apr-21,19-Jun-21,23-Sep-21,69,96,8.960454922,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-11,Pfizer,Infliximab,.,none,none,none,2021-06-19,Pfizer,Infliximab,.,none,none,none,2021-09-23,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,26,27,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,17,69,0,,,9,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,2,,700,1,18-29
298,,Male,UC,Inflectra,Oral Prednisone,Both oral/Rectal,Azathioprine/Immuran,0.18,Negative,12209,Positive,,Adult,,,Post-3rd,05-Nov-21,baseline,,,31,,22-Apr-21,01-Aug-21,05-Oct-21,101,65,9.409887709,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Inflectra,none,none,Both oral/Rectal,Azathioprine/Immuran,2021-08-01,Pfizer,Inflectra,none,Oral Prednisone,Both oral/Rectal,Azathioprine/Immuran,2021-10-05,Pfizer,Inflectra,none,none,Both oral/Rectal,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,22,23,1,0,0,0,1,1,1,Corticoteroids,1,0,0,0,0,1,1,Combination Therapy,1,0,0,0,1,1,1,Corticoteroids,1,0,0,0,0,1,1,Combination Therapy,,,101,0,,,9,0,0,Post-3rd Dose,1,1,31,0,0,0,,3,,,4,206,1,18-29
299,,Male,UC,Inflectra,Oral Prednisone,Both oral/Rectal,Azathioprine/Immuran,0.21,Negative,7774,Positive,,Adult,,,Post-2nd,09-Sep-21,baseline,,39,,,22-Apr-21,01-Aug-21,05-Oct-21,101,65,8.958552975,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Inflectra,none,none,Both oral/Rectal,Azathioprine/Immuran,2021-08-01,Pfizer,Inflectra,none,Oral Prednisone,Both oral/Rectal,Azathioprine/Immuran,2021-10-05,Pfizer,Inflectra,none,none,Both oral/Rectal,Azathioprine/Immuran,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,22,23,1,0,0,0,1,1,1,Corticoteroids,1,0,0,0,0,1,1,Combination Therapy,1,0,0,0,1,1,1,Corticoteroids,1,0,0,0,0,1,1,Combination Therapy,,39,101,0,,,9,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,6,,207,1,18-29
311,,Female,CD,Ustekinumab,none,none,none,4.61,Positive,40000,Positive,,Adult,62,,Post-3rd,01-Nov-21,baseline,,,32,,28-Apr-21,06-Jun-21,30-Sep-21,39,116,10.59663473,,,,,Outpatient,Baseline Serology,Adalimumab,Delta,,,,2021-09-21,2021-04-28,Pfizer,Ustekinumab,Adalimumab,none,none,none,2021-06-06,Pfizer,Ustekinumab,Adalimumab,none,none,none,2021-09-30,Pfizer,Ustekinumab,Adalimumab,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,2021-08-31,1,Female,22,23,1,0,1,0,0,0,0,Combination Therapy,1,0,1,0,0,0,0,Combination Therapy,1,0,1,0,0,0,0,Combination Therapy,1,0,1,0,0,0,0,Combination Therapy,,,39,1,,,11,0,1,Post-3rd Dose,1,1,32,0,0,0,2021-08-31,2,,,5,906,1,18-29
312,,Female,CD,Ustekinumab,none,none,none,4.59,Positive,36168,Positive,,Adult,21,,Post-2nd,21-Sep-21,baseline,,107,,,28-Apr-21,06-Jun-21,30-Sep-21,39,116,10.49593556,,,,,Outpatient,Baseline Serology,Adalimumab,Delta,,,,2021-09-21,2021-04-28,Pfizer,Ustekinumab,Adalimumab,none,none,none,2021-06-06,Pfizer,Ustekinumab,Adalimumab,none,none,none,2021-09-30,Pfizer,Ustekinumab,Adalimumab,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,2021-08-31,1,Female,22,23,1,0,1,0,0,0,0,Combination Therapy,1,0,1,0,0,0,0,Combination Therapy,1,0,1,0,0,0,0,Combination Therapy,1,0,1,0,0,0,0,Combination Therapy,,107,39,1,,,10,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,2021-08-31,2,,15,,907,1,18-29
314,,Male,UC,none,none,Oral 5ASA,Azathioprine/Immuran,2.16,Positive,40000,Positive,,Adult,36,,Post-2nd,16-Nov-21,Post Vaccine covid,,157,,,09-Apr-21,12-Jun-21,,64,,10.59663473,N/A ,N/A ,Pancolitis,,Outpatient,Post Vaccine Confirmed COVID,,,,,,2021-11-16,2021-04-09,Pfizer,none,none,none,Oral 5ASA,Azathioprine/Immuran,2021-06-12,Pfizer,none,none,none,Oral 5ASA,Azathioprine/Immuran,,,,,,,,,.,.,.,.,.,.,,,,,,1,1,1,,,2021-10-11,1,Male,27,28,0,0,0,0,0,1,1,Immunomodulator Only,0,0,0,0,0,1,1,Immunomodulator Only,0,0,0,0,0,1,1,Immunomodulator Only,0,0,0,0,0,0,0,,,157,64,0,,,11,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,2021-10-11,2,,22,,305,1,18-29
355,,Female,UC,Vedolizumab,none,none,none,0.11,Negative,10178,Positive,,Adult,,,Post-2nd,22-Jul-21,baseline,,48,,,23-Apr-21,04-Jun-21,18-Dec-21,42,197,9.228023107,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-23,Pfizer,Vedolizumab,.,none,none,none,2021-06-04,Pfizer,Vedolizumab,.,none,none,none,2021-12-18,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,26,26,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,48,42,1,,,9,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,7,,503,1,18-29
371,,Female,CD,Vedolizumab,Oral budesonide/Cortiment/Entocort,none,Methotrexate,0.03,Negative,5778,Positive,,Adult,,,Post-2nd,24-Jun-21,baseline,,38,,,03-Apr-21,17-May-21,03-Sep-21,44,109,8.661760959,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,Golimumab,,,,,,2021-04-03,Pfizer,Golimumab ,Vedolizumab,none,none,none,2021-05-17,Pfizer,Golimumab ,Vedolizumab,none,none,none,2021-09-03,Pfizer,Golimumab ,Vedolizumab,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,25,25,1,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,38,44,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,5,,110,1,18-29
450,,Male,UC,Ustekinumab,none,none,none,,,2801,Positive,,Adult,,,Post-2nd,28-Jul-21,baseline,,54,,,24-Apr-21,04-Jun-21,,41,,7.937803176,N/A ,N/A,Proctitis,,Outpatient,Baseline Serology,,,,,,,2021-04-24,Pfizer,Ustekinumab,.,none,none,none,2021-06-04,Pfizer,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,24,24,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,,54,41,1,,,8,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,8,,133,1,18-29
452,,Male,CD,Infliximab,none,none,Methotrexate,0.05,Negative,358,Positive,,Adult,,,Post-2nd,17-Sep-21,baseline,,119,,,22-Apr-21,21-May-21,,29,,5.880812277,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Infliximab,.,none,none,Methotrexate,2021-05-21,Pfizer,Infliximab,.,none,none,Methotrexate,,,,,,,,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,27,28,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,0,0,0,0,0,0,0,,,119,29,1,,,6,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,17,,934,1,18-29
453,,Male,CD,Infliximab,none,none,Methotrexate,0.04,Negative,2493,Positive,,Adult,,,Post-2nd,15-Jun-21,baseline,,25,,,22-Apr-21,21-May-21,,29,,7.821161856,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Infliximab,.,none,none,Methotrexate,2021-05-21,Pfizer,Infliximab,.,none,none,Methotrexate,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,27,27,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,0,0,0,0,0,0,0,,,25,29,1,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,4,,935,1,18-29
463,,Female,CD,Infliximab,none,none,Azathioprine/Immuran,0.02,Negative,2164,Positive,,Adult,,,Post-3rd,02-Nov-21,baseline,,,14,,22-Apr-21,21-May-21,19-Oct-21,29,151,7.679852263,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-05-21,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-10-19,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,28,29,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,,29,1,,,8,0,1,Post-3rd Dose,1,1,14,0,0,0,,3,,,2,369,1,18-29
464,,Female,CD,Infliximab,none,none,Azathioprine/Immuran,0.04,Negative,84,Positive,,Adult,,,Post-2nd,02-Sep-21,baseline,,104,,,22-Apr-21,21-May-21,19-Oct-21,29,151,4.428433007,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-05-21,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-10-19,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,28,29,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,104,29,1,,,4,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,15,,370,1,18-29
465,,Female,CD,Infliximab,none,none,Azathioprine/Immuran,0.04,Negative,456,Positive,,Adult,,,Post-2nd,10-Jun-21,baseline,,20,,,22-Apr-21,21-May-21,19-Oct-21,29,151,6.123150488,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-05-21,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-10-19,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,28,28,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,20,29,1,,,6,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,371,1,18-29
478,,Male,CD,Infliximab,none,none,none,0.02,Negative,121,Positive,,Adult,,,Post-1st,14-May-21,baseline,33,,,,11-Apr-21,27-Jun-21,28-Sep-21,77,93,4.796616651,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-11,Pfizer,Infliximab,.,none,none,none,2021-06-27,Pfizer,Infliximab,.,none,none,none,2021-09-28,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,27,27,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,33,,77,0,,,5,0,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,946,1,18-29
512,,Female,CD,Ustekinumab,none,none,Methotrexate,0.79,Positive,40000,Positive,,Adult,,,Post-3rd,12-Oct-21,baseline,,,12,,15-Apr-21,19-Jun-21,30-Sep-21,65,103,10.59663473,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,2021-10-12,2021-04-15,Pfizer,Infliximab,.,none,none,Methotrexate,2021-06-19,Pfizer,Infliximab,.,none,none,Methotrexate,2021-09-30,Pfizer,Infliximab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,,,,,,,1,,,1,Female,24,25,0,0,1,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,,65,0,,,11,0,1,Post-3rd Dose,1,1,12,0,0,0,2021-10-12,3,,,2,859,1,18-29
513,,Female,CD,Ustekinumab,none,none,Methotrexate,,,2936,Positive,,Adult,,,Post-2nd,15-Jul-21,baseline,,26,,,15-Apr-21,19-Jun-21,30-Sep-21,65,103,7.984837449,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,2021-10-12,2021-04-15,Pfizer,Infliximab,.,none,none,Methotrexate,2021-06-19,Pfizer,Infliximab,.,none,none,Methotrexate,2021-09-30,Pfizer,Infliximab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,24,24,0,0,1,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,26,65,0,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2021-10-12,3,,4,,860,1,18-29
550,,Female,CD,Infliximab,none,none,Methotrexate,0.06,Negative,2463,Positive,,Adult,,,Post-3rd,22-Dec-21,baseline,,,91,,09-Apr-21,02-May-21,22-Sep-21,23,143,7.809094796,ileocolonic,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-09,Pfizer,Infliximab,.,none,none,Methotrexate,2021-05-02,Pfizer,Infliximab,.,none,none,Methotrexate,2021-09-22,Pfizer,Infliximab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,23,24,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,,23,1,,,8,0,1,Post-3rd Dose,1,1,91,0,0,0,,3,,,13,137,1,18-29
551,,Female,CD,Infliximab,none,none,Methotrexate,0.03,Negative,5891,Positive,,Adult,,,Post-2nd,11-May-21,baseline,,9,,,09-Apr-21,02-May-21,22-Sep-21,23,143,8.681147091,ileocolonic,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-09,Pfizer,Infliximab,.,none,none,Methotrexate,2021-05-02,Pfizer,Infliximab,.,none,none,Methotrexate,2021-09-22,Pfizer,Infliximab,.,none,none,Methotrexate,,.,.,.,.,.,.,,1,,1,,,,1,,,,0,Female,23,23,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,9,23,1,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,1,,138,1,18-29
615,,Male,CD,Infliximab,none,none,Azathioprine/Immuran,,,9720,Positive,,Adult,206,,Post-2nd,28-Jul-21,covid,,26,,,18-May-21,02-Jul-21,,45,,9.181951185,ileocolonic,unknown,N/A,,Outpatient,Confirmed COVID,,,,,,,2021-05-18,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-07-02,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,2021-01-03,1,Male,23,23,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,0,0,0,0,0,0,0,,,26,45,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2021-01-03,,,4,,573,1,18-29
637,,Male,UC,Inflectra,none,none,none,0.01,Negative,10805,Positive,,Adult,,,Post-2nd,20-Jul-21,baseline,,41,,,29-Apr-21,09-Jun-21,26-Sep-21,41,109,9.287717993,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-29,Pfizer,Inflectra,.,none,none,none,2021-06-09,Pfizer,Inflectra,.,none,none,none,2021-09-26,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,20,20,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,41,41,1,,,9,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,6,,282,1,18-29
649,,Female,CD,Vedolizumab,none,none,none,0.05,Negative,46530,Positive,,Adult,-222,,Post-2nd,22-Mar-21,baseline,,30,,,13-Jan-21,20-Feb-21,28-Nov-21,38,281,10.74784825,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,B16172,,,,,2021-01-13,Pfizer,Vedolizumab,.,none,none,none,2021-02-20,Pfizer,Vedolizumab,.,none,none,none,2021-11-28,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,2021-10-30,0,Female,27,27,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,30,38,1,,,11,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2021-10-30,2,,4,,557,1,18-29
657,,Male,CD,Ustekinumab,none,none,Methotrexate,0.04,Negative,30269,Positive,,Adult,,,Post-3rd,25-Oct-21,baseline,,,24,,07-Apr-21,04-Jun-21,01-Oct-21,58,119,10.31786945,colonic,stricturing and upper GI,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-07,Pfizer,Ustekinumab,.,none,none,Methotrexate,2021-06-04,Pfizer,Ustekinumab,.,none,none,Methotrexate,2021-10-01,Pfizer,Ustekinumab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,23,24,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,,,58,0,,,10,0,1,Post-3rd Dose,1,1,24,0,0,0,,3,,,3,481,1,18-29
681,,Female,UC,Ustekinumab,none,none,none,,,437,Positive,,Adult,,,Post-2nd,09-Jul-21,baseline,,40,,,09-Apr-21,30-May-21,03-Sep-21,51,96,6.078788375,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-09,Pfizer,Adalimumab,.,none,none,Azathioprine/Immuran,2021-05-30,Pfizer,Adalimumab,.,none,none,Azathioprine/Immuran,2021-09-03,Pfizer,Adalimumab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,26,26,0,0,1,0,0,0,0,Ustekinumab Only,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,40,51,0,,,6,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,6,,971,1,18-29
696,,Male,CD,Remicade,none,none,Methotrexate,0.03,Negative,226,Positive,,Adult,-223,,Post-1st,21-May-21,baseline,51,,,,31-Mar-21,02-Jun-21,26-Oct-21,63,146,5.420092423,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-31,Pfizer,Remicade,.,none,none,Methotrexate,2021-06-02,Pfizer,Remicade,.,none,none,Methotrexate,2021-10-26,Pfizer,Remicade,.,none,none,Methotrexate,,.,.,.,.,.,.,1,,,,,,,,,,2021-12-30,0,Male,19,19,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,51,,63,0,,,5,0,1,Post-1st Dose,1,1,,0,0,0,2021-12-30,3,7,,,836,1,18-29
697,,Male,CD,Remicade,none,none,Methotrexate,,,1165,Positive,,Adult,-175,,Post-2nd,08-Jul-21,baseline,,36,,,31-Mar-21,02-Jun-21,26-Oct-21,63,146,7.060648025,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-31,Pfizer,Remicade,.,none,none,Methotrexate,2021-06-02,Pfizer,Remicade,.,none,none,Methotrexate,2021-10-26,Pfizer,Remicade,.,none,none,Methotrexate,,.,.,.,.,.,.,,,1,1,,,,1,,,2021-12-30,0,Male,19,19,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,36,63,0,,,7,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2021-12-30,3,,5,,837,1,18-29
698,,Female,CD,Ustekinumab,none,none,Azathioprine/Immuran,0.03,Negative,2491,Positive,,Adult,,,Post-2nd,10-Aug-21,baseline,,54,,,07-May-21,17-Jun-21,,41,,7.820319074,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-07,Pfizer,Ustekinumab,.,none,none,none,2021-06-17,Pfizer,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,21,22,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,,54,41,1,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,8,,613,1,18-29
709,,Female,CD,Adalimumab,none,none,none,0.07,Negative,15530,Positive,,Adult,,,Post-3rd,14-Oct-21,baseline,,,35,,17-Dec-20,07-Jan-21,09-Sep-21,21,245,9.650516038,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2020-12-17,Pfizer,Adalimumab,.,none,none,none,2021-01-07,Pfizer,Adalimumab,.,none,none,none,2021-09-09,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,23,24,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,21,1,,,10,0,1,Post-3rd Dose,1,1,35,0,0,0,,3,,,5,45,1,18-29
710,,Female,CD,Adalimumab,none,none,none,0.05,Negative,5644,Positive,,Adult,,,Post-2nd,23-Feb-21,baseline,,47,,,17-Dec-20,07-Jan-21,09-Sep-21,21,245,8.638277439,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2020-12-17,Pfizer,Adalimumab,.,none,none,none,2021-01-07,Pfizer,Adalimumab,.,none,none,none,2021-09-09,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,23,24,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,47,21,1,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,7,,46,1,18-29
711,,Female,CD,Adalimumab,none,none,none,0.05,Negative,1401,Positive,,Adult,,,Post-2nd,16-May-21,baseline,,129,,,17-Dec-20,07-Jan-21,09-Sep-21,21,245,7.245155656,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2020-12-17,Pfizer,Adalimumab,.,none,none,none,2021-01-07,Pfizer,Adalimumab,.,none,none,none,2021-09-09,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,23,24,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,129,21,1,,,7,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,18,,47,1,18-29
717,,Male,UC,other,none,Oral 5ASA,none,0.04,Negative,5996,Positive,,Adult,282,,Post-2nd,24-Apr-21,covid,,25,,,18-Feb-21,30-Mar-21,30-Dec-21,40,275,8.698831181,N/A ,N/A,Pancolitis,,Outpatient,Confirmed COVID,,,,,,,2021-02-18,Pfizer,none,.,none,Oral 5ASA,none,2021-03-30,Pfizer,none,.,Oral Prednisone,Oral 5ASA,none,2021-12-30,Pfizer,none,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,1,1,,,,1,,,2020-07-16,1,Male,29,29,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,1,1,0,Corticoteroids,0,0,0,0,0,0,1,Immunomodulator Only,,25,40,1,,,9,0,0,Post-2nd Dose (1-8 Weeks),1,1,,1,0,0,2020-07-16,,,4,,490,1,18-29
769,,Male,UC,Infliximab,none,none,none,0.09,Negative,5500,Positive,,Adult,,,Post-3rd,23-Dec-21,baseline,,,92,,10-Apr-21,10-Jun-21,22-Sep-21,61,104,8.612503371,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-10,Pfizer,Infliximab,.,none,none,none,2021-06-10,Pfizer,Infliximab,.,none,none,none,2021-09-22,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,24,25,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,61,0,,,9,0,0,Post-3rd Dose,1,1,92,0,0,0,,3,,,13,332,1,18-29
770,,Male,UC,Infliximab,none,none,none,,,6595,Positive,,Adult,,,Post-2nd,06-Jul-21,baseline,,26,,,10-Apr-21,10-Jun-21,22-Sep-21,61,104,8.794097391,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-10,Pfizer,Infliximab,.,none,none,none,2021-06-10,Pfizer,Infliximab,.,none,none,none,2021-09-22,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,24,24,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,26,61,0,,,9,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,333,1,18-29
791,,Female,UC,Infliximab,none,Rectal 5ASA,none,0.13,Negative,8632,Positive,,Adult,,,Post-3rd,26-Oct-21,baseline,,,23,,15-Jan-21,24-Feb-21,03-Oct-21,40,221,9.063243092,N/A ,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-01-15,Pfizer,Infliximab,.,none,Rectal 5ASA,none,2021-02-24,Pfizer,Infliximab,.,none,Rectal 5ASA,none,2021-10-03,Pfizer,Infliximab,.,none,Rectal 5ASA,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,28,29,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,,,40,1,,,9,0,0,Post-3rd Dose,1,1,23,0,0,0,,3,,,3,688,1,18-29
792,,Female,UC,Infliximab,none,Rectal 5ASA,none,0.09,Negative,2901,Positive,,Adult,,,Post-2nd,09-Apr-21,baseline,,44,,,15-Jan-21,24-Feb-21,03-Oct-21,40,221,7.972638415,N/A ,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-01-15,Pfizer,Infliximab,.,none,Rectal 5ASA,none,2021-02-24,Pfizer,Infliximab,.,none,Rectal 5ASA,none,2021-10-03,Pfizer,Infliximab,.,none,Rectal 5ASA,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,28,28,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,,44,40,1,,,8,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,6,,689,1,18-29
794,,Female,CD,Ustekinumab,none,none,none,0.05,Negative,366,Positive,,Adult,,,Post-1st,30-Mar-21,baseline,36,,,,22-Feb-21,01-Apr-21,25-Nov-21,38,238,5.902633333,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-02-22,Pfizer,Ustekinumab,.,none,none,none,2021-04-01,Pfizer,Ustekinumab,.,none,none,none,2021-11-25,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,25,25,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,36,,38,1,,,6,0,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,202,1,18-29
898,,Female,CD,Inflectra,none,Rectal 5ASA,none,0.06,Negative,367,Positive,,Adult,,,Post-1st,11-Jun-21,baseline,47,,,,25-Apr-21,16-Jun-21,08-Sep-21,52,84,5.905634291,,,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-25,Pfizer,Inflectra,.,none,Rectal 5ASA,none,2021-06-16,Pfizer,Inflectra,.,none,Rectal 5ASA,none,2021-09-08,Pfizer,Inflectra,.,none,Rectal 5ASA,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,25,25,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,47,,52,0,,,6,0,1,Post-1st Dose,1,1,,0,0,0,,3,7,,,438,1,18-29
899,,Female,CD,Inflectra,none,Rectal 5ASA,none,,,7113,Positive,,Adult,,,Post-2nd,09-Jul-21,baseline,,23,,,25-Apr-21,16-Jun-21,08-Sep-21,52,84,8.869651257,,,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-25,Pfizer,Inflectra,.,none,Rectal 5ASA,none,2021-06-16,Pfizer,Inflectra,.,none,Rectal 5ASA,none,2021-09-08,Pfizer,Inflectra,.,none,Rectal 5ASA,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,25,25,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,,23,52,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,439,1,18-29
909,,Female,UC,Tofacitinib,none,Oral 5ASA,none,0.01,Negative,427,Positive,,Adult,,,Post-1st,26-May-21,baseline,33,,,,23-Apr-21,29-Jun-21,06-Jan-22,67,191,6.056784013,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-23,Pfizer,Tofacitinib,.,none,Oral 5ASA,none,2021-06-29,Pfizer,Tofacitinib,.,none,Oral 5ASA,none,2022-01-06,Pfizer,Tofacitinib,Vedolizumab,none,Oral 5ASA,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,27,27,0,0,0,1,0,1,0,Tofacitinib Only,0,0,0,1,0,1,0,Tofacitinib Only,0,0,0,1,0,1,0,Tofacitinib Only,0,1,0,1,0,1,0,Combination Therapy,33,,67,0,,,6,0,0,Post-1st Dose,1,1,,0,0,0,,3,5,,,739,1,18-29
910,,Female,UC,Tofacitinib,none,Oral 5ASA,none,0.03,Negative,1739,Positive,,Adult,,,Post-2nd,21-Dec-21,baseline,,175,,,23-Apr-21,29-Jun-21,06-Jan-22,67,191,7.461180516,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-23,Pfizer,Tofacitinib,.,none,Oral 5ASA,none,2021-06-29,Pfizer,Tofacitinib,.,none,Oral 5ASA,none,2022-01-06,Pfizer,Tofacitinib,Vedolizumab,none,Oral 5ASA,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,27,28,0,0,0,1,0,1,0,Tofacitinib Only,0,0,0,1,0,1,0,Tofacitinib Only,0,0,0,1,0,1,0,Tofacitinib Only,0,1,0,1,0,1,0,Combination Therapy,,175,67,0,,,7,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,25,,740,1,18-29
911,,Female,UC,Tofacitinib,none,Oral 5ASA,none,0.02,Negative,7375,Positive,,Adult,,,Post-2nd,21-Jul-21,baseline,,22,,,23-Apr-21,29-Jun-21,06-Jan-22,67,191,8.905810502,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-23,Pfizer,Tofacitinib,.,none,Oral 5ASA,none,2021-06-29,Pfizer,Tofacitinib,.,none,Oral 5ASA,none,2022-01-06,Pfizer,Tofacitinib,Vedolizumab,none,Oral 5ASA,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,27,27,0,0,0,1,0,1,0,Tofacitinib Only,0,0,0,1,0,1,0,Tofacitinib Only,0,0,0,1,0,1,0,Tofacitinib Only,0,1,0,1,0,1,0,Combination Therapy,,22,67,0,,,9,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,741,1,18-29
918,,Female,UC,none,none,Oral 5ASA,Azathioprine/Immuran,0.02,Negative,3192,Positive,,Adult,,,Post-2nd,12-Nov-21,baseline,,128,,,09-May-21,07-Jul-21,,59,,8.068402959,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-05-09,Pfizer,Vedolizumab,.,none,Oral 5ASA,Azathioprine/Immuran,2021-07-07,Pfizer,Vedolizumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,26,27,0,0,0,0,0,1,1,Immunomodulator Only,0,1,0,0,0,1,1,Combination Therapy,0,1,0,0,0,0,0,Vedolizumab Only,0,0,0,0,0,0,0,,,128,59,0,,,8,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,18,,641,1,18-29
919,,Female,UC,none,none,Oral 5ASA,Azathioprine/Immuran,0.02,Negative,449,Positive,,Adult,,,Post-1st,31-May-21,baseline,22,,,,09-May-21,07-Jul-21,,59,,6.107690816,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-05-09,Pfizer,Vedolizumab,.,none,Oral 5ASA,Azathioprine/Immuran,2021-07-07,Pfizer,Vedolizumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,26,26,0,0,0,0,0,1,1,Immunomodulator Only,0,1,0,0,0,1,1,Combination Therapy,0,1,0,0,0,0,0,Vedolizumab Only,0,0,0,0,0,0,0,,22,,59,0,,,6,0,0,Post-1st Dose,1,1,,0,0,0,,,3,,,642,1,18-29
920,,Female,UC,none,none,Oral 5ASA,Azathioprine/Immuran,0.02,Negative,13978,Positive,,Adult,,,Post-2nd,19-Jul-21,baseline,,12,,,09-May-21,07-Jul-21,,59,,9.545261406,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-05-09,Pfizer,Vedolizumab,.,none,Oral 5ASA,Azathioprine/Immuran,2021-07-07,Pfizer,Vedolizumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,1,,1,,,,1,,,,0,Female,26,26,0,0,0,0,0,1,1,Immunomodulator Only,0,1,0,0,0,1,1,Combination Therapy,0,1,0,0,0,0,0,Vedolizumab Only,0,0,0,0,0,0,0,,,12,59,0,,,10,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,2,,643,1,18-29
923,,Female,CD,Ustekinumab,none,none,none,0.05,Negative,4330,Positive,,Adult,,,Post-2nd,01-Sep-21,baseline,,128,,,04-Apr-21,26-Apr-21,13-Nov-21,22,201,8.373392103,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-04,Pfizer,Ustekinumab,.,none,none,none,2021-04-26,Pfizer,Ustekinumab,.,none,none,none,2021-11-13,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,26,27,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,128,22,1,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,18,,865,1,18-29
924,,Female,CD,Ustekinumab,none,none,none,0.05,Negative,22319,Positive,,Adult,,,Post-2nd,06-May-21,baseline,,10,,,04-Apr-21,26-Apr-21,13-Nov-21,22,201,10.01320257,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-04,Pfizer,Ustekinumab,.,none,none,none,2021-04-26,Pfizer,Ustekinumab,.,none,none,none,2021-11-13,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,1,,1,,,,1,,,,0,Female,26,26,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,10,22,1,,,10,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,1,,866,1,18-29
929,,Female,CD,Vedolizumab,none,none,Methotrexate,0.03,Negative,12,Negative,,Adult,,,Post-1st,10-Jun-21,baseline,28,,,,13-May-21,12-Jul-21,,60,,2.451005098,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-13,Moderna,Vedolizumab,Golimumab ,none,none,Methotrexate,2021-07-12,Moderna,Vedolizumab,Golimumab ,none,none,Methotrexate,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,24,25,0,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,1,Combination Therapy,0,0,0,0,0,0,0,,28,,60,0,,,2,0,1,Post-1st Dose,1,1,,0,0,0,,,4,,,847,1,18-29
948,,Male,CD,Ustekinumab,none,none,none,0.02,Negative,30850,Positive,,Adult,,,Post-2nd,21-Jun-21,baseline,,7,,,19-Apr-21,14-Jun-21,02-Jan-22,56,202,10.336905,,,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-19,Pfizer,Ustekinumab,.,none,none,none,2021-06-14,Pfizer,Ustekinumab,.,none,none,none,2022-01-02,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,1,,1,,,,1,,,,0,Male,21,22,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,7,56,0,,,10,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,1,,421,1,18-29
962,,Female,CD,Inflectra,none,none,none,0.07,Negative,99,Positive,,Adult,,,Post-1st,07-May-21,baseline,33,,,,04-Apr-21,29-May-21,27-Sep-21,55,121,4.593097605,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-04,Pfizer,Inflectra,.,none,none,none,2021-05-29,Pfizer,Inflectra,.,none,none,none,2021-09-27,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,24,24,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,33,,55,0,,,5,0,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,867,1,18-29
963,,Female,CD,Inflectra,none,none,none,0.08,Negative,1010,Positive,,Adult,,,Post-2nd,22-Jun-21,baseline,,24,,,04-Apr-21,29-May-21,27-Sep-21,55,121,6.918002595,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-04,Pfizer,Inflectra,.,none,none,none,2021-05-29,Pfizer,Inflectra,.,none,none,none,2021-09-27,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,24,24,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,24,55,0,,,7,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,868,1,18-29
6,,Male,UC,Ustekinumab,none,Oral 5ASA,none,0.37,Negative,40000,Positive,,Adult,,,Post-3rd,26-Oct-21,baseline,,,25,,05-Apr-21,22-May-21,01-Oct-21,47,132,10.59663473,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-05,Pfizer,Ustekinumab,.,none,Oral 5ASA,none,2021-05-22,Pfizer,Ustekinumab,.,none,Oral 5ASA,none,2021-10-01,Pfizer,Ustekinumab,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,39,39,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,,,47,0,,,11,0,0,Post-3rd Dose,1,1,25,0,0,0,,3,,,4,248,2,30-39
7,,Male,UC,Ustekinumab,none,Oral 5ASA,none,0.66,Negative,5131,Positive,,Adult,,,Post-2nd,30-Sep-21,baseline,,131,,,05-Apr-21,22-May-21,01-Oct-21,47,132,8.54297789,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-05,Pfizer,Ustekinumab,.,none,Oral 5ASA,none,2021-05-22,Pfizer,Ustekinumab,.,none,Oral 5ASA,none,2021-10-01,Pfizer,Ustekinumab,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,39,39,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,,131,47,0,,,9,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,19,,249,2,30-39
8,,Male,UC,Ustekinumab,none,Oral 5ASA,none,0.02,Negative,2021,Positive,,Adult,,,Post-1st,30-Apr-21,baseline,25,,,,05-Apr-21,22-May-21,01-Oct-21,47,132,7.611149776,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-05,Pfizer,Ustekinumab,.,none,Oral 5ASA,none,2021-05-22,Pfizer,Ustekinumab,.,none,Oral 5ASA,none,2021-10-01,Pfizer,Ustekinumab,.,none,Oral 5ASA,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,39,39,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,25,,47,0,,,8,0,0,Post-1st Dose,1,1,,0,0,0,,3,4,,,250,2,30-39
9,,Male,UC,Ustekinumab,none,Oral 5ASA,none,,,16932,Positive,,Adult,,,Post-2nd,05-Jul-21,baseline,,44,,,05-Apr-21,22-May-21,01-Oct-21,47,132,9.736960602,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-05,Pfizer,Ustekinumab,.,none,Oral 5ASA,none,2021-05-22,Pfizer,Ustekinumab,.,none,Oral 5ASA,none,2021-10-01,Pfizer,Ustekinumab,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,39,39,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,,44,47,0,,,10,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,6,,251,2,30-39
26,,Male,CD,Adalimumab,none,none,none,0.51,Negative,1163,Positive,,Adult,,,Post-2nd,24-Apr-21,baseline,,61,,,14-Jan-21,22-Feb-21,08-Oct-21,39,228,7.058758153,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-01-14,Pfizer,Adalimumab,.,none,none,none,2021-02-22,Pfizer,Adalimumab,.,none,none,none,2021-10-08,Moderna,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,30,31,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,61,39,1,,,7,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,9,,177,2,30-39
33,,Male,UC,none,none,none,none,0.06,Negative,2568,Positive,,Adult,,,Post-2nd,18-Oct-21,baseline,,137,,,05-Apr-21,03-Jun-21,23-Dec-21,59,203,7.850687942,N/A,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-04-05,Pfizer,none,.,none,none,none,2021-06-03,Pfizer,none,.,none,none,none,2021-12-23,Pfizer,none,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,38,38,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,,137,59,0,,,8,0,0,Post-2nd Dose (8+ Weeks),1,1,,1,1,1,,3,,20,,645,2,30-39
34,,Male,UC,none,none,none,none,0.02,Negative,1004,Positive,,Adult,,,Post-1st,05-May-21,baseline,30,,,,05-Apr-21,03-Jun-21,23-Dec-21,59,203,6.91204606,N/A,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-04-05,Pfizer,none,.,none,none,none,2021-06-03,Pfizer,none,.,none,none,none,2021-12-23,Pfizer,none,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,38,38,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,30,,59,0,,,7,0,0,Post-1st Dose,1,1,,1,1,1,,3,4,,,646,2,30-39
35,,Male,UC,none,none,none,none,0.03,Negative,11254,Positive,,Adult,,,Post-2nd,14-Jun-21,baseline,,11,,,05-Apr-21,03-Jun-21,23-Dec-21,59,203,9.328496671,N/A,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-04-05,Pfizer,none,.,none,none,none,2021-06-03,Pfizer,none,.,none,none,none,2021-12-23,Pfizer,none,.,none,none,none,,.,.,.,.,.,.,,1,,1,,,,1,,,,0,Male,38,38,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,,11,59,0,,,9,0,0,Post-2nd Dose (1-8 Weeks),1,1,,1,1,1,,3,,2,,647,2,30-39
41,,Female,IBD-U,none,none,Oral 5ASA,none,,,5380,Positive,,Adult,,,Post-2nd,30-Jul-21,baseline,,55,,,17-Apr-21,05-Jun-21,,49,,8.590350712,N/A,N/A,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-17,Pfizer,none,.,none,Oral 5ASA,none,2021-06-05,Pfizer,none,.,none,Oral 5ASA,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,35,35,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,0,0,,,55,49,0,,,9,0,0,Post-2nd Dose (1-8 Weeks),1,1,,1,0,1,,,,8,,391,2,30-39
42,,Female,IBD-U,none,none,Oral 5ASA,none,0.03,Negative,330,Positive,,Adult,,,Post-1st,21-May-21,baseline,34,,,,17-Apr-21,05-Jun-21,,49,,5.800001332,N/A,N/A,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-17,Pfizer,none,.,none,Oral 5ASA,none,2021-06-05,Pfizer,none,.,none,Oral 5ASA,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,35,35,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,0,0,,34,,49,0,,,6,0,0,Post-1st Dose,1,1,,1,0,1,,,5,,,392,2,30-39
43,,Female,UC,none,none,Both oral/Rectal,none,0.02,Negative,458,Positive,,Adult,,,Post-1st,17-May-21,baseline,31,,,,16-Apr-21,13-Jun-21,28-Dec-21,58,198,6.12730577,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-04-16,Pfizer,none,.,none,Both oral/Rectal,none,2021-06-13,Pfizer,none,.,none,Both oral/Rectal,none,2021-12-28,Pfizer,none,.,none,Both oral/Rectal,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,38,38,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,31,,58,0,,,6,0,0,Post-1st Dose,1,1,,1,1,1,,3,4,,,616,2,30-39
44,,Female,UC,none,none,Both oral/Rectal,none,0.03,Negative,1224,Positive,,Adult,,,Post-2nd,18-Nov-21,baseline,,158,,,16-Apr-21,13-Jun-21,28-Dec-21,58,198,7.109470883,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-04-16,Pfizer,none,.,none,Both oral/Rectal,none,2021-06-13,Pfizer,none,.,none,Both oral/Rectal,none,2021-12-28,Pfizer,none,.,none,Both oral/Rectal,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,38,39,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,158,58,0,,,7,0,0,Post-2nd Dose (8+ Weeks),1,1,,1,1,1,,3,,23,,617,2,30-39
45,,Female,UC,none,none,Both oral/Rectal,none,,,17788,Positive,,Adult,,,Post-2nd,30-Jun-21,baseline,,17,,,16-Apr-21,13-Jun-21,28-Dec-21,58,198,9.786268108,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-04-16,Pfizer,none,.,none,Both oral/Rectal,none,2021-06-13,Pfizer,none,.,none,Both oral/Rectal,none,2021-12-28,Pfizer,none,.,none,Both oral/Rectal,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,38,39,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,17,58,0,,,10,0,0,Post-2nd Dose (1-8 Weeks),1,1,,1,1,1,,3,,2,,618,2,30-39
46,,Male,UC,Vedolizumab,none,none,none,0.16,Negative,9806,Positive,,Adult,,,Post-2nd,26-Nov-21,baseline,,163,,,21-Apr-21,16-Jun-21,,56,,9.190749722,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-21,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,2021-06-16,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,,,,,,,,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,29,30,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,0,0,0,0,0,0,,,163,56,0,,,9,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,23,,881,2,30-39
47,,Male,UC,Vedolizumab,none,none,none,,,31026,Positive,,Adult,,,Post-2nd,09-Jul-21,baseline,,23,,,21-Apr-21,16-Jun-21,,56,,10.34256795,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-21,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,2021-06-16,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,29,30,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,0,0,0,0,0,0,,,23,56,0,,,10,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,3,,882,2,30-39
48,,Male,UC,Vedolizumab,none,none,none,0.01,Negative,1553,Positive,,Adult,,,Post-1st,19-May-21,baseline,28,,,,21-Apr-21,16-Jun-21,,56,,7.348008213,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-21,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,2021-06-16,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,29,30,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,0,0,0,0,0,0,,28,,56,0,,,7,0,0,Post-1st Dose,1,1,,0,0,0,,,4,,,883,2,30-39
51,,Male,CD,Adalimumab,none,none,Methotrexate,0.09,Negative,19640,Positive,,Adult,,,Post-3rd,14-Oct-21,baseline,,,13,,03-Apr-21,25-Jun-21,01-Oct-21,83,98,9.88531849,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,Adalimumab,.,none,none,Methotrexate,2021-06-25,Pfizer,Adalimumab,.,none,none,Methotrexate,2021-10-01,Pfizer,Adalimumab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,29,30,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,,83,0,,,10,0,1,Post-3rd Dose,1,1,13,0,0,0,,3,,,2,185,2,30-39
52,,Male,CD,Adalimumab,none,none,Methotrexate,0.02,Negative,31,Negative,,Adult,,,Post-1st,06-May-21,baseline,33,,,,03-Apr-21,25-Jun-21,01-Oct-21,83,98,3.424262655,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,Adalimumab,.,none,none,Methotrexate,2021-06-25,Pfizer,Adalimumab,.,none,none,Methotrexate,2021-10-01,Pfizer,Adalimumab,.,none,none,Methotrexate,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,29,30,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,33,,83,0,,,3,0,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,186,2,30-39
62,,Female,UC,Adalimumab,none,none,none,0.02,Negative,394,Positive,,Adult,,,Post-1st,10-May-21,baseline,37,,,,03-Apr-21,07-May-21,03-Sep-21,34,119,5.975843166,N/A,N/A,Proctitis,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,Adalimumab,.,none,none,none,2021-05-07,Pfizer,Adalimumab,.,none,none,none,2021-09-03,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,30,30,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,37,,34,1,,,6,0,0,Post-1st Dose,1,1,,0,0,0,,3,5,,,107,2,30-39
68,,Female,UC,Remicade,none,none,none,0.03,Negative,21080,Positive,,Adult,,,Post-3rd,29-Sep-21,baseline,,,12,,08-Apr-21,11-Jun-21,17-Sep-21,64,98,9.956098978,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-08,Pfizer,Remicade,.,none,none,none,2021-06-11,Pfizer,Remicade,.,none,none,none,2021-09-17,Pfizer,Remicade,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,35,36,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,64,0,,,10,0,0,Post-3rd Dose,1,1,12,0,0,0,,3,,,2,845,2,30-39
69,,Female,UC,Remicade,none,none,none,,,5757,Positive,,Adult,,,Post-2nd,07-Jul-21,baseline,,26,,,08-Apr-21,11-Jun-21,17-Sep-21,64,98,8.658189155,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-08,Pfizer,Remicade,.,none,none,none,2021-06-11,Pfizer,Remicade,.,none,none,none,2021-09-17,Pfizer,Remicade,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,35,36,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,26,64,0,,,9,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,846,2,30-39
73,,Male,CD,Inflectra,none,none,none,0.38,Negative,19063,Positive,,Adult,,,Post-3rd,22-Oct-21,baseline,,,13,,11-Apr-21,24-May-21,09-Oct-21,43,138,9.855499317,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-11,Pfizer,Inflectra,.,none,none,none,2021-05-24,Pfizer,Inflectra,.,none,none,none,2021-10-09,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,33,34,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,43,0,,,10,0,1,Post-3rd Dose,1,1,13,0,0,0,,3,,,2,591,2,30-39
74,,Male,CD,Inflectra,none,none,none,0.47,Negative,3761,Positive,,Adult,,,Post-2nd,27-Aug-21,baseline,,95,,,11-Apr-21,24-May-21,09-Oct-21,43,138,8.232307206,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-11,Pfizer,Inflectra,.,none,none,none,2021-05-24,Pfizer,Inflectra,.,none,none,none,2021-10-09,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,33,34,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,95,43,0,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,14,,592,2,30-39
75,,Male,CD,Inflectra,none,none,none,,,1044,Positive,,Adult,,,Post-1st,07-May-21,baseline,26,,,,11-Apr-21,24-May-21,09-Oct-21,43,138,6.950814768,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-11,Pfizer,Inflectra,.,none,none,none,2021-05-24,Pfizer,Inflectra,.,none,none,none,2021-10-09,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,33,33,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,26,,43,0,,,7,0,1,Post-1st Dose,1,1,,0,0,0,,3,4,,,593,2,30-39
88,,Female,UC,Vedolizumab,Oral budesonide/Cortiment/Entocort,none,Azathioprine/Immuran,0.02,Negative,6967,Positive,,Adult,-50,,Post-3rd,10-Nov-21,baseline,,,28,,09-Apr-21,02-Jun-21,13-Oct-21,54,133,8.848911288,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-04-09,Pfizer,Vedolizumab,.,Oral budesonide/Cortiment/Entocort,none,Azathioprine/Immuran,2021-06-02,Pfizer,Vedolizumab,.,Oral budesonide/Cortiment/Entocort,none,Azathioprine/Immuran,2021-10-13,Pfizer,Vedolizumab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,,,,,1,,2021-12-30,0,Female,37,37,0,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,1,Combination Therapy,,,54,0,,,9,0,0,Post-3rd Dose,1,1,28,0,0,0,2021-12-30,3,,,4,334,2,30-39
89,,Female,UC,Vedolizumab,Oral budesonide/Cortiment/Entocort,none,Azathioprine/Immuran,0.01,Negative,2520,Positive,,Adult,-162,,Post-2nd,21-Jul-21,baseline,,49,,,09-Apr-21,02-Jun-21,13-Oct-21,54,133,7.832133221,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-04-09,Pfizer,Vedolizumab,.,Oral budesonide/Cortiment/Entocort,none,Azathioprine/Immuran,2021-06-02,Pfizer,Vedolizumab,.,Oral budesonide/Cortiment/Entocort,none,Azathioprine/Immuran,2021-10-13,Pfizer,Vedolizumab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,1,1,,,,1,,,2021-12-30,0,Female,37,37,0,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,1,Combination Therapy,,49,54,0,,,8,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2021-12-30,3,,7,,335,2,30-39
90,,Female,UC,Vedolizumab,Oral budesonide/Cortiment/Entocort,none,Azathioprine/Immuran,0.02,Negative,1296,Positive,,Adult,-237,,Post-1st,07-May-21,baseline,28,,,,09-Apr-21,02-Jun-21,13-Oct-21,54,133,7.166652,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-04-09,Pfizer,Vedolizumab,.,Oral budesonide/Cortiment/Entocort,none,Azathioprine/Immuran,2021-06-02,Pfizer,Vedolizumab,.,Oral budesonide/Cortiment/Entocort,none,Azathioprine/Immuran,2021-10-13,Pfizer,Vedolizumab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,1,,,,,,,,,,2021-12-30,0,Female,37,37,0,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,1,Combination Therapy,28,,54,0,,,7,0,0,Post-1st Dose,1,1,,0,0,0,2021-12-30,3,4,,,336,2,30-39
116,,Female,CD,Vedolizumab,none,none,Azathioprine/Immuran,0.05,Negative,592,Positive,,Adult,,,Post-1st,07-Jun-21,baseline,34,,,,04-May-21,20-Jun-21,30-Sep-21,47,102,6.384013263,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-04,Moderna,Vedolizumab,.,none,none,Azathioprine/Immuran,2021-06-20,Moderna,Vedolizumab,.,none,none,Azathioprine/Immuran,2021-09-30,Moderna,Vedolizumab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,39,39,0,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,1,Combination Therapy,34,,47,0,,,6,0,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,696,2,30-39
117,,Male,CD,Infliximab,none,none,none,0.04,Negative,1761,Positive,,Adult,,,Post-3rd,23-Dec-21,baseline,,,108,,09-Apr-21,12-Jun-21,06-Sep-21,64,86,7.473580321,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-09,Pfizer,Infliximab,.,none,none,none,2021-06-12,Pfizer,Infliximab,.,none,none,none,2021-09-06,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,29,30,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,64,0,,,7,0,1,Post-3rd Dose,1,1,108,0,0,0,,3,,,15,766,2,30-39
122,,Female,UC,Vedolizumab,none,none,none,0.02,Negative,432,Positive,,Adult,,,Post-1st,25-May-21,baseline,41,,,,14-Apr-21,20-Jun-21,,67,,6.067267511,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-14,Pfizer,Vedolizumab,.,none,none,none,2021-06-20,Pfizer,Vedolizumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,36,36,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,0,0,0,0,0,0,,41,,67,0,,,6,0,0,Post-1st Dose,1,1,,0,0,0,,,6,,,92,2,30-39
131,,Female,IBD-U,Infliximab,none,none,none,,,3698,Positive,,Adult,,,Post-2nd,07-Jul-21,baseline,,25,,,03-May-21,12-Jun-21,24-Sep-21,40,104,8.215628534,unknown,unknown,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-05-03,Pfizer,Infliximab,.,none,none,none,2021-06-12,Pfizer,Infliximab,.,none,none,none,2021-09-24,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,39,39,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,25,40,1,,,8,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,449,2,30-39
134,,Male,CD,none,none,none,Azathioprine/Immuran,0.04,Negative,9821,Positive,,Adult,,,Post-3rd,05-Nov-21,baseline,,,31,,10-Apr-21,17-Jun-21,05-Oct-21,68,110,9.192268047,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-10,Pfizer,none,none,none,none,Azathioprine/Immuran,2021-06-17,Pfizer,none,none,none,none,Azathioprine/Immuran,2021-10-05,Pfizer,Adalimumab,none,none,Oral 5ASA,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,34,34,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,1,0,0,0,0,1,1,Combination Therapy,,,68,0,,,9,0,1,Post-3rd Dose,1,1,31,0,0,0,,3,,,4,283,2,30-39
135,,Male,CD,none,none,none,Azathioprine/Immuran,,,6583,Positive,,Adult,,,Post-2nd,09-Jul-21,baseline,,22,,,10-Apr-21,17-Jun-21,05-Oct-21,68,110,8.792261038,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-10,Pfizer,none,none,none,none,Azathioprine/Immuran,2021-06-17,Pfizer,none,none,none,none,Azathioprine/Immuran,2021-10-05,Pfizer,Adalimumab,none,none,Oral 5ASA,Azathioprine/Immuran,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,34,34,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,1,0,0,0,0,1,1,Combination Therapy,,22,68,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,284,2,30-39
150,,Female,CD,Remicade,none,none,none,0.01,Negative,198,Positive,,Adult,,,Post-2nd,06-Dec-21,baseline,,157,,,26-Apr-21,02-Jul-21,,67,,5.289276622,colonic,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-26,Pfizer,Remicade,.,none,none,none,2021-07-02,Moderna,Remicade,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,38,39,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,157,67,0,,,5,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,22,,432,2,30-39
151,,Female,CD,Remicade,none,none,none,,,6055,Positive,,Adult,,,Post-2nd,28-Jul-21,baseline,,26,,,26-Apr-21,02-Jul-21,,67,,8.708656171,colonic,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-26,Pfizer,Remicade,.,none,none,none,2021-07-02,Moderna,Remicade,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,38,39,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,26,67,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,4,,433,2,30-39
152,,Female,CD,Remicade,none,none,none,0.02,Negative,41,Negative,,Adult,,,Post-1st,10-Jun-21,baseline,45,,,,26-Apr-21,02-Jul-21,,67,,3.7208625,colonic,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-26,Pfizer,Remicade,.,none,none,none,2021-07-02,Moderna,Remicade,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,38,39,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,45,,67,0,,,4,0,1,Post-1st Dose,1,1,,0,0,0,,,6,,,434,2,30-39
166,,Female,CD,none,none,Rectal 5ASA,Azathioprine/Immuran,0.02,Negative,167,Positive,,Adult,,,Post-1st,10-Jun-21,baseline,33,,,,08-May-21,11-Jun-21,23-Nov-21,34,165,5.117993812,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-08,Pfizer,none,.,none,Rectal 5ASA,Azathioprine/Immuran,2021-06-11,Pfizer,none,.,none,Rectal 5ASA,Azathioprine/Immuran,2021-11-23,Pfizer,Ustekinumab,.,none,Rectal 5ASA,Azathioprine/Immuran,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,36,36,0,0,0,0,0,1,1,Immunomodulator Only,0,0,0,0,0,1,1,Immunomodulator Only,0,0,0,0,0,1,1,Immunomodulator Only,0,0,1,0,0,1,1,Combination Therapy,33,,34,1,,,5,0,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,808,2,30-39
167,,Female,CD,none,none,Rectal 5ASA,Azathioprine/Immuran,,,1993,Positive,,Adult,,,Post-2nd,09-Jul-21,baseline,,28,,,08-May-21,11-Jun-21,23-Nov-21,34,165,7.597295964,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-08,Pfizer,none,.,none,Rectal 5ASA,Azathioprine/Immuran,2021-06-11,Pfizer,none,.,none,Rectal 5ASA,Azathioprine/Immuran,2021-11-23,Pfizer,Ustekinumab,.,none,Rectal 5ASA,Azathioprine/Immuran,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,36,36,0,0,0,0,0,1,1,Immunomodulator Only,0,0,0,0,0,1,1,Immunomodulator Only,0,0,0,0,0,1,1,Immunomodulator Only,0,0,1,0,0,1,1,Combination Therapy,,28,34,1,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,809,2,30-39
177,,Female,CD,Ustekinumab,none,none,Azathioprine/Immuran,0.04,Negative,2323,Positive,,Adult,,,Post-1st,09-Jun-21,baseline,43,,,,27-Apr-21,16-Jun-21,23-Oct-21,50,129,7.750786909,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-27,Pfizer,Ustekinumab,.,none,none,Azathioprine/Immuran,2021-06-16,Pfizer,Ustekinumab,.,none,none,Azathioprine/Immuran,2021-10-23,Pfizer,Ustekinumab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,39,39,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,43,,50,0,,,8,0,1,Post-1st Dose,1,1,,0,0,0,,3,6,,,158,2,30-39
180,,Male,UC,none,none,Both oral/Rectal,none,0.03,Negative,970,Positive,,Adult,,,Post-1st,31-May-21,baseline,36,,,,25-Apr-21,14-Jun-21,,50,,6.877502236,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-04-25,Moderna,none,.,none,Both oral/Rectal,none,2021-06-14,Moderna,none,.,none,Both oral/Rectal,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,35,35,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,0,0,,36,,50,0,,,7,0,0,Post-1st Dose,1,1,,1,0,1,,,5,,,422,2,30-39
181,,Male,UC,none,none,Both oral/Rectal,none,0.03,Negative,2345,Positive,,Adult,,,Post-2nd,23-Dec-21,baseline,,192,,,25-Apr-21,14-Jun-21,,50,,7.759827439,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-04-25,Moderna,none,.,none,Both oral/Rectal,none,2021-06-14,Moderna,none,.,none,Both oral/Rectal,none,,,,,,,,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,35,36,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,0,0,,,192,50,0,,,8,0,0,Post-2nd Dose (8+ Weeks),1,1,,1,0,1,,,,27,,423,2,30-39
182,,Male,UC,none,none,Both oral/Rectal,none,0.03,Negative,10164,Positive,,Adult,,,Post-2nd,22-Jul-21,baseline,,38,,,25-Apr-21,14-Jun-21,,50,,9.226646698,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-04-25,Moderna,none,.,none,Both oral/Rectal,none,2021-06-14,Moderna,none,.,none,Both oral/Rectal,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,35,36,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,0,0,,,38,50,0,,,9,0,0,Post-2nd Dose (1-8 Weeks),1,1,,1,0,1,,,,5,,424,2,30-39
188,,Female,UC,Adalimumab,none,none,none,0.04,Negative,558,Positive,,Adult,-130,,Post-2nd,25-Aug-21,baseline,,123,,,20-Mar-21,24-Apr-21,,35,,6.324896452,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,Omicron,,,,,2021-03-20,Pfizer,Adalimumab,.,none,none,none,2021-04-24,Pfizer,Adalimumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,1,,1,1,,,2022-01-02,0,Female,30,30,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,123,35,1,,,6,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,2022-01-02,2,,18,,984,2,30-39
189,,Female,UC,Adalimumab,none,none,none,0.03,Negative,4070,Positive,,Adult,-202,,Post-2nd,14-Jun-21,baseline,,51,,,20-Mar-21,24-Apr-21,,35,,8.311275421,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,Omicron,,,,,2021-03-20,Pfizer,Adalimumab,.,none,none,none,2021-04-24,Pfizer,Adalimumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,2022-01-02,0,Female,30,30,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,51,35,1,,,8,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2022-01-02,2,,7,,985,2,30-39
190,,Male,UC,none,none,Both oral/Rectal,none,0.02,Negative,126,Positive,,Adult,,,Post-1st,02-Jun-21,baseline,41,,,,22-Apr-21,02-Jul-21,03-Jan-22,71,185,4.836281907,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,none,.,none,Both oral/Rectal,none,2021-07-02,Pfizer,none,.,none,Both oral/Rectal,none,2022-01-03,Moderna,none,.,none,Both oral/Rectal,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,34,34,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,41,,71,0,,,5,0,0,Post-1st Dose,1,1,,1,1,1,,3,6,,,894,2,30-39
191,,Male,UC,none,none,Both oral/Rectal,none,,,2689,Positive,,Adult,,,Post-2nd,28-Jul-21,baseline,,26,,,22-Apr-21,02-Jul-21,03-Jan-22,71,185,7.896813084,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,none,.,none,Both oral/Rectal,none,2021-07-02,Pfizer,none,.,none,Both oral/Rectal,none,2022-01-03,Moderna,none,.,none,Both oral/Rectal,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,34,34,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,26,71,0,,,8,0,0,Post-2nd Dose (1-8 Weeks),1,1,,1,1,1,,3,,4,,895,2,30-39
208,,Male,UC,Inflectra,none,none,none,0.11,Negative,734,Positive,,Adult,,,Post-2nd,22-Dec-21,baseline,,196,,,14-Apr-21,09-Jun-21,28-Dec-21,56,202,6.598100226,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-14,Moderna,Inflectra,.,none,none,none,2021-06-09,Moderna,Inflectra,.,none,none,none,2021-12-28,Moderna,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,33,34,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,196,56,0,,,7,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,28,,279,2,30-39
209,,Male,UC,Inflectra,none,none,none,,,3901,Positive,,Adult,,,Post-2nd,09-Jul-21,baseline,,30,,,14-Apr-21,09-Jun-21,28-Dec-21,56,202,8.26906511,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-14,Moderna,Inflectra,.,none,none,none,2021-06-09,Moderna,Inflectra,.,none,none,none,2021-12-28,Moderna,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,33,33,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,30,56,0,,,8,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,280,2,30-39
210,,Male,CD,Remicade,Oral budesonide/Cortiment/Entocort,none,none,0.04,Negative,345,Positive,,Adult,,,Post-1st,08-Jun-21,baseline,19,,,,20-May-21,10-Jun-21,,21,,5.842674474,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-20,Moderna,Remicade,.,none,none,none,2021-06-10,Moderna,Remicade,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,38,38,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,19,,21,1,,,6,0,1,Post-1st Dose,1,1,,0,0,0,,,3,,,670,2,30-39
211,,Male,CD,Remicade,Oral budesonide/Cortiment/Entocort,none,none,0.04,Negative,4403,Positive,,Adult,,,Post-2nd,28-Jun-21,baseline,,18,,,20-May-21,10-Jun-21,,21,,8.390086828,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-20,Moderna,Remicade,.,none,none,none,2021-06-10,Moderna,Remicade,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,38,38,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,18,21,1,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,3,,671,2,30-39
216,,Male,CD,Vedolizumab,none,none,none,0.02,Negative,2648,Positive,,Adult,,,Post-2nd,28-Jun-21,baseline,,37,,,11-Apr-21,22-May-21,17-Sep-21,41,118,7.881446618,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-11,Pfizer,Vedolizumab,.,none,none,none,2021-05-22,Pfizer,Vedolizumab,.,none,none,none,2021-09-17,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,39,39,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,37,41,1,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,5,,474,2,30-39
292,,Male,UC,Tofacitinib,none,Rectal 5ASA,none,0.05,Negative,4686,Positive,,Adult,,,Post-2nd,25-Jun-21,baseline,,22,,,20-Apr-21,03-Jun-21,20-Oct-21,44,139,8.452270597,N/A,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-04-20,Moderna,Tofacitinib,.,none,Rectal 5ASA,none,2021-06-03,Moderna,Tofacitinib,.,none,Rectal 5ASA,none,2021-10-20,Moderna,Tofacitinib,.,none,Rectal 5ASA,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,36,36,0,0,0,1,0,1,0,Tofacitinib Only,0,0,0,1,0,1,0,Tofacitinib Only,0,0,0,1,0,1,0,Tofacitinib Only,0,0,0,1,0,1,0,Tofacitinib Only,,22,44,0,,,8,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,970,2,30-39
307,,Female,CD,Inflectra,none,none,Azathioprine/Immuran,0.06,Negative,6295,Positive,,Adult,,,Post-3rd,12-Nov-21,baseline,,,24,,12-May-21,24-Jul-21,19-Oct-21,73,87,8.747447402,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-12,Pfizer,Inflectra,.,none,none,Azathioprine/Immuran,2021-07-24,Pfizer,Inflectra,.,Oral Prednisone,none,Azathioprine/Immuran,2021-10-19,Pfizer,Inflectra,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,30,30,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,1,0,1,Corticoteroids,1,0,0,0,0,0,1,Combination Therapy,,,73,0,,,9,0,1,Post-3rd Dose,1,1,24,0,0,0,,3,,,3,143,2,30-39
308,,Female,CD,Inflectra,none,none,Azathioprine/Immuran,0.02,Negative,4450,Positive,,Adult,,,Post-2nd,28-Sep-21,baseline,,66,,,12-May-21,24-Jul-21,19-Oct-21,73,87,8.400704318,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-12,Pfizer,Inflectra,.,none,none,Azathioprine/Immuran,2021-07-24,Pfizer,Inflectra,.,Oral Prednisone,none,Azathioprine/Immuran,2021-10-19,Pfizer,Inflectra,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,30,30,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,1,0,1,Corticoteroids,1,0,0,0,0,0,1,Combination Therapy,,66,73,0,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,9,,144,2,30-39
321,,Female,CD,Vedolizumab,none,none,none,0.02,Negative,11649,Positive,,Adult,,,Post-2nd,19-Jul-21,baseline,,30,,,23-Apr-21,19-Jun-21,,57,,9.362975618,colonic,Inflamatory,N/A,none,Outpatient,Baseline Serology,,,,,,,2021-04-23,Pfizer,Vedolizumab,.,none,none,none,2021-06-19,Pfizer,Vedolizumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,31,31,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,0,0,0,0,0,0,,,30,57,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,4,,444,2,30-39
325,,Female,CD,Vedolizumab,none,none,none,0.02,Negative,597,Positive,,Adult,,,Post-1st,07-Jun-21,baseline,55,,,,13-Apr-21,20-Jun-21,03-Dec-21,68,166,6.391749595,ileal,Inflamatory,N/A,none,Outpatient,Baseline Serology,,,,,,,2021-04-13,Moderna,Vedolizumab,.,none,none,none,2021-06-20,Moderna,Vedolizumab,.,none,none,none,2021-12-03,Moderna,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,38,38,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,55,,68,0,,,6,0,1,Post-1st Dose,1,1,,0,0,0,,3,8,,,232,2,30-39
326,,Female,CD,Vedolizumab,none,none,none,0.02,Negative,4646,Positive,,Adult,,,Post-2nd,01-Dec-21,baseline,,164,,,13-Apr-21,20-Jun-21,03-Dec-21,68,166,8.443848005,ileal,Inflamatory,N/A,none,Outpatient,Baseline Serology,,,,,,,2021-04-13,Moderna,Vedolizumab,.,none,none,none,2021-06-20,Moderna,Vedolizumab,.,none,none,none,2021-12-03,Moderna,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,38,39,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,164,68,0,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,23,,233,2,30-39
329,,Female,CD,Vedolizumab,none,none,none,0.03,Negative,4274,Positive,,Adult,,,Post-2nd,26-May-21,baseline,,51,,,23-Feb-21,05-Apr-21,07-Dec-21,41,246,8.360375625,ileal,Inflamatory,N/A,none,Outpatient,Baseline Serology,,,,,,,2021-02-23,Pfizer,Vedolizumab,.,none,none,none,2021-04-05,Pfizer,Vedolizumab,.,none,none,none,2021-12-07,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,36,37,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,51,41,1,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,7,,209,2,30-39
330,,Female,CD,Vedolizumab,none,none,none,0.03,Negative,621,Positive,,Adult,,,Post-1st,30-Mar-21,baseline,35,,,,23-Feb-21,05-Apr-21,07-Dec-21,41,246,6.431814057,ileal,Inflamatory,N/A,none,Outpatient,Baseline Serology,,,,,,,2021-02-23,Pfizer,Vedolizumab,.,none,none,none,2021-04-05,Pfizer,Vedolizumab,.,none,none,none,2021-12-07,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,36,37,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,35,,41,1,,,6,0,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,210,2,30-39
331,,Female,CD,Vedolizumab,none,none,none,0.05,Negative,747,Positive,,Adult,,,Post-2nd,15-Sep-21,baseline,,163,,,23-Feb-21,05-Apr-21,07-Dec-21,41,246,6.616065185,ileal,Inflamatory,N/A,none,Outpatient,Baseline Serology,,,,,,,2021-02-23,Pfizer,Vedolizumab,.,none,none,none,2021-04-05,Pfizer,Vedolizumab,.,none,none,none,2021-12-07,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,36,37,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,163,41,1,,,7,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,23,,211,2,30-39
335,,Female,CD,Vedolizumab,none,none,none,0.1,Negative,691,Positive,,Adult,,,Post-2nd,29-Nov-21,baseline,,244,,,20-Feb-21,30-Mar-21,09-Dec-21,38,254,6.538284531,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-02-20,Pfizer,none,.,none,none,none,2021-03-30,Pfizer,none,.,none,none,none,2021-12-09,Pfizer,none,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,34,34,0,1,0,0,0,0,0,Vedolizumab Only,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,,244,38,1,,,7,0,1,Post-2nd Dose (8+ Weeks),1,1,,1,1,1,,3,,35,,450,2,30-39
342,,Male,IBD-U,Inflectra,none,none,none,,,5508,Positive,,Adult,-55,,Post-2nd,30-Jun-21,Post Vaccine covid,,15,,,08-Apr-21,15-Jun-21,10-Nov-21,68,148,8.613866079,N/A ,N/A,Pancolitis,,Outpatient,Post Vaccine Confirmed COVID,,Delta,,,,,2021-04-08,Pfizer,Inflectra,.,none,none,none,2021-06-15,Pfizer,Inflectra,.,none,none,none,2021-11-10,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,2021-08-24,0,Male,30,30,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,15,68,0,,,9,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2021-08-24,2,,2,,672,2,30-39
343,,Female,CD,Ustekinumab,none,none,none,0.04,Negative,2313,Positive,,Adult,,,Post-2nd,06-Aug-21,baseline,,97,,,07-Apr-21,01-May-21,30-Sep-21,24,152,7.746127712,ileocolonic,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-07,Pfizer,Ustekinumab,.,none,none,none,2021-05-01,Pfizer,Ustekinumab,.,none,none,none,2021-09-30,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,37,38,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,97,24,1,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,14,,492,2,30-39
344,,Female,CD,Ustekinumab,none,none,none,0.04,Negative,9147,Positive,,Adult,,,Post-2nd,12-May-21,baseline,,11,,,07-Apr-21,01-May-21,30-Sep-21,24,152,9.12115937,ileocolonic,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-07,Pfizer,Ustekinumab,.,none,none,none,2021-05-01,Pfizer,Ustekinumab,.,none,none,none,2021-09-30,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,1,,1,,,,1,,,,0,Female,37,37,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,11,24,1,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,2,,493,2,30-39
352,,Female,CD,Remicade,none,none,Methotrexate,0.02,Negative,125,Positive,,Adult,,,Post-1st,20-May-21,baseline,41,,,,09-Apr-21,20-Jun-21,24-Sep-21,72,96,4.829113417,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-09,Pfizer,Remicade,.,none,none,none,2021-06-20,Pfizer,Remicade,.,none,none,none,2021-09-24,Pfizer,Remicade,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,38,38,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,41,,72,0,,,5,0,1,Post-1st Dose,1,1,,0,0,0,,3,6,,,938,2,30-39
356,,Female,CD,Ustekinumab,none,none,Methotrexate,0.02,Negative,12399,Positive,,Adult,,,Post-3rd,23-Nov-21,baseline,,,45,,08-Apr-21,05-Jun-21,09-Oct-21,58,126,9.425403363,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-08,Moderna,Ustekinumab,.,none,none,Methotrexate,2021-06-05,Moderna,Ustekinumab,.,none,none,Methotrexate,2021-10-09,Pfizer,Ustekinumab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,36,37,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,,,58,0,,,9,0,1,Post-3rd Dose,1,1,45,0,0,0,,3,,,6,968,2,30-39
357,,Female,CD,Ustekinumab,none,none,Methotrexate,0.02,Negative,6831,Positive,,Adult,,,Post-2nd,01-Sep-21,baseline,,88,,,08-Apr-21,05-Jun-21,09-Oct-21,58,126,8.829167796,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-08,Moderna,Ustekinumab,.,none,none,Methotrexate,2021-06-05,Moderna,Ustekinumab,.,none,none,Methotrexate,2021-10-09,Pfizer,Ustekinumab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,36,37,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,,88,58,0,,,9,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,13,,969,2,30-39
361,,Male,CD,Adalimumab,none,none,none,0.1,Negative,4548,Positive,,Adult,,,Post-3rd,03-Dec-21,baseline,,,70,,08-May-21,04-Jul-21,24-Sep-21,57,82,8.422486829,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-08,Pfizer,Adalimumab,.,none,none,none,2021-07-04,Pfizer,Adalimumab,.,none,none,none,2021-09-24,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,34,35,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,57,0,,,8,0,1,Post-3rd Dose,1,1,70,0,0,0,,3,,,10,497,2,30-39
364,,Female,CD,Vedolizumab,Oral budesonide/Cortiment/Entocort,none,none,0.24,Negative,13806,Positive,,Adult,,,Post-3rd,09-Dec-21,baseline,,,72,,29-Apr-21,15-Jun-21,28-Sep-21,47,105,9.532836829,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-29,Pfizer,Ustekinumab,.,none,none,none,2021-06-15,Pfizer,Ustekinumab,.,none,none,none,2021-09-28,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,38,38,0,1,0,0,0,0,0,Vedolizumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,47,0,,,10,0,1,Post-3rd Dose,1,1,72,0,0,0,,3,,,10,408,2,30-39
365,,Female,CD,Vedolizumab,Oral budesonide/Cortiment/Entocort,none,none,0.05,Negative,22215,Positive,,Adult,,,Post-2nd,10-Aug-21,baseline,,56,,,29-Apr-21,15-Jun-21,28-Sep-21,47,105,10.00852752,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-29,Pfizer,Ustekinumab,.,none,none,none,2021-06-15,Pfizer,Ustekinumab,.,none,none,none,2021-09-28,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,38,38,0,1,0,0,0,0,0,Vedolizumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,56,47,0,,,10,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,8,,409,2,30-39
373,,Female,CD,Vedolizumab,none,none,none,0.04,Negative,31538,Positive,,Adult,,,Post-2nd,19-Feb-21,baseline,,7,,,03-Jan-21,12-Feb-21,03-Dec-21,40,294,10.35894528,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,2021-12-03,2021-01-03,Pfizer,Vedolizumab,.,none,none,none,2021-02-12,Pfizer,Vedolizumab,.,none,none,none,2021-12-03,Moderna,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,1,,1,,,,1,,,,0,Female,39,39,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,7,40,1,,,10,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2021-12-03,,,1,,274,2,30-39
374,,Female,CD,Vedolizumab,none,none,none,0.02,Negative,1873,Positive,,Adult,,,Post-1st,12-Feb-21,baseline,40,,,,03-Jan-21,12-Feb-21,03-Dec-21,40,294,7.535510241,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,2021-12-03,2021-01-03,Pfizer,Vedolizumab,.,none,none,none,2021-02-12,Pfizer,Vedolizumab,.,none,none,none,2021-12-03,Moderna,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,39,39,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,40,,40,1,,,8,0,1,Post-1st Dose,1,1,,0,0,0,2021-12-03,,6,,,275,2,30-39
376,,Female,CD,Adalimumab,none,none,none,0.28,Negative,12233,Positive,,Adult,273,,Post-2nd,17-Aug-21,covid,,58,,,22-Apr-21,20-Jun-21,,59,,9.411900672,colonic,Inflamatory,N/A,,Outpatient,Confirmed COVID,,,,,,,2021-04-22,Pfizer,Adalimumab,.,none,none,none,2021-06-20,Pfizer,Adalimumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,1,,1,1,,,2020-11-17,1,Female,31,31,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,58,59,0,,,9,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,2020-11-17,,,8,,713,2,30-39
380,,Female,UC,Adalimumab,none,none,none,0.01,Negative,1153,Positive,,Adult,,,Post-2nd,21-Jun-21,baseline,,23,,,10-Apr-21,29-May-21,21-Dec-21,49,206,7.049775539,N/A ,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-04-10,Pfizer,Adalimumab,.,none,none,none,2021-05-29,Pfizer,Adalimumab,.,none,none,none,2021-12-21,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,32,32,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,23,49,0,,,7,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,608,2,30-39
381,,Female,UC,Adalimumab,none,none,none,0.01,Negative,170,Positive,,Adult,,,Post-2nd,09-Sep-21,baseline,,103,,,10-Apr-21,29-May-21,21-Dec-21,49,206,5.137561588,N/A ,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-04-10,Pfizer,Adalimumab,.,none,none,none,2021-05-29,Pfizer,Adalimumab,.,none,none,none,2021-12-21,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,32,32,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,103,49,0,,,5,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,15,,609,2,30-39
382,,Female,UC,Adalimumab,none,none,none,0.02,Negative,164,Positive,,Adult,,,Post-1st,12-May-21,baseline,32,,,,10-Apr-21,29-May-21,21-Dec-21,49,206,5.098035484,N/A ,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-04-10,Pfizer,Adalimumab,.,none,none,none,2021-05-29,Pfizer,Adalimumab,.,none,none,none,2021-12-21,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,32,32,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,32,,49,0,,,5,0,0,Post-1st Dose,1,1,,0,0,0,,3,5,,,610,2,30-39
403,,Male,CD,Adalimumab,none,none,Methotrexate,0.09,Negative,1014,Positive,,Adult,,,Post-2nd,09-Aug-21,baseline,,52,,,09-Apr-21,18-Jun-21,07-Dec-21,70,172,6.921263629,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-09,Pfizer,Adalimumab,.,none,none,Methotrexate,2021-06-18,Pfizer,Adalimumab,.,none,none,Methotrexate,2021-12-07,Pfizer,Adalimumab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,38,39,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,52,70,0,,,7,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,7,,220,2,30-39
416,,Female,UC,none,none,Both oral/Rectal,none,0.06,Negative,20683,Positive,,Adult,293,,Post-2nd,16-Jul-21,covid,,18,,,02-May-21,28-Jun-21,,57,,9.937086725,N/A ,N/A,Proctitis,,Outpatient,Confirmed COVID,,,,,,,2021-05-02,Pfizer,none,.,none,Both oral/Rectal,none,2021-06-28,Pfizer,none,.,none,Both oral/Rectal,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,2020-09-26,1,Female,36,37,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,0,0,,,18,57,0,,,10,0,0,Post-2nd Dose (1-8 Weeks),1,1,,1,0,1,2020-09-26,,,3,,797,2,30-39
417,,Male,CD,Infliximab,none,none,Methotrexate,0.02,Negative,791,Positive,,Adult,226,,Post-2nd,14-Jul-21,covid,,33,,,21-Apr-21,11-Jun-21,08-Sep-21,51,89,6.672665657,ileal,fistulizing and perianal,N/A,,Outpatient,Confirmed COVID,,,,,,,2021-04-21,Pfizer,Infliximab,.,none,none,Methotrexate,2021-06-11,Pfizer,Infliximab,.,none,none,Methotrexate,2021-09-08,Pfizer,Infliximab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,1,1,,,,1,,,2020-11-30,1,Male,35,35,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,33,51,0,,,7,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2020-11-30,,,5,,843,2,30-39
428,,Male,CD,Remicade,none,none,Azathioprine/Immuran,0.03,Negative,85,Positive,,Adult,,,Post-1st,18-Jun-21,baseline,55,,,,24-Apr-21,16-Jun-21,15-Oct-21,53,121,4.441474093,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-24,Moderna,Remicade,.,none,none,Azathioprine/Immuran,2021-06-16,Moderna,Remicade,.,none,none,none,2021-10-15,Moderna,Remicade,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,34,35,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,55,,53,0,,,4,0,1,Post-1st Dose,1,1,,0,0,0,,3,8,,,35,2,30-39
429,,Male,CD,Remicade,none,none,Azathioprine/Immuran,0.04,Negative,1023,Positive,,Adult,,,Post-2nd,08-Oct-21,baseline,,114,,,24-Apr-21,16-Jun-21,15-Oct-21,53,121,6.930103683,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-24,Moderna,Remicade,.,none,none,Azathioprine/Immuran,2021-06-16,Moderna,Remicade,.,none,none,none,2021-10-15,Moderna,Remicade,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,34,35,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,114,53,0,,,7,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,16,,36,2,30-39
436,,Male,UC,Remicade,none,none,none,0.27,Negative,16613,Positive,,Adult,,,Post-3rd,03-Nov-21,baseline,,,36,,10-Apr-21,11-Jun-21,28-Sep-21,62,109,9.717928762,N/A ,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-04-10,Pfizer,Remicade,.,none,none,none,2021-06-11,Pfizer,Remicade,.,none,none,none,2021-09-28,Pfizer,Remicade,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,36,36,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,62,0,,,10,0,0,Post-3rd Dose,1,1,36,0,0,0,,3,,,5,1,2,30-39
437,,Male,UC,Remicade,none,none,none,0.17,Negative,3210,Positive,,Adult,,,Post-2nd,11-Aug-21,baseline,,61,,,10-Apr-21,11-Jun-21,28-Sep-21,62,109,8.073963909,N/A ,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-04-10,Pfizer,Remicade,.,none,none,none,2021-06-11,Pfizer,Remicade,.,none,none,none,2021-09-28,Pfizer,Remicade,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,36,36,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,61,62,0,,,8,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,9,,2,2,30-39
446,,Female,CD,Infliximab,none,none,none,0.69,Negative,953,Positive,,Adult,214,,Post-2nd,12-Jul-21,covid,,135,,,17-Jan-21,27-Feb-21,,41,,6.859929649,ileocolonic,Inflamatory,N/A,none,Outpatient,Confirmed COVID,,,,,,2021-02-16,2021-01-17,Moderna,Infliximab,.,none,none,none,2021-02-27,Moderna,Infliximab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,,1,1,1,,,2020-12-10,1,Female,34,34,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,135,41,1,,,7,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,2020-12-10,,,19,,701,2,30-39
447,,Female,CD,Infliximab,none,none,none,1.83,Positive,10002,Positive,,Adult,68,,Post-1st,16-Feb-21,covid,30,,,,17-Jan-21,27-Feb-21,,41,,9.210560348,ileocolonic,Inflamatory,N/A,none,Outpatient,Confirmed COVID,,,,,,2021-02-16,2021-01-17,Moderna,Infliximab,.,none,none,none,2021-02-27,Moderna,Infliximab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,2020-12-10,1,Female,34,34,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,30,,41,1,,,9,0,1,Post-1st Dose,1,1,,0,0,0,2020-12-10,,4,,,702,2,30-39
489,,Female,CD,Inflectra,none,none,Methotrexate,0.02,Negative,108,Positive,,Adult,,,Post-1st,03-May-21,baseline,25,,,,08-Apr-21,06-May-21,04-Sep-21,28,121,4.680277658,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-08,Pfizer,Inflectra,.,none,none,Methotrexate,2021-05-06,Pfizer,Inflectra,.,none,none,Methotrexate,2021-09-04,Pfizer,Inflectra,.,none,none,Methotrexate,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,33,33,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,25,,28,1,,,5,0,1,Post-1st Dose,1,1,,0,0,0,,3,4,,,227,2,30-39
490,,Female,CD,Inflectra,none,none,Methotrexate,0.02,Negative,1909,Positive,,Adult,,,Post-2nd,01-Jun-21,baseline,,26,,,08-Apr-21,06-May-21,04-Sep-21,28,121,7.554439585,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-08,Pfizer,Inflectra,.,none,none,Methotrexate,2021-05-06,Pfizer,Inflectra,.,none,none,Methotrexate,2021-09-04,Pfizer,Inflectra,.,none,none,Methotrexate,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,33,33,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,26,28,1,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,228,2,30-39
491,,Male,CD,Golimumab,none,none,none,0.05,Negative,5467,Positive,,Adult,,,Post-3rd,02-Nov-21,baseline,,,40,,15-Apr-21,09-May-21,23-Sep-21,24,137,8.606467007,ileocolonic,inflamatory and upperGI ,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-15,Pfizer,Golimumab ,.,none,none,Azathioprine/Immuran,2021-05-09,Pfizer,Golimumab ,.,none,none,Azathioprine/Immuran,2021-09-23,Pfizer,Golimumab ,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,30,30,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,,,24,1,,,9,0,1,Post-3rd Dose,1,1,40,0,0,0,,3,,,6,794,2,30-39
492,,Male,CD,Golimumab,none,none,none,0.05,Negative,113,Positive,,Adult,,,Post-2nd,24-Aug-21,baseline,,107,,,15-Apr-21,09-May-21,23-Sep-21,24,137,4.729156166,ileocolonic,inflamatory and upperGI ,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-15,Pfizer,Golimumab ,.,none,none,Azathioprine/Immuran,2021-05-09,Pfizer,Golimumab ,.,none,none,Azathioprine/Immuran,2021-09-23,Pfizer,Golimumab ,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,30,30,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,,107,24,1,,,5,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,15,,795,2,30-39
500,,Male,UC,Ustekinumab,none,none,none,0.02,Negative,4181,Positive,,Adult,,,Post-2nd,19-Jul-21,baseline,,38,,,06-Apr-21,11-Jun-21,17-Sep-21,66,98,8.338281813,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-06,Pfizer,Adalimumab,.,none,none,none,2021-06-11,Pfizer,Adalimumab,.,none,none,none,2021-09-17,Pfizer,none,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,38,39,0,0,1,0,0,0,0,Ustekinumab Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,No Imuunosuppressives,,38,66,0,,,8,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,1,0,,3,,5,,281,2,30-39
506,,Female,CD,Ustekinumab,none,none,none,0.07,Negative,2168,Positive,,Adult,,,Post-3rd,17-Sep-21,baseline,,,14,,07-Apr-21,03-May-21,03-Sep-21,26,123,7.681606487,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-07,Pfizer,Renflexis/IFX,none,none,none,none,2021-05-03,Pfizer,Renflexis/IFX,none,none,none,none,2021-09-03,Pfizer,Renflexis/IFX,none,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,37,37,0,0,1,0,0,0,0,Ustekinumab Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,26,1,,,8,0,1,Post-3rd Dose,1,1,14,0,0,0,,3,,,2,291,2,30-39
507,,Female,CD,Ustekinumab,none,none,none,0.12,Negative,17,Negative,,Adult,,,Post-2nd,03-Sep-21,baseline,,123,,,07-Apr-21,03-May-21,03-Sep-21,26,123,2.803360381,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-07,Pfizer,Renflexis/IFX,none,none,none,none,2021-05-03,Pfizer,Renflexis/IFX,none,none,none,none,2021-09-03,Pfizer,Renflexis/IFX,none,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,37,37,0,0,1,0,0,0,0,Ustekinumab Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,123,26,1,,,3,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,18,,292,2,30-39
522,,Male,CD,Ustekinumab,none,none,none,0.05,Negative,3698,Positive,,Adult,,,Post-1st,18-May-21,baseline,35,,,,13-Apr-21,27-May-21,12-Nov-21,44,169,8.215628534,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-13,Moderna,Ustekinumab,.,none,none,none,2021-05-27,Moderna,Ustekinumab,.,none,none,none,2021-11-12,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,32,32,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,35,,44,0,,,8,0,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,472,2,30-39
531,,Female,CD,Infliximab,none,none,Azathioprine/Immuran,0.01,Negative,2518,Positive,,Adult,,,Post-3rd,01-Nov-21,baseline,,,38,,22-Apr-21,01-Jun-21,24-Sep-21,40,115,7.831140783,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-06-01,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-09-24,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,35,35,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,,40,1,,,8,0,1,Post-3rd Dose,1,1,38,0,0,0,,3,,,5,899,2,30-39
532,,Female,CD,Infliximab,none,none,Azathioprine/Immuran,0.01,Negative,540,Positive,,Adult,,,Post-2nd,18-Jun-21,baseline,,17,,,22-Apr-21,01-Jun-21,24-Sep-21,40,115,6.29156914,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-06-01,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-09-24,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,35,35,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,17,40,1,,,6,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,2,,900,2,30-39
533,,Female,CD,Infliximab,none,none,Azathioprine/Immuran,0.01,Negative,26,Negative,,Adult,,,Post-1st,20-May-21,baseline,28,,,,22-Apr-21,01-Jun-21,24-Sep-21,40,115,3.250374492,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-06-01,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-09-24,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,35,35,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,28,,40,1,,,3,0,1,Post-1st Dose,1,1,,0,0,0,,3,4,,,901,2,30-39
536,,Female,UC,Infliximab,none,none,none,0.01,Negative,745,Positive,,Adult,,,Post-3rd,08-Oct-21,baseline,,,37,,21-Apr-21,19-May-21,01-Sep-21,28,105,6.613384218,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-21,Pfizer,Infliximab,.,none,none,none,2021-05-19,Pfizer,Infliximab,.,none,none,none,2021-09-01,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,36,37,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,28,1,,,7,0,0,Post-3rd Dose,1,1,37,0,0,0,,3,,,5,506,2,30-39
540,,Male,CD,Ustekinumab,none,none,none,0.02,Negative,5870,Positive,,Adult,,,Post-3rd,19-Oct-21,baseline,,,27,,16-Apr-21,12-Jun-21,22-Sep-21,57,102,8.677626948,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-16,Pfizer,Ustekinumab,.,none,none,none,2021-06-12,Pfizer,Ustekinumab,.,none,none,none,2021-09-22,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,36,36,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,57,0,,,9,0,1,Post-3rd Dose,1,1,27,0,0,0,,3,,,4,124,2,30-39
541,,Male,CD,Ustekinumab,none,none,none,0.02,Negative,3752,Positive,,Adult,,,Post-2nd,21-Jul-21,baseline,,39,,,16-Apr-21,12-Jun-21,22-Sep-21,57,102,8.22996435,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-16,Pfizer,Ustekinumab,.,none,none,none,2021-06-12,Pfizer,Ustekinumab,.,none,none,none,2021-09-22,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,36,36,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,39,57,0,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,6,,125,2,30-39
569,,Female,CD,Ustekinumab,none,none,none,0.03,Negative,15,Negative,,Adult,,,Post-1st,12-Jun-21,baseline,38,,,,05-May-21,17-Jun-21,22-Sep-21,43,97,2.701361213,ileocolonic,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-05,Pfizer,Ustekinumab,.,none,none,none,2021-06-17,Pfizer,Ustekinumab,.,none,none,none,2021-09-22,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,39,39,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,38,,43,0,,,3,0,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,571,2,30-39
571,,Female,CD,Infliximab,none,none,none,0.03,Negative,425,Positive,,Adult,,,Post-2nd,08-Sep-21,baseline,,112,,,21-Apr-21,19-May-21,18-Dec-21,28,213,6.052324435,ileocolonic,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-21,Pfizer,Infliximab,.,none,none,none,2021-05-19,Pfizer,Infliximab,.,none,none,none,2021-12-18,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,31,31,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,112,28,1,,,6,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,16,,912,2,30-39
596,,Female,CD,Remicade,none,none,Azathioprine/Immuran,0.01,Negative,491,Positive,,Adult,,,Post-2nd,21-Aug-21,baseline,,48,,,06-May-21,04-Jul-21,,59,,6.196851377,ileal,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-06,Pfizer,Remicade,.,none,none,Azathioprine/Immuran,2021-07-04,Pfizer,Remicade,.,none,none,Azathioprine/Immuran,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,37,37,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,0,0,0,0,0,0,0,,,48,59,0,,,6,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,7,,15,2,30-39
597,,Female,CD,Remicade,none,none,Azathioprine/Immuran,0.02,Negative,5,Negative,,Adult,,,Post-1st,10-Jun-21,baseline,35,,,,06-May-21,04-Jul-21,,59,,1.526056303,ileal,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-06,Pfizer,Remicade,.,none,none,Azathioprine/Immuran,2021-07-04,Pfizer,Remicade,.,none,none,Azathioprine/Immuran,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,37,37,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,0,0,0,0,0,0,0,,35,,59,0,,,2,0,1,Post-1st Dose,1,1,,0,0,0,,,5,,,16,2,30-39
603,,Female,CD,Inflectra,none,none,none,0.03,Negative,3771,Positive,,Adult,,,Post-2nd,27-Aug-21,baseline,,74,,,09-Apr-21,14-Jun-21,08-Dec-21,66,177,8.235122015,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-09,Pfizer,Inflectra,.,none,none,none,2021-06-14,Pfizer,Inflectra,.,none,none,none,2021-12-08,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,35,35,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,74,66,0,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,11,,435,2,30-39
604,,Male,UC,Remicade,none,none,none,0.04,Negative,24192,Positive,,Adult,,,Post-3rd,29-Oct-21,baseline,,,31,,26-Apr-21,01-Jun-21,28-Sep-21,36,119,10.09378141,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-04-26,Moderna,Remicade,.,none,none,none,2021-06-01,Moderna,Remicade,.,none,none,none,2021-09-28,Moderna,Remicade,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,36,36,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,36,1,,,10,0,0,Post-3rd Dose,1,1,31,0,0,0,,3,,,4,276,2,30-39
605,,Male,UC,Remicade,none,none,none,,,2180,Positive,,Adult,,,Post-2nd,15-Jul-21,baseline,,44,,,26-Apr-21,01-Jun-21,28-Sep-21,36,119,7.686942532,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-04-26,Moderna,Remicade,.,none,none,none,2021-06-01,Moderna,Remicade,.,none,none,none,2021-09-28,Moderna,Remicade,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,36,36,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,44,36,1,,,8,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,6,,277,2,30-39
606,,Male,UC,Remicade,none,none,none,0.05,Negative,742,Positive,,Adult,,,Post-1st,26-May-21,baseline,30,,,,26-Apr-21,01-Jun-21,28-Sep-21,36,119,6.608944849,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-04-26,Moderna,Remicade,.,none,none,none,2021-06-01,Moderna,Remicade,.,none,none,none,2021-09-28,Moderna,Remicade,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,36,36,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,30,,36,1,,,7,0,0,Post-1st Dose,1,1,,0,0,0,,3,4,,,278,2,30-39
610,,Male,CD,Ustekinumab,none,none,none,,,9237,Positive,,Adult,,,Post-2nd,27-Jul-21,baseline,,36,,,01-Apr-21,21-Jun-21,06-Dec-21,81,168,9.130929132,ileocolonic,fistulizing and upperGI ,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-01,Pfizer,Ustekinumab,.,none,none,none,2021-06-21,Pfizer,Ustekinumab,.,none,none,none,2021-12-06,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,39,39,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,36,81,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,5,,681,2,30-39
611,,Male,UC,Infliximab,none,Oral 5ASA,Methotrexate,0.03,Negative,1144,Positive,,Adult,,,Post-2nd,18-Aug-21,baseline,,42,,,12-May-21,07-Jul-21,24-Nov-21,56,140,7.042111331,N/A,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-05-12,Pfizer,Infliximab,.,none,Oral 5ASA,Methotrexate,2021-07-07,Pfizer,Infliximab,.,none,Oral 5ASA,Methotrexate,2021-11-24,Pfizer,Infliximab,.,none,Oral 5ASA,Methotrexate,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,34,35,1,0,0,0,0,1,1,Combination Therapy,1,0,0,0,0,1,1,Combination Therapy,1,0,0,0,0,1,1,Combination Therapy,1,0,0,0,0,1,1,Combination Therapy,,42,56,0,,,7,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,6,,502,2,30-39
617,,Female,UC,Inflectra,none,none,none,0.09,Negative,10109,Positive,,Adult,,,Post-3rd,18-Oct-21,baseline,,,20,,09-Apr-21,03-May-21,28-Sep-21,24,148,9.221151718,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-09,Pfizer,Inflectra,.,none,none,none,2021-05-03,Pfizer,Inflectra,.,none,none,none,2021-09-28,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,37,37,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,24,1,,,9,0,0,Post-3rd Dose,1,1,20,0,0,0,,3,,,3,640,2,30-39
619,,Male,UC,Adalimumab,none,none,none,0.06,Negative,8046,Positive,,Adult,-154,,Post-2nd,03-Aug-21,baseline,,46,,,22-Apr-21,18-Jun-21,,57,,8.992893066,N/A ,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Adalimumab,.,none,none,none,2021-06-18,Pfizer,Adalimumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,2022-01-04,0,Male,35,35,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,46,57,0,,,9,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2022-01-04,2,,7,,752,2,30-39
620,,Male,UC,Adalimumab,none,none,none,0.03,Negative,658,Positive,,Adult,-227,,Post-1st,22-May-21,baseline,30,,,,22-Apr-21,18-Jun-21,,57,,6.488444764,N/A ,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Adalimumab,.,none,none,none,2021-06-18,Pfizer,Adalimumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,2022-01-04,0,Male,35,35,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,30,,57,0,,,6,0,0,Post-1st Dose,1,1,,0,0,0,2022-01-04,2,4,,,753,2,30-39
621,,Male,UC,Adalimumab,none,none,none,0.18,Negative,711,Positive,,Adult,-5,,Post-2nd,30-Dec-21,baseline,,195,,,22-Apr-21,18-Jun-21,,57,,6.56667243,N/A ,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Adalimumab,.,none,none,none,2021-06-18,Pfizer,Adalimumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,,1,1,1,,,2022-01-04,0,Male,35,35,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,195,57,0,,,7,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,2022-01-04,2,,28,,754,2,30-39
624,,Male,CD,Vedolizumab,none,none,none,0.07,Negative,25287,Positive,,Adult,,,Post-2nd,18-Aug-21,baseline,,60,,,10-Apr-21,19-Jun-21,02-Nov-21,70,136,10.13805757,colonic,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-10,Pfizer,Vedolizumab,.,none,none,none,2021-06-19,Pfizer,Vedolizumab,.,none,none,none,2021-11-02,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,36,36,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,60,70,0,,,10,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,9,,777,2,30-39
625,,Male,CD,Vedolizumab,none,none,none,0.01,Negative,1949,Positive,,Adult,,,Post-2nd,23-Sep-21,baseline,,134,,,07-Apr-21,12-May-21,23-Sep-21,35,134,7.575225613,colonic,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-07,Pfizer,Vedolizumab,.,none,none,none,2021-05-12,Pfizer,Vedolizumab,.,none,none,none,2021-09-23,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,37,37,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,134,35,1,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,19,,244,2,30-39
626,,Male,CD,Vedolizumab,none,none,none,,,5191,Positive,,Adult,,,Post-2nd,06-Jul-21,baseline,,55,,,07-Apr-21,12-May-21,23-Sep-21,35,134,8.554643107,colonic,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-07,Pfizer,Vedolizumab,.,none,none,none,2021-05-12,Pfizer,Vedolizumab,.,none,none,none,2021-09-23,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,37,37,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,55,35,1,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,8,,245,2,30-39
635,,Female,CD,Infliximab,none,none,none,0.35,Negative,1431,Positive,,Adult,,,Post-2nd,24-Jun-21,baseline,,10,,,10-Apr-21,14-Jun-21,07-Sep-21,65,85,7.266408265,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-10,Pfizer,Infliximab,.,none,none,none,2021-06-14,Pfizer,Infliximab,.,none,none,none,2021-09-07,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,1,,1,,,,1,,,,0,Female,31,31,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,10,65,0,,,7,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,1,,403,2,30-39
636,,Female,CD,Infliximab,none,none,none,0.45,Negative,231,Positive,,Adult,,,Post-1st,22-May-21,baseline,42,,,,10-Apr-21,14-Jun-21,07-Sep-21,65,85,5.443283137,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-10,Pfizer,Infliximab,.,none,none,none,2021-06-14,Pfizer,Infliximab,.,none,none,none,2021-09-07,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,31,31,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,42,,65,0,,,5,0,1,Post-1st Dose,1,1,,0,0,0,,3,6,,,404,2,30-39
638,,Female,CD,Infliximab,none,none,none,0.03,Negative,1311,Positive,,Adult,,,Post-2nd,20-Sep-21,baseline,,50,,,02-Jul-21,01-Aug-21,,30,,7.178545484,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-07-02,Moderna,Inflectra,.,none,none,none,2021-08-01,Moderna,Inflectra,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,34,34,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,50,30,1,,,7,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,7,,484,2,30-39
641,,Female,CD,Vedolizumab,none,none,none,0.45,Negative,433,Positive,,Adult,,,Post-1st,28-May-21,baseline,55,,,,03-Apr-21,24-Jun-21,29-Sep-21,82,97,6.071661089,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,Vedolizumab,.,none,none,none,2021-06-24,Pfizer,Vedolizumab,.,none,none,none,2021-09-29,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,38,39,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,55,,82,0,,,6,0,1,Post-1st Dose,1,1,,0,0,0,,3,8,,,5,2,30-39
642,,Female,CD,Vedolizumab,none,none,none,0.26,Negative,11011,Positive,,Adult,,,Post-2nd,17-Aug-21,baseline,,54,,,03-Apr-21,24-Jun-21,29-Sep-21,82,97,9.306613724,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,Vedolizumab,.,none,none,none,2021-06-24,Pfizer,Vedolizumab,.,none,none,none,2021-09-29,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,38,39,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,54,82,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,8,,6,2,30-39
646,,Male,CD,Infliximab,none,none,none,0.11,Negative,5941,Positive,,Adult,,,Post-3rd,15-Oct-21,baseline,,,25,,08-Apr-21,02-Jul-21,20-Sep-21,85,80,8.689565417,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-08,Pfizer,Infliximab,.,none,none,none,2021-07-02,Pfizer,Infliximab,.,none,none,none,2021-09-20,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,34,34,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,85,0,,,9,0,1,Post-3rd Dose,1,1,25,0,0,0,,3,,,4,565,2,30-39
647,,Male,CD,Infliximab,none,none,none,0.1,Negative,797,Positive,,Adult,,,Post-2nd,24-Jul-21,baseline,,22,,,08-Apr-21,02-Jul-21,20-Sep-21,85,80,6.680854679,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-08,Pfizer,Infliximab,.,none,none,none,2021-07-02,Pfizer,Infliximab,.,none,none,none,2021-09-20,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,34,34,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,22,85,0,,,7,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,566,2,30-39
648,,Male,CD,Infliximab,none,none,none,0.08,Negative,1,Negative,,Adult,,,Post-1st,01-May-21,baseline,23,,,,08-Apr-21,02-Jul-21,20-Sep-21,85,80,,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-08,Pfizer,Infliximab,.,none,none,none,2021-07-02,Pfizer,Infliximab,.,none,none,none,2021-09-20,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,34,34,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,23,,85,0,,,0,0,1,Post-1st Dose,1,1,,0,0,0,,3,3,,,567,2,30-39
656,,Female,CD,Ustekinumab,none,none,none,0.02,Negative,604,Positive,,Adult,,,Post-1st,10-May-21,baseline,29,,,,11-Apr-21,26-Jul-21,29-Dec-21,106,156,6.403739747,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-11,Pfizer,Ustekinumab,.,none,none,none,2021-07-26,Pfizer,Ustekinumab,.,none,none,none,2021-12-29,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,35,36,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,29,,106,0,,,6,0,1,Post-1st Dose,1,1,,0,0,0,,3,4,,,800,2,30-39
658,,Female,UC,Infliximab,none,none,Methotrexate,0.1,Negative,40000,Positive,,Adult,,,Post-3rd,28-Oct-21,baseline,,,24,,10-Apr-21,09-Jun-21,04-Oct-21,60,117,10.59663473,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-10,Pfizer,Ustekinumab,.,none,none,none,2021-06-09,Pfizer,Ustekinumab,.,none,none,none,2021-10-04,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,37,38,1,0,0,0,0,0,1,Combination Therapy,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,60,0,,,11,0,0,Post-3rd Dose,1,1,24,0,0,0,,3,,,3,774,2,30-39
659,,Female,UC,Infliximab,none,none,Methotrexate,0.02,Negative,2297,Positive,,Adult,,,Post-1st,20-May-21,baseline,40,,,,10-Apr-21,09-Jun-21,04-Oct-21,60,117,7.739402737,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-10,Pfizer,Ustekinumab,.,none,none,none,2021-06-09,Pfizer,Ustekinumab,.,none,none,none,2021-10-04,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,37,38,1,0,0,0,0,0,1,Combination Therapy,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,40,,60,0,,,8,0,0,Post-1st Dose,1,1,,0,0,0,,3,6,,,775,2,30-39
660,,Female,UC,Infliximab,none,none,Methotrexate,0.08,Negative,28060,Positive,,Adult,,,Post-2nd,25-Jun-21,baseline,,16,,,10-Apr-21,09-Jun-21,04-Oct-21,60,117,10.24210748,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-10,Pfizer,Ustekinumab,.,none,none,none,2021-06-09,Pfizer,Ustekinumab,.,none,none,none,2021-10-04,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,37,38,1,0,0,0,0,0,1,Combination Therapy,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,16,60,0,,,10,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,2,,776,2,30-39
667,,Female,CD,Adalimumab,none,none,none,0.02,Negative,361,Positive,,Adult,,,Post-2nd,25-Aug-21,baseline,,75,,,12-Apr-21,11-Jun-21,02-Dec-21,60,174,5.889985378,ileal,unknown,N/A,none,Outpatient,Baseline Serology,,,,,,,2021-04-12,Pfizer,Adalimumab,.,none,none,none,2021-06-11,Pfizer,Adalimumab,.,none,none,none,2021-12-02,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,38,38,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,75,60,0,,,6,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,11,,632,2,30-39
668,,Male,CD,Adalimumab,none,none,none,0.04,Negative,997,Positive,,Adult,,,Post-1st,31-May-21,baseline,48,,,,13-Apr-21,07-Jun-21,28-Dec-21,55,204,6.904851066,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-13,Moderna,Adalimumab,.,none,none,none,2021-06-07,Pfizer,Adalimumab,.,none,none,none,2021-12-28,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,36,37,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,48,,55,0,,,7,0,1,Post-1st Dose,1,1,,0,0,0,,3,7,,,585,2,30-39
669,,Female,UC,Vedolizumab,none,none,none,0.03,Negative,1168,Positive,,Adult,,,Post-1st,03-May-21,baseline,23,,,,10-Apr-21,15-Jun-21,14-Dec-21,66,182,7.063048163,N/A ,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-04-10,Pfizer,Vedolizumab,.,none,none,none,2021-06-15,Pfizer,Vedolizumab,.,none,none,none,2021-12-14,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,34,34,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,23,,66,0,,,7,0,0,Post-1st Dose,1,1,,0,0,0,,3,3,,,633,2,30-39
670,,Female,UC,Vedolizumab,none,none,none,0.04,Negative,8755,Positive,,Adult,,,Post-2nd,18-Aug-21,baseline,,64,,,10-Apr-21,15-Jun-21,14-Dec-21,66,182,9.07741451,N/A ,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-04-10,Pfizer,Vedolizumab,.,none,none,none,2021-06-15,Pfizer,Vedolizumab,.,none,none,none,2021-12-14,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,34,35,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,64,66,0,,,9,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,9,,634,2,30-39
674,,Female,UC,Ustekinumab,none,yes ,none,0.24,Negative,25492,Positive,,Adult,,,Post-3rd,07-Dec-21,baseline,,,27,,28-Apr-21,18-Jun-21,10-Nov-21,51,145,10.14611211,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-28,Pfizer,Ustekinumab,.,none,yes ,none,2021-06-18,Pfizer,Ustekinumab,.,none,yes ,none,2021-11-10,Pfizer,Ustekinumab,.,none,yes ,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,37,38,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,,,51,0,,,10,0,0,Post-3rd Dose,1,1,27,0,0,0,,3,,,4,923,2,30-39
675,,Female,UC,Ustekinumab,none,yes ,none,,,32029,Positive,,Adult,,,Post-2nd,11-Jul-21,baseline,,23,,,28-Apr-21,18-Jun-21,10-Nov-21,51,145,10.3743939,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-28,Pfizer,Ustekinumab,.,none,yes ,none,2021-06-18,Pfizer,Ustekinumab,.,none,yes ,none,2021-11-10,Pfizer,Ustekinumab,.,none,yes ,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,37,37,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,,23,51,0,,,10,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,924,2,30-39
676,,Female,UC,Ustekinumab,none,yes ,none,0.03,Negative,313,Positive,,Adult,,,Post-1st,12-Jun-21,baseline,45,,,,28-Apr-21,18-Jun-21,10-Nov-21,51,145,5.745244264,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-28,Pfizer,Ustekinumab,.,none,yes ,none,2021-06-18,Pfizer,Ustekinumab,.,none,yes ,none,2021-11-10,Pfizer,Ustekinumab,.,none,yes ,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,37,37,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,45,,51,0,,,6,0,0,Post-1st Dose,1,1,,0,0,0,,3,6,,,925,2,30-39
679,,Male,CD,Infliximab,none,none,Azathioprine/Immuran,0.03,Negative,41,Negative,,Adult,,,Post-2nd,22-Jul-21,baseline,,14,,,12-May-21,08-Jul-21,23-Nov-21,57,138,3.706228092,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-12,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-07-08,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-11-23,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,38,38,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,14,57,0,,,4,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,2,,528,2,30-39
680,,Male,CD,Infliximab,none,none,Azathioprine/Immuran,0.03,Negative,3,Negative,,Adult,,,Post-1st,17-Jun-21,baseline,36,,,,12-May-21,08-Jul-21,23-Nov-21,57,138,0.993251773,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-12,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-07-08,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-11-23,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,38,38,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,36,,57,0,,,1,0,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,529,2,30-39
683,,Female,CD,Ustekinumab,none,none,none,0.02,Negative,514,Positive,,Adult,,,Post-1st,07-May-21,baseline,28,,,,09-Apr-21,12-May-21,23-Sep-21,33,134,6.242806753,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-09,Pfizer,Ustekinumab,.,none,none,none,2021-05-12,Pfizer,Ustekinumab,.,none,none,none,2021-09-23,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,39,39,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,28,,33,1,,,6,0,1,Post-1st Dose,1,1,,0,0,0,,3,4,,,977,2,30-39
690,,Male,UC,Tofacitinib,Oral budesonide/Cortiment/Entocort,none,none,1.04,Positive,24684,Positive,,Adult,174,,Post-1st,26-May-21,covid,34,,,,22-Apr-21,15-Jun-21,19-Dec-21,54,187,10.11392674,N/A ,N/A,Pancolitis,,Outpatient,Confirmed COVID,,,,,,2021-05-26,2021-04-22,Pfizer,Tofacitinib,.,none,none,none,2021-06-15,Pfizer,Tofacitinib,.,none,none,none,2021-12-19,Pfizer,Tofacitinib,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,2020-12-03,1,Male,39,39,0,0,0,1,0,0,0,Tofacitinib Only,0,0,0,1,0,0,0,Tofacitinib Only,0,0,0,1,0,0,0,Tofacitinib Only,0,0,0,1,0,0,0,Tofacitinib Only,34,,54,0,,,10,0,0,Post-1st Dose,1,1,,0,0,0,2020-12-03,,5,,,523,2,30-39
691,,Male,UC,Tofacitinib,Oral budesonide/Cortiment/Entocort,none,none,0.47,Negative,14568,Positive,,Adult,270,,Post-2nd,30-Aug-21,covid,,76,,,22-Apr-21,15-Jun-21,19-Dec-21,54,187,9.586568893,N/A ,N/A,Pancolitis,,Outpatient,Confirmed COVID,,,,,,2021-05-26,2021-04-22,Pfizer,Tofacitinib,.,none,none,none,2021-06-15,Pfizer,Tofacitinib,.,none,none,none,2021-12-19,Pfizer,Tofacitinib,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,2020-12-03,1,Male,39,39,0,0,0,1,0,0,0,Tofacitinib Only,0,0,0,1,0,0,0,Tofacitinib Only,0,0,0,1,0,0,0,Tofacitinib Only,0,0,0,1,0,0,0,Tofacitinib Only,,76,54,0,,,10,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,2020-12-03,,,11,,524,2,30-39
694,,Female,CD,Adalimumab,Oral budesonide/Cortiment/Entocort,none,none,0.27,Negative,1171,Positive,,Adult,,,Post-2nd,26-Aug-21,baseline,,195,,,12-Jan-21,12-Feb-21,15-Oct-21,31,245,7.065527963,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-01-12,Pfizer,Adalimumab,.,Oral budesonide/Cortiment/Entocort,none,none,2021-02-12,Pfizer,Adalimumab,.,Oral budesonide/Cortiment/Entocort,none,none,2021-10-15,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,32,32,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,195,31,1,,,7,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,28,,771,2,30-39
695,,Female,CD,Adalimumab,Oral budesonide/Cortiment/Entocort,none,none,0.05,Negative,176,Positive,,Adult,,,Post-1st,11-Feb-21,baseline,30,,,,12-Jan-21,12-Feb-21,15-Oct-21,31,245,5.167639043,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-01-12,Pfizer,Adalimumab,.,Oral budesonide/Cortiment/Entocort,none,none,2021-02-12,Pfizer,Adalimumab,.,Oral budesonide/Cortiment/Entocort,none,none,2021-10-15,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,32,32,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,30,,31,1,,,5,0,1,Post-1st Dose,1,1,,0,0,0,,3,4,,,772,2,30-39
701,,Male,CD,Adalimumab,none,none,none,0.13,Negative,483,Positive,,Adult,213,-188,Post-1st,15-Jun-21,covid,56,,,,20-Apr-21,16-Jun-21,,57,,6.180016654,ileal,Stricturing,N/A,,Outpatient,Confirmed COVID,,,2021-12-20,,,,2021-04-20,Pfizer,Adalimumab,.,none,none,none,2021-06-16,Pfizer,Adalimumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,2020-11-14,1,Male,38,38,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,56,,57,0,,,6,0,1,Post-1st Dose,1,1,,0,0,0,2020-11-14,,8,,,939,2,30-39
702,,Male,CD,Adalimumab,none,none,none,0.08,Negative,102,Positive,,Adult,398,-3,Post-2nd,17-Dec-21,covid,,184,,,20-Apr-21,16-Jun-21,,57,,4.620058798,ileal,Stricturing,N/A,,Outpatient,Confirmed COVID,,,2021-12-20,,,,2021-04-20,Pfizer,Adalimumab,.,none,none,none,2021-06-16,Pfizer,Adalimumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,,1,1,1,,,2020-11-14,1,Male,38,39,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,184,57,0,,,5,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,2020-11-14,,,26,,940,2,30-39
708,,Male,CD,Ustekinumab,none,none,none,0.06,Negative,13170,Positive,,Adult,-132,,Post-2nd,25-Aug-21,baseline,,53,,,05-May-21,03-Jul-21,,59,,9.485681609,ileal,Stricturing,N/A,none,,Baseline Serology,,,,,,,2021-05-05,Pfizer,Ustekinumab,.,none,none,none,2021-07-03,Pfizer,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,2022-01-04,0,Male,34,35,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,,53,59,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2022-01-04,2,,8,,673,2,30-39
722,,Male,UC,Renflexis/IFX,none,none,none,,,13174,Positive,,Adult,,,Post-2nd,26-Jul-21,baseline,,35,,,25-Apr-21,21-Jun-21,,57,,9.486030832,N/A ,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-04-25,Moderna,Renflexis/IFX,.,none,none,none,2021-06-21,Moderna,Renflexis/IFX,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,34,34,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,35,57,0,,,9,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,5,,128,2,30-39
727,,Female,CD,Adalimumab,none,none,none,0.07,Negative,29594,Positive,,Adult,,,Post-3rd,03-Nov-21,baseline,,,26,,05-Jan-21,12-Feb-21,08-Oct-21,38,238,10.29532354,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-01-05,Pfizer,Adalimumab,.,none,none,none,2021-02-12,Pfizer,Adalimumab,.,none,none,none,2021-10-08,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,36,37,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,38,1,,,10,0,1,Post-3rd Dose,1,1,26,0,0,0,,3,,,4,562,2,30-39
728,,Female,CD,Adalimumab,none,none,none,0.03,Negative,5564,Positive,,Adult,,,Post-2nd,12-Mar-21,baseline,,28,,,05-Jan-21,12-Feb-21,08-Oct-21,38,238,8.624108498,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-01-05,Pfizer,Adalimumab,.,none,none,none,2021-02-12,Pfizer,Adalimumab,.,none,none,none,2021-10-08,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,36,36,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,28,38,1,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,563,2,30-39
729,,Female,CD,Adalimumab,none,none,none,0.04,Negative,137,Positive,,Adult,,,Post-2nd,13-Sep-21,baseline,,213,,,05-Jan-21,12-Feb-21,08-Oct-21,38,238,4.921439715,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-01-05,Pfizer,Adalimumab,.,none,none,none,2021-02-12,Pfizer,Adalimumab,.,none,none,none,2021-10-08,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,36,36,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,213,38,1,,,5,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,30,,564,2,30-39
735,,Female,CD,Vedolizumab,none,none,none,0.02,Negative,133,Positive,,Adult,,,Post-1st,19-May-21,baseline,43,,,,06-Apr-21,10-Jun-21,28-Dec-21,65,201,4.887337078,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-06,Pfizer,Vedolizumab,.,none,none,none,2021-06-10,Pfizer,Vedolizumab,.,none,none,none,2021-12-28,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,34,34,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,43,,65,0,,,5,0,1,Post-1st Dose,1,1,,0,0,0,,3,6,,,120,2,30-39
739,,Female,CD,Adalimumab,none,none,none,0.03,Negative,5238,Positive,,Adult,-180,,Post-2nd,29-Jun-21,baseline,,21,,,11-Apr-21,08-Jun-21,,58,,8.563752297,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-11,Pfizer,Adalimumab,.,none,none,none,2021-06-08,Pfizer,Adalimumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,2021-12-26,0,Female,33,33,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,21,58,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2021-12-26,2,,3,,339,2,30-39
740,,Female,CD,Adalimumab,none,none,none,0.03,Negative,228,Positive,,Adult,-208,,Post-1st,01-Jun-21,baseline,51,,,,11-Apr-21,08-Jun-21,,58,,5.430660554,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-11,Pfizer,Adalimumab,.,none,none,none,2021-06-08,Pfizer,Adalimumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,2021-12-26,0,Female,33,33,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,51,,58,0,,,5,0,1,Post-1st Dose,1,1,,0,0,0,2021-12-26,2,7,,,340,2,30-39
746,,Female,CD,Adalimumab,none,none,none,0.02,Negative,419,Positive,,Adult,,,Post-2nd,17-Aug-21,baseline,,126,,,02-Mar-21,13-Apr-21,29-Dec-21,42,260,6.037632228,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-02,Pfizer,Adalimumab,.,none,none,none,2021-04-13,Pfizer,Adalimumab,.,none,none,none,2021-12-29,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,30,31,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,126,42,1,,,6,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,18,,786,2,30-39
747,,Female,CD,Adalimumab,none,none,none,0.02,Negative,927,Positive,,Adult,,,Post-2nd,07-Jun-21,baseline,,55,,,02-Mar-21,13-Apr-21,29-Dec-21,42,260,6.831414046,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-02,Pfizer,Adalimumab,.,none,none,none,2021-04-13,Pfizer,Adalimumab,.,none,none,none,2021-12-29,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,30,31,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,55,42,1,,,7,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,8,,787,2,30-39
748,,Female,CD,Adalimumab,none,none,none,0.02,Negative,476,Positive,,Adult,,,Post-1st,05-Apr-21,baseline,34,,,,02-Mar-21,13-Apr-21,29-Dec-21,42,260,6.166257837,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-02,Pfizer,Adalimumab,.,none,none,none,2021-04-13,Pfizer,Adalimumab,.,none,none,none,2021-12-29,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,30,30,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,34,,42,1,,,6,0,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,788,2,30-39
749,,Female,CD,Ustekinumab,none,none,none,0.06,Negative,191,Positive,,Adult,,,Post-2nd,02-Sep-21,baseline,,207,,,31-Dec-20,07-Feb-21,08-Nov-21,38,274,5.250701513,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2020-12-31,Pfizer,Ustekinumab,.,none,none,none,2021-02-07,Pfizer,Ustekinumab,.,none,none,none,2021-11-08,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,35,35,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,207,38,1,,,5,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,30,,578,2,30-39
750,,Female,CD,Ustekinumab,none,none,none,0.05,Negative,1295,Positive,,Adult,,,Post-2nd,18-Mar-21,baseline,,39,,,31-Dec-20,07-Feb-21,08-Nov-21,38,274,7.165879799,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2020-12-31,Pfizer,Ustekinumab,.,none,none,none,2021-02-07,Pfizer,Ustekinumab,.,none,none,none,2021-11-08,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,35,35,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,39,38,1,,,7,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,6,,579,2,30-39
751,,Female,CD,Remicade,none,none,none,0.06,Negative,98,Positive,,Adult,-127,,Post-1st,13-May-21,baseline,35,,,,08-Apr-21,17-Jul-21,21-Oct-21,100,96,4.580877493,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-08,Pfizer,Remicade,.,none,none,none,2021-07-17,Pfizer,Remicade,.,none,none,none,2021-10-21,Pfizer,Remicade,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,2021-09-17,0,Female,34,35,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,35,,100,0,,,5,0,1,Post-1st Dose,1,1,,0,0,0,2021-09-17,2,5,,,721,2,30-39
752,,Male,UC,Adalimumab,none,Rectal 5ASA,none,0.06,Negative,6783,Positive,,Adult,,,Post-3rd,06-Oct-21,baseline,,,31,,07-Apr-21,11-May-21,05-Sep-21,34,117,8.82223373,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-04-07,Pfizer,Adalimumab,.,none,Rectal 5ASA,none,2021-05-11,Pfizer,Adalimumab,.,none,Rectal 5ASA,none,2021-09-05,Pfizer,Adalimumab,.,none,Rectal 5ASA,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,35,36,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,,,34,1,,,9,0,0,Post-3rd Dose,1,1,31,0,0,0,,3,,,4,205,2,30-39
774,,Male,CD,Ustekinumab,none,none,Azathioprine/Immuran,0.03,Negative,6624,Positive,,Adult,,,Post-2nd,12-Aug-21,baseline,,60,,,06-Apr-21,13-Jun-21,31-Oct-21,68,140,8.798499985,colonic,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-06,Pfizer,Ustekinumab,none,none,Oral 5ASA,Azathioprine/Immuran,2021-06-13,Pfizer,Ustekinumab,none,Oral budesonide/Cortiment/Entocort,Oral 5ASA,Azathioprine/Immuran,2021-10-31,Pfizer,Ustekinumab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,30,31,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,1,1,Combination Therapy,0,0,1,0,0,1,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,,60,68,0,,,9,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,9,,31,2,30-39
775,,Male,CD,Ustekinumab,none,none,Azathioprine/Immuran,0.03,Negative,111,Positive,,Adult,,,Post-1st,18-May-21,baseline,42,,,,06-Apr-21,13-Jun-21,31-Oct-21,68,140,4.711330382,colonic,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-06,Pfizer,Ustekinumab,none,none,Oral 5ASA,Azathioprine/Immuran,2021-06-13,Pfizer,Ustekinumab,none,Oral budesonide/Cortiment/Entocort,Oral 5ASA,Azathioprine/Immuran,2021-10-31,Pfizer,Ustekinumab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,30,31,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,1,1,Combination Therapy,0,0,1,0,0,1,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,42,,68,0,,,5,0,1,Post-1st Dose,1,1,,0,0,0,,3,6,,,32,2,30-39
824,,Male,CD,none,none,yes ,none,,,10271,Positive,,Adult,,,Post-2nd,06-Jul-21,baseline,,17,,,28-Apr-21,19-Jun-21,14-Dec-21,52,178,9.23705046,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-28,Pfizer,none,.,none,yes ,none,2021-06-19,Pfizer,none,.,none,yes ,none,2021-12-14,Pfizer,none,.,none,yes ,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,36,37,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,17,52,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,1,1,1,,3,,2,,241,2,30-39
825,,Male,CD,none,none,yes ,none,0.03,Negative,592,Positive,,Adult,,,Post-1st,04-Jun-21,baseline,37,,,,28-Apr-21,19-Jun-21,14-Dec-21,52,178,6.384013263,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-28,Pfizer,none,.,none,yes ,none,2021-06-19,Pfizer,none,.,none,yes ,none,2021-12-14,Pfizer,none,.,none,yes ,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,36,37,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,37,,52,0,,,6,0,1,Post-1st Dose,1,1,,1,1,1,,3,5,,,242,2,30-39
826,,Male,CD,none,none,yes ,none,0.31,Negative,2628,Positive,,Adult,,,Post-2nd,10-Dec-21,baseline,,174,,,28-Apr-21,19-Jun-21,14-Dec-21,52,178,7.873940327,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-28,Pfizer,none,.,none,yes ,none,2021-06-19,Pfizer,none,.,none,yes ,none,2021-12-14,Pfizer,none,.,none,yes ,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,36,37,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,174,52,0,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,1,1,1,,3,,25,,243,2,30-39
834,,Female,UC,Vedolizumab,none,Oral 5ASA,none,0.05,Negative,8212,Positive,,Adult,,,Post-2nd,15-Mar-21,baseline,,36,,,03-Jan-21,07-Feb-21,30-Nov-21,35,296,9.01329089,N/A ,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-01-03,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,2021-02-07,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,2021-11-30,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,37,37,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,,36,35,1,,,9,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,5,,806,2,30-39
835,,Female,UC,Vedolizumab,none,Oral 5ASA,none,0.23,Negative,1990,Positive,,Adult,,,Post-2nd,09-Nov-21,baseline,,275,,,03-Jan-21,07-Feb-21,30-Nov-21,35,296,7.595990415,N/A ,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-01-03,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,2021-02-07,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,2021-11-30,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,37,37,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,,275,35,1,,,8,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,39,,807,2,30-39
844,,Male,UC,Vedolizumab,none,none,none,0.01,Negative,32337,Positive,,Adult,,,Post-2nd,24-Jul-21,baseline,,14,,,21-May-21,10-Jul-21,,50,,10.38397046,N/A ,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-05-21,Moderna,Vedolizumab,.,none,none,none,2021-07-10,Moderna,Vedolizumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,34,34,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,0,0,0,0,0,0,,,14,50,0,,,10,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,2,,485,2,30-39
845,,Male,UC,Vedolizumab,none,none,none,,,976,Positive,,Adult,,,Post-1st,07-Jul-21,baseline,47,,,,21-May-21,10-Jul-21,,50,,6.88295016,N/A ,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-05-21,Moderna,Vedolizumab,.,none,none,none,2021-07-10,Moderna,Vedolizumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,34,34,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,0,0,0,0,0,0,,47,,50,0,,,7,0,0,Post-1st Dose,1,1,,0,0,0,,,7,,,486,2,30-39
846,,Male,UC,Vedolizumab,none,none,none,0.13,Negative,11144,Positive,,Adult,,,Post-2nd,22-Dec-21,baseline,,165,,,21-May-21,10-Jul-21,,50,,9.318665489,N/A ,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-05-21,Moderna,Vedolizumab,.,none,none,none,2021-07-10,Moderna,Vedolizumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,34,35,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,0,0,0,0,0,0,,,165,50,0,,,9,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,24,,487,2,30-39
850,,Male,CD,Ustekinumab,none,none,none,0.02,Negative,2716,Positive,,Adult,,,Post-2nd,16-Sep-21,New biologic/Tofacitinib start,,89,,,04-May-21,19-Jun-21,,46,,7.906878669,ileal,fistulizng,N/A,,Outpatient,New biologic/Tofacitinib start,,,,,,,2021-05-04,Pfizer,Ustekinumab,.,none,none,none,2021-06-19,Pfizer,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,38,38,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,,89,46,0,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,13,,703,2,30-39
851,,Male,CD,Ustekinumab,none,none,none,0.01,Negative,105,Positive,,Adult,,,Post-1st,25-May-21,New biologic/Tofacitinib start,21,,,,04-May-21,19-Jun-21,,46,,4.650143552,ileal,fistulizng,N/A,,Outpatient,New biologic/Tofacitinib start,,,,,,,2021-05-04,Pfizer,Ustekinumab,.,none,none,none,2021-06-19,Pfizer,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,38,38,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,21,,46,0,,,5,0,1,Post-1st Dose,1,1,,0,0,0,,,3,,,704,2,30-39
908,,Male,CD,Infliximab,none,none,Azathioprine/Immuran,1.5,Positive,4699,Positive,,Adult,,,Post-1st,19-Jun-21,covid,24,,,,26-May-21,08-Jul-21,,43,,8.45519012,ileocolonic,Perianal CD,N/A,,Outpatient,Confirmed COVID,,,,,,2021-06-19,2021-05-26,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-07-08,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,1,Male,38,38,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,0,0,0,0,0,0,0,,24,,43,0,,,8,0,1,Post-1st Dose,1,1,,0,0,0,2021-06-19,1,3,,,992,2,30-39
927,,Male,CD,Remicade,none,none,Azathioprine/Immuran,0.14,Negative,439,Positive,,Adult,,,Post-2nd,18-Sep-21,baseline,,133,,,15-Apr-21,08-May-21,30-Sep-21,23,145,6.084499413,ileocolonic,stricturing and upper GI,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-15,Pfizer,Remicade,.,none,none,Azathioprine/Immuran,2021-05-08,Pfizer,Remicade,.,none,none,Azathioprine/Immuran,2021-09-30,Pfizer,Remicade,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,35,35,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,133,23,1,,,6,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,19,,728,2,30-39
928,,Male,CD,Remicade,none,none,Azathioprine/Immuran,0.12,Negative,683,Positive,,Adult,,,Post-2nd,26-Jun-21,baseline,,49,,,15-Apr-21,08-May-21,30-Sep-21,23,145,6.52649486,ileocolonic,stricturing and upper GI,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-15,Pfizer,Remicade,.,none,none,Azathioprine/Immuran,2021-05-08,Pfizer,Remicade,.,none,none,Azathioprine/Immuran,2021-09-30,Pfizer,Remicade,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,35,35,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,49,23,1,,,7,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,7,,729,2,30-39
939,,Male,CD,Inflectra,Oral Prednisone,none,none,0.01,Negative,3392,Positive,,Adult,,,Post-3rd,29-Sep-21,baseline,,,27,,14-Apr-21,12-May-21,02-Sep-21,28,113,8.129057065,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-14,Moderna,Inflectra,.,Oral Prednisone,none,none,2021-05-12,Moderna,Inflectra,.,Oral Prednisone,none,none,2021-09-02,Moderna,Inflectra,.,Oral Prednisone,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,33,34,1,0,0,0,1,0,0,Corticoteroids,1,0,0,0,1,0,0,Corticoteroids,1,0,0,0,1,0,0,Corticoteroids,1,0,0,0,1,0,0,Corticoteroids,,,28,1,,,8,0,1,Post-3rd Dose,1,1,27,0,0,0,,3,,,4,749,2,30-39
940,,Male,CD,Inflectra,Oral Prednisone,none,none,0.01,Negative,3,Negative,,Adult,,,Post-1st,10-May-21,baseline,26,,,,14-Apr-21,12-May-21,02-Sep-21,28,113,0.955511445,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-14,Moderna,Inflectra,.,Oral Prednisone,none,none,2021-05-12,Moderna,Inflectra,.,Oral Prednisone,none,none,2021-09-02,Moderna,Inflectra,.,Oral Prednisone,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,33,33,1,0,0,0,1,0,0,Corticoteroids,1,0,0,0,1,0,0,Corticoteroids,1,0,0,0,1,0,0,Corticoteroids,1,0,0,0,1,0,0,Corticoteroids,26,,28,1,,,1,0,1,Post-1st Dose,1,1,,0,0,0,,3,4,,,750,2,30-39
941,,Male,CD,Inflectra,Oral Prednisone,none,none,0.01,Negative,3289,Positive,,Adult,,,Post-2nd,31-May-21,baseline,,19,,,14-Apr-21,12-May-21,02-Sep-21,28,113,8.098338846,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-14,Moderna,Inflectra,.,Oral Prednisone,none,none,2021-05-12,Moderna,Inflectra,.,Oral Prednisone,none,none,2021-09-02,Moderna,Inflectra,.,Oral Prednisone,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,33,33,1,0,0,0,1,0,0,Corticoteroids,1,0,0,0,1,0,0,Corticoteroids,1,0,0,0,1,0,0,Corticoteroids,1,0,0,0,1,0,0,Corticoteroids,,19,28,1,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,751,2,30-39
944,,Female,CD,Adalimumab,none,none,none,0.03,Negative,228,Positive,,Adult,,,Post-1st,25-May-21,baseline,34,,,,21-Apr-21,19-Jun-21,27-Oct-21,59,130,5.428468051,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,2022-01-09,,2021-04-21,Pfizer,Adalimumab,.,none,none,none,2021-06-19,Pfizer,Adalimumab,.,none,none,none,2021-10-27,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,36,36,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,34,,59,0,,,5,0,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,668,2,30-39
945,,Female,CD,Adalimumab,none,none,none,,,3140,Positive,,Adult,,,Post-2nd,14-Jul-21,baseline,,25,,,21-Apr-21,19-Jun-21,27-Oct-21,59,130,8.052073616,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,2022-01-09,,2021-04-21,Pfizer,Adalimumab,.,none,none,none,2021-06-19,Pfizer,Adalimumab,.,none,none,none,2021-10-27,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,36,36,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,25,59,0,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,669,2,30-39
951,,Male,UC,Vedolizumab,none,Rectal 5ASA,none,0.02,Negative,19199,Positive,,Adult,,,Post-2nd,20-May-21,baseline,,12,,,06-Apr-21,08-May-21,,32,,9.862592639,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-06,Pfizer,Vedolizumab,.,none,Rectal 5ASA,none,2021-05-08,Pfizer,Vedolizumab,.,none,Rectal 5ASA,none,,,,,,,,,.,.,.,.,.,.,,1,,1,,,,1,,,,0,Male,35,35,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,0,0,0,0,0,0,,,12,32,1,,,10,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,2,,129,2,30-39
952,,Male,UC,Vedolizumab,none,Rectal 5ASA,none,0.1,Negative,3650,Positive,,Adult,,,Post-2nd,04-Oct-21,baseline,,149,,,06-Apr-21,08-May-21,,32,,8.202427651,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-06,Pfizer,Vedolizumab,.,none,Rectal 5ASA,none,2021-05-08,Pfizer,Vedolizumab,.,none,Rectal 5ASA,none,,,,,,,,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,35,36,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,0,0,0,0,0,0,,,149,32,1,,,8,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,21,,130,2,30-39
953,,Female,CD,Vedolizumab,none,none,Azathioprine/Immuran,0.77,Positive,6100,Positive,,Adult,,,Post-2nd,05-Aug-21,baseline,,63,,,02-Apr-21,03-Jun-21,,62,,8.71596208,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,Adalimumab,,,,,2021-05-12,2021-04-02,Pfizer,Vedolizumab,Adalimumab,none,none,Azathioprine/Immuran,2021-06-03,Pfizer,Vedolizumab,Adalimumab,none,none,Azathioprine/Immuran,,,,,,,,,.,.,.,.,.,.,,,,,1,,1,1,,,,1,Female,30,30,1,1,0,0,0,0,1,Combination Therapy,1,1,0,0,0,0,1,Combination Therapy,1,1,0,0,0,0,1,Combination Therapy,0,0,0,0,0,0,0,,,63,62,0,,,9,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,2021-05-12,1,,9,,386,2,30-39
954,,Female,CD,Vedolizumab,none,none,Azathioprine/Immuran,0.78,Positive,982,Positive,,Adult,,,Post-1st,12-May-21,baseline,40,,,,02-Apr-21,03-Jun-21,,62,,6.88948947,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,Adalimumab,,,,,2021-05-12,2021-04-02,Pfizer,Vedolizumab,Adalimumab,none,none,Azathioprine/Immuran,2021-06-03,Pfizer,Vedolizumab,Adalimumab,none,none,Azathioprine/Immuran,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,1,Female,30,30,1,1,0,0,0,0,1,Combination Therapy,1,1,0,0,0,0,1,Combination Therapy,1,1,0,0,0,0,1,Combination Therapy,0,0,0,0,0,0,0,,40,,62,0,,,7,0,1,Post-1st Dose,1,1,,0,0,0,2021-05-12,1,6,,,387,2,30-39
956,,Female,CD,Adalimumab,none,none,none,0.05,Negative,53759,Positive,,Adult,,,Post-2nd,18-May-21,baseline,,14,,,23-Mar-21,04-May-21,,42,,10.89226637,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-23,Pfizer,Adalimumab,.,none,none,none,2021-05-04,Pfizer,Adalimumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,34,34,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,14,42,1,,,11,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,2,,745,2,30-39
957,,Female,CD,Adalimumab,none,none,none,0.04,Negative,2184,Positive,,Adult,,,Post-2nd,21-Sep-21,baseline,,140,,,23-Mar-21,04-May-21,,42,,7.688867548,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-23,Pfizer,Adalimumab,.,none,none,none,2021-05-04,Pfizer,Adalimumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,34,35,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,140,42,1,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,20,,746,2,30-39
966,,Female,CD,Adalimumab,none,none,none,0.08,Negative,513,Positive,,Adult,236,,Post-2nd,10-Nov-21,covid,,175,,,28-Apr-21,19-May-21,07-Dec-21,21,202,6.241055268,ileocolonic,Inflamatory,N/A,,Outpatient,Confirmed COVID,,B117(Alpha),,,,2021-05-18,2021-04-28,Pfizer,Adalimumab,.,none,none,none,2021-05-19,Pfizer,Adalimumab,.,none,none,none,2021-12-07,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,2021-03-19,1,Female,32,32,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,175,21,1,,,6,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,2021-03-19,,,25,,941,2,30-39
967,,Female,CD,Adalimumab,none,none,none,0.99,Positive,7161,Positive,,Adult,60,,Post-1st,18-May-21,covid,20,,,,28-Apr-21,19-May-21,07-Dec-21,21,202,8.876460772,ileocolonic,Inflamatory,N/A,,Outpatient,Confirmed COVID,,B117(Alpha),,,,2021-05-18,2021-04-28,Pfizer,Adalimumab,.,none,none,none,2021-05-19,Pfizer,Adalimumab,.,none,none,none,2021-12-07,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,2021-03-19,1,Female,32,32,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,20,,21,1,,,9,0,1,Post-1st Dose,1,1,,0,0,0,2021-03-19,,3,,,942,2,30-39
974,,Female,CD,Ustekinumab,none,none,none,,,6603,Positive,,Adult,,,Post-2nd,12-Jul-21,baseline,,19,,,27-Apr-21,23-Jun-21,,57,,8.795233935,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-27,Pfizer,Ustekinumab,.,none,none,none,2021-06-23,Pfizer,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,34,34,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,,19,57,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,3,,594,2,30-39
975,,Female,CD,Ustekinumab,none,none,none,0.03,Negative,71,Positive,,Adult,,,Post-1st,07-Jun-21,baseline,41,,,,27-Apr-21,23-Jun-21,,57,,4.257030144,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-27,Pfizer,Ustekinumab,.,none,none,none,2021-06-23,Pfizer,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,34,34,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,41,,57,0,,,4,0,1,Post-1st Dose,1,1,,0,0,0,,,6,,,595,2,30-39
980,,Male,CD,Inflectra,none,none,Azathioprine/Immuran,0.1,Negative,2185,Positive,,Adult,272,,Post-2nd,13-Dec-21,covid,,165,,,03-May-21,01-Jul-21,,59,,7.689416873,ileocolonic,Stricturing,N/A,,Outpatient,Confirmed COVID,,,,,,,2021-05-03,Pfizer,Inflectra,.,none,none,Azathioprine/Immuran,2021-07-01,Pfizer,Inflectra,.,none,none,Azathioprine/Immuran,,,,,,,,,.,.,.,.,.,.,,,,,,1,1,1,,,2021-03-16,1,Male,36,37,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,0,0,0,0,0,0,0,,,165,59,0,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,2021-03-16,,,24,,973,2,30-39
981,,Male,CD,Inflectra,none,none,Azathioprine/Immuran,0.06,Negative,5525,Positive,,Adult,155,,Post-2nd,18-Aug-21,covid,,48,,,03-May-21,01-Jul-21,,59,,8.617074725,ileocolonic,Stricturing,N/A,,Outpatient,Confirmed COVID,,,,,,,2021-05-03,Pfizer,Inflectra,.,none,none,Azathioprine/Immuran,2021-07-01,Pfizer,Inflectra,.,none,none,Azathioprine/Immuran,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,2021-03-16,1,Male,36,37,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,0,0,0,0,0,0,0,,,48,59,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2021-03-16,,,7,,974,2,30-39
982,,Male,CD,Inflectra,none,none,Azathioprine/Immuran,0.13,Negative,2177,Positive,,Adult,101,,Post-1st,25-Jun-21,covid,53,,,,03-May-21,01-Jul-21,,59,,7.685473361,ileocolonic,Stricturing,N/A,,Outpatient,Confirmed COVID,,,,,,,2021-05-03,Pfizer,Inflectra,.,none,none,Azathioprine/Immuran,2021-07-01,Pfizer,Inflectra,.,none,none,Azathioprine/Immuran,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,2021-03-16,1,Male,36,37,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,0,0,0,0,0,0,0,,53,,59,0,,,8,0,1,Post-1st Dose,1,1,,0,0,0,2021-03-16,,8,,,975,2,30-39
3,,Female,UC,Remicade,none,none,Azathioprine/Immuran,0.01,Negative,2332,Positive,,Adult,,,Post-3rd,27-Oct-21,baseline,,,34,,29-Mar-21,01-Jun-21,23-Sep-21,64,114,7.754438665,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-03-29,Pfizer,Remicade,.,none,none,Azathioprine/Immuran,2021-06-01,Pfizer,Remicade,.,none,none,Azathioprine/Immuran,2021-09-23,Pfizer,Remicade,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,43,44,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,,64,0,,,8,0,0,Post-3rd Dose,1,1,34,0,0,0,,3,,,5,637,3,40-49
4,,Female,UC,Remicade,none,none,Azathioprine/Immuran,0.02,Negative,3374,Positive,,Adult,,,Post-2nd,24-Jun-21,baseline,,23,,,29-Mar-21,01-Jun-21,23-Sep-21,64,114,8.123913538,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-03-29,Pfizer,Remicade,.,none,none,Azathioprine/Immuran,2021-06-01,Pfizer,Remicade,.,none,none,Azathioprine/Immuran,2021-09-23,Pfizer,Remicade,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,43,43,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,23,64,0,,,8,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,638,3,40-49
5,,Female,UC,Remicade,none,none,Azathioprine/Immuran,0.02,Negative,64,Positive,,Adult,,,Post-1st,13-May-21,baseline,45,,,,29-Mar-21,01-Jun-21,23-Sep-21,64,114,4.157319361,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-03-29,Pfizer,Remicade,.,none,none,Azathioprine/Immuran,2021-06-01,Pfizer,Remicade,.,none,none,Azathioprine/Immuran,2021-09-23,Pfizer,Remicade,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,43,43,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,45,,64,0,,,4,0,0,Post-1st Dose,1,1,,0,0,0,,3,6,,,639,3,40-49
23,,Male,UC,Remicade,none,none,Azathioprine/Immuran,0.04,Negative,5055,Positive,,Adult,,,Post-3rd,15-Dec-21,baseline,,,22,,06-Apr-21,23-Jun-21,23-Nov-21,78,153,8.528212258,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-06,Pfizer,Remicade,.,none,none,Azathioprine/Immuran,2021-06-23,Pfizer,Remicade,.,none,none,Azathioprine/Immuran,2021-11-23,Pfizer,Remicade,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,44,44,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,,78,0,,,9,0,0,Post-3rd Dose,1,1,22,0,0,0,,3,,,3,651,3,40-49
24,,Male,UC,Remicade,none,none,Azathioprine/Immuran,0.04,Negative,105,Positive,,Adult,,,Post-1st,26-May-21,baseline,50,,,,06-Apr-21,23-Jun-21,23-Nov-21,78,153,4.652053772,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-06,Pfizer,Remicade,.,none,none,Azathioprine/Immuran,2021-06-23,Pfizer,Remicade,.,none,none,Azathioprine/Immuran,2021-11-23,Pfizer,Remicade,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,44,44,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,50,,78,0,,,5,0,0,Post-1st Dose,1,1,,0,0,0,,3,7,,,652,3,40-49
25,,Male,UC,Remicade,none,none,Azathioprine/Immuran,0.04,Negative,307,Positive,,Adult,,,Post-2nd,03-Nov-21,baseline,,133,,,06-Apr-21,23-Jun-21,23-Nov-21,78,153,5.727173427,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-06,Pfizer,Remicade,.,none,none,Azathioprine/Immuran,2021-06-23,Pfizer,Remicade,.,none,none,Azathioprine/Immuran,2021-11-23,Pfizer,Remicade,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,44,44,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,133,78,0,,,6,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,19,,653,3,40-49
49,,Female,CD,Ustekinumab,none,none,none,0.37,Negative,1582,Positive,,Adult,,,Post-1st,30-May-21,baseline,43,,,,17-Apr-21,12-Jun-21,15-Jan-22,56,217,7.366508357,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-17,Pfizer,Ustekinumab,.,none,none,none,2021-06-12,Pfizer,Ustekinumab,.,none,none,none,2022-01-15,,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,48,48,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,43,,56,0,,,7,0,1,Post-1st Dose,1,1,,0,0,0,,3,6,,,943,3,40-49
50,,Female,CD,Ustekinumab,none,none,none,,,19787,Positive,,Adult,,,Post-2nd,08-Jul-21,baseline,,26,,,17-Apr-21,12-Jun-21,15-Jan-22,56,217,9.892790543,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-17,Pfizer,Ustekinumab,.,none,none,none,2021-06-12,Pfizer,Ustekinumab,.,none,none,none,2022-01-15,,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,48,48,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,26,56,0,,,10,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,944,3,40-49
72,,Female,CD,Ustekinumab,none,none,none,0.06,Negative,252,Positive,,Adult,,,Post-1st,21-May-21,baseline,39,,,,12-Apr-21,20-Jul-21,,99,,5.530618856,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-12,Pfizer,Ustekinumab,.,none,none,none,2021-07-20,Pfizer,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,46,46,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,39,,99,0,,,6,0,1,Post-1st Dose,1,1,,0,0,0,,,6,,,674,3,40-49
83,,Male,UC,Ustekinumab,none,none,none,0.43,Negative,19643,Positive,,Adult,,,Post-3rd,15-Nov-21,baseline,,,66,,30-Mar-21,20-May-21,10-Sep-21,51,113,9.885486501,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-03-30,Pfizer,Ustekinumab,.,none,none,none,2021-05-20,Pfizer,Ustekinumab,.,none,none,none,2021-09-10,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,41,41,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,51,0,,,10,0,0,Post-3rd Dose,1,1,66,0,0,0,,3,,,9,778,3,40-49
84,,Male,UC,Ustekinumab,none,none,none,0.35,Negative,404,Positive,,Adult,,,Post-1st,24-Apr-21,baseline,25,,,,30-Mar-21,20-May-21,10-Sep-21,51,113,6.001662372,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-03-30,Pfizer,Ustekinumab,.,none,none,none,2021-05-20,Pfizer,Ustekinumab,.,none,none,none,2021-09-10,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,41,41,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,25,,51,0,,,6,0,0,Post-1st Dose,1,1,,0,0,0,,3,4,,,779,3,40-49
85,,Male,UC,Ustekinumab,none,none,none,0.26,Negative,4866,Positive,,Adult,,,Post-2nd,23-Jul-21,baseline,,64,,,30-Mar-21,20-May-21,10-Sep-21,51,113,8.489945317,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-03-30,Pfizer,Ustekinumab,.,none,none,none,2021-05-20,Pfizer,Ustekinumab,.,none,none,none,2021-09-10,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,41,41,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,64,51,0,,,8,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,9,,780,3,40-49
95,,Female,CD,Vedolizumab,none,none,none,0.03,Negative,126,Positive,,Adult,,,Post-1st,11-May-21,baseline,15,,,,26-Apr-21,23-Jun-21,,58,,4.832305759,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-26,Pfizer,Vedolizumab,.,none,none,none,2021-06-23,Pfizer,Vedolizumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,48,48,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,0,0,0,0,0,0,,15,,58,0,,,5,0,1,Post-1st Dose,1,1,,0,0,0,,,2,,,337,3,40-49
111,,Female,CD,Ustekinumab,none,none,none,0.15,Negative,4893,Positive,,Adult,,,Post-3rd,20-Sep-21,baseline,,,18,,31-Mar-21,05-May-21,02-Sep-21,35,120,8.495540454,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-31,Pfizer,Ustekinumab,.,none,none,none,2021-05-05,Pfizer,Ustekinumab,.,none,none,none,2021-09-02,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,49,49,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,35,1,,,8,0,1,Post-3rd Dose,1,1,18,0,0,0,,3,,,3,354,3,40-49
112,,Female,CD,Ustekinumab,none,none,none,0.07,Negative,87,Positive,,Adult,,,Post-2nd,01-Sep-21,baseline,,119,,,31-Mar-21,05-May-21,02-Sep-21,35,120,4.467056884,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-31,Pfizer,Ustekinumab,.,none,none,none,2021-05-05,Pfizer,Ustekinumab,.,none,none,none,2021-09-02,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,49,49,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,119,35,1,,,4,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,17,,355,3,40-49
113,,Female,CD,Ustekinumab,none,none,none,0.07,Negative,34,Negative,,Adult,,,Post-1st,04-May-21,baseline,34,,,,31-Mar-21,05-May-21,02-Sep-21,35,120,3.532225644,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-31,Pfizer,Ustekinumab,.,none,none,none,2021-05-05,Pfizer,Ustekinumab,.,none,none,none,2021-09-02,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,49,49,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,34,,35,1,,,4,0,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,356,3,40-49
114,,Female,CD,Ustekinumab,none,none,none,0.07,Negative,136,Positive,,Adult,,,Post-2nd,28-Jun-21,baseline,,54,,,31-Mar-21,05-May-21,02-Sep-21,35,120,4.911183215,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-31,Pfizer,Ustekinumab,.,none,none,none,2021-05-05,Pfizer,Ustekinumab,.,none,none,none,2021-09-02,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,49,49,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,54,35,1,,,5,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,8,,357,3,40-49
115,,Female,CD,Vedolizumab,none,none,Azathioprine/Immuran,0.05,Negative,15571,Positive,,Adult,,,Post-3rd,03-Nov-21,baseline,,,34,,04-May-21,20-Jun-21,30-Sep-21,47,102,9.653191177,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-04,Moderna,Vedolizumab,.,none,none,Azathioprine/Immuran,2021-06-20,Moderna,Vedolizumab,.,none,none,Azathioprine/Immuran,2021-09-30,Moderna,Vedolizumab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,39,40,0,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,1,Combination Therapy,,,47,0,,,10,0,1,Post-3rd Dose,1,1,34,0,0,0,,3,,,5,695,3,40-49
121,,Male,CD,none,none,Oral 5ASA,Methotrexate,0.19,Negative,40000,Positive,,Adult,,,Post-3rd,31-Dec-21,baseline,,,35,,13-Apr-21,29-Jun-21,26-Nov-21,77,150,10.59663473,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-13,Pfizer,none,.,none,Oral 5ASA,Methotrexate,2021-06-29,Pfizer,none,.,none,Oral 5ASA,Methotrexate,2021-11-26,Pfizer,none,.,none,Oral 5ASA,Methotrexate,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,45,46,0,0,0,0,0,1,1,Immunomodulator Only,0,0,0,0,0,1,1,Immunomodulator Only,0,0,0,0,0,1,1,Immunomodulator Only,0,0,0,0,0,1,1,Immunomodulator Only,,,77,0,,,11,0,1,Post-3rd Dose,1,1,35,0,0,0,,3,,,5,726,3,40-49
126,,Female,UC,Tofacitinib,none,Rectal 5ASA,none,,,1051,Positive,,Adult,,,Post-2nd,16-Jul-21,baseline,,28,,,13-Apr-21,18-Jun-21,10-Sep-21,66,84,6.957592514,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-13,Pfizer,Tofacitinib,.,none,Rectal 5ASA,none,2021-06-18,Pfizer,Tofacitinib,.,none,Rectal 5ASA,none,2021-09-10,Pfizer,Tofacitinib,.,none,Rectal 5ASA,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,44,44,0,0,0,1,0,1,0,Tofacitinib Only,0,0,0,1,0,1,0,Tofacitinib Only,0,0,0,1,0,1,0,Tofacitinib Only,0,0,0,1,0,1,0,Tofacitinib Only,,28,66,0,,,7,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,991,3,40-49
130,,Female,IBD-U,Infliximab,none,none,none,0.09,Negative,7312,Positive,,Adult,,,Post-3rd,23-Dec-21,baseline,,,90,,03-May-21,12-Jun-21,24-Sep-21,40,104,8.897326816,unknown,unknown,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-05-03,Pfizer,Infliximab,.,none,none,none,2021-06-12,Pfizer,Infliximab,.,none,none,none,2021-09-24,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,39,40,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,40,1,,,9,0,0,Post-3rd Dose,1,1,90,0,0,0,,3,,,13,448,3,40-49
138,,Female,CD,Ustekinumab,none,none,none,0.08,Negative,20289,Positive,,Adult,,,Post-3rd,29-Sep-21,baseline,,,14,,08-Apr-21,16-Jun-21,15-Sep-21,69,91,9.917814431,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-08,Pfizer,Ustekinumab,.,none,none,none,2021-06-16,Pfizer,Ustekinumab,.,none,none,none,2021-09-15,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,47,47,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,69,0,,,10,0,1,Post-3rd Dose,1,1,14,0,0,0,,3,,,2,879,3,40-49
139,,Female,CD,Ustekinumab,none,none,none,0.08,Negative,506,Positive,,Adult,,,Post-1st,18-May-21,baseline,40,,,,08-Apr-21,16-Jun-21,15-Sep-21,69,91,6.227326871,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-08,Pfizer,Ustekinumab,.,none,none,none,2021-06-16,Pfizer,Ustekinumab,.,none,none,none,2021-09-15,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,47,47,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,40,,69,0,,,6,0,1,Post-1st Dose,1,1,,0,0,0,,3,6,,,880,3,40-49
163,,Male,CD,Inflectra,none,none,none,0.11,Negative,1644,Positive,,Adult,,,Post-3rd,15-Dec-21,baseline,,,83,,13-Apr-21,31-May-21,23-Sep-21,48,115,7.404826747,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-13,Pfizer,Adalimumab,.,none,none,none,2021-05-31,Pfizer,Inflectra,.,none,none,none,2021-09-23,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,49,49,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,48,0,,,7,0,1,Post-3rd Dose,1,1,83,0,0,0,,3,,,12,824,3,40-49
164,,Male,CD,Inflectra,none,none,none,0.03,Negative,246,Positive,,Adult,,,Post-1st,26-May-21,baseline,43,,,,13-Apr-21,31-May-21,23-Sep-21,48,115,5.506144214,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-13,Pfizer,Adalimumab,.,none,none,none,2021-05-31,Pfizer,Inflectra,.,none,none,none,2021-09-23,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,49,49,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,43,,48,0,,,6,0,1,Post-1st Dose,1,1,,0,0,0,,3,6,,,825,3,40-49
165,,Male,CD,Inflectra,none,none,none,0.04,Negative,540,Positive,,Adult,,,Post-2nd,09-Sep-21,baseline,,101,,,13-Apr-21,31-May-21,23-Sep-21,48,115,6.291383937,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-13,Pfizer,Adalimumab,.,none,none,none,2021-05-31,Pfizer,Inflectra,.,none,none,none,2021-09-23,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,49,49,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,101,48,0,,,6,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,14,,826,3,40-49
168,,Male,CD,Adalimumab,none,none,none,0.05,Negative,6050,Positive,,Adult,,,Post-2nd,05-Aug-21,baseline,,55,,,09-Apr-21,11-Jun-21,29-Dec-21,63,201,8.707797022,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-09,Pfizer,Adalimumab,.,none,none,none,2021-06-11,Pfizer,Adalimumab,.,none,none,none,2021-12-29,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,45,46,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,55,63,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,8,,453,3,40-49
173,,Female,CD,Ustekinumab,none,none,none,0.02,Negative,848,Positive,,Adult,,,Post-2nd,14-Dec-21,baseline,,179,,,23-Apr-21,18-Jun-21,,56,,6.743116457,,,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-23,Moderna,Ustekinumab,.,none,none,none,2021-06-18,Moderna,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,43,44,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,,179,56,0,,,7,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,26,,478,3,40-49
174,,Female,CD,Ustekinumab,none,none,none,0.02,Negative,965,Positive,,Adult,,,Post-1st,02-Jun-21,baseline,40,,,,23-Apr-21,18-Jun-21,,56,,6.872128101,,,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-23,Moderna,Ustekinumab,.,none,none,none,2021-06-18,Moderna,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,43,43,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,40,,56,0,,,7,0,1,Post-1st Dose,1,1,,0,0,0,,,6,,,479,3,40-49
175,,Female,CD,Ustekinumab,none,none,none,,,7097,Positive,,Adult,,,Post-2nd,12-Jul-21,baseline,,24,,,23-Apr-21,18-Jun-21,,56,,8.867469709,,,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-23,Moderna,Ustekinumab,.,none,none,none,2021-06-18,Moderna,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,43,43,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,,24,56,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,3,,480,3,40-49
194,,Female,CD,Ustekinumab,none,none,none,0.05,Negative,2186,Positive,,Adult,,,Post-2nd,31-Aug-21,baseline,,75,,,15-Apr-21,17-Jun-21,,63,,7.689599914,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-15,Pfizer,Ustekinumab,.,none,none,none,2021-06-17,Pfizer,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,43,43,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,,75,63,0,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,11,,159,3,40-49
206,,Male,UC,Remicade,none,none,none,0.07,Negative,7548,Positive,,Adult,-74,,Post-2nd,17-Jun-21,Post Vaccine covid,,35,,,01-Apr-21,13-May-21,23-Dec-21,42,224,8.929064403,N/A,N/A,Left Sided Colitis,,Outpatient,Post Vaccine Confirmed COVID,,Delta,,,,2021-09-24,2021-04-01,Pfizer,Remicade,.,none,none,none,2021-05-13,Pfizer,Remicade,.,none,none,none,2021-12-23,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,2021-08-30,0,Male,45,45,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,35,42,1,,,9,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2021-08-30,2,,5,,908,3,40-49
207,,Male,UC,Remicade,none,none,none,1.54,Positive,40000,Positive,,Adult,25,,Post-2nd,24-Sep-21,Post Vaccine covid,,134,,,01-Apr-21,13-May-21,23-Dec-21,42,224,10.59663473,N/A,N/A,Left Sided Colitis,,Outpatient,Post Vaccine Confirmed COVID,,Delta,,,,2021-09-24,2021-04-01,Pfizer,Remicade,.,none,none,none,2021-05-13,Pfizer,Remicade,.,none,none,none,2021-12-23,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,2021-08-30,1,Male,45,45,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,134,42,1,,,11,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,2021-08-30,2,,19,,909,3,40-49
215,,Male,CD,Vedolizumab,none,none,none,0.02,Negative,442,Positive,,Adult,,,Post-3rd,18-Nov-21,baseline,,,62,,11-Apr-21,22-May-21,17-Sep-21,41,118,6.09221445,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-11,Pfizer,Vedolizumab,.,none,none,none,2021-05-22,Pfizer,Vedolizumab,.,none,none,none,2021-09-17,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,39,40,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,,41,1,,,6,0,1,Post-3rd Dose,1,1,62,0,0,0,,3,,,9,473,3,40-49
217,,Male,CD,Ustekinumab,none,none,Methotrexate,1.34,Positive,40000,Positive,,Adult,184,,Post-3rd,05-Nov-21,Post Vaccine covid,,,40,,08-Apr-21,10-Jun-21,26-Sep-21,63,108,10.59663473,ileocolonic,stricturing and upper GI,N/A,,Outpatient,Post Vaccine Confirmed COVID,,,,,,2021-11-05,2021-04-08,Pfizer,Ustekinumab,.,none,none,Methotrexate,2021-06-10,Pfizer,Ustekinumab,.,none,none,Methotrexate,2021-09-26,Pfizer,Ustekinumab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,,,,,,,1,,2021-05-05,1,Male,44,44,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,,,63,0,,,11,0,1,Post-3rd Dose,1,1,40,0,0,0,2021-05-05,1,,,6,891,3,40-49
218,,Male,CD,Adalimumab,none,none,none,0.15,Negative,25019,Positive,,Adult,,,Post-3rd,29-Oct-21,baseline,,,23,,22-Apr-21,05-Jun-21,06-Oct-21,44,123,10.12738682,colonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Adalimumab,.,none,none,none,2021-06-05,Pfizer,Adalimumab,.,none,none,none,2021-10-06,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,41,42,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,44,0,,,10,0,1,Post-3rd Dose,1,1,23,0,0,0,,3,,,3,916,3,40-49
219,,Male,CD,Adalimumab,none,none,none,0.05,Negative,437,Positive,,Adult,,,Post-1st,03-Jun-21,baseline,42,,,,22-Apr-21,05-Jun-21,06-Oct-21,44,123,6.080619458,colonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Adalimumab,.,none,none,none,2021-06-05,Pfizer,Adalimumab,.,none,none,none,2021-10-06,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,41,42,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,42,,44,0,,,6,0,1,Post-1st Dose,1,1,,0,0,0,,3,6,,,917,3,40-49
220,,Male,CD,Adalimumab,none,none,none,0.04,Negative,13168,Positive,,Adult,,,Post-2nd,25-Jun-21,baseline,,20,,,22-Apr-21,05-Jun-21,06-Oct-21,44,123,9.485567705,colonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Adalimumab,.,none,none,none,2021-06-05,Pfizer,Adalimumab,.,none,none,none,2021-10-06,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,41,42,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,20,44,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,918,3,40-49
221,,Female,UC,none,none,none,none,0.11,Negative,7730,Positive,,Adult,,,Post-3rd,29-Oct-21,baseline,,,45,,07-May-21,09-Jul-21,14-Sep-21,63,67,8.952825331,N/A,N/A,Proctitis,,Outpatient,Baseline Serology,,,,,,,2021-05-07,Pfizer,none,.,none,none,none,2021-07-09,Pfizer,none,.,none,none,none,2021-09-14,Moderna,none,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,42,42,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,,,63,0,,,9,0,0,Post-3rd Dose,1,1,45,1,1,1,,3,,,6,178,3,40-49
222,,Female,UC,none,none,none,none,,,13848,Positive,,Adult,,,Post-2nd,30-Jul-21,baseline,,21,,,07-May-21,09-Jul-21,14-Sep-21,63,67,9.535874433,N/A,N/A,Proctitis,,Outpatient,Baseline Serology,,,,,,,2021-05-07,Pfizer,none,.,none,none,none,2021-07-09,Pfizer,none,.,none,none,none,2021-09-14,Moderna,none,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,42,42,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,,21,63,0,,,10,0,0,Post-2nd Dose (1-8 Weeks),1,1,,1,1,1,,3,,3,,179,3,40-49
223,,Female,UC,none,none,none,none,0.02,Negative,614,Positive,,Adult,,,Post-1st,15-Jun-21,baseline,39,,,,07-May-21,09-Jul-21,14-Sep-21,63,67,6.420157781,N/A,N/A,Proctitis,,Outpatient,Baseline Serology,,,,,,,2021-05-07,Pfizer,none,.,none,none,none,2021-07-09,Pfizer,none,.,none,none,none,2021-09-14,Moderna,none,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,42,42,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,39,,63,0,,,6,0,0,Post-1st Dose,1,1,,1,1,1,,3,6,,,180,3,40-49
228,,Female,CD,Ustekinumab,none,none,none,0.03,Negative,549,Positive,,Adult,,,Post-1st,07-Jul-21,baseline,48,,,,20-May-21,08-Jul-21,,49,,6.308462674,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-20,Pfizer,Ustekinumab,.,none,none,none,2021-07-08,Pfizer,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,43,43,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,48,,49,0,,,6,0,1,Post-1st Dose,1,1,,0,0,0,,,7,,,405,3,40-49
229,,Male,CD,Ustekinumab,none,none,none,0.04,Negative,12952,Positive,,Adult,,,Post-3rd,30-Sep-21,baseline,,,23,,23-Apr-21,14-Jun-21,07-Sep-21,52,85,9.469013216,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-23,Pfizer,Ustekinumab,.,none,none,none,2021-06-14,Pfizer,Ustekinumab,.,none,none,none,2021-09-07,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,47,47,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,52,0,,,9,0,1,Post-3rd Dose,1,1,23,0,0,0,,3,,,3,441,3,40-49
230,,Male,CD,Ustekinumab,none,none,none,0.03,Negative,10851,Positive,,Adult,,,Post-2nd,23-Jul-21,baseline,,39,,,23-Apr-21,14-Jun-21,07-Sep-21,52,85,9.291966441,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-23,Pfizer,Ustekinumab,.,none,none,none,2021-06-14,Pfizer,Ustekinumab,.,none,none,none,2021-09-07,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,47,47,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,39,52,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,6,,442,3,40-49
231,,Male,CD,Ustekinumab,none,none,none,0.02,Negative,120,Positive,,Adult,,,Post-1st,31-May-21,baseline,38,,,,23-Apr-21,14-Jun-21,07-Sep-21,52,85,4.784988613,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-23,Pfizer,Ustekinumab,.,none,none,none,2021-06-14,Pfizer,Ustekinumab,.,none,none,none,2021-09-07,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,47,47,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,38,,52,0,,,5,0,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,443,3,40-49
235,,Male,CD,Adalimumab,none,none,none,0.04,Negative,42,Negative,,Adult,,,Post-1st,28-Jun-21,baseline,46,,,,13-May-21,23-Jun-21,02-Jan-22,41,193,3.737669618,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-13,Moderna,Adalimumab,.,none,none,none,2021-06-23,Moderna,Adalimumab,.,none,none,none,2022-01-02,Moderna,Adalimumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,47,47,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,46,,41,1,,,4,0,1,Post-1st Dose,1,1,,0,0,0,,3,7,,,212,3,40-49
241,,Male,CD,Adalimumab,none,none,none,0.39,Negative,11447,Positive,,Adult,66,,Post-2nd,21-Jul-21,Post Vaccine covid,,47,,,10-Apr-21,04-Jun-21,,55,,9.345465494,ileocolonic,Inflamatory,N/A,,Outpatient,Post Vaccine Confirmed COVID,,,,,,,2021-04-10,Pfizer,Adalimumab,.,none,none,none,2021-06-04,Pfizer,Adalimumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,2021-05-16,1,Male,42,42,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,47,55,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2021-05-16,1,,7,,928,3,40-49
245,,Male,CD,Adalimumab,none,none,none,,,1356,Positive,,Adult,,,Post-1st,13-Jul-21,baseline,40,,,,03-Jun-21,16-Aug-21,,74,,7.212146965,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-06-03,Pfizer,Adalimumab,.,none,none,none,2021-08-16,Pfizer,Adalimumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,45,45,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,40,,74,0,,,7,0,1,Post-1st Dose,1,1,,0,0,0,,,6,,,635,3,40-49
246,,Male,CD,Adalimumab,none,none,none,0.04,Negative,5335,Positive,,Adult,,,Post-2nd,26-Oct-21,baseline,,71,,,03-Jun-21,16-Aug-21,,74,,8.582044164,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-06-03,Pfizer,Adalimumab,.,none,none,none,2021-08-16,Pfizer,Adalimumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,45,45,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,71,74,0,,,9,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,10,,636,3,40-49
247,,Male,IBD-U,Adalimumab,none,none,none,0.03,Negative,546,Positive,,Adult,,,Post-1st,17-Jun-21,baseline,55,,,,23-Apr-21,22-Jun-21,,60,,6.302252608,N/A,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-04-23,Moderna,Adalimumab,.,none,none,none,2021-06-22,Moderna,Adalimumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,44,44,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,55,,60,0,,,6,0,0,Post-1st Dose,1,1,,0,0,0,,,8,,,79,3,40-49
248,,Male,IBD-U,Adalimumab,none,none,none,0.4,Negative,895,Positive,,Adult,,,Post-2nd,19-Nov-21,baseline,,150,,,23-Apr-21,22-Jun-21,,60,,6.79671198,N/A,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-04-23,Moderna,Adalimumab,.,none,none,none,2021-06-22,Moderna,Adalimumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,44,44,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,150,60,0,,,7,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,21,,80,3,40-49
251,,Female,CD,Infliximab,none,none,Azathioprine/Immuran,0.05,Negative,191,Positive,,Adult,,,Post-2nd,11-Sep-21,baseline,,71,,,16-May-21,02-Jul-21,,47,,5.251749731,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-16,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-07-02,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,,,,,,,,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,46,46,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,0,0,0,0,0,0,0,,,71,47,0,,,5,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,10,,972,3,40-49
253,,Male,UC,Inflectra,none,none,none,0.06,Negative,4224,Positive,,Adult,,,Post-2nd,11-Aug-21,baseline,,18,,,25-May-21,24-Jul-21,,60,,8.348537825,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-05-25,Pfizer,Inflectra,.,none,none,none,2021-07-24,Pfizer,Inflectra,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,40,40,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,18,60,0,,,8,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,3,,187,3,40-49
254,,Male,UC,Remicade,none,none,none,0.02,Negative,246,Positive,,Adult,217,,Post-2nd,29-Nov-21,Post Vaccine covid,,175,,,07-Apr-21,07-Jun-21,16-Dec-21,61,192,5.503296947,N/A,N/A,Pancolitis,,Outpatient,Post Vaccine Confirmed COVID,,,,,,2021-06-17,2021-04-07,Pfizer,Remicade,.,none,none,none,2021-06-07,Pfizer,Remicade,.,none,none,none,2021-12-16,Pfizer,Remicade,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,2021-04-26,1,Male,40,40,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,175,61,0,,,6,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,2021-04-26,1,,25,,229,3,40-49
255,,Male,UC,Remicade,none,none,none,0.92,Positive,2371,Positive,,Adult,52,,Post-2nd,17-Jun-21,Post Vaccine covid,,10,,,07-Apr-21,07-Jun-21,16-Dec-21,61,192,7.771193607,N/A,N/A,Pancolitis,,Outpatient,Post Vaccine Confirmed COVID,,,,,,2021-06-17,2021-04-07,Pfizer,Remicade,.,none,none,none,2021-06-07,Pfizer,Remicade,.,none,none,none,2021-12-16,Pfizer,Remicade,.,none,none,none,,.,.,.,.,.,.,,1,,1,,,,1,,,2021-04-26,1,Male,40,40,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,10,61,0,,,8,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2021-04-26,1,,1,,230,3,40-49
256,,Female,CD,Ustekinumab,none,none,none,,,80000,Positive,,Adult,,,Post-2nd,08-Jul-21,baseline,,15,,,23-Apr-21,23-Jun-21,02-Dec-21,61,162,11.28978191,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-23,Pfizer,Ustekinumab,.,none,none,none,2021-06-23,Pfizer,Ustekinumab,.,none,none,none,2021-12-02,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,41,41,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,15,61,0,,,11,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,2,,733,3,40-49
257,,Female,CD,Ustekinumab,none,none,none,0.05,Negative,3552,Positive,,Adult,,,Post-2nd,01-Nov-21,baseline,,131,,,23-Apr-21,23-Jun-21,02-Dec-21,61,162,8.175294257,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-23,Pfizer,Ustekinumab,.,none,none,none,2021-06-23,Pfizer,Ustekinumab,.,none,none,none,2021-12-02,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,41,42,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,131,61,0,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,19,,734,3,40-49
258,,Female,CD,Ustekinumab,none,none,none,0.02,Negative,441,Positive,,Adult,,,Post-1st,15-Jun-21,baseline,53,,,,23-Apr-21,23-Jun-21,02-Dec-21,61,162,6.088818092,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-23,Pfizer,Ustekinumab,.,none,none,none,2021-06-23,Pfizer,Ustekinumab,.,none,none,none,2021-12-02,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,41,41,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,53,,61,0,,,6,0,1,Post-1st Dose,1,1,,0,0,0,,3,8,,,735,3,40-49
264,,Female,CD,Adalimumab,none,none,none,0.03,Negative,6595,Positive,,Adult,,,Post-2nd,16-Jun-21,baseline,,19,,,21-Apr-21,28-May-21,23-Oct-21,37,148,8.793991247,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-21,Moderna,Adalimumab,.,none,none,none,2021-05-28,Moderna,Adalimumab,.,none,none,none,2021-10-23,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,49,49,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,19,37,1,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,197,3,40-49
273,,Female,CD,Ustekinumab,none,none,none,,,8443,Positive,,Adult,,,Post-2nd,09-Jul-21,baseline,,43,,,21-Apr-21,27-May-21,16-Nov-21,36,173,9.041092975,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-21,Pfizer,Ustekinumab,.,none,none,none,2021-05-27,Pfizer,Ustekinumab,.,none,none,none,2021-11-16,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,47,47,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,43,36,1,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,6,,576,3,40-49
274,,Male,UC,Vedolizumab,none,none,none,0.04,Negative,12333,Positive,,Adult,,,Post-3rd,25-Nov-21,baseline,,,84,,29-Mar-21,20-May-21,02-Sep-21,52,105,9.419993333,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-03-29,Pfizer,Vedolizumab,.,none,none,none,2021-05-20,Pfizer,Vedolizumab,.,none,none,none,2021-09-02,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,45,46,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,,52,0,,,9,0,0,Post-3rd Dose,1,1,84,0,0,0,,3,,,12,307,3,40-49
275,,Male,UC,Vedolizumab,none,none,none,0.03,Negative,15164,Positive,,Adult,,,Post-2nd,04-Jun-21,baseline,,15,,,29-Mar-21,20-May-21,02-Sep-21,52,105,9.626646503,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-03-29,Pfizer,Vedolizumab,.,none,none,none,2021-05-20,Pfizer,Vedolizumab,.,none,none,none,2021-09-02,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,45,45,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,15,52,0,,,10,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,2,,308,3,40-49
276,,Female,CD,none,none,Oral 5ASA,none,0.06,Negative,18547,Positive,,Adult,,,Post-3rd,20-Dec-21,baseline,,,19,,19-Apr-21,29-May-21,01-Dec-21,40,186,9.828074113,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-19,Pfizer,none,.,none,Oral 5ASA,none,2021-05-29,Pfizer,none,.,none,Oral 5ASA,none,2021-12-01,Pfizer,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,40,40,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,,40,1,,,10,0,1,Post-3rd Dose,1,1,19,1,1,1,,3,,,3,167,3,40-49
277,,Female,CD,none,none,Oral 5ASA,none,0.03,Negative,3914,Positive,,Adult,,,Post-2nd,18-Jun-21,baseline,,20,,,19-Apr-21,29-May-21,01-Dec-21,40,186,8.272315148,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-19,Pfizer,none,.,none,Oral 5ASA,none,2021-05-29,Pfizer,none,.,none,Oral 5ASA,none,2021-12-01,Pfizer,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,40,40,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,20,40,1,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,1,1,1,,3,,3,,168,3,40-49
278,,Female,CD,none,none,Oral 5ASA,none,0.01,Negative,597,Positive,,Adult,,,Post-2nd,09-Nov-21,baseline,,164,,,19-Apr-21,29-May-21,01-Dec-21,40,186,6.392252066,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-19,Pfizer,none,.,none,Oral 5ASA,none,2021-05-29,Pfizer,none,.,none,Oral 5ASA,none,2021-12-01,Pfizer,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,40,40,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,164,40,1,,,6,0,1,Post-2nd Dose (8+ Weeks),1,1,,1,1,1,,3,,23,,169,3,40-49
293,,Female,CD,Inflectra,none,none,none,0.02,Negative,1273,Positive,,Adult,,,Post-3rd,22-Sep-21,baseline,,,20,,02-Apr-21,01-May-21,02-Sep-21,29,124,7.149288695,colonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-02,Pfizer,Inflectra,.,none,none,none,2021-05-01,Pfizer,Inflectra,.,none,none,none,2021-09-02,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,43,43,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,29,1,,,7,0,1,Post-3rd Dose,1,1,20,0,0,0,,3,,,3,367,3,40-49
294,,Female,CD,Inflectra,none,none,none,0.02,Negative,108,Positive,,Adult,,,Post-2nd,30-Jun-21,baseline,,60,,,02-Apr-21,01-May-21,02-Sep-21,29,124,4.683056725,colonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-02,Pfizer,Inflectra,.,none,none,none,2021-05-01,Pfizer,Inflectra,.,none,none,none,2021-09-02,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,43,43,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,60,29,1,,,5,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,9,,368,3,40-49
296,,Female,CD,Ustekinumab,none,none,none,0.03,Negative,12198,Positive,,Adult,,,Post-3rd,15-Sep-21,baseline,,,14,,07-Apr-21,16-May-21,01-Sep-21,39,108,9.409010887,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-07,Pfizer,Ustekinumab,.,none,none,none,2021-05-16,Pfizer,Ustekinumab,.,none,none,none,2021-09-01,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,45,45,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,39,1,,,9,0,1,Post-3rd Dose,1,1,14,0,0,0,,3,,,2,655,3,40-49
297,,Female,CD,Ustekinumab,none,none,none,,,2258,Positive,,Adult,,,Post-2nd,15-Jul-21,baseline,,60,,,07-Apr-21,16-May-21,01-Sep-21,39,108,7.722367597,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-07,Pfizer,Ustekinumab,.,none,none,none,2021-05-16,Pfizer,Ustekinumab,.,none,none,none,2021-09-01,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,45,45,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,60,39,1,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,9,,656,3,40-49
300,,Female,CD,none,none,none,Azathioprine/Immuran,0.01,Negative,9724,Positive,,Adult,,,Post-3rd,29-Oct-21,baseline,,,31,,19-Apr-21,14-Jun-21,28-Sep-21,56,106,9.182383186,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-19,Moderna,none,.,none,none,Azathioprine/Immuran,2021-06-14,Moderna,none,.,none,none,Azathioprine/Immuran,2021-09-28,Moderna,none,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,40,41,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,,,56,0,,,9,0,1,Post-3rd Dose,1,1,31,0,0,0,,3,,,4,286,3,40-49
301,,Female,CD,none,none,none,Azathioprine/Immuran,0.01,Negative,2426,Positive,,Adult,,,Post-2nd,22-Jul-21,baseline,,38,,,19-Apr-21,14-Jun-21,28-Sep-21,56,106,7.793834195,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-19,Moderna,none,.,none,none,Azathioprine/Immuran,2021-06-14,Moderna,none,.,none,none,Azathioprine/Immuran,2021-09-28,Moderna,none,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,40,40,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,,38,56,0,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,5,,287,3,40-49
318,,Female,UC,Adalimumab,none,none,Methotrexate,0.02,Negative,652,Positive,,Adult,,,Post-2nd,24-Jun-21,baseline,,21,,,05-Apr-21,03-Jun-21,04-Sep-21,59,93,6.479584333,N/A ,N/A,Pancolitis,none,Outpatient,Baseline Serology,,,,,,,2021-04-05,Moderna,Adalimumab,.,none,none,Methotrexate,2021-06-03,Moderna,Adalimumab,.,none,none,Methotrexate,2021-09-04,Pfizer,Adalimumab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,48,48,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,21,59,0,,,6,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,470,3,40-49
319,,Female,UC,Adalimumab,none,none,Methotrexate,0.02,Negative,118,Positive,,Adult,,,Post-1st,04-May-21,baseline,29,,,,05-Apr-21,03-Jun-21,04-Sep-21,59,93,4.767289035,N/A ,N/A,Pancolitis,none,Outpatient,Baseline Serology,,,,,,,2021-04-05,Moderna,Adalimumab,.,none,none,Methotrexate,2021-06-03,Moderna,Adalimumab,.,none,none,Methotrexate,2021-09-04,Pfizer,Adalimumab,.,none,none,Methotrexate,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,48,48,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,29,,59,0,,,5,0,0,Post-1st Dose,1,1,,0,0,0,,3,4,,,471,3,40-49
322,,Female,CD,Vedolizumab,none,none,none,0.01,Negative,681,Positive,,Adult,,,Post-1st,07-May-21,baseline,34,,,,03-Apr-21,08-May-21,19-Sep-21,35,134,6.523268577,ileal,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,Vedolizumab,.,none,none,none,2021-05-08,Pfizer,Vedolizumab,.,none,none,none,2021-09-19,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,41,41,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,34,,35,1,,,7,0,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,896,3,40-49
323,,Female,CD,Vedolizumab,none,none,none,0.02,Negative,4255,Positive,,Adult,,,Post-2nd,23-Jun-21,baseline,,46,,,03-Apr-21,08-May-21,19-Sep-21,35,134,8.355873542,ileal,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,Vedolizumab,.,none,none,none,2021-05-08,Pfizer,Vedolizumab,.,none,none,none,2021-09-19,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,41,41,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,46,35,1,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,7,,897,3,40-49
324,,Female,CD,Vedolizumab,none,none,none,0.02,Negative,3525,Positive,,Adult,,,Post-2nd,08-Sep-21,baseline,,123,,,03-Apr-21,08-May-21,19-Sep-21,35,134,8.167493861,ileal,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,Vedolizumab,.,none,none,none,2021-05-08,Pfizer,Vedolizumab,.,none,none,none,2021-09-19,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,41,41,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,123,35,1,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,18,,898,3,40-49
336,,Male,CD,Inflectra,none,none,none,0.52,Negative,3880,Positive,,Adult,,,Post-3rd,07-Dec-21,baseline,,,76,,09-Apr-21,12-May-21,22-Sep-21,33,133,8.263616205,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-09,Pfizer,Inflectra,.,none,none,none,2021-05-12,Pfizer,Inflectra,.,none,none,none,2021-09-22,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,44,44,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,33,1,,,8,0,1,Post-3rd Dose,1,1,76,0,0,0,,3,,,11,697,3,40-49
337,,Male,CD,Inflectra,none,none,none,0.03,Negative,702,Positive,,Adult,,,Post-2nd,22-Jun-21,baseline,,41,,,09-Apr-21,12-May-21,22-Sep-21,33,133,6.5532209,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-09,Pfizer,Inflectra,.,none,none,none,2021-05-12,Pfizer,Inflectra,.,none,none,none,2021-09-22,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,44,44,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,41,33,1,,,7,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,6,,698,3,40-49
338,,Male,CD,Inflectra,none,none,none,0.03,Negative,504,Positive,,Adult,,,Post-2nd,17-Aug-21,baseline,,97,,,09-Apr-21,12-May-21,22-Sep-21,33,133,6.223171329,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-09,Pfizer,Inflectra,.,none,none,none,2021-05-12,Pfizer,Inflectra,.,none,none,none,2021-09-22,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,44,44,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,97,33,1,,,6,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,14,,699,3,40-49
347,,Female,CD,Vedolizumab,none,none,none,0.05,Negative,40000,Positive,,Adult,,,Post-3rd,17-Nov-21,baseline,,,27,,14-Apr-21,28-May-21,21-Oct-21,44,146,10.59663473,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-14,Moderna,Vedolizumab,.,none,none,none,2021-05-28,Moderna,Vedolizumab,.,none,none,none,2021-10-21,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,42,43,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,,44,0,,,11,0,1,Post-3rd Dose,1,1,27,0,0,0,,3,,,4,810,3,40-49
348,,Female,CD,Vedolizumab,none,none,none,0.04,Negative,17240,Positive,,Adult,,,Post-2nd,21-Jun-21,baseline,,24,,,14-Apr-21,28-May-21,21-Oct-21,44,146,9.754993345,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-14,Moderna,Vedolizumab,.,none,none,none,2021-05-28,Moderna,Vedolizumab,.,none,none,none,2021-10-21,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,42,42,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,24,44,0,,,10,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,811,3,40-49
358,,Female,CD,Ustekinumab,none,none,none,0.05,Negative,13866,Positive,,Adult,,,Post-2nd,30-Jun-21,baseline,,19,,,21-Apr-21,11-Jun-21,07-Sep-21,51,88,9.537216715,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-21,Pfizer,Ustekinumab,.,none,none,none,2021-06-11,Pfizer,Ustekinumab,.,none,none,none,2021-09-07,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,45,45,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,19,51,0,,,10,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,957,3,40-49
359,,Male,CD,Vedolizumab,none,none,none,0.02,Negative,14754,Positive,,Adult,,,Post-3rd,28-Oct-21,baseline,,,38,,08-Apr-21,16-Jun-21,20-Sep-21,69,96,9.599249178,colonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-08,Pfizer,Vedolizumab,.,none,none,none,2021-06-16,Pfizer,Vedolizumab,.,none,none,none,2021-09-20,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,43,43,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,,69,0,,,10,0,1,Post-3rd Dose,1,1,38,0,0,0,,3,,,5,252,3,40-49
360,,Male,CD,Vedolizumab,none,none,none,,,8761,Positive,,Adult,,,Post-2nd,07-Jul-21,baseline,,21,,,08-Apr-21,16-Jun-21,20-Sep-21,69,96,9.078110989,colonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-08,Pfizer,Vedolizumab,.,none,none,none,2021-06-16,Pfizer,Vedolizumab,.,none,none,none,2021-09-20,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,43,43,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,21,69,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,253,3,40-49
372,,Female,CD,Vedolizumab,none,none,none,1.11,Positive,1655,Positive,,Adult,,,Post-2nd,03-Dec-21,baseline,,294,,,03-Jan-21,12-Feb-21,03-Dec-21,40,294,7.41173754,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,2021-12-03,2021-01-03,Pfizer,Vedolizumab,.,none,none,none,2021-02-12,Pfizer,Vedolizumab,.,none,none,none,2021-12-03,Moderna,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,1,Female,39,40,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,294,40,1,,,7,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,2021-12-03,,,42,,273,3,40-49
377,,Male,UC,Vedolizumab,none,none,Methotrexate,0.46,Negative,12262,Positive,,Adult,378,,Post-2nd,08-Dec-21,covid,,158,,,23-May-21,03-Jul-21,,41,,9.414219551,N/A ,N/A,Unknown,,Outpatient,Confirmed COVID,Golimumab,,,,,,2021-05-23,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,2021-07-03,Moderna,Vedolizumab,.,none,Oral 5ASA,none,,,,,,,,,.,.,.,.,.,.,,,,,,1,1,1,,,2020-11-25,1,Male,46,47,1,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,0,0,0,0,0,0,,,158,41,1,,,9,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,2020-11-25,,,23,,718,3,40-49
378,,Male,UC,Vedolizumab,none,none,Methotrexate,0.57,Negative,25010,Positive,,Adult,199,,Post-1st,12-Jun-21,covid,20,,,,23-May-21,03-Jul-21,,41,,10.12703102,N/A ,N/A,Unknown,,Outpatient,Confirmed COVID,Golimumab,,,,,,2021-05-23,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,2021-07-03,Moderna,Vedolizumab,.,none,Oral 5ASA,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,2020-11-25,1,Male,46,46,1,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,0,0,0,0,0,0,,20,,41,1,,,10,0,0,Post-1st Dose,1,1,,0,0,0,2020-11-25,,3,,,719,3,40-49
379,,Male,UC,Vedolizumab,none,none,Methotrexate,0.54,Negative,78173,Positive,,Adult,238,,Post-2nd,21-Jul-21,covid,,18,,,23-May-21,03-Jul-21,,41,,11.26668088,N/A ,N/A,Unknown,,Outpatient,Confirmed COVID,Golimumab,,,,,,2021-05-23,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,2021-07-03,Moderna,Vedolizumab,.,none,Oral 5ASA,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,2020-11-25,1,Male,46,46,1,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,0,0,0,0,0,0,,,18,41,1,,,11,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2020-11-25,,,3,,720,3,40-49
398,,Male,CD,Vedolizumab,none,none,none,0.05,Negative,4543,Positive,,Adult,,,Post-3rd,03-Nov-21,baseline,,,54,,09-Apr-21,16-Jun-21,10-Sep-21,68,86,8.4212328,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-09,Pfizer,Vedolizumab,Ustekinumab,none,none,none,2021-06-16,Pfizer,Vedolizumab,Ustekinumab,none,none,none,2021-09-10,Pfizer,Vedolizumab,Ustekinumab,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,47,48,0,1,0,0,0,0,0,Vedolizumab Only,0,1,1,0,0,0,0,Combination Therapy,0,1,1,0,0,0,0,Combination Therapy,0,1,1,0,0,0,0,Combination Therapy,,,68,0,,,8,0,1,Post-3rd Dose,1,1,54,0,0,0,,3,,,8,560,3,40-49
399,,Male,CD,Vedolizumab,none,none,none,,,2914,Positive,,Adult,,,Post-2nd,12-Jul-21,baseline,,26,,,09-Apr-21,16-Jun-21,10-Sep-21,68,86,7.97717903,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-09,Pfizer,Vedolizumab,Ustekinumab,none,none,none,2021-06-16,Pfizer,Vedolizumab,Ustekinumab,none,none,none,2021-09-10,Pfizer,Vedolizumab,Ustekinumab,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,47,48,0,1,0,0,0,0,0,Vedolizumab Only,0,1,1,0,0,0,0,Combination Therapy,0,1,1,0,0,0,0,Combination Therapy,0,1,1,0,0,0,0,Combination Therapy,,26,68,0,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,561,3,40-49
407,,Female,CD,Adalimumab,none,none,none,0.04,Negative,4679,Positive,,Adult,,,Post-3rd,17-Nov-21,baseline,,,53,,30-Mar-21,06-May-21,25-Sep-21,37,142,8.450882434,ileocolonic,Stricturing,N/A,ileostomy,Outpatient,Baseline Serology,,,,,,,2021-03-30,Pfizer,Adalimumab,.,none,none,none,2021-05-06,Pfizer,Adalimumab,.,none,none,none,2021-09-25,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,42,42,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,37,1,,,8,0,1,Post-3rd Dose,1,1,53,0,0,0,,3,,,8,9,3,40-49
408,,Female,CD,Adalimumab,none,none,none,0.13,Negative,5836,Positive,,Adult,256,,Post-2nd,18-Aug-21,covid,,46,,,04-Jun-21,03-Jul-21,23-Dec-21,29,173,8.671852313,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Confirmed COVID,,,,,,,2021-06-04,Pfizer,Adalimumab,.,none,none,none,2021-07-03,Pfizer,Adalimumab,.,none,none,none,2021-12-23,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,2020-12-05,1,Female,44,44,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,46,29,1,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2020-12-05,,,7,,76,3,40-49
414,,Female,CD,Vedolizumab,none,none,none,0.46,Negative,40000,Positive,,Adult,,,Post-3rd,25-Nov-21,baseline,,,17,,06-May-21,08-Jul-21,08-Nov-21,63,123,10.59663473,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,Adalimumab,,,,,,2021-05-06,Pfizer,Adalimumab,.,none,none,none,2021-07-08,Pfizer,Adalimumab,.,none,none,none,2021-11-08,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,48,49,1,1,0,0,0,0,0,Combination Therapy,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,63,0,,,11,0,1,Post-3rd Dose,1,1,17,0,0,0,,3,,,2,621,3,40-49
415,,Female,CD,Vedolizumab,none,none,none,0.45,Negative,18776,Positive,,Adult,,,Post-2nd,30-Jul-21,baseline,,22,,,06-May-21,08-Jul-21,08-Nov-21,63,123,9.840345389,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,Adalimumab,,,,,,2021-05-06,Pfizer,Adalimumab,.,none,none,none,2021-07-08,Pfizer,Adalimumab,.,none,none,none,2021-11-08,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,48,49,1,1,0,0,0,0,0,Combination Therapy,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,22,63,0,,,10,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,622,3,40-49
424,,Female,IBD-U,Adalimumab,none,none,none,,,3706,Positive,,Adult,,,Post-2nd,30-Jul-21,baseline,,45,,,19-Apr-21,15-Jun-21,05-Jan-22,57,204,8.217708407,colonic,Inflamatory,Unknown,none,Outpatient,Baseline Serology,,,,,,,2021-04-19,Moderna,Adalimumab,.,none,none,none,2021-06-15,Moderna,Adalimumab,.,none,none,none,2022-01-05,Moderna,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,41,41,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,45,57,0,,,8,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,6,,131,3,40-49
432,,Female,CD,Adalimumab,none,none,none,0.03,Negative,4015,Positive,,Adult,,,Post-3rd,22-Dec-21,baseline,,,27,,29-Apr-21,21-Jun-21,25-Nov-21,53,157,8.297742812,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-29,Pfizer,Adalimumab,.,none,none,none,2021-06-21,Pfizer,Adalimumab,.,none,none,none,2021-11-25,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,49,49,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,53,0,,,8,0,1,Post-3rd Dose,1,1,27,0,0,0,,3,,,4,958,3,40-49
433,,Female,CD,Adalimumab,none,none,none,,,5015,Positive,,Adult,,,Post-2nd,05-Jul-21,baseline,,14,,,29-Apr-21,21-Jun-21,25-Nov-21,53,157,8.520268458,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-29,Pfizer,Adalimumab,.,none,none,none,2021-06-21,Pfizer,Adalimumab,.,none,none,none,2021-11-25,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,49,49,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,14,53,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,2,,959,3,40-49
434,,Female,CD,Adalimumab,none,none,none,0.02,Negative,159,Positive,,Adult,,,Post-1st,14-Jun-21,baseline,46,,,,29-Apr-21,21-Jun-21,25-Nov-21,53,157,5.071416766,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-29,Pfizer,Adalimumab,.,none,none,none,2021-06-21,Pfizer,Adalimumab,.,none,none,none,2021-11-25,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,49,49,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,46,,53,0,,,5,0,1,Post-1st Dose,1,1,,0,0,0,,3,7,,,960,3,40-49
435,,Female,CD,Adalimumab,none,none,none,0.02,Negative,625,Positive,,Adult,,,Post-2nd,19-Nov-21,baseline,,151,,,29-Apr-21,21-Jun-21,25-Nov-21,53,157,6.437591637,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-29,Pfizer,Adalimumab,.,none,none,none,2021-06-21,Pfizer,Adalimumab,.,none,none,none,2021-11-25,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,49,49,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,151,53,0,,,6,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,22,,961,3,40-49
448,,Female,UC,Inflectra,none,none,Methotrexate,,,10012,Positive,,Adult,,,Post-2nd,08-Jul-21,baseline,,13,,,26-Apr-21,25-Jun-21,20-Dec-21,60,178,9.211569616,N/A ,N/A,Proctitis,none,Outpatient,Baseline Serology,,,,,,,2021-04-26,Pfizer,Inflectra,.,none,none,Methotrexate,2021-06-25,Pfizer,Inflectra,.,none,none,Methotrexate,2021-12-20,,Inflectra,.,none,none,Methotrexate,,.,.,.,.,.,.,,1,,1,,,,1,,,,0,Female,43,43,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,13,60,0,,,9,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,2,,436,3,40-49
449,,Female,UC,Inflectra,none,none,Methotrexate,0.05,Negative,135,Positive,,Adult,,,Post-2nd,22-Dec-21,baseline,,180,,,26-Apr-21,25-Jun-21,20-Dec-21,60,178,4.904533763,N/A ,N/A,Proctitis,none,Outpatient,Baseline Serology,,,,,,,2021-04-26,Pfizer,Inflectra,.,none,none,Methotrexate,2021-06-25,Pfizer,Inflectra,.,none,none,Methotrexate,2021-12-20,,Inflectra,.,none,none,Methotrexate,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,43,43,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,180,60,0,,,5,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,26,,437,3,40-49
476,,Female,CD,Ustekinumab,none,none,none,0.05,Negative,78052,Positive,,Adult,,,Post-2nd,14-Jul-21,baseline,,26,,,27-Apr-21,18-Jun-21,03-Sep-21,52,77,11.26512927,ileal,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-27,Moderna,Ustekinumab,.,none,none,none,2021-06-18,Moderna,Ustekinumab,.,none,none,none,2021-09-03,Moderna,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,45,45,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,26,52,0,,,11,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,553,3,40-49
477,,Female,UC,Infliximab,none,none,none,,,47,Negative,,Adult,,,Post-2nd,20-Jul-21,baseline,,194,,,17-Dec-20,07-Jan-21,22-Sep-21,21,258,3.848017675,N/A ,N/A,Proctitis,,Outpatient,Baseline Serology,,,,,,,2020-12-17,Pfizer,Infliximab,.,none,none,none,2021-01-07,Pfizer,Infliximab,.,none,none,none,2021-09-22,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,42,43,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,194,21,1,,,4,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,28,,601,3,40-49
484,,Female,UC,Infliximab,none,Oral 5ASA,none,0.04,Negative,10986,Positive,,Adult,,,Post-3rd,21-Oct-21,baseline,,,36,,10-Jan-21,18-Feb-21,15-Sep-21,39,209,9.304377014,N/A ,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-01-10,Pfizer,Infliximab,.,none,Oral 5ASA,none,2021-02-18,Pfizer,Infliximab,.,none,Oral 5ASA,none,2021-09-15,Pfizer,Infliximab,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,48,48,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,,,39,1,,,9,0,0,Post-3rd Dose,1,1,36,0,0,0,,3,,,5,316,3,40-49
485,,Female,UC,Infliximab,none,Oral 5ASA,none,0.02,Negative,86,Positive,,Adult,,,Post-2nd,26-Aug-21,baseline,,189,,,10-Jan-21,18-Feb-21,15-Sep-21,39,209,4.450852826,N/A ,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-01-10,Pfizer,Infliximab,.,none,Oral 5ASA,none,2021-02-18,Pfizer,Infliximab,.,none,Oral 5ASA,none,2021-09-15,Pfizer,Infliximab,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,48,48,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,,189,39,1,,,4,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,27,,317,3,40-49
487,,Male,CD,Infliximab,none,none,none,0.02,Negative,6328,Positive,,Adult,,,Post-3rd,15-Nov-21,baseline,,,49,,10-Apr-21,10-Jun-21,27-Sep-21,61,109,8.752723707,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-10,Pfizer,Infliximab,.,none,none,none,2021-06-10,Pfizer,Infliximab,.,none,none,none,2021-09-27,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,41,41,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,61,0,,,9,0,1,Post-3rd Dose,1,1,49,0,0,0,,3,,,7,599,3,40-49
488,,Male,CD,Infliximab,none,none,none,0.04,Negative,2004,Positive,,Adult,,,Post-2nd,18-Jun-21,baseline,,8,,,10-Apr-21,10-Jun-21,27-Sep-21,61,109,7.602850561,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-10,Pfizer,Infliximab,.,none,none,none,2021-06-10,Pfizer,Infliximab,.,none,none,none,2021-09-27,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,1,,1,,,,1,,,,0,Male,41,41,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,8,61,0,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,1,,600,3,40-49
495,,Male,CD,Remicade,none,Oral 5ASA,Azathioprine/Immuran,0.81,Positive,1618,Positive,,Adult,,,Post-3rd,17-Dec-21,baseline,,,28,,10-Apr-21,11-Jun-21,19-Nov-21,62,161,7.3890079,unknown,unknown,N/A,,Outpatient,Baseline Serology,,,,,,2021-12-17,2021-04-10,Pfizer,Remicade,.,none,Oral 5ASA,Azathioprine/Immuran,2021-06-11,Pfizer,Remicade,.,none,Oral 5ASA,Azathioprine/Immuran,2021-11-19,Pfizer,Remicade,.,none,Oral 5ASA,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,,,,,1,,,1,Male,47,48,1,0,0,0,0,1,1,Combination Therapy,1,0,0,0,0,1,1,Combination Therapy,1,0,0,0,0,1,1,Combination Therapy,1,0,0,0,0,1,1,Combination Therapy,,,62,0,,,7,0,1,Post-3rd Dose,1,1,28,0,0,0,2021-12-17,3,,,4,116,3,40-49
496,,Male,CD,Remicade,none,Oral 5ASA,Azathioprine/Immuran,,,797,Positive,,Adult,,,Post-2nd,29-Jul-21,baseline,,48,,,10-Apr-21,11-Jun-21,19-Nov-21,62,161,6.680352671,unknown,unknown,N/A,,Outpatient,Baseline Serology,,,,,,2021-12-17,2021-04-10,Pfizer,Remicade,.,none,Oral 5ASA,Azathioprine/Immuran,2021-06-11,Pfizer,Remicade,.,none,Oral 5ASA,Azathioprine/Immuran,2021-11-19,Pfizer,Remicade,.,none,Oral 5ASA,Azathioprine/Immuran,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,47,47,1,0,0,0,0,1,1,Combination Therapy,1,0,0,0,0,1,1,Combination Therapy,1,0,0,0,0,1,1,Combination Therapy,1,0,0,0,0,1,1,Combination Therapy,,48,62,0,,,7,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2021-12-17,3,,7,,117,3,40-49
497,,Male,CD,Ustekinumab,none,none,Azathioprine/Immuran,0.03,Negative,15266,Positive,,Adult,,,Post-3rd,19-Nov-21,baseline,,,44,,11-Apr-21,11-Jun-21,06-Oct-21,61,117,9.63335721,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-11,Moderna,Ustekinumab,.,none,none,Azathioprine/Immuran,2021-06-11,Moderna,Ustekinumab,.,none,none,Azathioprine/Immuran,2021-10-06,Moderna,Ustekinumab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,47,47,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,,,61,0,,,10,0,1,Post-3rd Dose,1,1,44,0,0,0,,3,,,6,3,3,40-49
498,,Male,CD,Ustekinumab,none,none,Azathioprine/Immuran,0.02,Negative,4169,Positive,,Adult,,,Post-2nd,16-Jul-21,baseline,,35,,,11-Apr-21,11-Jun-21,06-Oct-21,61,117,8.335383504,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-11,Moderna,Ustekinumab,.,none,none,Azathioprine/Immuran,2021-06-11,Moderna,Ustekinumab,.,none,none,Azathioprine/Immuran,2021-10-06,Moderna,Ustekinumab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,47,47,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,,35,61,0,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,5,,4,3,40-49
504,,Female,CD,Ustekinumab,none,none,none,0.01,Negative,918,Positive,,Adult,,,Post-2nd,30-Jun-21,baseline,,20,,,14-Apr-21,10-Jun-21,19-Nov-21,57,162,6.822197391,ileocolonic,fistulizing and perianal,N/A,ileostomy,Outpatient,Baseline Serology,,,,,,,2021-04-14,Pfizer,Ustekinumab,.,none,none,none,2021-06-10,Pfizer,Ustekinumab,.,none,none,none,2021-11-19,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,42,43,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,20,57,0,,,7,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,77,3,40-49
505,,Female,CD,Ustekinumab,none,none,none,0.01,Negative,5,Negative,,Adult,,,Post-1st,08-Jun-21,baseline,55,,,,14-Apr-21,10-Jun-21,19-Nov-21,57,162,1.568615918,ileocolonic,fistulizing and perianal,N/A,ileostomy,Outpatient,Baseline Serology,,,,,,,2021-04-14,Pfizer,Ustekinumab,.,none,none,none,2021-06-10,Pfizer,Ustekinumab,.,none,none,none,2021-11-19,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,42,43,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,55,,57,0,,,2,0,1,Post-1st Dose,1,1,,0,0,0,,3,8,,,78,3,40-49
537,,Female,CD,Ustekinumab,none,none,none,0.02,Negative,19233,Positive,,Adult,,,Post-2nd,17-Jun-21,baseline,,16,,,14-Apr-21,01-Jun-21,29-Dec-21,48,211,9.864382833,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-14,Moderna,Ustekinumab,.,none,none,none,2021-06-01,Moderna,Ustekinumab,.,none,none,none,2021-12-29,Moderna,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,49,49,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,16,48,0,,,10,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,2,,539,3,40-49
539,,Female,CD,Ustekinumab,none,none,none,0.02,Negative,1648,Positive,,Adult,,,Post-1st,21-May-21,baseline,37,,,,14-Apr-21,01-Jun-21,29-Dec-21,48,211,7.407135655,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-14,Moderna,Ustekinumab,.,none,none,none,2021-06-01,Moderna,Ustekinumab,.,none,none,none,2021-12-29,Moderna,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,49,49,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,37,,48,0,,,7,0,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,541,3,40-49
546,,Female,CD,Infliximab,none,none,none,0.13,Negative,26073,Positive,,Adult,,,Post-2nd,25-Jun-21,baseline,,13,,,22-Apr-21,12-Jun-21,12-Nov-21,51,153,10.16865941,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Moderna,Infliximab,.,none,none,none,2021-06-12,Moderna,Infliximab,.,none,none,none,2021-11-12,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,1,,1,,,,1,,,,0,Female,42,42,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,13,51,0,,,10,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,2,,872,3,40-49
547,,Female,CD,Ustekinumab,none,none,none,0.43,Negative,17803,Positive,,Adult,189,,Post-3rd,28-Sep-21,Baseline to COVID,,,21,,18-Apr-21,01-Jun-21,07-Sep-21,44,98,9.787122261,ileocolonic,fistulizing and perianal,N/A,both,Outpatient,Baseline to COVID,,,,,,2021-05-20,2021-04-18,Pfizer,Ustekinumab,.,none,none,none,2021-06-01,Pfizer,Ustekinumab,.,none,none,none,2021-09-07,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,2021-03-23,1,Female,48,48,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,44,0,,,10,0,1,Post-3rd Dose,1,1,21,0,0,0,2021-03-23,,,,3,862,3,40-49
548,,Female,CD,Ustekinumab,none,none,none,2.18,Positive,5941,Positive,,Adult,58,,Post-1st,20-May-21,Baseline to COVID,32,,,,18-Apr-21,01-Jun-21,07-Sep-21,44,98,8.689615916,ileocolonic,fistulizing and perianal,N/A,both,Outpatient,Baseline to COVID,,,,,,2021-05-20,2021-04-18,Pfizer,Ustekinumab,.,none,none,none,2021-06-01,Pfizer,Ustekinumab,.,none,none,none,2021-09-07,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,2021-03-23,1,Female,48,48,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,32,,44,0,,,9,0,1,Post-1st Dose,1,1,,0,0,0,2021-03-23,,5,,,863,3,40-49
549,,Female,CD,Ustekinumab,none,none,none,1.27,Positive,10390,Positive,,Adult,90,,Post-2nd,21-Jun-21,Baseline to COVID,,20,,,18-Apr-21,01-Jun-21,07-Sep-21,44,98,9.248618333,ileocolonic,fistulizing and perianal,N/A,both,Outpatient,Baseline to COVID,,,,,,2021-05-20,2021-04-18,Pfizer,Ustekinumab,.,none,none,none,2021-06-01,Pfizer,Ustekinumab,.,none,none,none,2021-09-07,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,2021-03-23,1,Female,48,48,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,20,44,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2021-03-23,,,3,,864,3,40-49
567,,Female,IBD-U,Vedolizumab,none,none,Methotrexate,0.01,Negative,9329,Positive,,Adult,,,Post-2nd,06-Aug-21,baseline,,53,,,08-Apr-21,14-Jun-21,04-Jan-22,67,204,9.140883107,ileal,fistulizng,Pancolitis,both,Outpatient,Baseline Serology,Ustekinumab,,,,,,2021-04-08,Pfizer,Vedolizumab,Ustekinumab,none,none,Methotrexate,2021-06-14,Pfizer,Vedolizumab,Ustekinumab,none,none,Methotrexate,2022-01-04,Moderna,Vedolizumab,Ustekinumab,none,none,Methotrexate,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,45,45,0,1,1,0,0,0,1,Combination Therapy,0,1,1,0,0,0,1,Combination Therapy,0,1,1,0,0,0,1,Combination Therapy,0,1,1,0,0,0,1,Combination Therapy,,53,67,0,,,9,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,8,,604,3,40-49
568,,Female,CD,Ustekinumab,none,none,none,0.02,Negative,2196,Positive,,Adult,,,Post-3rd,28-Oct-21,baseline,,,36,,05-May-21,17-Jun-21,22-Sep-21,43,97,7.694301724,ileocolonic,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-05,Pfizer,Ustekinumab,.,none,none,none,2021-06-17,Pfizer,Ustekinumab,.,none,none,none,2021-09-22,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,39,40,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,43,0,,,8,0,1,Post-3rd Dose,1,1,36,0,0,0,,3,,,5,570,3,40-49
570,,Female,CD,Ustekinumab,none,none,none,0.03,Negative,4194,Positive,,Adult,,,Post-2nd,05-Aug-21,baseline,,49,,,05-May-21,17-Jun-21,22-Sep-21,43,97,8.341457897,ileocolonic,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-05,Pfizer,Ustekinumab,.,none,none,none,2021-06-17,Pfizer,Ustekinumab,.,none,none,none,2021-09-22,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,39,40,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,49,43,0,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,7,,572,3,40-49
572,,Female,CD,Inflectra,none,none,Methotrexate,0.04,Negative,3990,Positive,,Adult,,,Post-3rd,29-Sep-21,baseline,,,20,,22-Apr-21,16-Jun-21,09-Sep-21,55,85,8.291571572,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Inflectra,.,none,none,Methotrexate,2021-06-16,Pfizer,Inflectra,.,none,none,Methotrexate,2021-09-09,Pfizer,Inflectra,.,none,none,Methotrexate,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,40,41,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,,55,0,,,8,0,1,Post-3rd Dose,1,1,20,0,0,0,,3,,,3,361,3,40-49
573,,Female,CD,Inflectra,none,none,Methotrexate,0.03,Negative,1,Negative,,Adult,,,Post-1st,12-Jun-21,baseline,51,,,,22-Apr-21,16-Jun-21,09-Sep-21,55,85,-0.510825624,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Inflectra,.,none,none,Methotrexate,2021-06-16,Pfizer,Inflectra,.,none,none,Methotrexate,2021-09-09,Pfizer,Inflectra,.,none,none,Methotrexate,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,40,41,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,51,,55,0,,,-1,0,1,Post-1st Dose,1,1,,0,0,0,,3,7,,,362,3,40-49
574,,Female,CD,Inflectra,none,none,Methotrexate,,,377,Positive,,Adult,,,Post-2nd,09-Jul-21,baseline,,23,,,22-Apr-21,16-Jun-21,09-Sep-21,55,85,5.933040627,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Inflectra,.,none,none,Methotrexate,2021-06-16,Pfizer,Inflectra,.,none,none,Methotrexate,2021-09-09,Pfizer,Inflectra,.,none,none,Methotrexate,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,40,41,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,23,55,0,,,6,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,363,3,40-49
583,,Female,CD,Ustekinumab,none,none,Azathioprine/Immuran,0.11,Negative,4703,Positive,,Adult,,,Post-3rd,03-Nov-21,baseline,,,62,,15-Apr-21,18-Jun-21,02-Sep-21,64,76,8.455934619,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-15,Moderna,Ustekinumab,.,none,none,Azathioprine/Immuran,2021-06-18,Pfizer,Ustekinumab,.,none,none,Azathioprine/Immuran,2021-09-02,Pfizer,Ustekinumab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,46,47,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,,,64,0,,,8,0,1,Post-3rd Dose,1,1,62,0,0,0,,3,,,9,298,3,40-49
584,,Female,CD,Ustekinumab,none,none,Azathioprine/Immuran,0.06,Negative,1408,Positive,,Adult,,,Post-1st,14-May-21,baseline,29,,,,15-Apr-21,18-Jun-21,02-Sep-21,64,76,7.249783481,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-15,Moderna,Ustekinumab,.,none,none,Azathioprine/Immuran,2021-06-18,Pfizer,Ustekinumab,.,none,none,Azathioprine/Immuran,2021-09-02,Pfizer,Ustekinumab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,46,46,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,29,,64,0,,,7,0,1,Post-1st Dose,1,1,,0,0,0,,3,4,,,299,3,40-49
585,,Female,CD,Ustekinumab,none,none,Azathioprine/Immuran,0.08,Negative,2881,Positive,,Adult,,,Post-2nd,24-Aug-21,baseline,,67,,,15-Apr-21,18-Jun-21,02-Sep-21,64,76,7.965858024,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-15,Moderna,Ustekinumab,.,none,none,Azathioprine/Immuran,2021-06-18,Pfizer,Ustekinumab,.,none,none,Azathioprine/Immuran,2021-09-02,Pfizer,Ustekinumab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,46,46,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,,67,64,0,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,10,,300,3,40-49
590,,Female,UC,none,none,Oral 5ASA,none,0.19,Negative,20473,Positive,,Adult,393,,Post-2nd,13-Apr-21,covid,,61,,,04-Jan-21,11-Feb-21,01-Dec-21,38,293,9.926837801,N/A ,N/A,Unknown,,Outpatient,Confirmed COVID,,,,,,,2021-01-04,Pfizer,none,.,none,Oral 5ASA,none,2021-02-11,Pfizer,none,.,none,Oral 5ASA,none,2021-12-01,Pfizer,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,,,1,,1,1,,,2020-03-16,1,Female,49,49,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,61,38,1,,,10,0,0,Post-2nd Dose (8+ Weeks),1,1,,1,1,1,2020-03-16,,,9,,983,3,40-49
600,,Female,CD,Adalimumab,none,none,Methotrexate,0.03,Negative,2458,Positive,,Adult,302,,Post-3rd,22-Oct-21,covid,,,25,,30-Apr-21,16-Jun-21,27-Sep-21,47,103,7.80702192,ileocolonic,fistulizing and upperGI ,N/A,,Outpatient,Confirmed COVID,,,,,,,2021-04-30,Pfizer,Adalimumab,.,none,none,Methotrexate,2021-06-16,Pfizer,Adalimumab,.,none,none,Methotrexate,2021-09-27,Pfizer,Adalimumab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,,,,,,,1,,2020-12-24,1,Female,44,44,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,,47,0,,,8,0,1,Post-3rd Dose,1,1,25,0,0,0,2020-12-24,,,,4,840,3,40-49
601,,Female,CD,Adalimumab,none,none,Methotrexate,,,886,Positive,,Adult,197,,Post-2nd,09-Jul-21,covid,,23,,,30-Apr-21,16-Jun-21,27-Sep-21,47,103,6.787055494,ileocolonic,fistulizing and upperGI ,N/A,,Outpatient,Confirmed COVID,,,,,,,2021-04-30,Pfizer,Adalimumab,.,none,none,Methotrexate,2021-06-16,Pfizer,Adalimumab,.,none,none,Methotrexate,2021-09-27,Pfizer,Adalimumab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,1,1,,,,1,,,2020-12-24,1,Female,44,44,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,23,47,0,,,7,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2020-12-24,,,3,,841,3,40-49
602,,Female,CD,Adalimumab,none,none,Methotrexate,0.04,Negative,250,Positive,,Adult,159,,Post-1st,01-Jun-21,covid,32,,,,30-Apr-21,16-Jun-21,27-Sep-21,47,103,5.521060838,ileocolonic,fistulizing and upperGI ,N/A,,Outpatient,Confirmed COVID,,,,,,,2021-04-30,Pfizer,Adalimumab,.,none,none,Methotrexate,2021-06-16,Pfizer,Adalimumab,.,none,none,Methotrexate,2021-09-27,Pfizer,Adalimumab,.,none,none,Methotrexate,,.,.,.,.,.,.,1,,,,,,,,,,2020-12-24,1,Female,44,44,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,32,,47,0,,,6,0,1,Post-1st Dose,1,1,,0,0,0,2020-12-24,,5,,,842,3,40-49
608,,Female,UC,Infliximab,none,none,none,0.06,Negative,24142,Positive,,Adult,,,Post-3rd,23-Sep-21,baseline,,,21,,03-Apr-21,06-May-21,02-Sep-21,33,119,10.09170006,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,Infliximab,.,none,none,none,2021-05-06,Pfizer,Infliximab,.,none,none,none,2021-09-02,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,47,47,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,33,1,,,10,0,0,Post-3rd Dose,1,1,21,0,0,0,,3,,,3,410,3,40-49
609,,Female,UC,Infliximab,none,none,none,0.03,Negative,26979,Positive,,Adult,,,Post-2nd,07-Jun-21,baseline,,32,,,03-Apr-21,06-May-21,02-Sep-21,33,119,10.20281036,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,Infliximab,.,none,none,none,2021-05-06,Pfizer,Infliximab,.,none,none,none,2021-09-02,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,47,47,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,32,33,1,,,10,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,5,,411,3,40-49
616,,Male,UC,Infliximab,none,none,Azathioprine/Immuran,0.03,Negative,2117,Positive,,Adult,,,Post-2nd,25-Aug-21,Suspected COVID-19/Symptomatic,,69,,,23-Apr-21,17-Jun-21,,55,,7.6579442,N/A ,N/A,Unknown,,Outpatient,Suspected COVID-19/Symptomatic,,,,,,,2021-04-23,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-06-17,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,,,,,,,,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,42,43,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,0,0,0,0,0,0,0,,,69,55,0,,,8,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,10,,603,3,40-49
623,,Female,CD,Adalimumab,none,none,none,0.03,Negative,59,Positive,,Adult,,,Post-2nd,10-Sep-21,baseline,,203,,,13-Jan-21,19-Feb-21,,37,,4.077537444,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-01-13,Pfizer,Adalimumab,.,none,none,none,2021-02-19,Pfizer,Adalimumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,45,45,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,203,37,1,,,4,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,29,,425,3,40-49
633,,Male,CD,Ustekinumab,none,none,none,0.03,Negative,4140,Positive,,Adult,,,Post-2nd,18-Jun-21,baseline,,31,,,15-Apr-21,18-May-21,04-Jan-22,33,231,8.328499375,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-15,Pfizer,Ustekinumab,.,none,none,none,2021-05-18,Pfizer,Vedolizumab,.,none,none,none,2022-01-04,Moderna,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,48,49,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,31,33,1,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,374,3,40-49
634,,Male,CD,Ustekinumab,none,none,none,0.04,Negative,2094,Positive,,Adult,,,Post-2nd,22-Sep-21,baseline,,127,,,15-Apr-21,18-May-21,04-Jan-22,33,231,7.646879146,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-15,Pfizer,Ustekinumab,.,none,none,none,2021-05-18,Pfizer,Vedolizumab,.,none,none,none,2022-01-04,Moderna,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,48,49,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,127,33,1,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,18,,375,3,40-49
643,,Male,CD,Inflectra,none,none,none,,,7011,Positive,,Adult,,,Post-2nd,12-Jul-21,baseline,,14,,,03-May-21,28-Jun-21,21-Sep-21,56,85,8.855249886,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-03,Pfizer,Inflectra,.,none,none,none,2021-06-28,Pfizer,Inflectra,.,none,none,none,2021-09-21,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,44,44,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,14,56,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,2,,25,3,40-49
644,,Male,CD,Inflectra,none,none,none,0.02,Negative,121,Positive,,Adult,,,Post-1st,14-Jun-21,baseline,42,,,,03-May-21,28-Jun-21,21-Sep-21,56,85,4.791649753,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-03,Pfizer,Inflectra,.,none,none,none,2021-06-28,Pfizer,Inflectra,.,none,none,none,2021-09-21,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,44,44,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,42,,56,0,,,5,0,1,Post-1st Dose,1,1,,0,0,0,,3,6,,,26,3,40-49
653,,Female,CD,Ustekinumab,none,none,none,0.07,Negative,30138,Positive,,Adult,,,Post-3rd,21-Dec-21,baseline,,,12,,14-Apr-21,06-May-21,09-Dec-21,22,217,10.31353879,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-14,Pfizer,Ustekinumab,.,none,none,none,2021-05-06,Pfizer,Ustekinumab,.,none,none,none,2021-12-09,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,46,47,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,22,1,,,10,0,1,Post-3rd Dose,1,1,12,0,0,0,,3,,,2,412,3,40-49
654,,Female,CD,Ustekinumab,none,none,none,0.02,Negative,7079,Positive,,Adult,,,Post-2nd,25-May-21,baseline,,19,,,14-Apr-21,06-May-21,09-Dec-21,22,217,8.864916186,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-14,Pfizer,Ustekinumab,.,none,none,none,2021-05-06,Pfizer,Ustekinumab,.,none,none,none,2021-12-09,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,46,46,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,19,22,1,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,413,3,40-49
671,,Female,UC,none,none,none,none,3.75,Positive,20944,Positive,,Adult,87,,Post-1st,10-Feb-21,covid,27,,,,14-Jan-21,22-Feb-21,06-Dec-21,39,287,9.949612263,N/A ,N/A,Left Sided Colitis,,Outpatient,Confirmed COVID,,,,,,2021-02-10,2021-01-14,Pfizer,none,.,none,none,none,2021-02-22,Pfizer,none,.,none,none,none,2021-12-06,Pfizer,none,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,2020-11-15,1,Female,47,47,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,27,,39,1,,,10,0,0,Post-1st Dose,1,1,,1,1,1,2020-11-15,,4,,,389,3,40-49
672,,Female,UC,none,none,none,none,0.37,Negative,1791,Positive,,Adult,341,,Post-2nd,22-Oct-21,covid,,242,,,14-Jan-21,22-Feb-21,06-Dec-21,39,287,7.490361884,N/A ,N/A,Left Sided Colitis,,Outpatient,Confirmed COVID,,,,,,2021-02-10,2021-01-14,Pfizer,none,.,none,none,none,2021-02-22,Pfizer,none,.,none,none,none,2021-12-06,Pfizer,none,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,2020-11-15,1,Female,47,48,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,,242,39,1,,,7,0,0,Post-2nd Dose (8+ Weeks),1,1,,1,1,1,2020-11-15,,,35,,390,3,40-49
682,,Female,CD,Ustekinumab,none,none,none,0.02,Negative,3692,Positive,,Adult,,,Post-2nd,16-Aug-21,baseline,,96,,,09-Apr-21,12-May-21,23-Sep-21,33,134,8.213950681,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-09,Pfizer,Ustekinumab,.,none,none,none,2021-05-12,Pfizer,Ustekinumab,.,none,none,none,2021-09-23,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,39,40,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,96,33,1,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,14,,976,3,40-49
684,,Male,CD,Infliximab,none,none,none,0.08,Negative,10169,Positive,,Adult,,,Post-2nd,19-Jul-21,baseline,,24,,,20-Apr-21,25-Jun-21,21-Dec-21,66,179,9.227089322,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-20,AstraZeneca,Infliximab,.,none,none,none,2021-06-25,Pfizer,Infliximab,.,none,none,none,2021-12-21,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,49,49,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,24,66,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),0,1,,0,0,0,,3,,3,,629,3,40-49
686,,Male,CD,Infliximab,none,none,none,0.05,Negative,44,Negative,,Adult,,,Post-1st,28-May-21,baseline,38,,,,20-Apr-21,25-Jun-21,21-Dec-21,66,179,3.772760938,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-20,AstraZeneca,Infliximab,.,none,none,none,2021-06-25,Pfizer,Infliximab,.,none,none,none,2021-12-21,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,49,49,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,38,,66,0,,,4,0,1,Post-1st Dose,0,1,,0,0,0,,3,5,,,631,3,40-49
689,,Male,CD,Adalimumab,none,none,none,1.3,Positive,38645,Positive,,Adult,147,,Post-1st,17-May-21,covid,36,,,,11-Apr-21,17-Jun-21,01-Dec-21,67,167,10.5621675,ileocolonic,Inflamatory,N/A,,Outpatient,Confirmed COVID,,,,,,2021-05-17,2021-04-11,Pfizer,Adalimumab,.,none,none,none,2021-06-17,Pfizer,Adalimumab,.,none,none,none,2021-12-01,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,2020-12-21,1,Male,49,49,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,36,,67,0,,,11,0,1,Post-1st Dose,1,1,,0,0,0,2020-12-21,,5,,,126,3,40-49
714,,Female,CD,Adalimumab,none,none,Azathioprine/Immuran,0.02,Negative,2664,Positive,,Adult,,,Post-2nd,24-Mar-21,baseline,,28,,,17-Jan-21,24-Feb-21,25-Nov-21,38,274,7.887621568,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-01-17,Moderna,Adalimumab,.,none,none,Azathioprine/Immuran,2021-02-24,Moderna,Adalimumab,.,none,none,Azathioprine/Immuran,2021-11-25,Moderna,Adalimumab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,40,40,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,28,38,1,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,53,3,40-49
715,,Female,CD,Adalimumab,none,none,Azathioprine/Immuran,0.02,Negative,46,Negative,,Adult,,,Post-2nd,16-Sep-21,baseline,,204,,,17-Jan-21,24-Feb-21,25-Nov-21,38,274,3.835141961,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-01-17,Moderna,Adalimumab,.,none,none,Azathioprine/Immuran,2021-02-24,Moderna,Adalimumab,.,none,none,Azathioprine/Immuran,2021-11-25,Moderna,Adalimumab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,40,41,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,204,38,1,,,4,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,29,,54,3,40-49
716,,Female,CD,Adalimumab,none,none,Azathioprine/Immuran,0.02,Negative,52,Positive,,Adult,,,Post-1st,23-Feb-21,baseline,37,,,,17-Jan-21,24-Feb-21,25-Nov-21,38,274,3.953164949,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-01-17,Moderna,Adalimumab,.,none,none,Azathioprine/Immuran,2021-02-24,Moderna,Adalimumab,.,none,none,Azathioprine/Immuran,2021-11-25,Moderna,Adalimumab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,40,40,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,37,,38,1,,,4,0,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,55,3,40-49
718,,Female,CD,Ustekinumab,none,none,none,0.02,Negative,6700,Positive,,Adult,,,Post-3rd,18-Nov-21,baseline,,,76,,19-Feb-21,29-Mar-21,03-Sep-21,38,158,8.809832954,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-02-19,Pfizer,Ustekinumab,.,none,none,none,2021-03-29,Pfizer,Ustekinumab,.,none,none,none,2021-09-03,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,42,43,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,38,1,,,9,0,1,Post-3rd Dose,1,1,76,0,0,0,,3,,,11,664,3,40-49
719,,Female,CD,Ustekinumab,none,none,none,0.02,Negative,2620,Positive,,Adult,,,Post-2nd,25-Aug-21,baseline,,149,,,19-Feb-21,29-Mar-21,03-Sep-21,38,158,7.870815086,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-02-19,Pfizer,Ustekinumab,.,none,none,none,2021-03-29,Pfizer,Ustekinumab,.,none,none,none,2021-09-03,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,42,43,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,149,38,1,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,21,,665,3,40-49
720,,Female,CD,Ustekinumab,none,none,none,0.03,Negative,9554,Positive,,Adult,,,Post-2nd,19-May-21,baseline,,51,,,19-Feb-21,29-Mar-21,03-Sep-21,38,158,9.16469426,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-02-19,Pfizer,Ustekinumab,.,none,none,none,2021-03-29,Pfizer,Ustekinumab,.,none,none,none,2021-09-03,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,42,42,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,51,38,1,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,7,,666,3,40-49
721,,Female,CD,Ustekinumab,none,none,none,0.01,Negative,1014,Positive,,Adult,,,Post-1st,24-Mar-21,baseline,33,,,,19-Feb-21,29-Mar-21,03-Sep-21,38,158,6.921362282,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-02-19,Pfizer,Ustekinumab,.,none,none,none,2021-03-29,Pfizer,Ustekinumab,.,none,none,none,2021-09-03,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,42,42,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,33,,38,1,,,7,0,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,667,3,40-49
725,,Female,CD,Adalimumab,none,none,none,0.02,Negative,1566,Positive,,Adult,,,Post-2nd,13-May-21,baseline,,17,,,29-Mar-21,26-Apr-21,14-Sep-21,28,141,7.356216018,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-29,Pfizer,Adalimumab,.,none,none,none,2021-04-26,Pfizer,Adalimumab,.,none,none,none,2021-09-14,Pfizer,Adalimumab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,49,49,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,1,Combination Therapy,,17,28,1,,,7,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,2,,402,3,40-49
726,,Female,UC,none,none,Oral 5ASA,none,0.39,Negative,31543,Positive,,Adult,333,,Post-2nd,03-Nov-21,covid,,33,,,29-Aug-21,01-Oct-21,,33,,10.35909429,N/A ,N/A,Pancolitis,,Outpatient,Confirmed COVID,,,,,,,2021-08-29,Pfizer,none,.,none,Oral 5ASA,none,2021-10-01,Pfizer,none,.,none,Oral 5ASA,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,2020-12-05,1,Female,48,48,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,0,0,,,33,33,1,,,10,0,0,Post-2nd Dose (1-8 Weeks),1,1,,1,0,1,2020-12-05,,,5,,257,3,40-49
753,,Male,CD,Infliximab,none,none,none,0.02,Negative,9865,Positive,,Adult,,,Post-3rd,29-Dec-21,baseline,,,43,,14-Apr-21,30-Jun-21,16-Nov-21,77,139,9.196768692,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-14,Pfizer,Infliximab,.,none,none,none,2021-06-30,Pfizer,Infliximab,.,none,none,none,2021-11-16,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,41,41,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,77,0,,,9,0,1,Post-3rd Dose,1,1,43,0,0,0,,3,,,6,876,3,40-49
754,,Male,CD,Infliximab,none,none,none,0.02,Negative,43,Negative,,Adult,,,Post-1st,06-May-21,baseline,22,,,,14-Apr-21,30-Jun-21,16-Nov-21,77,139,3.768152635,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-14,Pfizer,Infliximab,.,none,none,none,2021-06-30,Pfizer,Infliximab,.,none,none,none,2021-11-16,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,41,41,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,22,,77,0,,,4,0,1,Post-1st Dose,1,1,,0,0,0,,3,3,,,877,3,40-49
755,,Male,CD,Infliximab,none,none,none,,,9573,Positive,,Adult,,,Post-2nd,30-Jul-21,baseline,,30,,,14-Apr-21,30-Jun-21,16-Nov-21,77,139,9.166743698,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-14,Pfizer,Infliximab,.,none,none,none,2021-06-30,Pfizer,Infliximab,.,none,none,none,2021-11-16,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,41,41,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,30,77,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,878,3,40-49
762,,Female,UC,Ustekinumab,none,Both oral/Rectal,none,0.01,Negative,8472,Positive,,Adult,-126,,Post-2nd,17-Aug-21,baseline,,64,,,14-Apr-21,14-Jun-21,,61,,9.04449828,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,Omicron,,,,,2021-04-14,Moderna,Ustekinumab,.,none,Both oral/Rectal,none,2021-06-14,Moderna,Ustekinumab,.,none,Both oral/Rectal,none,,,,,,,,,.,.,.,.,.,.,,,,,1,,1,1,,,2021-12-21,0,Female,46,47,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,0,0,0,0,0,0,0,,,64,61,0,,,9,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,2021-12-21,2,,9,,926,3,40-49
763,,Male,CD,Ustekinumab,none,none,none,0.03,Negative,8842,Positive,,Adult,,,Post-3rd,10-Dec-21,baseline,,,42,,22-Apr-21,15-Jun-21,29-Oct-21,54,136,9.087211824,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Ustekinumab,.,none,none,none,2021-06-15,Pfizer,Ustekinumab,.,none,none,none,2021-10-29,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,45,45,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,54,0,,,9,0,1,Post-3rd Dose,1,1,42,0,0,0,,3,,,6,952,3,40-49
764,,Male,CD,Ustekinumab,none,none,none,0.02,Negative,140,Positive,,Adult,,,Post-1st,20-May-21,baseline,28,,,,22-Apr-21,15-Jun-21,29-Oct-21,54,136,4.940927882,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Ustekinumab,.,none,none,none,2021-06-15,Pfizer,Ustekinumab,.,none,none,none,2021-10-29,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,45,45,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,28,,54,0,,,5,0,1,Post-1st Dose,1,1,,0,0,0,,3,4,,,953,3,40-49
765,,Male,CD,Ustekinumab,none,none,none,,,2220,Positive,,Adult,,,Post-2nd,09-Jul-21,baseline,,24,,,22-Apr-21,15-Jun-21,29-Oct-21,54,136,7.705172381,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Ustekinumab,.,none,none,none,2021-06-15,Pfizer,Ustekinumab,.,none,none,none,2021-10-29,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,45,45,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,24,54,0,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,954,3,40-49
771,,Female,UC,Ustekinumab,none,none,none,0.03,Negative,4626,Positive,,Adult,,,Post-2nd,19-Apr-21,baseline,,88,,,29-Dec-20,21-Jan-21,19-Oct-21,23,271,8.43946946,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2020-12-29,Pfizer,Ustekinumab,.,none,none,none,2021-01-21,Pfizer,Ustekinumab,.,none,none,none,2021-10-19,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,39,40,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,88,23,1,,,8,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,13,,915,3,40-49
810,,Male,CD,Infliximab,none,none,none,0.03,Negative,139,Positive,,Adult,,,Post-2nd,21-Oct-21,baseline,,195,,,27-Feb-21,09-Apr-21,,41,,4.931592087,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,2022-01-01,,2021-02-27,Pfizer,Infliximab,.,none,none,none,2021-04-09,Pfizer,Infliximab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,43,43,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,195,41,1,,,5,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,28,,812,3,40-49
811,,Male,CD,Infliximab,none,none,none,0.02,Negative,232,Positive,,Adult,,,Post-1st,08-Apr-21,baseline,40,,,,27-Feb-21,09-Apr-21,,41,,5.445443431,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,2022-01-01,,2021-02-27,Pfizer,Infliximab,.,none,none,none,2021-04-09,Pfizer,Infliximab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,43,43,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,40,,41,1,,,5,0,1,Post-1st Dose,1,1,,0,0,0,,,6,,,813,3,40-49
812,,Female,CD,Vedolizumab,none,none,none,0.06,Negative,1207,Positive,,Adult,,,Post-1st,13-May-21,baseline,23,,,,20-Apr-21,23-Jul-21,,94,,7.09614174,colonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-20,Moderna,Vedolizumab,.,none,none,none,2021-07-23,Moderna,Vedolizumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,40,40,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,0,0,0,0,0,0,,23,,94,0,,,7,0,1,Post-1st Dose,1,1,,0,0,0,,,3,,,382,3,40-49
813,,Female,CD,Vedolizumab,none,none,none,0.03,Negative,36676,Positive,,Adult,,,Post-2nd,06-Aug-21,baseline,,14,,,20-Apr-21,23-Jul-21,,94,,10.5098806,colonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-20,Moderna,Vedolizumab,.,none,none,none,2021-07-23,Moderna,Vedolizumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,40,40,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,0,0,0,0,0,0,,,14,94,0,,,11,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,2,,383,3,40-49
837,,Male,CD,Ustekinumab,none,none,none,0.1,Negative,244,Positive,,Adult,,,Post-1st,04-Jun-21,baseline,26,,,,09-May-21,08-Jul-21,22-Oct-21,60,106,5.497168225,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-09,Pfizer,Ustekinumab,.,none,none,none,2021-07-08,Moderna,Ustekinumab,.,none,none,none,2021-10-22,Moderna,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,49,49,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,26,,60,0,,,5,0,1,Post-1st Dose,1,1,,0,0,0,,3,4,,,71,3,40-49
838,,Male,CD,Ustekinumab,none,none,none,0.1,Negative,12709,Positive,,Adult,,,Post-2nd,30-Jul-21,baseline,,22,,,09-May-21,08-Jul-21,22-Oct-21,60,106,9.450097156,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-09,Pfizer,Ustekinumab,.,none,none,none,2021-07-08,Moderna,Ustekinumab,.,none,none,none,2021-10-22,Moderna,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,49,49,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,22,60,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,72,3,40-49
847,,Male,UC,Vedolizumab,none,none,none,0.13,Negative,8216,Positive,,Adult,,,Post-3rd,05-Oct-21,baseline,,,26,,22-Apr-21,20-May-21,09-Sep-21,28,112,9.013802237,N/A ,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Vedolizumab,.,none,none,none,2021-05-20,Pfizer,Vedolizumab,.,none,none,none,2021-09-09,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,41,42,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,,28,1,,,9,0,0,Post-3rd Dose,1,1,26,0,0,0,,3,,,4,234,3,40-49
848,,Male,UC,Vedolizumab,none,none,none,0.04,Negative,73,Positive,,Adult,,,Post-1st,13-May-21,baseline,21,,,,22-Apr-21,20-May-21,09-Sep-21,28,112,4.284964922,N/A ,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Vedolizumab,.,none,none,none,2021-05-20,Pfizer,Vedolizumab,.,none,none,none,2021-09-09,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,41,41,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,21,,28,1,,,4,0,0,Post-1st Dose,1,1,,0,0,0,,3,3,,,235,3,40-49
849,,Male,UC,Vedolizumab,none,none,none,0.03,Negative,157,Positive,,Adult,,,Post-2nd,10-Jun-21,baseline,,21,,,22-Apr-21,20-May-21,09-Sep-21,28,112,5.05815481,N/A ,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Vedolizumab,.,none,none,none,2021-05-20,Pfizer,Vedolizumab,.,none,none,none,2021-09-09,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,41,41,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,21,28,1,,,5,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,236,3,40-49
914,,Female,CD,Vedolizumab,none,none,none,0.05,Negative,20206,Positive,,Adult,,,Post-3rd,29-Nov-21,baseline,,,41,,02-May-21,19-Jul-21,19-Oct-21,78,92,9.91372992,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-02,Pfizer,Vedolizumab,.,none,none,none,2021-07-19,Pfizer,Vedolizumab,.,none,none,none,2021-10-19,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,40,41,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,,78,0,,,10,0,1,Post-3rd Dose,1,1,41,0,0,0,,3,,,6,468,3,40-49
915,,Female,CD,Vedolizumab,none,none,none,0.04,Negative,907,Positive,,Adult,,,Post-1st,15-Jun-21,baseline,44,,,,02-May-21,19-Jul-21,19-Oct-21,78,92,6.810473156,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-02,Pfizer,Vedolizumab,.,none,none,none,2021-07-19,Pfizer,Vedolizumab,.,none,none,none,2021-10-19,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,40,40,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,44,,78,0,,,7,0,1,Post-1st Dose,1,1,,0,0,0,,3,6,,,469,3,40-49
946,,Female,CD,Remicade,none,none,none,0.01,Negative,3913,Positive,,Adult,,,Post-2nd,10-Aug-21,baseline,,59,,,28-Apr-21,12-Jun-21,27-Dec-21,45,198,8.272034066,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-28,Pfizer,Remicade,.,none,none,none,2021-06-12,Pfizer,Remicade,.,none,none,none,2021-12-27,Pfizer,Remicade,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,41,42,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,59,45,0,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,8,,731,3,40-49
947,,Female,CD,Remicade,none,none,none,0.01,Negative,85,Positive,,Adult,,,Post-1st,17-May-21,baseline,19,,,,28-Apr-21,12-Jun-21,27-Dec-21,45,198,4.445001434,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-28,Pfizer,Remicade,.,none,none,none,2021-06-12,Pfizer,Remicade,.,none,none,none,2021-12-27,Pfizer,Remicade,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,41,41,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,19,,45,0,,,4,0,1,Post-1st Dose,1,1,,0,0,0,,3,3,,,732,3,40-49
955,,Male,CD,Ustekinumab,none,none,none,0.01,Negative,2985,Positive,,Adult,,,Post-2nd,14-Sep-21,baseline,,88,,,22-Apr-21,18-Jun-21,22-Oct-21,57,126,8.00148902,colonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Ustekinumab,.,none,none,none,2021-06-18,Pfizer,Ustekinumab,.,none,none,none,2021-10-22,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,46,46,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,88,57,0,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,13,,927,3,40-49
1,,Female,CD,Adalimumab,none,none,none,0.7,Positive,5465,Positive,,Adult,,,Post-3rd,12-Nov-21,baseline,,,29,,09-Apr-21,18-Jun-21,14-Oct-21,70,118,8.606027905,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,2021-11-12,2021-04-09,Moderna,Adalimumab,.,none,none,none,2021-06-18,Moderna,Adalimumab,.,none,none,none,2021-10-14,Moderna,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,1,Female,53,53,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,70,0,,,9,0,1,Post-3rd Dose,1,1,29,0,0,0,2021-11-12,3,,,4,294,4,50-59
2,,Female,CD,Adalimumab,none,none,none,0.64,Negative,96,Positive,,Adult,,,Post-1st,01-Jun-21,baseline,53,,,,09-Apr-21,18-Jun-21,14-Oct-21,70,118,4.568506202,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,2021-11-12,2021-04-09,Moderna,Adalimumab,.,none,none,none,2021-06-18,Moderna,Adalimumab,.,none,none,none,2021-10-14,Moderna,Adalimumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,53,53,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,53,,70,0,,,5,0,1,Post-1st Dose,1,1,,0,0,0,2021-11-12,3,8,,,295,4,50-59
13,,Female,CD,none,none,none,none,0.18,Negative,1689,Positive,,Adult,,,Post-1st,19-May-21,baseline,40,,,,09-Apr-21,11-Jun-21,13-Dec-21,63,185,7.431951122,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-09,Moderna,none,.,none,none,none,2021-06-11,Moderna,none,.,none,none,none,2021-12-13,Pfizer,none,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,57,57,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,40,,63,0,,,7,0,1,Post-1st Dose,1,1,,1,1,1,,3,6,,,199,4,50-59
14,,Female,CD,none,none,none,none,0.09,Negative,3751,Positive,,Adult,,,Post-2nd,09-Nov-21,baseline,,151,,,09-Apr-21,11-Jun-21,13-Dec-21,63,185,8.22975109,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-09,Moderna,none,.,none,none,none,2021-06-11,Moderna,none,.,none,none,none,2021-12-13,Pfizer,none,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,57,58,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,,151,63,0,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,1,1,1,,3,,22,,200,4,50-59
15,,Female,CD,none,none,none,none,,,14975,Positive,,Adult,,,Post-2nd,28-Jul-21,baseline,,47,,,09-Apr-21,11-Jun-21,13-Dec-21,63,185,9.614137423,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-09,Moderna,none,.,none,none,none,2021-06-11,Moderna,none,.,none,none,none,2021-12-13,Pfizer,none,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,57,57,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,,47,63,0,,,10,0,1,Post-2nd Dose (1-8 Weeks),1,1,,1,1,1,,3,,7,,201,4,50-59
19,,Female,UC,Inflectra,none,none,none,0.05,Negative,5799,Positive,,Adult,,,Post-3rd,05-Nov-21,baseline,,,30,,02-Apr-21,13-May-21,06-Oct-21,41,146,8.665509743,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-02,Pfizer,Inflectra,.,none,none,none,2021-05-13,Pfizer,Inflectra,.,none,none,none,2021-10-06,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,51,52,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,41,1,,,9,0,0,Post-3rd Dose,1,1,30,0,0,0,,3,,,4,323,4,50-59
20,,Female,UC,Inflectra,none,none,none,0.06,Negative,83,Positive,,Adult,,,Post-1st,06-May-21,baseline,34,,,,02-Apr-21,13-May-21,06-Oct-21,41,146,4.415219602,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-02,Pfizer,Inflectra,.,none,none,none,2021-05-13,Pfizer,Inflectra,.,none,none,none,2021-10-06,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,51,51,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,34,,41,1,,,4,0,0,Post-1st Dose,1,1,,0,0,0,,3,5,,,324,4,50-59
21,,Female,UC,Inflectra,none,none,none,0.08,Negative,274,Positive,,Adult,,,Post-2nd,01-Oct-21,baseline,,141,,,02-Apr-21,13-May-21,06-Oct-21,41,146,5.613493003,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-02,Pfizer,Inflectra,.,none,none,none,2021-05-13,Pfizer,Inflectra,.,none,none,none,2021-10-06,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,51,52,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,141,41,1,,,6,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,20,,325,4,50-59
22,,Female,UC,Inflectra,none,none,none,,,1723,Positive,,Adult,,,Post-2nd,05-Jul-21,baseline,,53,,,02-Apr-21,13-May-21,06-Oct-21,41,146,7.451532003,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-02,Pfizer,Inflectra,.,none,none,none,2021-05-13,Pfizer,Inflectra,.,none,none,none,2021-10-06,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,51,51,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,53,41,1,,,7,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,8,,326,4,50-59
53,,Female,CD,Adalimumab,none,none,Azathioprine/Immuran,0.1,Negative,63,Positive,,Adult,,,Post-1st,11-May-21,baseline,28,,,,13-Apr-21,27-May-21,16-Dec-21,44,203,4.136765278,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-13,Pfizer,Adalimumab,.,none,none,Azathioprine/Immuran,2021-05-27,Pfizer,Adalimumab,.,none,none,Azathioprine/Immuran,2021-12-16,Pfizer,Adalimumab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,54,54,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,28,,44,0,,,4,0,1,Post-1st Dose,1,1,,0,0,0,,3,4,,,96,4,50-59
54,,Female,CD,Adalimumab,none,none,Azathioprine/Immuran,,,1447,Positive,,Adult,,,Post-2nd,09-Jul-21,baseline,,43,,,13-Apr-21,27-May-21,16-Dec-21,44,203,7.277385934,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-13,Pfizer,Adalimumab,.,none,none,Azathioprine/Immuran,2021-05-27,Pfizer,Adalimumab,.,none,none,Azathioprine/Immuran,2021-12-16,Pfizer,Adalimumab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,54,54,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,43,44,0,,,7,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,6,,97,4,50-59
55,,Female,CD,Adalimumab,none,none,Azathioprine/Immuran,0.17,Negative,293,Positive,,Adult,,,Post-2nd,03-Oct-21,baseline,,129,,,13-Apr-21,27-May-21,16-Dec-21,44,203,5.679831254,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-13,Pfizer,Adalimumab,.,none,none,Azathioprine/Immuran,2021-05-27,Pfizer,Adalimumab,.,none,none,Azathioprine/Immuran,2021-12-16,Pfizer,Adalimumab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,54,54,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,129,44,0,,,6,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,18,,98,4,50-59
76,,Male,CD,Vedolizumab,Oral Prednisone,none,none,0.01,Negative,8460,Positive,,Adult,,,Post-3rd,14-Oct-21,baseline,,,21,,10-Apr-21,26-Jun-21,23-Sep-21,77,89,9.043139913,ileal,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-10,Pfizer,Vedolizumab,.,Oral Prednisone,none,none,2021-06-26,Pfizer,Vedolizumab,.,Oral Prednisone,none,none,2021-09-23,Pfizer,Vedolizumab,.,Oral Prednisone,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,54,54,0,1,0,0,1,0,0,Corticoteroids,0,1,0,0,1,0,0,Corticoteroids,0,1,0,0,1,0,0,Corticoteroids,0,1,0,0,1,0,0,Corticoteroids,,,77,0,,,9,0,1,Post-3rd Dose,1,1,21,0,0,0,,3,,,3,445,4,50-59
77,,Male,CD,Vedolizumab,Oral Prednisone,none,none,,,18,Negative,,Adult,,,Post-1st,04-May-21,baseline,24,,,,10-Apr-21,26-Jun-21,23-Sep-21,77,89,2.87356464,ileal,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-10,Pfizer,Vedolizumab,.,Oral Prednisone,none,none,2021-06-26,Pfizer,Vedolizumab,.,Oral Prednisone,none,none,2021-09-23,Pfizer,Vedolizumab,.,Oral Prednisone,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,54,54,0,1,0,0,1,0,0,Corticoteroids,0,1,0,0,1,0,0,Corticoteroids,0,1,0,0,1,0,0,Corticoteroids,0,1,0,0,1,0,0,Corticoteroids,24,,77,0,,,3,0,1,Post-1st Dose,1,1,,0,0,0,,3,3,,,446,4,50-59
78,,Male,CD,none,none,none,none,0.04,Negative,29201,Positive,,Adult,,,Post-2nd,16-Jul-21,baseline,,21,,,23-Apr-21,25-Jun-21,04-Jan-22,63,193,10.28197193,colonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-23,Moderna,none,.,none,none,none,2021-06-25,Moderna,none,.,none,none,none,2022-01-04,Moderna,none,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,52,52,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,,21,63,0,,,10,0,1,Post-2nd Dose (1-8 Weeks),1,1,,1,1,1,,3,,3,,153,4,50-59
79,,Male,CD,none,none,none,none,0.18,Negative,1579,Positive,,Adult,,,Post-1st,25-May-21,baseline,32,,,,23-Apr-21,25-Jun-21,04-Jan-22,63,193,7.364357003,colonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-23,Moderna,none,.,none,none,none,2021-06-25,Moderna,none,.,none,none,none,2022-01-04,Moderna,none,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,52,52,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,32,,63,0,,,7,0,1,Post-1st Dose,1,1,,1,1,1,,3,5,,,154,4,50-59
92,,Male,CD,Adalimumab,none,none,none,0.17,Negative,12395,Positive,,Adult,,,Post-3rd,04-Oct-21,baseline,,,11,,05-Apr-21,26-May-21,23-Sep-21,51,120,9.425080715,colonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-05,Pfizer,Adalimumab,.,none,none,none,2021-05-26,Pfizer,Adalimumab,.,none,none,none,2021-09-23,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,50,50,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,51,0,,,9,0,1,Post-3rd Dose,1,1,11,0,0,0,,3,,,2,160,4,50-59
93,,Male,CD,Adalimumab,none,none,none,0.11,Negative,7424,Positive,,Adult,,,Post-2nd,11-Jun-21,baseline,,16,,,05-Apr-21,26-May-21,23-Sep-21,51,120,8.912527152,colonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-05,Pfizer,Adalimumab,.,none,none,none,2021-05-26,Pfizer,Adalimumab,.,none,none,none,2021-09-23,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,50,50,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,16,51,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,2,,161,4,50-59
94,,Male,CD,Adalimumab,none,none,none,0.09,Negative,282,Positive,,Adult,,,Post-1st,29-Apr-21,baseline,24,,,,05-Apr-21,26-May-21,23-Sep-21,51,120,5.640132448,colonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-05,Pfizer,Adalimumab,.,none,none,none,2021-05-26,Pfizer,Adalimumab,.,none,none,none,2021-09-23,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,50,50,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,24,,51,0,,,6,0,1,Post-1st Dose,1,1,,0,0,0,,3,3,,,162,4,50-59
102,,Female,CD,none,none,none,Methotrexate,0.02,Negative,805,Positive,,Adult,,,Post-3rd,29-Oct-21,baseline,,,29,,03-Apr-21,03-Jun-21,30-Sep-21,61,119,6.690966493,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,none,.,none,none,Methotrexate,2021-06-03,Pfizer,none,.,none,none,Methotrexate,2021-09-30,Pfizer,none,.,none,none,Methotrexate,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,53,54,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,,,61,0,,,7,0,1,Post-3rd Dose,1,1,29,0,0,0,,3,,,4,742,4,50-59
103,,Female,CD,none,none,none,Methotrexate,0.02,Negative,114,Positive,,Adult,,,Post-1st,29-Apr-21,baseline,26,,,,03-Apr-21,03-Jun-21,30-Sep-21,61,119,4.739701079,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,none,.,none,none,Methotrexate,2021-06-03,Pfizer,none,.,none,none,Methotrexate,2021-09-30,Pfizer,none,.,none,none,Methotrexate,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,53,53,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,26,,61,0,,,5,0,1,Post-1st Dose,1,1,,0,0,0,,3,4,,,743,4,50-59
104,,Female,CD,none,none,none,Methotrexate,0.02,Negative,316,Positive,,Adult,,,Post-2nd,22-Jun-21,baseline,,19,,,03-Apr-21,03-Jun-21,30-Sep-21,61,119,5.755425708,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,none,.,none,none,Methotrexate,2021-06-03,Pfizer,none,.,none,none,Methotrexate,2021-09-30,Pfizer,none,.,none,none,Methotrexate,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,53,54,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,,19,61,0,,,6,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,744,4,50-59
105,,Male,CD,Adalimumab,none,none,none,,,7418,Positive,,Adult,,,Post-2nd,07-Jul-21,baseline,,21,,,19-Apr-21,16-Jun-21,,58,,8.911664758,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-19,Pfizer,Adalimumab,.,none,none,none,2021-06-16,Pfizer,Adalimumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,55,55,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,21,58,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,3,,910,4,50-59
109,,Female,CD,Vedolizumab,none,none,none,0.04,Negative,10411,Positive,,Adult,,,Post-3rd,12-Nov-21,baseline,,,51,,05-Apr-21,20-Jun-21,22-Sep-21,76,94,9.250589402,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-05,Pfizer,Vedolizumab,.,none,none,none,2021-06-20,Pfizer,Vedolizumab,.,none,none,none,2021-09-22,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,57,58,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,,76,0,,,9,0,1,Post-3rd Dose,1,1,51,0,0,0,,3,,,7,213,4,50-59
110,,Female,CD,Vedolizumab,none,none,none,0.05,Negative,9120,Positive,,Adult,,,Post-2nd,22-Jul-21,baseline,,32,,,05-Apr-21,20-Jun-21,22-Sep-21,76,94,9.118247013,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-05,Pfizer,Vedolizumab,.,none,none,none,2021-06-20,Pfizer,Vedolizumab,.,none,none,none,2021-09-22,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,57,58,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,32,76,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,5,,214,4,50-59
120,,Female,CD,Ustekinumab,none,none,none,,,18225,Positive,,Adult,,,Post-2nd,16-Jul-21,baseline,,16,,,25-Apr-21,30-Jun-21,,66,,9.810571505,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-25,Pfizer,none,.,none,none,none,2021-06-30,Pfizer,Ustekinumab,.,Oral budesonide/Cortiment/Entocort,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,55,55,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,,16,66,0,,,10,0,1,Post-2nd Dose (1-8 Weeks),1,1,,1,0,0,,,,2,,8,4,50-59
127,,Female,UC,Tofacitinib,none,none,none,0.02,Negative,488,Positive,,Adult,,,Post-2nd,24-Nov-21,baseline,,165,,,13-Apr-21,12-Jun-21,10-Jan-22,60,212,6.190520303,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-13,Pfizer,Tofacitinib,.,none,none,none,2021-06-12,Pfizer,Tofacitinib,.,none,none,none,2022-01-10,Moderna,Tofacitinib,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,52,52,0,0,0,1,0,0,0,Tofacitinib Only,0,0,0,1,0,0,0,Tofacitinib Only,0,0,0,1,0,0,0,Tofacitinib Only,0,0,0,1,0,0,0,Tofacitinib Only,,165,60,0,,,6,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,24,,873,4,50-59
128,,Female,UC,Tofacitinib,none,none,none,0.02,Negative,169,Positive,,Adult,,,Post-1st,12-May-21,baseline,29,,,,13-Apr-21,12-Jun-21,10-Jan-22,60,212,5.127529046,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-13,Pfizer,Tofacitinib,.,none,none,none,2021-06-12,Pfizer,Tofacitinib,.,none,none,none,2022-01-10,Moderna,Tofacitinib,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,52,52,0,0,0,1,0,0,0,Tofacitinib Only,0,0,0,1,0,0,0,Tofacitinib Only,0,0,0,1,0,0,0,Tofacitinib Only,0,0,0,1,0,0,0,Tofacitinib Only,29,,60,0,,,5,0,0,Post-1st Dose,1,1,,0,0,0,,3,4,,,874,4,50-59
129,,Female,UC,Tofacitinib,none,none,none,0.03,Negative,994,Positive,,Adult,,,Post-2nd,06-Aug-21,baseline,,55,,,13-Apr-21,12-Jun-21,10-Jan-22,60,212,6.90213954,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-13,Pfizer,Tofacitinib,.,none,none,none,2021-06-12,Pfizer,Tofacitinib,.,none,none,none,2022-01-10,Moderna,Tofacitinib,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,52,52,0,0,0,1,0,0,0,Tofacitinib Only,0,0,0,1,0,0,0,Tofacitinib Only,0,0,0,1,0,0,0,Tofacitinib Only,0,0,0,1,0,0,0,Tofacitinib Only,,55,60,0,,,7,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,8,,875,4,50-59
136,,Female,UC,Adalimumab,Oral Prednisone,Rectal 5ASA,none,0.02,Negative,254,Positive,,Adult,,,Post-2nd,18-Aug-21,baseline,,134,,,24-Feb-21,06-Apr-21,10-Nov-21,41,218,5.53772789,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-02-24,Pfizer,Adalimumab,.,none,Oral 5ASA,none,2021-04-06,Pfizer,Adalimumab,.,Oral Prednisone,Oral 5ASA,none,2021-11-10,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,52,52,1,0,0,0,1,1,0,Corticoteroids,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,1,1,0,Corticoteroids,1,0,0,0,0,0,0,Anti-TNF Only,,134,41,1,,,6,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,19,,654,4,50-59
142,,Male,CD,none,none,Oral 5ASA,none,0.33,Negative,5598,Positive,,Adult,,,Post-3rd,20-Sep-21,baseline,,,13,,03-Apr-21,06-May-21,07-Sep-21,33,124,8.630182533,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,none,.,none,Oral 5ASA,none,2021-05-06,Pfizer,none,.,none,Oral 5ASA,none,2021-09-07,Pfizer,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,55,55,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,,33,1,,,9,0,1,Post-3rd Dose,1,1,13,1,1,1,,3,,,2,582,4,50-59
143,,Male,CD,none,none,Oral 5ASA,none,0.14,Negative,131,Positive,,Adult,,,Post-2nd,21-May-21,baseline,,15,,,03-Apr-21,06-May-21,07-Sep-21,33,124,4.878246106,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,none,.,none,Oral 5ASA,none,2021-05-06,Pfizer,none,.,none,Oral 5ASA,none,2021-09-07,Pfizer,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,55,55,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,15,33,1,,,5,0,1,Post-2nd Dose (1-8 Weeks),1,1,,1,1,1,,3,,2,,583,4,50-59
144,,Male,CD,none,none,Oral 5ASA,none,0.14,Negative,0,Negative,,Adult,,,Post-1st,03-May-21,baseline,30,,,,03-Apr-21,06-May-21,07-Sep-21,33,124,,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,none,.,none,Oral 5ASA,none,2021-05-06,Pfizer,none,.,none,Oral 5ASA,none,2021-09-07,Pfizer,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,55,55,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,30,,33,1,,,,0,1,Post-1st Dose,1,1,,1,1,1,,3,4,,,584,4,50-59
155,,Female,CD,Adalimumab,none,none,none,0.02,Negative,15623,Positive,,Adult,,,Post-3rd,18-Oct-21,baseline,,,21,,11-Apr-21,10-May-21,27-Sep-21,29,140,9.656505867,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-11,Pfizer,Adalimumab,.,none,none,none,2021-05-10,Pfizer,Adalimumab,.,none,none,none,2021-09-27,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,50,51,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,29,1,,,10,0,1,Post-3rd Dose,1,1,21,0,0,0,,3,,,3,548,4,50-59
156,,Female,CD,Adalimumab,none,none,none,0.02,Negative,317,Positive,,Adult,,,Post-2nd,15-Sep-21,baseline,,128,,,11-Apr-21,10-May-21,27-Sep-21,29,140,5.758901774,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-11,Pfizer,Adalimumab,.,none,none,none,2021-05-10,Pfizer,Adalimumab,.,none,none,none,2021-09-27,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,50,51,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,128,29,1,,,6,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,18,,549,4,50-59
157,,Female,CD,Adalimumab,none,none,none,0.02,Negative,8076,Positive,,Adult,,,Post-2nd,27-May-21,baseline,,17,,,11-Apr-21,10-May-21,27-Sep-21,29,140,8.996701508,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-11,Pfizer,Adalimumab,.,none,none,none,2021-05-10,Pfizer,Adalimumab,.,none,none,none,2021-09-27,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,50,51,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,17,29,1,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,2,,550,4,50-59
158,,Male,UC,none,none,Oral 5ASA,none,0.03,Negative,520,Positive,,Adult,,,Post-1st,08-Jun-21,baseline,46,,,,23-Apr-21,11-Jun-21,01-Jan-22,49,204,6.254021101,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-23,Pfizer,none,.,none,Oral 5ASA,none,2021-06-11,Pfizer,none,.,none,Oral 5ASA,none,2022-01-01,Pfizer,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,50,50,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,46,,49,0,,,6,0,0,Post-1st Dose,1,1,,1,1,1,,3,7,,,580,4,50-59
159,,Male,UC,none,none,Oral 5ASA,none,0.02,Negative,7700,Positive,,Adult,,,Post-2nd,19-Jul-21,baseline,,38,,,23-Apr-21,11-Jun-21,01-Jan-22,49,204,8.948988595,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-23,Pfizer,none,.,none,Oral 5ASA,none,2021-06-11,Pfizer,none,.,none,Oral 5ASA,none,2022-01-01,Pfizer,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,50,50,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,38,49,0,,,9,0,0,Post-2nd Dose (1-8 Weeks),1,1,,1,1,1,,3,,5,,581,4,50-59
160,,Male,UC,Ustekinumab,none,none,none,0.02,Negative,190,Positive,,Adult,,,Post-1st,17-Jun-21,baseline,35,,,,13-May-21,03-Jul-21,06-Jan-22,51,187,5.245970886,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-05-13,Pfizer,Ustekinumab,.,none,none,none,2021-07-03,Pfizer,Ustekinumab,.,none,none,none,2022-01-06,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,56,56,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,35,,51,0,,,5,0,0,Post-1st Dose,1,1,,0,0,0,,3,5,,,542,4,50-59
161,,Male,UC,Ustekinumab,none,none,none,0.03,Negative,16325,Positive,,Adult,,,Post-2nd,17-Jul-21,baseline,,14,,,13-May-21,03-Jul-21,06-Jan-22,51,187,9.700471331,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-05-13,Pfizer,Ustekinumab,.,none,none,none,2021-07-03,Pfizer,Ustekinumab,.,none,none,none,2022-01-06,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,56,56,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,14,51,0,,,10,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,2,,543,4,50-59
162,,Male,UC,Ustekinumab,none,none,none,0.03,Negative,827,Positive,,Adult,,,Post-2nd,30-Nov-21,baseline,,150,,,13-May-21,03-Jul-21,06-Jan-22,51,187,6.717925607,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-05-13,Pfizer,Ustekinumab,.,none,none,none,2021-07-03,Pfizer,Ustekinumab,.,none,none,none,2022-01-06,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,56,57,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,150,51,0,,,7,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,21,,544,4,50-59
178,,Male,CD,none,none,none,Azathioprine/Immuran,0.02,Negative,1961,Positive,,Adult,,,Post-2nd,19-Jul-21,baseline,,24,,,16-Apr-21,25-Jun-21,04-Jan-22,70,193,7.581260819,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-16,Pfizer,none,.,none,none,Azathioprine/Immuran,2021-06-25,Pfizer,none,.,none,none,Azathioprine/Immuran,2022-01-04,Moderna,none,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,53,54,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,,24,70,0,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,980,4,50-59
179,,Male,CD,none,none,none,Azathioprine/Immuran,0.02,Negative,6,Negative,,Adult,,,Post-1st,21-May-21,baseline,35,,,,16-Apr-21,25-Jun-21,04-Jan-22,70,193,1.704748092,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-16,Pfizer,none,.,none,none,Azathioprine/Immuran,2021-06-25,Pfizer,none,.,none,none,Azathioprine/Immuran,2022-01-04,Moderna,none,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,53,54,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,35,,70,0,,,2,0,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,981,4,50-59
183,,Male,CD,Adalimumab,none,none,Azathioprine/Immuran,0.04,Negative,1541,Positive,,Adult,,,Post-3rd,28-Oct-21,baseline,,,54,,17-Apr-21,11-Jun-21,04-Sep-21,55,85,7.33992723,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-17,Pfizer,Adalimumab,.,none,none,Azathioprine/Immuran,2021-06-11,Pfizer,Adalimumab,.,none,none,Azathioprine/Immuran,2021-09-04,Pfizer,Adalimumab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,51,51,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,,55,0,,,7,0,1,Post-3rd Dose,1,1,54,0,0,0,,3,,,8,627,4,50-59
184,,Male,CD,Adalimumab,none,none,Azathioprine/Immuran,0.05,Negative,14,Negative,,Adult,,,Post-1st,29-May-21,baseline,42,,,,17-Apr-21,11-Jun-21,04-Sep-21,55,85,2.660259537,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-17,Pfizer,Adalimumab,.,none,none,Azathioprine/Immuran,2021-06-11,Pfizer,Adalimumab,.,none,none,Azathioprine/Immuran,2021-09-04,Pfizer,Adalimumab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,51,51,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,42,,55,0,,,3,0,1,Post-1st Dose,1,1,,0,0,0,,3,6,,,628,4,50-59
185,,Male,CD,Ustekinumab,none,none,none,0.03,Negative,2359,Positive,,Adult,,,Post-2nd,22-Dec-21,baseline,,181,,,15-Apr-21,24-Jun-21,23-Dec-21,70,182,7.765865899,ileocolonic,,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-15,Pfizer,Ustekinumab,.,none,none,none,2021-06-24,Pfizer,Ustekinumab,.,none,none,none,2021-12-23,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,51,52,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,181,70,0,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,26,,817,4,50-59
186,,Male,CD,Ustekinumab,none,none,none,0.02,Negative,11028,Positive,,Adult,,,Post-2nd,07-Aug-21,baseline,,44,,,15-Apr-21,24-Jun-21,23-Dec-21,70,182,9.308229043,ileocolonic,,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-15,Pfizer,Ustekinumab,.,none,none,none,2021-06-24,Pfizer,Ustekinumab,.,none,none,none,2021-12-23,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,51,51,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,44,70,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,6,,818,4,50-59
187,,Male,CD,Ustekinumab,none,none,none,0.02,Negative,978,Positive,,Adult,,,Post-1st,25-May-21,baseline,40,,,,15-Apr-21,24-Jun-21,23-Dec-21,70,182,6.885202875,ileocolonic,,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-15,Pfizer,Ustekinumab,.,none,none,none,2021-06-24,Pfizer,Ustekinumab,.,none,none,none,2021-12-23,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,51,51,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,40,,70,0,,,7,0,1,Post-1st Dose,1,1,,0,0,0,,3,6,,,819,4,50-59
195,,Female,UC,Vedolizumab,Oral Prednisone,none,Methotrexate,,,1856,Positive,,Adult,,,Post-2nd,05-Jul-21,baseline,,25,,,28-Apr-21,10-Jun-21,16-Dec-21,43,189,7.525909481,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-28,Pfizer,Vedolizumab,.,Oral Prednisone,none,Methotrexate,2021-06-10,Pfizer,Vedolizumab,.,Oral Prednisone,none,Methotrexate,2021-12-16,Pfizer,Vedolizumab,.,Oral Prednisone,none,Methotrexate,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,58,58,0,1,0,0,1,0,1,Corticoteroids,0,1,0,0,1,0,1,Corticoteroids,0,1,0,0,1,0,1,Corticoteroids,0,1,0,0,1,0,1,Corticoteroids,,25,43,0,,,8,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,454,4,50-59
196,,Female,UC,Vedolizumab,Oral Prednisone,none,Methotrexate,,,82,Positive,,Adult,,,Post-1st,02-Jun-21,baseline,35,,,,28-Apr-21,10-Jun-21,16-Dec-21,43,189,4.407938016,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-28,Pfizer,Vedolizumab,.,Oral Prednisone,none,Methotrexate,2021-06-10,Pfizer,Vedolizumab,.,Oral Prednisone,none,Methotrexate,2021-12-16,Pfizer,Vedolizumab,.,Oral Prednisone,none,Methotrexate,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,58,58,0,1,0,0,1,0,1,Corticoteroids,0,1,0,0,1,0,1,Corticoteroids,0,1,0,0,1,0,1,Corticoteroids,0,1,0,0,1,0,1,Corticoteroids,35,,43,0,,,4,0,0,Post-1st Dose,1,1,,0,0,0,,3,5,,,455,4,50-59
197,,Female,CD,Ustekinumab,none,none,none,0.03,Negative,8790,Positive,,Adult,,,Post-3rd,24-Nov-21,baseline,,,75,,01-May-21,29-May-21,10-Sep-21,28,104,9.081369991,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-01,Moderna,Ustekinumab,.,none,none,none,2021-05-29,Moderna,Ustekinumab,.,none,none,none,2021-09-10,Moderna,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,58,59,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,28,1,,,9,0,1,Post-3rd Dose,1,1,75,0,0,0,,3,,,11,172,4,50-59
198,,Female,CD,Ustekinumab,none,none,none,0.01,Negative,2586,Positive,,Adult,,,Post-2nd,09-Jun-21,baseline,,11,,,01-May-21,29-May-21,10-Sep-21,28,104,7.857867559,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-01,Moderna,Ustekinumab,.,none,none,none,2021-05-29,Moderna,Ustekinumab,.,none,none,none,2021-09-10,Moderna,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,1,,1,,,,1,,,,0,Female,58,58,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,11,28,1,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,2,,173,4,50-59
199,,Female,CD,Ustekinumab,none,none,none,0.02,Negative,2836,Positive,,Adult,,,Post-2nd,02-Sep-21,baseline,,96,,,01-May-21,29-May-21,10-Sep-21,28,104,7.950290921,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-01,Moderna,Ustekinumab,.,none,none,none,2021-05-29,Moderna,Ustekinumab,.,none,none,none,2021-09-10,Moderna,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,58,59,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,96,28,1,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,14,,174,4,50-59
203,,Female,UC,none,none,Oral 5ASA,none,,,25891,Positive,,Adult,69,,Post-1st,07-Jul-21,covid,40,,,,28-May-21,08-Jul-21,07-Jan-22,41,183,10.16164297,N/A,N/A,Pancolitis,,Outpatient,Confirmed COVID,,B117(Alpha),,,,2021-07-22,2021-05-28,Pfizer,none,.,none,Oral 5ASA,none,2021-07-08,Pfizer,none,.,none,Oral 5ASA,none,2022-01-07,,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,1,,,,,,,,,,2021-04-29,1,Female,58,58,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,40,,41,1,,,10,0,0,Post-1st Dose,1,1,,1,1,1,2021-04-29,,6,,,831,4,50-59
204,,Female,UC,none,none,Oral 5ASA,none,5.22,Positive,51122,Positive,,Adult,84,,Post-2nd,22-Jul-21,covid,,14,,,28-May-21,08-Jul-21,07-Jan-22,41,183,10.84197217,N/A,N/A,Pancolitis,,Outpatient,Confirmed COVID,,B117(Alpha),,,,2021-07-22,2021-05-28,Pfizer,none,.,none,Oral 5ASA,none,2021-07-08,Pfizer,none,.,none,Oral 5ASA,none,2022-01-07,,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,1,1,,,,1,,,2021-04-29,1,Female,58,58,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,14,41,1,,,11,0,0,Post-2nd Dose (1-8 Weeks),1,1,,1,1,1,2021-04-29,,,2,,832,4,50-59
224,,Male,IBD-U,Ustekinumab,none,none,none,0.07,Negative,23705,Positive,,Adult,,,Post-3rd,03-Dec-21,baseline,,,13,,13-Apr-21,20-May-21,20-Nov-21,37,184,10.07344128,colonic,N/A,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-13,Pfizer,Ustekinumab,.,none,none,none,2021-05-20,Pfizer,Ustekinumab,.,none,none,none,2021-11-20,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,54,55,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,37,1,,,10,0,0,Post-3rd Dose,1,1,13,0,0,0,,3,,,2,93,4,50-59
225,,Male,IBD-U,Ustekinumab,none,none,none,0.1,Negative,917,Positive,,Adult,,,Post-2nd,29-Sep-21,baseline,,132,,,13-Apr-21,20-May-21,20-Nov-21,37,184,6.820998415,colonic,N/A,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-13,Pfizer,Ustekinumab,.,none,none,none,2021-05-20,Pfizer,Ustekinumab,.,none,none,none,2021-11-20,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,54,54,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,132,37,1,,,7,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,19,,94,4,50-59
226,,Male,IBD-U,Ustekinumab,none,none,none,0.09,Negative,10395,Positive,,Adult,,,Post-2nd,02-Jun-21,baseline,,13,,,13-Apr-21,20-May-21,20-Nov-21,37,184,9.24907058,colonic,N/A,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-13,Pfizer,Ustekinumab,.,none,none,none,2021-05-20,Pfizer,Ustekinumab,.,none,none,none,2021-11-20,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,1,,1,,,,1,,,,0,Male,54,54,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,13,37,1,,,9,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,2,,95,4,50-59
237,,Male,CD,Vedolizumab,none,none,none,0.06,Negative,3111,Positive,,Adult,,,Post-3rd,30-Dec-21,baseline,,,117,,23-Apr-21,21-Jun-21,04-Sep-21,59,75,8.042667352,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-23,AstraZeneca,Vedolizumab,.,none,none,none,2021-06-21,Moderna,Vedolizumab,.,none,none,none,2021-09-04,Moderna,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,55,56,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,,59,0,,,8,0,1,Post-3rd Dose,0,1,117,0,0,0,,3,,,17,150,4,50-59
238,,Male,CD,Vedolizumab,none,none,none,0.08,Negative,2598,Positive,,Adult,,,Post-2nd,22-Jul-21,baseline,,31,,,23-Apr-21,21-Jun-21,04-Sep-21,59,75,7.86265115,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-23,AstraZeneca,Vedolizumab,.,none,none,none,2021-06-21,Moderna,Vedolizumab,.,none,none,none,2021-09-04,Moderna,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,55,55,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,31,59,0,,,8,0,1,Post-2nd Dose (1-8 Weeks),0,1,,0,0,0,,3,,4,,151,4,50-59
239,,Male,CD,Vedolizumab,none,none,none,0.07,Negative,30,Negative,,Adult,,,Post-1st,17-May-21,baseline,24,,,,23-Apr-21,21-Jun-21,04-Sep-21,59,75,3.391147046,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-23,AstraZeneca,Vedolizumab,.,none,none,none,2021-06-21,Moderna,Vedolizumab,.,none,none,none,2021-09-04,Moderna,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,55,55,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,24,,59,0,,,3,0,1,Post-1st Dose,0,1,,0,0,0,,3,3,,,152,4,50-59
242,,Female,CD,Adalimumab,none,none,none,0.02,Negative,5952,Positive,,Adult,,,Post-3rd,20-Sep-21,baseline,,,17,,16-Mar-21,06-Apr-21,03-Sep-21,21,150,8.691432172,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-16,Pfizer,Adalimumab,.,none,none,none,2021-04-06,Pfizer,Adalimumab,.,none,none,none,2021-09-03,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,58,58,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,21,1,,,9,0,1,Post-3rd Dose,1,1,17,0,0,0,,3,,,2,781,4,50-59
243,,Female,CD,Adalimumab,none,none,none,,,430,Positive,,Adult,,,Post-2nd,25-May-21,baseline,,49,,,16-Mar-21,06-Apr-21,03-Sep-21,21,150,6.063785209,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-16,Pfizer,Adalimumab,.,none,none,none,2021-04-06,Pfizer,Adalimumab,.,none,none,none,2021-09-03,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,58,58,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,49,21,1,,,6,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,7,,782,4,50-59
244,,Female,CD,Adalimumab,none,none,none,,,112,Positive,,Adult,,,Post-2nd,16-Jul-21,baseline,,101,,,16-Mar-21,06-Apr-21,03-Sep-21,21,150,4.722063937,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-16,Pfizer,Adalimumab,.,none,none,none,2021-04-06,Pfizer,Adalimumab,.,none,none,none,2021-09-03,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,58,58,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,101,21,1,,,5,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,14,,783,4,50-59
259,,Male,CD,none,none,none,none,0.02,Negative,10835,Positive,,Adult,,,Post-2nd,05-Aug-21,baseline,,29,,,29-May-21,07-Jul-21,22-Dec-21,39,168,9.290527685,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-29,Pfizer,none,.,none,none,none,2021-07-07,Pfizer,none,.,none,none,none,2021-12-22,Pfizer,none,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,53,53,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,,29,39,1,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,1,1,1,,3,,4,,58,4,50-59
260,,Male,CD,none,none,none,none,0.04,Negative,1191,Positive,,Adult,,,Post-2nd,17-Nov-21,baseline,,133,,,29-May-21,07-Jul-21,22-Dec-21,39,168,7.082296648,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-29,Pfizer,none,.,none,none,none,2021-07-07,Pfizer,none,.,none,none,none,2021-12-22,Pfizer,none,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,53,53,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,,133,39,1,,,7,0,1,Post-2nd Dose (8+ Weeks),1,1,,1,1,1,,3,,19,,59,4,50-59
261,,Male,CD,none,none,none,none,0.02,Negative,242,Positive,,Adult,,,Post-1st,30-Jun-21,baseline,32,,,,29-May-21,07-Jul-21,22-Dec-21,39,168,5.490589254,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-29,Pfizer,none,.,none,none,none,2021-07-07,Pfizer,none,.,none,none,none,2021-12-22,Pfizer,none,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,53,53,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,32,,39,1,,,5,0,1,Post-1st Dose,1,1,,1,1,1,,3,5,,,60,4,50-59
263,,Female,CD,Adalimumab,none,none,none,0.05,Negative,1924,Positive,,Adult,,,Post-3rd,16-Dec-21,baseline,,,54,,21-Apr-21,28-May-21,23-Oct-21,37,148,7.561901722,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-21,Moderna,Adalimumab,.,none,none,none,2021-05-28,Moderna,Adalimumab,.,none,none,none,2021-10-23,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,49,50,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,37,1,,,8,0,1,Post-3rd Dose,1,1,54,0,0,0,,3,,,8,196,4,50-59
265,,Female,CD,Adalimumab,none,none,none,0.02,Negative,167,Positive,,Adult,,,Post-2nd,21-Sep-21,baseline,,116,,,21-Apr-21,28-May-21,23-Oct-21,37,148,5.11679549,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-21,Moderna,Adalimumab,.,none,none,none,2021-05-28,Moderna,Adalimumab,.,none,none,none,2021-10-23,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,49,50,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,116,37,1,,,5,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,17,,198,4,50-59
266,,Male,UC,none,none,yes ,none,0.11,Negative,11629,Positive,,Adult,,,Post-2nd,24-Jun-21,baseline,,17,,,10-Apr-21,07-Jun-21,13-Dec-21,58,189,9.361240059,N/A,N/A,Proctitis,,Outpatient,Baseline Serology,,,,,,,2021-04-10,Pfizer,none,.,none,yes ,none,2021-06-07,Pfizer,none,.,none,yes ,none,2021-12-13,Pfizer,none,.,none,yes ,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,56,56,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,17,58,0,,,9,0,0,Post-2nd Dose (1-8 Weeks),1,1,,1,1,1,,3,,2,,345,4,50-59
267,,Female,CD,Adalimumab,none,none,none,0.04,Negative,58071,Positive,,Adult,,,Post-3rd,24-Sep-21,baseline,,,21,,07-Apr-21,11-Jun-21,03-Sep-21,65,84,10.96942168,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-07,Pfizer,Adalimumab,.,none,none,none,2021-06-11,Pfizer,Adalimumab,.,none,none,none,2021-09-03,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,59,59,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,65,0,,,11,0,1,Post-3rd Dose,1,1,21,0,0,0,,3,,,3,406,4,50-59
268,,Female,CD,Adalimumab,none,none,none,0.03,Negative,7572,Positive,,Adult,,,Post-2nd,30-Jun-21,baseline,,19,,,07-Apr-21,11-Jun-21,03-Sep-21,65,84,8.932199306,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-07,Pfizer,Adalimumab,.,none,none,none,2021-06-11,Pfizer,Adalimumab,.,none,none,none,2021-09-03,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,59,59,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,19,65,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,407,4,50-59
281,,Female,UC,none,none,Oral 5ASA,none,,,22184,Positive,,Adult,,,Post-2nd,03-Jul-21,baseline,,28,,,12-Apr-21,05-Jun-21,28-Dec-21,54,206,10.00712208,N/A,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-04-12,Moderna,none,.,none,Oral 5ASA,none,2021-06-05,Moderna,none,.,none,Oral 5ASA,none,2021-12-28,Pfizer,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,56,56,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,28,54,0,,,10,0,0,Post-2nd Dose (1-8 Weeks),1,1,,1,1,1,,3,,4,,586,4,50-59
285,,Male,CD,Inflectra,none,none,none,0.03,Negative,85,Positive,,Adult,,,Post-2nd,02-Dec-21,baseline,,172,,,30-Mar-21,13-Jun-21,10-Dec-21,75,180,4.440295543,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-30,Pfizer,Inflectra,.,none,none,none,2021-06-13,Pfizer,Inflectra,.,none,none,none,2021-12-10,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,58,58,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,172,75,0,,,4,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,25,,51,4,50-59
286,,Male,CD,Inflectra,none,none,none,,,691,Positive,,Adult,,,Post-2nd,21-Jul-21,baseline,,38,,,30-Mar-21,13-Jun-21,10-Dec-21,75,180,6.537995095,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-30,Pfizer,Inflectra,.,none,none,none,2021-06-13,Pfizer,Inflectra,.,none,none,none,2021-12-10,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,58,58,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,38,75,0,,,7,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,5,,52,4,50-59
291,,Female,UC,none,none,none,none,,,5580,Positive,,Adult,,,Post-2nd,05-Jul-21,baseline,,19,,,12-Apr-21,16-Jun-21,,65,,8.627015737,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-04-12,Pfizer,none,.,none,none,none,2021-06-16,Pfizer,none,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,52,52,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,,,19,65,0,,,9,0,0,Post-2nd Dose (1-8 Weeks),1,1,,1,0,1,,,,3,,491,4,50-59
295,,Male,CD,Ustekinumab,none,none,none,,,27432,Positive,,Adult,,,Post-2nd,26-Jul-21,baseline,,14,,,02-May-21,12-Jul-21,,71,,10.21945091,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-02,Pfizer,Ustekinumab,.,none,none,none,2021-07-12,Moderna,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,55,55,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,,14,71,0,,,10,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,2,,171,4,50-59
306,,Male,CD,Adalimumab,none,none,none,0.03,Negative,2366,Positive,,Adult,,,Post-2nd,03-Sep-21,baseline,,68,,,06-May-21,27-Jun-21,01-Jan-22,52,188,7.768786969,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-06,Pfizer,Adalimumab,.,none,none,none,2021-06-27,Pfizer,Adalimumab,.,none,none,none,2022-01-01,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,57,57,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,68,52,0,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,10,,853,4,50-59
309,,Female,CD,Vedolizumab,none,none,none,0.01,Negative,56345,Positive,,Adult,,,Post-3rd,19-Oct-21,baseline,,,20,,22-Apr-21,11-Jun-21,29-Sep-21,50,110,10.93924169,,,,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Vedolizumab,.,none,none,none,2021-06-11,Pfizer,Vedolizumab,.,none,none,none,2021-09-29,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,56,56,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,,50,0,,,11,0,1,Post-3rd Dose,1,1,20,0,0,0,,3,,,3,464,4,50-59
310,,Female,CD,Vedolizumab,none,none,none,0.01,Negative,7049,Positive,,Adult,,,Post-2nd,02-Sep-21,baseline,,83,,,22-Apr-21,11-Jun-21,29-Sep-21,50,110,8.860598482,,,,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Vedolizumab,.,none,none,none,2021-06-11,Pfizer,Vedolizumab,.,none,none,none,2021-09-29,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,56,56,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,83,50,0,,,9,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,12,,465,4,50-59
327,,Male,UC,Remicade,none,none,none,0.08,Negative,453,Positive,,Adult,,,Post-2nd,22-Dec-21,baseline,,190,,,19-Apr-21,15-Jun-21,,57,,6.116112852,N/A ,N/A,Pancolitis,none,Outpatient,Baseline Serology,,,,,,,2021-04-19,Pfizer,Remicade,.,none,none,none,2021-06-15,Pfizer,Remicade,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,52,53,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,190,57,0,,,6,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,27,,619,4,50-59
328,,Male,UC,Remicade,none,none,none,,,6062,Positive,,Adult,,,Post-2nd,07-Jul-21,baseline,,22,,,19-Apr-21,15-Jun-21,,57,,8.709778561,N/A ,N/A,Pancolitis,none,Outpatient,Baseline Serology,,,,,,,2021-04-19,Pfizer,Remicade,.,none,none,none,2021-06-15,Pfizer,Remicade,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,52,53,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,22,57,0,,,9,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,3,,620,4,50-59
332,,Female,CD,Inflectra,none,none,none,0.04,Negative,348,Positive,,Adult,,,Post-2nd,04-Sep-21,baseline,,46,,,18-Jun-21,20-Jul-21,29-Oct-21,32,101,5.850764665,colonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-06-18,Pfizer,Inflectra,.,none,none,none,2021-07-20,Pfizer,Inflectra,.,none,none,none,2021-10-29,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,59,59,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,46,32,1,,,6,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,7,,285,4,50-59
345,,Female,CD,Ustekinumab,none,none,none,0.03,Negative,626,Positive,,Adult,,,Post-1st,18-May-21,baseline,27,,,,21-Apr-21,17-Jun-21,,57,,6.439190614,colonic,Inflamatory,N/A,both,Outpatient,Baseline Serology,,,,,,,2021-04-21,Pfizer,Ustekinumab,.,none,none,none,2021-06-17,Pfizer,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,50,50,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,27,,57,0,,,6,0,1,Post-1st Dose,1,1,,0,0,0,,,4,,,145,4,50-59
346,,Female,CD,Ustekinumab,none,none,none,0.03,Negative,28498,Positive,,Adult,,,Post-2nd,20-Jul-21,baseline,,33,,,21-Apr-21,17-Jun-21,,57,,10.25760322,colonic,Inflamatory,N/A,both,Outpatient,Baseline Serology,,,,,,,2021-04-21,Pfizer,Ustekinumab,.,none,none,none,2021-06-17,Pfizer,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,50,50,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,,33,57,0,,,10,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,5,,146,4,50-59
362,,Female,CD,Vedolizumab,none,none,none,0.1,Negative,21697,Positive,,Adult,,,Post-3rd,27-Oct-21,baseline,,,26,,27-May-21,24-Jun-21,01-Oct-21,28,99,9.984938499,ileocolonic,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-27,Moderna,Vedolizumab,Ustekinumab,none,none,none,2021-06-24,Moderna,Vedolizumab,Ustekinumab,none,none,none,2021-10-01,Moderna,Vedolizumab,Ustekinumab,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,55,56,0,1,0,0,0,0,0,Vedolizumab Only,0,1,1,0,0,0,0,Combination Therapy,0,1,1,0,0,0,0,Combination Therapy,0,1,1,0,0,0,0,Combination Therapy,,,28,1,,,10,0,1,Post-3rd Dose,1,1,26,0,0,0,,3,,,4,13,4,50-59
363,,Female,CD,Vedolizumab,none,none,none,,,21561,Positive,,Adult,,,Post-2nd,09-Jul-21,baseline,,15,,,27-May-21,24-Jun-21,01-Oct-21,28,99,9.978627492,ileocolonic,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-27,Moderna,Vedolizumab,Ustekinumab,none,none,none,2021-06-24,Moderna,Vedolizumab,Ustekinumab,none,none,none,2021-10-01,Moderna,Vedolizumab,Ustekinumab,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,55,55,0,1,0,0,0,0,0,Vedolizumab Only,0,1,1,0,0,0,0,Combination Therapy,0,1,1,0,0,0,0,Combination Therapy,0,1,1,0,0,0,0,Combination Therapy,,15,28,1,,,10,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,2,,14,4,50-59
366,,Female,CD,Adalimumab,none,none,none,0.12,Negative,213,Positive,,Adult,444,,Post-2nd,24-Dec-21,covid,,201,,,16-Apr-21,06-Jun-21,31-Dec-21,51,208,5.359412466,ileocolonic,Inflamatory,N/A,none,Outpatient,Confirmed COVID,,,,,,,2021-04-16,Pfizer,Adalimumab,.,none,none,none,2021-06-06,Pfizer,Adalimumab,.,none,none,none,2021-12-31,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,2020-10-06,1,Female,52,52,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,201,51,0,,,5,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,2020-10-06,,,29,,191,4,50-59
367,,Female,CD,Adalimumab,none,none,none,0.22,Negative,3486,Positive,,Adult,225,,Post-1st,19-May-21,covid,33,,,,16-Apr-21,06-Jun-21,31-Dec-21,51,208,8.156366785,ileocolonic,Inflamatory,N/A,none,Outpatient,Confirmed COVID,,,,,,,2021-04-16,Pfizer,Adalimumab,.,none,none,none,2021-06-06,Pfizer,Adalimumab,.,none,none,none,2021-12-31,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,2020-10-06,1,Female,52,52,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,33,,51,0,,,8,0,1,Post-1st Dose,1,1,,0,0,0,2020-10-06,,5,,,192,4,50-59
368,,Female,CD,Vedolizumab,none,none,none,0.03,Negative,12249,Positive,,Adult,,,Post-2nd,24-Jul-21,baseline,,27,,,30-Apr-21,27-Jun-21,03-Jan-22,58,190,9.413215908,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-30,Pfizer,Vedolizumab,.,none,none,none,2021-06-27,Moderna,Vedolizumab,.,none,none,none,2022-01-03,Moderna,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,54,54,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,27,58,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,962,4,50-59
369,,Female,CD,Adalimumab,none,none,none,0.04,Negative,6698,Positive,,Adult,,,Post-3rd,07-Oct-21,baseline,,,18,,30-Mar-21,06-May-21,19-Sep-21,37,136,8.809594113,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-30,Pfizer,Adalimumab,.,none,none,none,2021-05-06,Pfizer,Adalimumab,.,none,none,none,2021-09-19,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,51,51,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,37,1,,,9,0,1,Post-3rd Dose,1,1,18,0,0,0,,3,,,3,568,4,50-59
370,,Female,CD,Adalimumab,none,none,none,0.03,Negative,124,Positive,,Adult,,,Post-1st,13-Apr-21,baseline,14,,,,30-Mar-21,06-May-21,19-Sep-21,37,136,4.819474789,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-30,Pfizer,Adalimumab,.,none,none,none,2021-05-06,Pfizer,Adalimumab,.,none,none,none,2021-09-19,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,51,51,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,14,,37,1,,,5,0,1,Post-1st Dose,1,1,,0,0,0,,3,2,,,569,4,50-59
375,,Male,CD,Adalimumab,none,none,none,,,929,Positive,,Adult,408,,Post-2nd,07-Jul-21,covid,,28,,,08-Apr-21,09-Jun-21,09-Dec-21,62,183,6.833570381,colonic,Inflamatory,N/A,,Outpatient,Confirmed COVID,,,,,,,2021-04-08,Pfizer,Adalimumab,.,none,none,none,2021-06-09,Pfizer,Adalimumab,.,none,none,none,2021-12-09,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,2020-05-25,1,Male,50,50,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,28,62,0,,,7,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2020-05-25,,,4,,577,4,50-59
383,,Female,CD,Adalimumab,none,none,Methotrexate,0.01,Negative,1980,Positive,,Adult,,,Post-2nd,22-Jul-21,baseline,,40,,,16-Apr-21,12-Jun-21,18-Dec-21,57,189,7.590953129,ileocolonic,Inflamatory,N/A,none,Outpatient,Baseline Serology,,,,,,,2021-04-16,Pfizer,Adalimumab,.,none,none,Methotrexate,2021-06-12,Pfizer,Adalimumab,.,none,none,Methotrexate,2021-12-18,,Adalimumab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,50,50,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,40,57,0,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,6,,261,4,50-59
384,,Female,CD,Adalimumab,none,none,Methotrexate,0.01,Negative,143,Positive,,Adult,,,Post-2nd,07-Dec-21,baseline,,178,,,16-Apr-21,12-Jun-21,18-Dec-21,57,189,4.960744524,ileocolonic,Inflamatory,N/A,none,Outpatient,Baseline Serology,,,,,,,2021-04-16,Pfizer,Adalimumab,.,none,none,Methotrexate,2021-06-12,Pfizer,Adalimumab,.,none,none,Methotrexate,2021-12-18,,Adalimumab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,50,51,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,178,57,0,,,5,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,25,,262,4,50-59
389,,Female,CD,Infliximab,none,none,none,0.02,Negative,2755,Positive,,Adult,,,Post-2nd,04-Aug-21,baseline,,35,,,20-Apr-21,30-Jun-21,,71,,7.921317902,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-20,Moderna,Infliximab,.,none,none,none,2021-06-30,Moderna,Infliximab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,50,50,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,35,71,0,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,5,,761,4,50-59
390,,Female,CD,Adalimumab,none,none,Methotrexate,0.01,Negative,1911,Positive,,Adult,,,Post-3rd,08-Nov-21,baseline,,,41,,12-Apr-21,16-Jun-21,28-Sep-21,65,104,7.555172608,colonic,Perianal CD,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-12,Pfizer,Adalimumab,.,none,none,Methotrexate,2021-06-16,Pfizer,Adalimumab,.,none,none,Methotrexate,2021-09-28,Pfizer,Adalimumab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,57,58,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,,65,0,,,8,0,1,Post-3rd Dose,1,1,41,0,0,0,,3,,,6,329,4,50-59
391,,Female,CD,Adalimumab,none,none,Methotrexate,,,240,Positive,,Adult,,,Post-2nd,08-Jul-21,baseline,,22,,,12-Apr-21,16-Jun-21,28-Sep-21,65,104,5.481888143,colonic,Perianal CD,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-12,Pfizer,Adalimumab,.,none,none,Methotrexate,2021-06-16,Pfizer,Adalimumab,.,none,none,Methotrexate,2021-09-28,Pfizer,Adalimumab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,57,57,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,22,65,0,,,5,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,330,4,50-59
394,,Female,CD,Infliximab,none,none,none,0.14,Negative,1216,Positive,,Adult,395,,Post-3rd,30-Dec-21,covid,,,91,,18-Apr-21,21-May-21,30-Sep-21,33,132,7.102993061,ileal,Inflamatory,N/A,,Outpatient,Confirmed COVID,,,,,,,2021-04-18,Pfizer,Infliximab,.,none,none,none,2021-05-21,Pfizer,Infliximab,.,none,none,none,2021-09-30,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,2020-11-30,1,Female,59,59,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,33,1,,,7,0,1,Post-3rd Dose,1,1,91,0,0,0,2020-11-30,,,,13,395,4,50-59
395,,Female,CD,Infliximab,none,none,none,0.17,Negative,1293,Positive,,Adult,291,,Post-2nd,17-Sep-21,covid,,119,,,18-Apr-21,21-May-21,30-Sep-21,33,132,7.164333606,ileal,Inflamatory,N/A,,Outpatient,Confirmed COVID,,,,,,,2021-04-18,Pfizer,Infliximab,.,none,none,none,2021-05-21,Pfizer,Infliximab,.,none,none,none,2021-09-30,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,2020-11-30,1,Female,59,59,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,119,33,1,,,7,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,2020-11-30,,,17,,396,4,50-59
409,,Female,CD,Adalimumab,none,none,none,0.15,Negative,2329,Positive,,Adult,,,Post-3rd,11-Nov-21,baseline,,,47,,22-Apr-21,21-Jun-21,25-Sep-21,60,96,7.75319427,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Adalimumab,.,none,none,none,2021-06-21,Pfizer,Adalimumab,.,none,none,none,2021-09-25,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,53,53,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,60,0,,,8,0,1,Post-3rd Dose,1,1,47,0,0,0,,3,,,7,574,4,50-59
410,,Female,CD,Adalimumab,none,none,none,0.05,Negative,6888,Positive,,Adult,,,Post-2nd,23-Jul-21,baseline,,32,,,22-Apr-21,21-Jun-21,25-Sep-21,60,96,8.83750701,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Adalimumab,.,none,none,none,2021-06-21,Pfizer,Adalimumab,.,none,none,none,2021-09-25,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,53,53,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,32,60,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,5,,575,4,50-59
418,,Female,UC,Adalimumab,none,none,none,0.06,Negative,1150,Positive,,Adult,336,,Post-2nd,25-Oct-21,covid,,121,,,26-Apr-21,26-Jun-21,14-Dec-21,61,171,7.047169335,N/A ,N/A,Pancolitis,none,Outpatient,Confirmed COVID,,,,,,,2021-04-26,Moderna,Adalimumab,.,none,none,none,2021-06-26,Moderna,Adalimumab,.,none,none,none,2021-12-14,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,2020-11-23,1,Female,49,50,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,121,61,0,,,7,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,2020-11-23,,,17,,83,4,50-59
419,,Female,UC,Adalimumab,none,none,none,0.1,Negative,5111,Positive,,Adult,240,,Post-2nd,21-Jul-21,covid,,25,,,26-Apr-21,26-Jun-21,14-Dec-21,61,171,8.539130793,N/A ,N/A,Pancolitis,none,Outpatient,Confirmed COVID,,,,,,,2021-04-26,Moderna,Adalimumab,.,none,none,none,2021-06-26,Moderna,Adalimumab,.,none,none,none,2021-12-14,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,2020-11-23,1,Female,49,50,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,25,61,0,,,9,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2020-11-23,,,4,,84,4,50-59
420,,Female,UC,none,none,Oral 5ASA,none,0.44,Negative,19615,Positive,,Adult,347,,Post-3rd,28-Oct-21,covid,,,21,,16-Apr-21,08-May-21,07-Oct-21,22,152,9.884029466,N/A ,N/A,Left Sided Colitis,none,Outpatient,Confirmed COVID,,,,,,,2021-04-16,Pfizer,none,.,none,Oral 5ASA,none,2021-05-08,Pfizer,none,.,none,Oral 5ASA,none,2021-10-07,Pfizer,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,,,,,,,1,,2020-11-15,1,Female,53,53,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,,22,1,,,10,0,0,Post-3rd Dose,1,1,21,1,1,1,2020-11-15,,,,3,902,4,50-59
421,,Female,UC,none,none,Oral 5ASA,none,,,6765,Positive,,Adult,257,,Post-2nd,30-Jul-21,covid,,83,,,16-Apr-21,08-May-21,07-Oct-21,22,152,8.819458411,N/A ,N/A,Left Sided Colitis,none,Outpatient,Confirmed COVID,,,,,,,2021-04-16,Pfizer,none,.,none,Oral 5ASA,none,2021-05-08,Pfizer,none,.,none,Oral 5ASA,none,2021-10-07,Pfizer,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,,,1,,1,1,,,2020-11-15,1,Female,53,53,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,83,22,1,,,9,0,0,Post-2nd Dose (8+ Weeks),1,1,,1,1,1,2020-11-15,,,12,,903,4,50-59
422,,Female,CD,Ustekinumab,none,none,none,0.03,Negative,199,Positive,,Adult,,,Post-2nd,14-Oct-21,baseline,,232,,,14-Jan-21,24-Feb-21,,41,,5.292802186,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-01-14,Pfizer,Ustekinumab,.,none,none,none,2021-02-24,Pfizer,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,57,58,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,,232,41,1,,,5,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,33,,475,4,50-59
423,,Female,CD,Vedolizumab,none,none,Methotrexate,,,3665,Positive,,Adult,,,Post-2nd,14-Jul-21,baseline,,31,,,10-Apr-21,13-Jun-21,15-Dec-21,64,185,8.206692749,colonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-10,Pfizer,Vedolizumab,.,none,none,Methotrexate,2021-06-13,Pfizer,Vedolizumab,.,none,none,Methotrexate,2021-12-15,Pfizer,Vedolizumab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,54,55,0,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,1,Combination Therapy,,31,64,0,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,226,4,50-59
430,,Male,CD,Infliximab,none,none,none,0.01,Negative,3093,Positive,,Adult,,,Post-3rd,28-Oct-21,baseline,,,29,,14-Apr-21,15-Jun-21,29-Sep-21,62,106,8.036896773,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-14,Pfizer,Infliximab,.,none,none,none,2021-06-15,Pfizer,Infliximab,.,none,none,none,2021-09-29,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,57,57,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,62,0,,,8,0,1,Post-3rd Dose,1,1,29,0,0,0,,3,,,4,476,4,50-59
431,,Male,CD,Infliximab,none,none,none,0.01,Negative,1114,Positive,,Adult,,,Post-2nd,14-Jul-21,baseline,,29,,,14-Apr-21,15-Jun-21,29-Sep-21,62,106,7.015802183,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-14,Pfizer,Infliximab,.,none,none,none,2021-06-15,Pfizer,Infliximab,.,none,none,none,2021-09-29,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,57,57,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,29,62,0,,,7,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,477,4,50-59
438,,Female,CD,Adalimumab,none,none,none,0.05,Negative,73,Positive,,Adult,,,Post-1st,17-May-21,baseline,30,,,,17-Apr-21,27-Aug-21,03-Nov-21,132,68,4.286341385,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-17,Pfizer,Adalimumab,.,none,none,none,2021-08-27,Pfizer,Adalimumab,.,none,none,none,2021-11-03,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,53,53,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,30,,132,0,,,4,0,1,Post-1st Dose,1,1,,0,0,0,,3,4,,,269,4,50-59
445,,Female,CD,Inflectra,none,none,none,0.77,Positive,653,Positive,,Adult,,,Post-2nd,20-Jul-21,baseline,,25,,,17-Apr-21,25-Jun-21,14-Dec-21,69,172,6.480811139,ileocolonic,Inflamatory,N/A,none,Outpatient,Baseline Serology,,,,,,2021-07-20,2021-04-17,Pfizer,Inflectra,.,none,none,none,2021-06-25,Pfizer,Inflectra,.,none,none,none,2021-12-14,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,1,Female,51,51,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,25,69,0,,,6,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2021-07-20,2,,4,,712,4,50-59
455,,Male,CD,Ustekinumab,none,none,none,0.56,Negative,21748,Positive,,Adult,166,,Post-2nd,23-Jul-21,covid,,46,,,04-Apr-21,07-Jun-21,28-Feb-22,64,266,9.987290873,ileocolonic,Stricturing,N/A,,Outpatient,Confirmed COVID,,,,,,2021-05-11,2021-04-04,Pfizer,Ustekinumab,.,none,none,none,2021-06-07,Pfizer,Ustekinumab,.,none,none,none,2022-02-28,,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,2021-02-07,1,Male,55,55,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,46,64,0,,,10,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2021-02-07,,,7,,558,4,50-59
456,,Male,CD,Ustekinumab,none,none,none,1.6,Positive,14007,Positive,,Adult,93,,Post-1st,11-May-21,covid,37,,,,04-Apr-21,07-Jun-21,28-Feb-22,64,266,9.547283926,ileocolonic,Stricturing,N/A,,Outpatient,Confirmed COVID,,,,,,2021-05-11,2021-04-04,Pfizer,Ustekinumab,.,none,none,none,2021-06-07,Pfizer,Ustekinumab,.,none,none,none,2022-02-28,,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,2021-02-07,1,Male,55,55,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,37,,64,0,,,10,0,1,Post-1st Dose,1,1,,0,0,0,2021-02-07,,5,,,559,4,50-59
470,,Male,CD,Ustekinumab,none,none,none,0.04,Negative,574,Positive,,Adult,,,Post-2nd,24-Dec-21,baseline,,165,,,27-May-21,12-Jul-21,,46,,6.352455165,ileocolonic,fistulizng,N/A,none,Outpatient,Baseline Serology,,,,,,,2021-05-27,Pfizer,Ustekinumab,.,none,none,none,2021-07-12,Pfizer,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,58,59,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,,165,46,0,,,6,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,24,,551,4,50-59
471,,Male,CD,Ustekinumab,none,none,none,,,129,Positive,,Adult,,,Post-1st,12-Jul-21,baseline,46,,,,27-May-21,12-Jul-21,,46,,4.856706812,ileocolonic,fistulizng,N/A,none,Outpatient,Baseline Serology,,,,,,,2021-05-27,Pfizer,Ustekinumab,.,none,none,none,2021-07-12,Pfizer,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,58,58,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,46,,46,0,,,5,0,1,Post-1st Dose,1,1,,0,0,0,,,7,,,552,4,50-59
474,,Female,CD,Golimumab,Oral Prednisone,none,none,0.05,Negative,5113,Positive,,Adult,,,Post-3rd,22-Sep-21,baseline,,,20,,06-Apr-21,28-May-21,02-Sep-21,52,97,8.539619824,ileocolonic,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-06,Pfizer,Golimumab ,.,none,none,none,2021-05-28,Pfizer,Golimumab ,.,none,none,none,2021-09-02,Pfizer,Golimumab ,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,50,51,1,0,0,0,1,0,0,Corticoteroids,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,,,52,0,,,9,0,1,Post-3rd Dose,1,1,20,1,1,1,,3,,,3,978,4,50-59
475,,Female,CD,Golimumab,Oral Prednisone,none,none,0.05,Negative,276,Positive,,Adult,,,Post-2nd,23-Aug-21,baseline,,87,,,06-Apr-21,28-May-21,02-Sep-21,52,97,5.618587629,ileocolonic,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-06,Pfizer,Golimumab ,.,none,none,none,2021-05-28,Pfizer,Golimumab ,.,none,none,none,2021-09-02,Pfizer,Golimumab ,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,50,51,1,0,0,0,1,0,0,Corticoteroids,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,,87,52,0,,,6,0,1,Post-2nd Dose (8+ Weeks),1,1,,1,1,1,,3,,12,,979,4,50-59
486,,Male,CD,Infliximab,none,none,none,0.02,Negative,690,Positive,,Adult,,,Post-2nd,09-Sep-21,baseline,,98,,,23-Apr-21,03-Jun-21,,41,,6.535966697,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-23,Pfizer,Infliximab,.,none,none,none,2021-06-03,Pfizer,Renflexis/IFX,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,55,56,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,98,41,1,,,7,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,14,,947,4,50-59
493,,Male,CD,Ustekinumab,none,none,none,0.1,Negative,40000,Positive,,Adult,,,Post-3rd,22-Oct-21,baseline,,,21,,21-Apr-21,24-Jun-21,01-Oct-21,64,99,10.59663473,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-21,Moderna,Ustekinumab,.,none,none,none,2021-06-24,Moderna,Ustekinumab,.,none,none,none,2021-10-01,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,58,59,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,64,0,,,11,0,1,Post-3rd Dose,1,1,21,0,0,0,,3,,,3,820,4,50-59
494,,Male,CD,Ustekinumab,none,none,none,0.03,Negative,2310,Positive,,Adult,,,Post-1st,26-May-21,baseline,35,,,,21-Apr-21,24-Jun-21,01-Oct-21,64,99,7.74478633,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-21,Moderna,Ustekinumab,.,none,none,none,2021-06-24,Moderna,Ustekinumab,.,none,none,none,2021-10-01,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,58,58,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,35,,64,0,,,8,0,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,821,4,50-59
503,,Male,UC,Infliximab,none,none,none,0.01,Negative,10,Negative,,Adult,,,Post-2nd,09-Nov-21,baseline,,124,,,15-May-21,08-Jul-21,18-Dec-21,54,163,2.282382386,N/A ,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-05-15,Pfizer,Infliximab,none,none,none,Azathioprine/Immuran,2021-07-08,Pfizer,Infliximab,none,none,none,Azathioprine/Immuran,2021-12-18,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,57,57,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,124,54,0,,,2,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,18,,263,4,50-59
514,,Male,UC,Remicade,none,yes ,Methotrexate,0.12,Negative,1102,Positive,,Adult,,,Post-3rd,28-Oct-21,baseline,,,29,,08-Apr-21,15-May-21,29-Sep-21,37,137,7.00460972,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-04-08,Pfizer,Remicade,.,none,yes ,Methotrexate,2021-05-15,Pfizer,Remicade,.,none,yes ,Methotrexate,2021-09-29,Pfizer,Remicade,.,none,yes ,Methotrexate,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,51,51,1,0,0,0,0,1,1,Combination Therapy,1,0,0,0,0,1,1,Combination Therapy,1,0,0,0,0,1,1,Combination Therapy,1,0,0,0,0,1,1,Combination Therapy,,,37,1,,,7,0,0,Post-3rd Dose,1,1,29,0,0,0,,3,,,4,596,4,50-59
515,,Male,UC,Remicade,none,yes ,Methotrexate,0.07,Negative,5,Negative,,Adult,,,Post-1st,04-May-21,baseline,26,,,,08-Apr-21,15-May-21,29-Sep-21,37,137,1.526056303,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-04-08,Pfizer,Remicade,.,none,yes ,Methotrexate,2021-05-15,Pfizer,Remicade,.,none,yes ,Methotrexate,2021-09-29,Pfizer,Remicade,.,none,yes ,Methotrexate,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,51,51,1,0,0,0,0,1,1,Combination Therapy,1,0,0,0,0,1,1,Combination Therapy,1,0,0,0,0,1,1,Combination Therapy,1,0,0,0,0,1,1,Combination Therapy,26,,37,1,,,2,0,0,Post-1st Dose,1,1,,0,0,0,,3,4,,,597,4,50-59
516,,Male,UC,Remicade,none,yes ,Methotrexate,0.07,Negative,808,Positive,,Adult,,,Post-2nd,31-May-21,baseline,,16,,,08-Apr-21,15-May-21,29-Sep-21,37,137,6.693943055,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-04-08,Pfizer,Remicade,.,none,yes ,Methotrexate,2021-05-15,Pfizer,Remicade,.,none,yes ,Methotrexate,2021-09-29,Pfizer,Remicade,.,none,yes ,Methotrexate,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,51,51,1,0,0,0,0,1,1,Combination Therapy,1,0,0,0,0,1,1,Combination Therapy,1,0,0,0,0,1,1,Combination Therapy,1,0,0,0,0,1,1,Combination Therapy,,16,37,1,,,7,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,2,,598,4,50-59
517,,Male,CD,Ustekinumab,none,none,none,0.03,Negative,6596,Positive,,Adult,,,Post-3rd,07-Oct-21,baseline,,,35,,12-Apr-21,09-May-21,02-Sep-21,27,116,8.794264165,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-12,Pfizer,Ustekinumab,.,none,none,none,2021-05-09,Pfizer,Ustekinumab,.,none,none,none,2021-09-02,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,57,58,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,27,1,,,9,0,1,Post-3rd Dose,1,1,35,0,0,0,,3,,,5,858,4,50-59
518,,Male,CD,Ustekinumab,none,none,none,0.05,Negative,4330,Positive,,Adult,,,Post-3rd,02-Nov-21,baseline,,,21,,15-Apr-21,16-Jun-21,12-Oct-21,62,118,8.373299726,unknown,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-15,Pfizer,Infliximab,.,none,none,none,2021-06-16,Pfizer,Infliximab,.,none,none,none,2021-10-12,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,55,55,0,0,1,0,0,0,0,Ustekinumab Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,62,0,,,8,0,1,Post-3rd Dose,1,1,21,0,0,0,,3,,,3,675,4,50-59
519,,Male,CD,Ustekinumab,none,none,none,,,10291,Positive,,Adult,,,Post-2nd,13-Jul-21,baseline,,27,,,15-Apr-21,16-Jun-21,12-Oct-21,62,118,9.239063874,unknown,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-15,Pfizer,Infliximab,.,none,none,none,2021-06-16,Pfizer,Infliximab,.,none,none,none,2021-10-12,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,55,55,0,0,1,0,0,0,0,Ustekinumab Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,27,62,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,676,4,50-59
521,,Male,CD,Ustekinumab,none,none,none,,,1012,Positive,,Adult,,,Post-2nd,28-Jul-21,baseline,,43,,,14-Apr-21,15-Jun-21,16-Dec-21,62,184,6.919782659,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-14,Pfizer,Ustekinumab,.,none,none,none,2021-06-15,Pfizer,Ustekinumab,.,none,none,none,2021-12-16,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,52,52,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,43,62,0,,,7,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,6,,982,4,50-59
527,,Female,UC,Ustekinumab,none,none,Methotrexate,0.56,Negative,14665,Positive,,Adult,,,Post-3rd,03-Nov-21,baseline,,,29,,02-Apr-21,15-May-21,05-Oct-21,43,143,9.593239438,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-02,Pfizer,Ustekinumab,.,none,none,Methotrexate,2021-05-15,Pfizer,Ustekinumab,.,none,none,Methotrexate,2021-10-05,Pfizer,Ustekinumab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,52,53,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,,,43,0,,,10,0,0,Post-3rd Dose,1,1,29,0,0,0,,3,,,4,141,4,50-59
528,,Female,UC,Ustekinumab,none,none,Methotrexate,,,3066,Positive,,Adult,,,Post-2nd,27-Jul-21,baseline,,73,,,02-Apr-21,15-May-21,05-Oct-21,43,143,8.028259514,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-02,Pfizer,Ustekinumab,.,none,none,Methotrexate,2021-05-15,Pfizer,Ustekinumab,.,none,none,Methotrexate,2021-10-05,Pfizer,Ustekinumab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,52,53,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,,73,43,0,,,8,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,10,,142,4,50-59
534,,Male,CD,Vedolizumab,none,none,none,0.12,Negative,21450,Positive,,Adult,490,,Post-2nd,23-Aug-21,covid,,39,,,10-Jun-21,15-Jul-21,,35,,9.973489248,colonic,Inflamatory,N/A,,Outpatient,Confirmed COVID,,,,,,,2021-06-10,Pfizer,Vedolizumab,.,none,none,none,2021-07-15,Pfizer,Vedolizumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,2020-04-20,1,Male,50,50,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,0,0,0,0,0,0,,,39,35,1,,,10,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2020-04-20,,,6,,922,4,50-59
535,,Female,CD,Ustekinumab,none,none,none,,,8620,Positive,,Adult,,,Post-2nd,21-Jul-21,baseline,,42,,,30-Mar-21,09-Jun-21,27-Dec-21,71,201,9.061828763,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-30,Pfizer,Ustekinumab,.,none,none,none,2021-06-09,Pfizer,Ustekinumab,.,none,none,none,2021-12-27,,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,57,57,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,42,71,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,6,,17,4,50-59
538,,Female,CD,Ustekinumab,none,none,none,0.03,Negative,1770,Positive,,Adult,,,Post-2nd,16-Dec-21,baseline,,198,,,14-Apr-21,01-Jun-21,29-Dec-21,48,211,7.478960789,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-14,Moderna,Ustekinumab,.,none,none,none,2021-06-01,Moderna,Ustekinumab,.,none,none,none,2021-12-29,Moderna,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,49,50,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,198,48,0,,,7,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,28,,540,4,50-59
542,,Female,CD,Ustekinumab,none,none,none,0.07,Negative,18419,Positive,,Adult,,,Post-3rd,28-Oct-21,baseline,,,26,,03-May-21,30-May-21,02-Oct-21,27,125,9.821159736,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-03,Pfizer,Ustekinumab,.,none,none,none,2021-05-30,Pfizer,Ustekinumab,.,none,none,none,2021-10-02,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,54,55,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,27,1,,,10,0,1,Post-3rd Dose,1,1,26,0,0,0,,3,,,4,814,4,50-59
543,,Female,CD,Ustekinumab,none,none,none,0.07,Negative,2923,Positive,,Adult,,,Post-2nd,23-Sep-21,baseline,,116,,,03-May-21,30-May-21,02-Oct-21,27,125,7.980194693,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-03,Pfizer,Ustekinumab,.,none,none,none,2021-05-30,Pfizer,Ustekinumab,.,none,none,none,2021-10-02,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,54,55,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,116,27,1,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,17,,815,4,50-59
552,,Female,CD,Infliximab,none,none,none,0.02,Negative,1379,Positive,,Adult,,,Post-3rd,29-Sep-21,baseline,,,12,,08-Apr-21,11-Jun-21,17-Sep-21,64,98,7.229403901,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-08,AstraZeneca,Infliximab,.,none,none,none,2021-06-11,Pfizer,Infliximab,.,none,none,none,2021-09-17,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,58,58,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,64,0,,,7,0,1,Post-3rd Dose,0,1,12,0,0,0,,3,,,2,215,4,50-59
553,,Female,CD,Infliximab,none,none,none,,,139,Positive,,Adult,,,Post-2nd,28-Jul-21,baseline,,47,,,08-Apr-21,11-Jun-21,17-Sep-21,64,98,4.937347498,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-08,AstraZeneca,Infliximab,.,none,none,none,2021-06-11,Pfizer,Infliximab,.,none,none,none,2021-09-17,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,58,58,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,47,64,0,,,5,0,1,Post-2nd Dose (1-8 Weeks),0,1,,0,0,0,,3,,7,,216,4,50-59
554,,Female,CD,Infliximab,none,none,none,0.02,Negative,18,Negative,,Adult,,,Post-1st,11-May-21,baseline,33,,,,08-Apr-21,11-Jun-21,17-Sep-21,64,98,2.879198457,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-08,AstraZeneca,Infliximab,.,none,none,none,2021-06-11,Pfizer,Infliximab,.,none,none,none,2021-09-17,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,58,58,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,33,,64,0,,,3,0,1,Post-1st Dose,0,1,,0,0,0,,3,5,,,217,4,50-59
555,,Female,CD,Infliximab,none,none,none,0.02,Negative,108,Positive,,Adult,,,Post-2nd,18-Aug-21,baseline,,68,,,08-Apr-21,11-Jun-21,17-Sep-21,64,98,4.684905154,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-08,AstraZeneca,Infliximab,.,none,none,none,2021-06-11,Pfizer,Infliximab,.,none,none,none,2021-09-17,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,58,58,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,68,64,0,,,5,0,1,Post-2nd Dose (8+ Weeks),0,1,,0,0,0,,3,,10,,218,4,50-59
558,,Female,CD,Infliximab,none,none,none,0.19,Negative,10914,Positive,,Adult,,,Post-3rd,05-Nov-21,baseline,,,31,,22-Apr-21,14-May-21,05-Oct-21,22,144,9.297801648,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Infliximab,.,none,none,none,2021-05-14,Pfizer,Infliximab,.,none,none,none,2021-10-05,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,50,50,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,22,1,,,9,0,1,Post-3rd Dose,1,1,31,0,0,0,,3,,,4,147,4,50-59
559,,Female,CD,Infliximab,none,none,none,0.05,Negative,322,Positive,,Adult,,,Post-2nd,24-Sep-21,baseline,,133,,,22-Apr-21,14-May-21,05-Oct-21,22,144,5.774240938,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Infliximab,.,none,none,none,2021-05-14,Pfizer,Infliximab,.,none,none,none,2021-10-05,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,50,50,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,133,22,1,,,6,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,19,,148,4,50-59
560,,Female,CD,Infliximab,none,none,none,0.05,Negative,9853,Positive,,Adult,,,Post-2nd,25-May-21,baseline,,11,,,22-Apr-21,14-May-21,05-Oct-21,22,144,9.195521107,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Infliximab,.,none,none,none,2021-05-14,Pfizer,Infliximab,.,none,none,none,2021-10-05,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,1,,1,,,,1,,,,0,Female,50,50,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,11,22,1,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,2,,149,4,50-59
563,,Female,CD,Infliximab,none,none,Methotrexate,0.29,Negative,40000,Positive,,Adult,393,,Post-3rd,25-Oct-21,covid,,,17,,19-Apr-21,13-Jun-21,08-Oct-21,55,117,10.59663473,colonic,fistulizng,N/A,,Inpatient,Confirmed COVID,,,,,,,2021-04-19,Pfizer,Infliximab,.,none,none,none,2021-06-13,Pfizer,Infliximab,.,none,none,none,2021-10-08,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,2020-09-27,1,Female,56,57,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,55,0,,,11,0,1,Post-3rd Dose,1,1,17,0,0,0,2020-09-27,,,,2,512,4,50-59
564,,Female,CD,Infliximab,none,none,Methotrexate,0.27,Negative,16271,Positive,,Adult,351,,Post-2nd,13-Sep-21,covid,,92,,,19-Apr-21,13-Jun-21,08-Oct-21,55,117,9.697145807,colonic,fistulizng,N/A,,Inpatient,Confirmed COVID,,,,,,,2021-04-19,Pfizer,Infliximab,.,none,none,none,2021-06-13,Pfizer,Infliximab,.,none,none,none,2021-10-08,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,2020-09-27,1,Female,56,57,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,92,55,0,,,10,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,2020-09-27,,,13,,513,4,50-59
565,,Female,CD,Infliximab,none,none,Methotrexate,0.51,Negative,61528,Positive,,Adult,271,,Post-2nd,25-Jun-21,covid,,12,,,19-Apr-21,13-Jun-21,08-Oct-21,55,117,11.02724926,colonic,fistulizng,N/A,,Inpatient,Confirmed COVID,,,,,,,2021-04-19,Pfizer,Infliximab,.,none,none,none,2021-06-13,Pfizer,Infliximab,.,none,none,none,2021-10-08,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,1,,1,,,,1,,,2020-09-27,1,Female,56,57,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,12,55,0,,,11,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2020-09-27,,,2,,514,4,50-59
566,,Female,CD,Infliximab,none,none,Methotrexate,0.52,Negative,12636,Positive,,Adult,236,,Post-1st,21-May-21,covid,32,,,,19-Apr-21,13-Jun-21,08-Oct-21,55,117,9.444336817,colonic,fistulizng,N/A,,Inpatient,Confirmed COVID,,,,,,,2021-04-19,Pfizer,Infliximab,.,none,none,none,2021-06-13,Pfizer,Infliximab,.,none,none,none,2021-10-08,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,2020-09-27,1,Female,56,56,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,32,,55,0,,,9,0,1,Post-1st Dose,1,1,,0,0,0,2020-09-27,,5,,,515,4,50-59
576,,Female,CD,Infliximab,none,none,none,0.02,Negative,8423,Positive,,Adult,,,Post-3rd,13-Dec-21,baseline,,,28,,07-Jan-21,15-Feb-21,15-Nov-21,39,273,9.038697594,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-01-07,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-02-15,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-11-15,Pfizer,Inflectra,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,50,50,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,,39,1,,,9,0,1,Post-3rd Dose,1,1,28,0,0,0,,3,,,4,963,4,50-59
577,,Female,CD,Infliximab,none,none,none,0.02,Negative,235,Positive,,Adult,,,Post-2nd,15-Mar-21,baseline,,28,,,07-Jan-21,15-Feb-21,15-Nov-21,39,273,5.461286195,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-01-07,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-02-15,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-11-15,Pfizer,Inflectra,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,50,50,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,28,39,1,,,5,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,964,4,50-59
578,,Female,CD,Infliximab,none,none,none,0.02,Negative,14,Negative,,Adult,,,Post-1st,11-Feb-21,baseline,35,,,,07-Jan-21,15-Feb-21,15-Nov-21,39,273,2.624668592,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-01-07,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-02-15,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-11-15,Pfizer,Inflectra,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,50,50,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,35,,39,1,,,3,0,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,965,4,50-59
579,,Female,CD,Ustekinumab,none,none,none,0.05,Negative,846,Positive,,Adult,,,Post-2nd,17-Aug-21,baseline,,92,,,25-Apr-21,17-May-21,30-Nov-21,22,197,6.740755738,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-25,Pfizer,Ustekinumab,.,none,none,none,2021-05-17,Pfizer,Ustekinumab,.,none,none,none,2021-11-30,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,59,59,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,92,22,1,,,7,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,13,,170,4,50-59
580,,Male,CD,Ustekinumab,none,none,none,1.76,Positive,25663,Positive,,Adult,,,Post-3rd,27-Sep-21,baseline,,,24,,09-Apr-21,10-May-21,03-Sep-21,31,116,10.15280165,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,2021-09-27,2021-04-09,Moderna,Ustekinumab,.,none,none,none,2021-05-10,Moderna,Ustekinumab,.,none,none,none,2021-09-03,Moderna,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,1,Male,54,55,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,31,1,,,10,0,1,Post-3rd Dose,1,1,24,0,0,0,2021-09-27,3,,,3,136,4,50-59
589,,Male,UC,Infliximab,none,none,Azathioprine/Immuran,0.02,Negative,452,Positive,,Adult,,,Post-2nd,23-Jul-21,baseline,,74,,,12-Apr-21,10-May-21,06-Aug-21,28,88,6.11368218,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-04-12,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-05-10,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-08-06,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,50,50,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,74,28,1,,,6,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,11,,338,4,50-59
598,,Male,CD,Ustekinumab,none,none,none,0.06,Negative,19905,Positive,,Adult,,,Post-2nd,19-Aug-21,baseline,,35,,,13-Apr-21,15-Jul-21,,93,,9.898701116,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-13,Moderna,Ustekinumab,.,none,none,none,2021-07-15,Moderna,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,57,58,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,,35,93,0,,,10,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,5,,747,4,50-59
599,,Male,CD,Ustekinumab,none,none,none,0.02,Negative,3147,Positive,,Adult,,,Post-1st,04-May-21,baseline,21,,,,13-Apr-21,15-Jul-21,,93,,8.054300221,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-13,Moderna,Ustekinumab,.,none,none,none,2021-07-15,Moderna,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,57,58,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,21,,93,0,,,8,0,1,Post-1st Dose,1,1,,0,0,0,,,3,,,748,4,50-59
607,,Male,CD,Vedolizumab,none,none,none,0.09,Negative,1571,Positive,,Adult,,,Post-1st,07-May-21,baseline,38,,,,30-Mar-21,11-Jun-21,,73,,7.359658581,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-30,Pfizer,Vedolizumab,.,none,none,none,2021-06-11,Pfizer,Vedolizumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,55,56,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,0,0,0,0,0,0,,38,,73,0,,,7,0,1,Post-1st Dose,1,1,,0,0,0,,,5,,,447,4,50-59
612,,Male,CD,Adalimumab,none,none,none,0.78,Positive,546,Positive,,Adult,,,Post-2nd,16-Aug-21,baseline,,61,,,13-Apr-21,16-Jun-21,29-Sep-21,64,105,6.303351308,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,2021-05-12,2021-04-13,Pfizer,Adalimumab,.,none,none,none,2021-06-16,Pfizer,Adalimumab,.,none,none,none,2021-09-29,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,1,Male,53,53,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,61,64,0,,,6,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,2021-05-12,1,,9,,203,4,50-59
613,,Male,CD,Adalimumab,none,none,none,0.7,Positive,1297,Positive,,Adult,,,Post-1st,12-May-21,baseline,29,,,,13-Apr-21,16-Jun-21,29-Sep-21,64,105,7.167500733,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,2021-05-12,2021-04-13,Pfizer,Adalimumab,.,none,none,none,2021-06-16,Pfizer,Adalimumab,.,none,none,none,2021-09-29,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,1,Male,53,53,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,29,,64,0,,,7,0,1,Post-1st Dose,1,1,,0,0,0,2021-05-12,1,4,,,204,4,50-59
618,,Female,CD,Infliximab,none,none,none,0.05,Negative,136,Positive,,Adult,-232,,Post-1st,22-Feb-21,baseline,40,,,,13-Jan-21,23-Feb-21,09-Oct-21,41,228,4.909709376,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-01-13,Pfizer,Infliximab,.,none,none,none,2021-02-23,Pfizer,Infliximab,.,none,none,none,2021-10-09,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,2021-10-12,0,Female,55,55,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,40,,41,1,,,5,0,1,Post-1st Dose,1,1,,0,0,0,2021-10-12,3,6,,,932,4,50-59
622,,Female,CD,Adalimumab,none,none,none,0.01,Negative,11661,Positive,,Adult,,,Post-3rd,18-Nov-21,baseline,,,38,,11-Apr-21,16-Jun-21,11-Oct-21,66,117,9.363996644,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-11,Pfizer,Adalimumab,.,none,none,none,2021-06-16,Pfizer,Adalimumab,.,none,none,none,2021-10-11,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,54,55,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,66,0,,,9,0,1,Post-3rd Dose,1,1,38,0,0,0,,3,,,5,644,4,50-59
639,,Female,CD,Adalimumab,none,none,none,0.02,Negative,18,Negative,,Adult,,,Post-1st,13-May-21,baseline,19,,,,24-Apr-21,01-Jul-21,,68,,2.912350665,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-24,Moderna,Adalimumab,.,none,none,Methotrexate,2021-07-01,Moderna,Adalimumab,.,none,none,Methotrexate,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,58,58,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,0,0,0,0,0,0,0,,19,,68,0,,,3,0,1,Post-1st Dose,1,1,,0,0,0,,,3,,,904,4,50-59
640,,Female,CD,Adalimumab,none,none,none,0.02,Negative,893,Positive,,Adult,,,Post-2nd,28-Sep-21,baseline,,89,,,24-Apr-21,01-Jul-21,,68,,6.794698557,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-24,Moderna,Adalimumab,.,none,none,Methotrexate,2021-07-01,Moderna,Adalimumab,.,none,none,Methotrexate,,,,,,,,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,58,58,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,0,0,0,0,0,0,0,,,89,68,0,,,7,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,13,,905,4,50-59
645,,Female,CD,Vedolizumab,none,none,none,6.22,Positive,5467,Positive,,Adult,39,,Post-1st,21-May-21,Baseline to COVID,16,,,,05-May-21,20-Jul-21,,76,,8.60650359,ileal,Stricturing,N/A,,Outpatient,Baseline to COVID,,Negative,,,,2021-05-21,2021-05-05,Pfizer,Vedolizumab,.,none,none,none,2021-07-20,Pfizer,Vedolizumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,2021-04-12,1,Female,50,50,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,0,0,0,0,0,0,,16,,76,0,,,9,0,1,Post-1st Dose,1,1,,0,0,0,2021-04-12,,2,,,132,4,50-59
650,,Male,CD,Vedolizumab,none,none,Methotrexate,0.1,Negative,35410,Positive,,Adult,324,,Post-3rd,30-Dec-21,covid,,,55,,07-Apr-21,28-May-21,05-Nov-21,51,161,10.47474672,ileal,Stricturing,N/A,,Outpatient,Confirmed COVID,,,,,,,2021-04-07,Pfizer,Vedolizumab,.,none,none,Methotrexate,2021-05-28,Pfizer,Vedolizumab,.,none,none,Methotrexate,2021-11-05,Pfizer,Vedolizumab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,,,,,,,1,,2021-02-09,1,Male,58,58,0,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,1,Combination Therapy,,,51,0,,,10,0,1,Post-3rd Dose,1,1,55,0,0,0,2021-02-09,,,,8,351,4,50-59
651,,Male,CD,Vedolizumab,none,none,Methotrexate,0.25,Negative,1306,Positive,,Adult,98,,Post-1st,18-May-21,covid,41,,,,07-Apr-21,28-May-21,05-Nov-21,51,161,7.17472431,ileal,Stricturing,N/A,,Outpatient,Confirmed COVID,,,,,,,2021-04-07,Pfizer,Vedolizumab,.,none,none,Methotrexate,2021-05-28,Pfizer,Vedolizumab,.,none,none,Methotrexate,2021-11-05,Pfizer,Vedolizumab,.,none,none,Methotrexate,,.,.,.,.,.,.,1,,,,,,,,,,2021-02-09,1,Male,58,58,0,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,1,Combination Therapy,41,,51,0,,,7,0,1,Post-1st Dose,1,1,,0,0,0,2021-02-09,,6,,,352,4,50-59
652,,Male,CD,Vedolizumab,none,none,Methotrexate,0.09,Negative,5810,Positive,,Adult,213,,Post-2nd,10-Sep-21,covid,,105,,,07-Apr-21,28-May-21,05-Nov-21,51,161,8.667249788,ileal,Stricturing,N/A,,Outpatient,Confirmed COVID,,,,,,,2021-04-07,Pfizer,Vedolizumab,.,none,none,Methotrexate,2021-05-28,Pfizer,Vedolizumab,.,none,none,Methotrexate,2021-11-05,Pfizer,Vedolizumab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,,,1,,1,1,,,2021-02-09,1,Male,58,58,0,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,1,Combination Therapy,0,1,0,0,0,0,1,Combination Therapy,,105,51,0,,,9,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,2021-02-09,,,15,,353,4,50-59
655,,Female,CD,Ustekinumab,none,none,none,0.02,Negative,80,Positive,,Adult,,,Post-1st,09-Jun-21,baseline,30,,,,10-May-21,02-Jul-21,,53,,4.382026635,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-10,Moderna,Ustekinumab,.,none,none,none,2021-07-02,Moderna,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,52,52,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,30,,53,0,,,4,0,1,Post-1st Dose,1,1,,0,0,0,,,4,,,118,4,50-59
673,,Female,CD,Ustekinumab,none,none,none,0.06,Negative,1501,Positive,,Adult,,,Post-2nd,24-Aug-21,baseline,,88,,,02-Apr-21,28-May-21,17-Dec-21,56,203,7.313620307,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-02,Pfizer,Ustekinumab,.,none,none,none,2021-05-28,Pfizer,Ustekinumab,.,none,none,none,2021-12-17,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,58,58,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,88,56,0,,,7,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,13,,106,4,50-59
677,,Male,CD,Ustekinumab,none,none,none,0.04,Negative,212,Positive,,Adult,,,Post-1st,17-May-21,baseline,37,,,,10-Apr-21,11-Jun-21,18-Dec-21,62,190,5.358471289,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-10,AstraZeneca,Ustekinumab,.,none,none,none,2021-06-11,Pfizer,Ustekinumab,.,none,none,none,2021-12-18,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,57,57,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,37,,62,0,,,5,0,1,Post-1st Dose,0,1,,0,0,0,,3,5,,,74,4,50-59
678,,Male,CD,Ustekinumab,none,none,none,0.19,Negative,505,Positive,,Adult,,,Post-2nd,16-Dec-21,baseline,,188,,,10-Apr-21,11-Jun-21,18-Dec-21,62,190,6.225152312,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-10,AstraZeneca,Ustekinumab,.,none,none,none,2021-06-11,Pfizer,Ustekinumab,.,none,none,none,2021-12-18,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,57,58,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,188,62,0,,,6,0,1,Post-2nd Dose (8+ Weeks),0,1,,0,0,0,,3,,27,,75,4,50-59
685,,Male,CD,Infliximab,none,none,none,0.32,Negative,530,Positive,,Adult,,,Post-2nd,16-Dec-21,baseline,,174,,,20-Apr-21,25-Jun-21,21-Dec-21,66,179,6.272688309,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-20,AstraZeneca,Infliximab,.,none,none,none,2021-06-25,Pfizer,Infliximab,.,none,none,none,2021-12-21,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,49,50,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,174,66,0,,,6,0,1,Post-2nd Dose (8+ Weeks),0,1,,0,0,0,,3,,25,,630,4,50-59
699,,Female,CD,Infliximab,none,none,none,0.03,Negative,121,Positive,,Adult,-205,,Post-1st,02-Jun-21,baseline,34,,,,29-Apr-21,16-Jun-21,,48,,4.793308128,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-29,Pfizer,Inflectra,.,none,none,none,2021-06-16,Pfizer,Inflectra,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,2021-12-24,0,Female,55,55,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,34,,48,0,,,5,0,1,Post-1st Dose,1,1,,0,0,0,2021-12-24,2,5,,,892,4,50-59
700,,Female,CD,Infliximab,none,none,none,,,3792,Positive,,Adult,-151,,Post-2nd,26-Jul-21,baseline,,40,,,29-Apr-21,16-Jun-21,,48,,8.240648863,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-29,Pfizer,Inflectra,.,none,none,none,2021-06-16,Pfizer,Inflectra,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,2021-12-24,0,Female,55,55,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,40,48,0,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2021-12-24,2,,6,,893,4,50-59
703,,Female,CD,Adalimumab,none,none,none,0.11,Negative,12703,Positive,,Adult,,,Post-3rd,05-Oct-21,baseline,,,13,,18-Apr-21,28-May-21,22-Sep-21,40,117,9.449593465,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-18,Pfizer,Adalimumab,.,none,none,none,2021-05-28,Pfizer,Adalimumab,.,none,none,none,2021-09-22,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,52,52,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,40,1,,,9,0,1,Post-3rd Dose,1,1,13,0,0,0,,3,,,2,121,4,50-59
704,,Female,CD,Adalimumab,none,none,none,,,1860,Positive,,Adult,,,Post-2nd,02-Jul-21,baseline,,35,,,18-Apr-21,28-May-21,22-Sep-21,40,117,7.528224234,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-18,Pfizer,Adalimumab,.,none,none,none,2021-05-28,Pfizer,Adalimumab,.,none,none,none,2021-09-22,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,52,52,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,35,40,1,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,5,,122,4,50-59
705,,Female,CD,Ustekinumab,none,none,none,0.17,Negative,9708,Positive,,Adult,,,Post-3rd,25-Oct-21,baseline,,,54,,31-Dec-20,09-Feb-21,01-Sep-21,40,204,9.180726168,ileocolonic,unknown,N/A,none,Outpatient,Baseline Serology,,,,,,,2020-12-31,Pfizer,Ustekinumab,.,none,none,none,2021-02-09,Pfizer,Ustekinumab,.,none,none,none,2021-09-01,Moderna,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,51,52,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,40,1,,,9,0,1,Post-3rd Dose,1,1,54,0,0,0,,3,,,8,193,4,50-59
706,,Female,CD,Ustekinumab,none,none,none,0.02,Negative,411,Positive,,Adult,,,Post-1st,10-Feb-21,baseline,41,,,,31-Dec-20,09-Feb-21,01-Sep-21,40,204,6.018349876,ileocolonic,unknown,N/A,none,Outpatient,Baseline Serology,,,,,,,2020-12-31,Pfizer,Ustekinumab,.,none,none,none,2021-02-09,Pfizer,Ustekinumab,.,none,none,none,2021-09-01,Moderna,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,51,51,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,41,,40,1,,,6,0,1,Post-1st Dose,1,1,,0,0,0,,3,6,,,194,4,50-59
707,,Female,CD,Ustekinumab,none,none,none,0.02,Negative,5755,Positive,,Adult,,,Post-2nd,12-Apr-21,baseline,,62,,,31-Dec-20,09-Feb-21,01-Sep-21,40,204,8.657772191,ileocolonic,unknown,N/A,none,Outpatient,Baseline Serology,,,,,,,2020-12-31,Pfizer,Ustekinumab,.,none,none,none,2021-02-09,Pfizer,Ustekinumab,.,none,none,none,2021-09-01,Moderna,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,51,51,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,62,40,1,,,9,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,9,,195,4,50-59
712,,Female,UC,none,none,none,Azathioprine/Immuran,0.02,Negative,9428,Positive,,Adult,,,Post-3rd,03-Nov-21,baseline,,,42,,03-Mar-21,21-Apr-21,22-Sep-21,49,154,9.151407443,N/A ,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-03-03,Pfizer,none,.,none,none,Azathioprine/Immuran,2021-04-21,Pfizer,none,.,none,none,Azathioprine/Immuran,2021-09-22,Pfizer,none,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,55,56,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,,,49,0,,,9,0,0,Post-3rd Dose,1,1,42,0,0,0,,3,,,6,384,4,50-59
713,,Female,UC,none,none,none,Azathioprine/Immuran,0.03,Negative,515,Positive,,Adult,,,Post-2nd,20-Aug-21,baseline,,121,,,03-Mar-21,21-Apr-21,22-Sep-21,49,154,6.243195555,N/A ,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-03-03,Pfizer,none,.,none,none,Azathioprine/Immuran,2021-04-21,Pfizer,none,.,none,none,Azathioprine/Immuran,2021-09-22,Pfizer,none,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,55,56,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,,121,49,0,,,6,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,17,,385,4,50-59
723,,Female,CD,Adalimumab,none,none,none,0.03,Negative,380,Positive,,Adult,,,Post-3rd,30-Nov-21,baseline,,,77,,29-Mar-21,26-Apr-21,14-Sep-21,28,141,5.939118067,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-29,Pfizer,Adalimumab,.,none,none,none,2021-04-26,Pfizer,Adalimumab,.,none,none,none,2021-09-14,Pfizer,Adalimumab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,49,50,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,1,Combination Therapy,,,28,1,,,6,0,1,Post-3rd Dose,1,1,77,0,0,0,,3,,,11,400,4,50-59
724,,Female,CD,Adalimumab,none,none,none,0.07,Negative,56,Positive,,Adult,,,Post-2nd,26-Aug-21,baseline,,122,,,29-Mar-21,26-Apr-21,14-Sep-21,28,141,4.02356438,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-29,Pfizer,Adalimumab,.,none,none,none,2021-04-26,Pfizer,Adalimumab,.,none,none,none,2021-09-14,Pfizer,Adalimumab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,49,50,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,1,Combination Therapy,,122,28,1,,,4,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,17,,401,4,50-59
744,,Male,CD,Vedolizumab,none,none,none,0.05,Negative,6428,Positive,,Adult,,,Post-2nd,05-Mar-21,baseline,,13,,,13-Jan-21,20-Feb-21,22-Sep-21,38,214,8.76844984,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-01-13,Pfizer,Vedolizumab,.,none,none,none,2021-02-20,Pfizer,Vedolizumab,.,none,none,none,2021-09-22,Moderna,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,1,,1,,,,1,,,,0,Male,52,52,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,13,38,1,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,2,,267,4,50-59
745,,Male,CD,Vedolizumab,none,none,none,0.04,Negative,666,Positive,,Adult,,,Post-2nd,09-Sep-21,baseline,,201,,,13-Jan-21,20-Feb-21,22-Sep-21,38,214,6.50068889,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-01-13,Pfizer,Vedolizumab,.,none,none,none,2021-02-20,Pfizer,Vedolizumab,.,none,none,none,2021-09-22,Moderna,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,52,53,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,201,38,1,,,7,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,29,,268,4,50-59
772,,Male,CD,Ustekinumab,none,none,none,0.05,Negative,934,Positive,,Adult,,,Post-1st,14-May-21,baseline,23,,,,21-Apr-21,08-Jun-21,06-Jan-22,48,212,6.839369366,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-21,Moderna,Ustekinumab,.,none,none,none,2021-06-08,Moderna,Ustekinumab,.,none,none,none,2022-01-06,Moderna,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,53,53,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,23,,48,0,,,7,0,1,Post-1st Dose,1,1,,0,0,0,,3,3,,,331,4,50-59
773,,Male,CD,Infliximab,none,none,none,0.02,Negative,1490,Positive,,Adult,,,Post-2nd,20-Aug-21,baseline,,66,,,04-May-21,15-Jun-21,,42,,7.306262907,ileal,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-04,Pfizer,Infliximab,.,none,none,none,2021-06-15,Pfizer,Infliximab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,57,58,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,66,42,1,,,7,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,9,,27,4,50-59
777,,Male,CD,Ustekinumab,none,none,Azathioprine/Immuran,0.06,Negative,12401,Positive,,Adult,,,Post-3rd,20-Oct-21,Suspected COVID-19/Symptomatic,,,23,,10-Apr-21,03-Jun-21,27-Sep-21,54,116,9.425532394,ileocolonic,Stricturing,N/A,,Outpatient,Suspected COVID-19/Symptomatic,,,,,,,2021-04-10,Pfizer,Ustekinumab,.,none,none,Azathioprine/Immuran,2021-06-03,Pfizer,Ustekinumab,.,none,none,Azathioprine/Immuran,2021-09-27,Pfizer,Ustekinumab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,59,59,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,,,54,0,,,9,0,1,Post-3rd Dose,1,1,23,0,0,0,,3,,,3,727,4,50-59
787,,Male,UC,none,none,Oral 5ASA,none,0.14,Negative,7931,Positive,,Adult,,,Post-2nd,05-Aug-21,Suspected COVID-19/Symptomatic,,34,,,23-Apr-21,02-Jul-21,,70,,8.978509192,N/A,N/A,Unknown,,Outpatient,Suspected COVID-19/Symptomatic,,,,,,,2021-04-23,Pfizer,none,.,none,Oral 5ASA,none,2021-07-02,Pfizer,none,.,none,Oral 5ASA,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,55,55,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,0,0,,,34,70,0,,,9,0,0,Post-2nd Dose (1-8 Weeks),1,1,,1,0,1,,,,5,,314,4,50-59
788,,Male,UC,none,none,Oral 5ASA,none,0.12,Negative,117,Positive,,Adult,,,Post-1st,18-Jun-21,Suspected COVID-19/Symptomatic,56,,,,23-Apr-21,02-Jul-21,,70,,4.76046307,N/A,N/A,Unknown,,Outpatient,Suspected COVID-19/Symptomatic,,,,,,,2021-04-23,Pfizer,none,.,none,Oral 5ASA,none,2021-07-02,Pfizer,none,.,none,Oral 5ASA,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,55,55,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,0,0,,56,,70,0,,,5,0,0,Post-1st Dose,1,1,,1,0,1,,,8,,,315,4,50-59
793,,Male,UC,Ustekinumab,none,none,none,,,1995,Positive,,Adult,,,Post-2nd,23-Jul-21,baseline,,85,,,23-Mar-21,29-Apr-21,,37,,7.59859981,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-03-23,Pfizer,Ustekinumab,.,none,none,none,2021-04-29,Pfizer,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,56,56,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,,85,37,1,,,8,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,12,,830,4,50-59
799,,Male,CD,Ustekinumab,none,none,none,0.1,Negative,11541,Positive,,Adult,,,Post-3rd,10-Nov-21,baseline,,,34,,08-Jul-21,12-Aug-21,07-Oct-21,35,56,9.353678521,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-07-08,Pfizer,Ustekinumab,.,none,none,Azathioprine/Immuran,2021-08-12,Pfizer,Ustekinumab,.,none,none,Azathioprine/Immuran,2021-10-07,Pfizer,Ustekinumab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,50,50,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,,,35,1,,,9,0,1,Post-3rd Dose,1,1,34,0,0,0,,3,,,5,724,4,50-59
800,,Male,CD,Ustekinumab,none,none,none,0.31,Negative,59,Positive,,Adult,,,Post-1st,06-Aug-21,baseline,29,,,,08-Jul-21,12-Aug-21,07-Oct-21,35,56,4.069026754,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-07-08,Pfizer,Ustekinumab,.,none,none,Azathioprine/Immuran,2021-08-12,Pfizer,Ustekinumab,.,none,none,Azathioprine/Immuran,2021-10-07,Pfizer,Ustekinumab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,50,50,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,29,,35,1,,,4,0,1,Post-1st Dose,1,1,,0,0,0,,3,4,,,725,4,50-59
801,,Male,CD,Infliximab,none,none,Azathioprine/Immuran,0.06,Negative,12398,Positive,,Adult,,,Post-3rd,15-Oct-21,baseline,,,32,,13-Apr-21,07-May-21,13-Sep-21,24,129,9.425314645,ileal,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-13,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-05-07,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-09-13,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,51,51,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,,24,1,,,9,0,1,Post-3rd Dose,1,1,32,0,0,0,,3,,,5,37,4,50-59
802,,Male,CD,Infliximab,none,none,Azathioprine/Immuran,0.07,Negative,1607,Positive,,Adult,,,Post-2nd,23-Jun-21,baseline,,47,,,13-Apr-21,07-May-21,13-Sep-21,24,129,7.381999902,ileal,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-13,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-05-07,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-09-13,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,51,51,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,47,24,1,,,7,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,7,,38,4,50-59
803,,Male,CD,Infliximab,none,none,Azathioprine/Immuran,0.06,Negative,1834,Positive,,Adult,,,Post-2nd,09-Sep-21,baseline,,125,,,13-Apr-21,07-May-21,13-Sep-21,24,129,7.514309177,ileal,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-13,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-05-07,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-09-13,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,51,51,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,125,24,1,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,18,,39,4,50-59
804,,Male,CD,Infliximab,none,none,Azathioprine/Immuran,0.08,Negative,41,Negative,,Adult,,,Post-1st,06-May-21,baseline,23,,,,13-Apr-21,07-May-21,13-Sep-21,24,129,3.718438256,ileal,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-13,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-05-07,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-09-13,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,51,51,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,23,,24,1,,,4,0,1,Post-1st Dose,1,1,,0,0,0,,3,3,,,40,4,50-59
814,,Female,CD,Ustekinumab,none,none,none,0.02,Negative,490,Positive,,Adult,,,Post-2nd,30-Nov-21,baseline,,155,,,24-Apr-21,28-Jun-21,14-Dec-21,65,169,6.195017449,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-24,Pfizer,Ustekinumab,.,none,none,none,2021-06-28,Pfizer,Ustekinumab,.,none,none,none,2021-12-14,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,58,59,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,155,65,0,,,6,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,22,,56,4,50-59
815,,Female,CD,Ustekinumab,none,none,none,0.03,Negative,550,Positive,,Adult,,,Post-1st,10-Jun-21,baseline,47,,,,24-Apr-21,28-Jun-21,14-Dec-21,65,169,6.310463584,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-24,Pfizer,Ustekinumab,.,none,none,none,2021-06-28,Pfizer,Ustekinumab,.,none,none,none,2021-12-14,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,58,58,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,47,,65,0,,,6,0,1,Post-1st Dose,1,1,,0,0,0,,3,7,,,57,4,50-59
821,,Male,CD,Remicade,none,none,none,0.03,Negative,97,Positive,,Adult,-221,,Post-1st,26-May-21,baseline,42,,,,14-Apr-21,13-Jun-21,13-Dec-21,60,183,4.569543008,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-14,Pfizer,Remicade,.,none,none,none,2021-06-13,Pfizer,Remicade,.,none,none,none,2021-12-13,Pfizer,Remicade,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,2022-01-02,0,Male,55,55,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,42,,60,0,,,5,0,1,Post-1st Dose,1,1,,0,0,0,2022-01-02,3,6,,,533,4,50-59
822,,Male,CD,Remicade,none,none,none,0.2,Negative,127,Positive,,Adult,-53,,Post-2nd,10-Nov-21,baseline,,150,,,14-Apr-21,13-Jun-21,13-Dec-21,60,183,4.84103251,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-14,Pfizer,Remicade,.,none,none,none,2021-06-13,Pfizer,Remicade,.,none,none,none,2021-12-13,Pfizer,Remicade,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,2022-01-02,0,Male,55,55,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,150,60,0,,,5,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,2022-01-02,3,,21,,534,4,50-59
823,,Male,CD,Remicade,none,none,none,0.03,Negative,1842,Positive,,Adult,-165,,Post-2nd,21-Jul-21,baseline,,38,,,14-Apr-21,13-Jun-21,13-Dec-21,60,183,7.51877007,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-14,Pfizer,Remicade,.,none,none,none,2021-06-13,Pfizer,Remicade,.,none,none,none,2021-12-13,Pfizer,Remicade,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,2022-01-02,0,Male,55,55,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,38,60,0,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2022-01-02,3,,5,,535,4,50-59
831,,Female,CD,Ustekinumab,none,none,none,0.02,Negative,5778,Positive,,Adult,,,Post-3rd,09-Nov-21,baseline,,,68,,13-Apr-21,22-Jun-21,02-Sep-21,70,72,8.661812881,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-13,Pfizer,Vedolizumab,.,none,none,none,2021-06-22,Pfizer,Vedolizumab,.,none,none,none,2021-09-02,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,51,52,0,0,1,0,0,0,0,Ustekinumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,,70,0,,,9,0,1,Post-3rd Dose,1,1,68,0,0,0,,3,,,10,791,4,50-59
832,,Female,CD,Ustekinumab,none,none,none,0.05,Negative,1626,Positive,,Adult,,,Post-1st,25-May-21,baseline,42,,,,13-Apr-21,22-Jun-21,02-Sep-21,70,72,7.393939789,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-13,Pfizer,Vedolizumab,.,none,none,none,2021-06-22,Pfizer,Vedolizumab,.,none,none,none,2021-09-02,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,51,51,0,0,1,0,0,0,0,Ustekinumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,42,,70,0,,,7,0,1,Post-1st Dose,1,1,,0,0,0,,3,6,,,792,4,50-59
833,,Female,CD,Ustekinumab,none,none,none,0.07,Negative,26157,Positive,,Adult,,,Post-2nd,22-Jul-21,baseline,,30,,,13-Apr-21,22-Jun-21,02-Sep-21,70,72,10.17187594,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-13,Pfizer,Vedolizumab,.,none,none,none,2021-06-22,Pfizer,Vedolizumab,.,none,none,none,2021-09-02,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,51,51,0,0,1,0,0,0,0,Ustekinumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,30,70,0,,,10,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,793,4,50-59
836,,Male,CD,Ustekinumab,none,none,none,0.24,Negative,16349,Positive,,Adult,,,Post-3rd,12-Nov-21,baseline,,,21,,09-May-21,08-Jul-21,22-Oct-21,60,106,9.701928129,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-09,Pfizer,Ustekinumab,.,none,none,none,2021-07-08,Moderna,Ustekinumab,.,none,none,none,2021-10-22,Moderna,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,49,50,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,60,0,,,10,0,1,Post-3rd Dose,1,1,21,0,0,0,,3,,,3,70,4,50-59
839,,Male,CD,Ustekinumab,none,none,none,0.03,Negative,6859,Positive,,Adult,-59,,Post-3rd,05-Nov-21,baseline,,,28,,06-Apr-21,16-May-21,08-Oct-21,40,145,8.833331517,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-06,Pfizer,Ustekinumab,.,none,none,none,2021-05-16,Pfizer,Ustekinumab,.,none,none,none,2021-10-08,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,2022-01-03,0,Male,50,50,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,40,1,,,9,0,1,Post-3rd Dose,1,1,28,0,0,0,2022-01-03,3,,,4,554,4,50-59
840,,Male,CD,Ustekinumab,none,none,none,0.03,Negative,662,Positive,,Adult,-139,,Post-2nd,17-Aug-21,baseline,,93,,,06-Apr-21,16-May-21,08-Oct-21,40,145,6.495114487,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-06,Pfizer,Ustekinumab,.,none,none,none,2021-05-16,Pfizer,Ustekinumab,.,none,none,none,2021-10-08,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,2022-01-03,0,Male,50,50,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,93,40,1,,,6,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,2022-01-03,3,,13,,555,4,50-59
841,,Male,CD,Ustekinumab,none,none,none,0.02,Negative,127,Positive,,Adult,-242,,Post-1st,06-May-21,baseline,30,,,,06-Apr-21,16-May-21,08-Oct-21,40,145,4.845760651,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-06,Pfizer,Ustekinumab,.,none,none,none,2021-05-16,Pfizer,Ustekinumab,.,none,none,none,2021-10-08,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,2022-01-03,0,Male,50,50,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,30,,40,1,,,5,0,1,Post-1st Dose,1,1,,0,0,0,2022-01-03,3,4,,,556,4,50-59
842,,Male,CD,Infliximab,none,none,Azathioprine/Immuran,0.02,Negative,40,Negative,,Adult,,,Post-1st,04-May-21,baseline,27,,,,07-Apr-21,11-Jun-21,30-Dec-21,65,202,3.676300672,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-07,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-06-11,Pfizer,Ustekinumab,.,none,none,Azathioprine/Immuran,2021-12-30,Pfizer,Ustekinumab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,58,58,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,27,,65,0,,,4,0,1,Post-1st Dose,1,1,,0,0,0,,3,4,,,518,4,50-59
843,,Male,CD,Infliximab,none,none,Azathioprine/Immuran,,,61,Positive,,Adult,,,Post-2nd,30-Jul-21,baseline,,49,,,07-Apr-21,11-Jun-21,30-Dec-21,65,202,4.110873864,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-07,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-06-11,Pfizer,Ustekinumab,.,none,none,Azathioprine/Immuran,2021-12-30,Pfizer,Ustekinumab,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,58,59,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,,49,65,0,,,4,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,7,,519,4,50-59
862,,Female,CD,Ustekinumab,none,none,none,0.05,Negative,27081,Positive,,Adult,,,Post-3rd,30-Nov-21,baseline,,,17,,14-Apr-21,11-Jun-21,13-Nov-21,58,155,10.20658765,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-14,Moderna,Ustekinumab,.,none,none,none,2021-06-11,Moderna,Ustekinumab,.,none,none,none,2021-11-13,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,55,56,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,58,0,,,10,0,1,Post-3rd Dose,1,1,17,0,0,0,,3,,,2,884,4,50-59
863,,Female,CD,Ustekinumab,none,none,none,0.02,Negative,607,Positive,,Adult,,,Post-1st,26-May-21,baseline,42,,,,14-Apr-21,11-Jun-21,13-Nov-21,58,155,6.409022903,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-14,Moderna,Ustekinumab,.,none,none,none,2021-06-11,Moderna,Ustekinumab,.,none,none,none,2021-11-13,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,55,55,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,42,,58,0,,,6,0,1,Post-1st Dose,1,1,,0,0,0,,3,6,,,885,4,50-59
864,,Female,CD,Ustekinumab,none,none,none,,,3205,Positive,,Adult,,,Post-2nd,23-Jul-21,baseline,,42,,,14-Apr-21,11-Jun-21,13-Nov-21,58,155,8.07252977,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-14,Moderna,Ustekinumab,.,none,none,none,2021-06-11,Moderna,Ustekinumab,.,none,none,none,2021-11-13,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,55,56,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,42,58,0,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,6,,886,4,50-59
865,,Female,CD,Ustekinumab,none,none,none,0.01,Negative,1023,Positive,,Adult,,,Post-2nd,06-Nov-21,baseline,,148,,,14-Apr-21,11-Jun-21,13-Nov-21,58,155,6.930397009,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-14,Moderna,Ustekinumab,.,none,none,none,2021-06-11,Moderna,Ustekinumab,.,none,none,none,2021-11-13,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,55,56,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,148,58,0,,,7,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,21,,887,4,50-59
878,,Female,CD,Adalimumab,none,none,none,0.03,Negative,4141,Positive,,Adult,,,Post-2nd,21-Jun-21,baseline,,18,,,12-Apr-21,03-Jun-21,16-Dec-21,52,196,8.328668434,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-12,Moderna,Adalimumab,.,none,none,none,2021-06-03,Moderna,Adalimumab,.,none,none,none,2021-12-16,Moderna,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,52,52,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,18,52,0,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,18,4,50-59
879,,Female,CD,Adalimumab,none,none,none,0.02,Negative,426,Positive,,Adult,,,Post-2nd,01-Oct-21,baseline,,120,,,12-Apr-21,03-Jun-21,16-Dec-21,52,196,6.053264948,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-12,Moderna,Adalimumab,.,none,none,none,2021-06-03,Moderna,Adalimumab,.,none,none,none,2021-12-16,Moderna,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,52,53,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,120,52,0,,,6,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,17,,19,4,50-59
880,,Female,CD,Adalimumab,none,none,none,0.01,Negative,680,Positive,,Adult,,,Post-1st,10-May-21,baseline,28,,,,12-Apr-21,03-Jun-21,16-Dec-21,52,196,6.521651524,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-12,Moderna,Adalimumab,.,none,none,none,2021-06-03,Moderna,Adalimumab,.,none,none,none,2021-12-16,Moderna,Adalimumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,52,52,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,28,,52,0,,,7,0,1,Post-1st Dose,1,1,,0,0,0,,3,4,,,20,4,50-59
887,,Male,CD,Adalimumab,none,none,none,0.08,Negative,2111,Positive,,Adult,,,Post-2nd,17-Aug-21,baseline,,101,,,11-Apr-21,08-May-21,,27,,7.655011785,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-11,Pfizer,Ustekinumab,.,none,none,none,2021-05-08,Pfizer,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,56,56,1,0,0,0,0,0,0,Anti-TNF Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,,101,27,1,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,14,,388,4,50-59
895,,Male,CD,Vedolizumab,none,none,none,0.08,Negative,40000,Positive,,Adult,,,Post-3rd,15-Oct-21,baseline,,,8,,01-Apr-21,28-May-21,07-Oct-21,57,132,10.59663473,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-01,Pfizer,Vedolizumab,.,none,none,none,2021-05-28,Pfizer,Vedolizumab,.,none,none,none,2021-10-07,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,57,58,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,,57,0,,,11,0,1,Post-3rd Dose,1,1,8,0,0,0,,3,,,1,264,4,50-59
896,,Male,CD,Vedolizumab,none,none,none,0.07,Negative,2402,Positive,,Adult,,,Post-1st,30-Apr-21,baseline,29,,,,01-Apr-21,28-May-21,07-Oct-21,57,132,7.784098634,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-01,Pfizer,Vedolizumab,.,none,none,none,2021-05-28,Pfizer,Vedolizumab,.,none,none,none,2021-10-07,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,57,58,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,29,,57,0,,,8,0,1,Post-1st Dose,1,1,,0,0,0,,3,4,,,265,4,50-59
897,,Male,CD,Vedolizumab,none,none,none,0.04,Negative,35266,Positive,,Adult,,,Post-2nd,25-Jun-21,baseline,,28,,,01-Apr-21,28-May-21,07-Oct-21,57,132,10.4706661,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-01,Pfizer,Vedolizumab,.,none,none,none,2021-05-28,Pfizer,Vedolizumab,.,none,none,none,2021-10-07,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,57,58,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,28,57,0,,,10,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,266,4,50-59
903,,Male,UC,none,none,yes ,Azathioprine/Immuran,0.01,Negative,692,Positive,,Adult,,,Post-1st,21-May-21,baseline,42,,,,09-Apr-21,11-Jun-21,13-Dec-21,63,185,6.539730454,N/A ,N/A,,,Outpatient,Baseline Serology,,,,,,,2021-04-09,Moderna,none,.,none,yes ,Azathioprine/Immuran,2021-06-11,Moderna,none,.,none,yes ,Azathioprine/Immuran,2021-12-13,Pfizer,none,.,none,yes ,Azathioprine/Immuran,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,59,59,0,0,0,0,0,1,1,Immunomodulator Only,0,0,0,0,0,1,1,Immunomodulator Only,0,0,0,0,0,1,1,Immunomodulator Only,0,0,0,0,0,1,1,Immunomodulator Only,42,,63,0,,,7,0,0,Post-1st Dose,1,1,,0,0,0,,3,6,,,296,4,50-59
904,,Male,UC,none,none,yes ,Azathioprine/Immuran,0.01,Negative,11614,Positive,,Adult,,,Post-2nd,04-Aug-21,baseline,,54,,,09-Apr-21,11-Jun-21,13-Dec-21,63,185,9.359957936,N/A ,N/A,,,Outpatient,Baseline Serology,,,,,,,2021-04-09,Moderna,none,.,none,yes ,Azathioprine/Immuran,2021-06-11,Moderna,none,.,none,yes ,Azathioprine/Immuran,2021-12-13,Pfizer,none,.,none,yes ,Azathioprine/Immuran,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,59,59,0,0,0,0,0,1,1,Immunomodulator Only,0,0,0,0,0,1,1,Immunomodulator Only,0,0,0,0,0,1,1,Immunomodulator Only,0,0,0,0,0,1,1,Immunomodulator Only,,54,63,0,,,9,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,8,,297,4,50-59
905,,Male,CD,Ustekinumab,Oral Prednisone,none,Methotrexate,0.02,Negative,18020,Positive,,Adult,,,Post-3rd,30-Sep-21,baseline,,,22,,09-Apr-21,06-May-21,08-Sep-21,27,125,9.799209784,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-09,Pfizer,Ustekinumab,.,Oral Prednisone,none,Methotrexate,2021-05-06,Pfizer,Ustekinumab,.,Oral Prednisone,none,Methotrexate,2021-09-08,Pfizer,Ustekinumab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,57,58,0,0,1,0,1,0,1,Corticoteroids,0,0,1,0,1,0,1,Corticoteroids,0,0,1,0,1,0,1,Corticoteroids,0,0,1,0,0,0,1,Combination Therapy,,,27,1,,,10,0,1,Post-3rd Dose,1,1,22,0,0,0,,3,,,3,827,4,50-59
906,,Male,CD,Ustekinumab,Oral Prednisone,none,Methotrexate,0.02,Negative,77,Positive,,Adult,,,Post-1st,05-May-21,baseline,26,,,,09-Apr-21,06-May-21,08-Sep-21,27,125,4.345103281,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-09,Pfizer,Ustekinumab,.,Oral Prednisone,none,Methotrexate,2021-05-06,Pfizer,Ustekinumab,.,Oral Prednisone,none,Methotrexate,2021-09-08,Pfizer,Ustekinumab,.,none,none,Methotrexate,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,57,57,0,0,1,0,1,0,1,Corticoteroids,0,0,1,0,1,0,1,Corticoteroids,0,0,1,0,1,0,1,Corticoteroids,0,0,1,0,0,0,1,Combination Therapy,26,,27,1,,,4,0,1,Post-1st Dose,1,1,,0,0,0,,3,4,,,828,4,50-59
907,,Male,CD,Ustekinumab,Oral Prednisone,none,Methotrexate,0.02,Negative,376,Positive,,Adult,,,Post-2nd,23-Jun-21,baseline,,48,,,09-Apr-21,06-May-21,08-Sep-21,27,125,5.928524747,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-09,Pfizer,Ustekinumab,.,Oral Prednisone,none,Methotrexate,2021-05-06,Pfizer,Ustekinumab,.,Oral Prednisone,none,Methotrexate,2021-09-08,Pfizer,Ustekinumab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,57,57,0,0,1,0,1,0,1,Corticoteroids,0,0,1,0,1,0,1,Corticoteroids,0,0,1,0,1,0,1,Corticoteroids,0,0,1,0,0,0,1,Combination Therapy,,48,27,1,,,6,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,7,,829,4,50-59
925,,Male,CD,Infliximab,none,none,Azathioprine/Immuran,,,2299,Positive,,Adult,-79,,Post-2nd,06-Jul-21,baseline,,22,,,29-Apr-21,14-Jun-21,,46,,7.740403498,colonic,Perianal CD,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-29,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-06-14,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,2021-09-23,0,Male,57,57,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,0,0,0,0,0,0,0,,,22,46,0,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2021-09-23,2,,3,,466,4,50-59
926,,Male,CD,Infliximab,none,none,Azathioprine/Immuran,0.02,Negative,44,Negative,,Adult,-119,,Post-1st,27-May-21,baseline,28,,,,29-Apr-21,14-Jun-21,,46,,3.777348102,colonic,Perianal CD,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-29,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,2021-06-14,Pfizer,Infliximab,.,none,none,Azathioprine/Immuran,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,2021-09-23,0,Male,57,57,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,0,0,0,0,0,0,0,,28,,46,0,,,4,0,1,Post-1st Dose,1,1,,0,0,0,2021-09-23,2,4,,,467,4,50-59
933,,Female,UC,none,none,Oral 5ASA,none,,,2472,Positive,,Adult,,,Post-2nd,16-Jul-21,baseline,,38,,,08-Apr-21,08-Jun-21,07-Dec-21,61,182,7.812580533,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-08,Pfizer,none,.,none,Oral 5ASA,none,2021-06-08,Pfizer,none,.,none,Oral 5ASA,none,2021-12-07,Pfizer,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,52,52,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,38,61,0,,,8,0,0,Post-2nd Dose (1-8 Weeks),1,1,,1,1,1,,3,,5,,104,4,50-59
934,,Female,UC,none,none,Oral 5ASA,none,0.04,Negative,65,Positive,,Adult,,,Post-1st,11-May-21,baseline,33,,,,08-Apr-21,08-Jun-21,07-Dec-21,61,182,4.171305603,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-08,Pfizer,none,.,none,Oral 5ASA,none,2021-06-08,Pfizer,none,.,none,Oral 5ASA,none,2021-12-07,Pfizer,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,52,52,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,33,,61,0,,,4,0,0,Post-1st Dose,1,1,,1,1,1,,3,5,,,105,4,50-59
935,,Female,CD,Adalimumab,none,none,none,0.16,Negative,9061,Positive,,Adult,,,Post-3rd,04-Oct-21,baseline,,,24,,15-Apr-21,14-Jun-21,10-Sep-21,60,88,9.111778912,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-15,Pfizer,Adalimumab,.,none,none,none,2021-06-14,Pfizer,Adalimumab,.,none,none,none,2021-09-10,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,55,56,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,60,0,,,9,0,1,Post-3rd Dose,1,1,24,0,0,0,,3,,,3,986,4,50-59
936,,Female,CD,Adalimumab,none,none,none,0.08,Negative,3335,Positive,,Adult,,,Post-2nd,29-Jun-21,baseline,,15,,,15-Apr-21,14-Jun-21,10-Sep-21,60,88,8.112108011,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-15,Pfizer,Adalimumab,.,none,none,none,2021-06-14,Pfizer,Adalimumab,.,none,none,none,2021-09-10,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,55,55,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,15,60,0,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,2,,987,4,50-59
942,,Female,CD,Ustekinumab,none,none,none,0.21,Negative,1927,Positive,,Adult,,,Post-2nd,20-Oct-21,baseline,,147,,,13-Apr-21,26-May-21,17-Nov-21,43,175,7.563615875,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-13,Pfizer,Ustekinumab,.,none,none,none,2021-05-26,Pfizer,Ustekinumab,.,none,none,none,2021-11-17,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,58,58,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,147,43,0,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,21,,246,4,50-59
943,,Female,CD,Ustekinumab,none,none,none,0.21,Negative,452,Positive,,Adult,,,Post-1st,19-May-21,baseline,36,,,,13-Apr-21,26-May-21,17-Nov-21,43,175,6.113460916,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-13,Pfizer,Ustekinumab,.,none,none,none,2021-05-26,Pfizer,Ustekinumab,.,none,none,none,2021-11-17,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,58,58,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,36,,43,0,,,6,0,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,247,4,50-59
958,,Female,CD,Renflexis/IFX,none,none,none,0.13,Negative,74,Positive,,Adult,,,Post-2nd,29-Oct-21,baseline,,121,,,12-Apr-21,30-Jun-21,,79,,4.304065093,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-12,Pfizer,Renflexis/IFX,.,none,none,none,2021-06-30,Pfizer,Renflexis/IFX,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,53,53,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,121,79,0,,,4,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,17,,936,4,50-59
959,,Female,CD,Renflexis/IFX,none,none,none,,,2387,Positive,,Adult,,,Post-2nd,23-Jul-21,baseline,,23,,,12-Apr-21,30-Jun-21,,79,,7.777708836,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-12,Pfizer,Renflexis/IFX,.,none,none,none,2021-06-30,Pfizer,Renflexis/IFX,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,53,53,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,23,79,0,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,3,,937,4,50-59
960,,Female,CD,Adalimumab,none,none,none,0.05,Negative,27869,Positive,,Adult,,,Post-3rd,08-Oct-21,baseline,,,36,,06-Apr-21,10-May-21,02-Sep-21,34,115,10.23527742,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-06,Moderna,Adalimumab,.,none,none,none,2021-05-10,Moderna,Adalimumab,.,none,none,none,2021-09-02,Moderna,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,56,57,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,34,1,,,10,0,1,Post-3rd Dose,1,1,36,0,0,0,,3,,,5,950,4,50-59
961,,Female,CD,Adalimumab,none,none,none,0.04,Negative,17299,Positive,,Adult,,,Post-2nd,28-May-21,baseline,,18,,,06-Apr-21,10-May-21,02-Sep-21,34,115,9.758398195,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-06,Moderna,Adalimumab,.,none,none,none,2021-05-10,Moderna,Adalimumab,.,none,none,none,2021-09-02,Moderna,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,56,56,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,18,34,1,,,10,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,951,4,50-59
968,,Male,CD,Infliximab,none,none,none,0.07,Negative,14962,Positive,,Adult,,,Post-3rd,26-Nov-21,baseline,,,30,,16-Apr-21,13-Jun-21,27-Oct-21,58,136,9.613295666,unknown,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-16,Pfizer,Infliximab,.,none,none,none,2021-06-13,Pfizer,Infliximab,.,none,none,none,2021-10-27,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,59,59,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,58,0,,,10,0,1,Post-3rd Dose,1,1,30,0,0,0,,3,,,4,223,4,50-59
969,,Male,CD,Infliximab,none,none,none,0.05,Negative,4678,Positive,,Adult,,,Post-2nd,20-Jul-21,baseline,,37,,,16-Apr-21,13-Jun-21,27-Oct-21,58,136,8.4506687,unknown,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-16,Pfizer,Infliximab,.,none,none,none,2021-06-13,Pfizer,Infliximab,.,none,none,none,2021-10-27,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,59,59,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,37,58,0,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,5,,224,4,50-59
970,,Male,CD,Infliximab,none,none,none,0.05,Negative,33,Negative,,Adult,,,Post-1st,10-Jun-21,baseline,55,,,,16-Apr-21,13-Jun-21,27-Oct-21,58,136,3.484312288,unknown,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-16,Pfizer,Infliximab,.,none,none,none,2021-06-13,Pfizer,Infliximab,.,none,none,none,2021-10-27,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,59,59,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,55,,58,0,,,3,0,1,Post-1st Dose,1,1,,0,0,0,,3,8,,,225,4,50-59
983,,Female,CD,Adalimumab,none,none,none,0.45,Negative,13498,Positive,,Adult,273,,Post-3rd,27-Oct-21,covid,,,21,,12-Apr-21,13-Jun-21,06-Oct-21,62,115,9.510319031,colonic,Inflamatory,N/A,,Outpatient,Confirmed COVID,,,,,,2021-05-17,2021-04-12,Pfizer,Adalimumab,.,none,none,none,2021-06-13,Pfizer,Adalimumab,.,none,none,none,2021-10-06,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,2021-01-27,1,Female,55,55,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,62,0,,,10,0,1,Post-3rd Dose,1,1,21,0,0,0,2021-01-27,,,,3,648,4,50-59
984,,Female,CD,Adalimumab,none,none,none,3.32,Positive,22465,Positive,,Adult,110,,Post-1st,17-May-21,covid,35,,,,12-Apr-21,13-Jun-21,06-Oct-21,62,115,10.01969156,colonic,Inflamatory,N/A,,Outpatient,Confirmed COVID,,,,,,2021-05-17,2021-04-12,Pfizer,Adalimumab,.,none,none,none,2021-06-13,Pfizer,Adalimumab,.,none,none,none,2021-10-06,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,2021-01-27,1,Female,55,55,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,35,,62,0,,,10,0,1,Post-1st Dose,1,1,,0,0,0,2021-01-27,,5,,,649,4,50-59
985,,Female,CD,Adalimumab,none,none,none,,,10572,Positive,,Adult,161,,Post-2nd,07-Jul-21,covid,,24,,,12-Apr-21,13-Jun-21,06-Oct-21,62,115,9.265945358,colonic,Inflamatory,N/A,,Outpatient,Confirmed COVID,,,,,,2021-05-17,2021-04-12,Pfizer,Adalimumab,.,none,none,none,2021-06-13,Pfizer,Adalimumab,.,none,none,none,2021-10-06,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,2021-01-27,1,Female,55,55,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,24,62,0,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2021-01-27,,,3,,650,4,50-59
988,,Female,UC,Vedolizumab,none,none,none,0.02,Negative,4583,Positive,,Adult,,,Post-2nd,05-Apr-21,baseline,,75,,,30-Dec-20,20-Jan-21,10-Sep-21,21,233,8.430043623,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2020-12-30,Pfizer,Vedolizumab,.,none,none,none,2021-01-20,Pfizer,Vedolizumab,.,none,none,none,2021-09-10,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,52,52,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,1,0,0,0,0,0,0,Anti-TNF Only,,75,21,1,,,8,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,11,,301,4,50-59
16,,Male,UC,none,none,Oral 5ASA,none,,,2403,Positive,,Elderly,268,,Post-2nd,02-Jul-21,covid,,23,,,30-Mar-21,09-Jun-21,10-Dec-21,71,184,7.78443162,N/A,N/A,Pancolitis,,Outpatient,Confirmed COVID,,,,,,,2021-03-30,Pfizer,none,.,none,Oral 5ASA,none,2021-06-09,Pfizer,none,.,none,Oral 5ASA,none,2021-12-10,Pfizer,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,1,1,,,,1,,,2020-10-07,1,Male,65,65,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,23,71,0,,,8,0,0,Post-2nd Dose (1-8 Weeks),1,1,,1,1,1,2020-10-07,,,3,,81,5,60-69
17,,Male,UC,none,none,Oral 5ASA,none,0.03,Negative,963,Positive,,Elderly,205,,Post-1st,30-Apr-21,covid,31,,,,30-Mar-21,09-Jun-21,10-Dec-21,71,184,6.869741837,N/A,N/A,Pancolitis,,Outpatient,Confirmed COVID,,,,,,,2021-03-30,Pfizer,none,.,none,Oral 5ASA,none,2021-06-09,Pfizer,none,.,none,Oral 5ASA,none,2021-12-10,Pfizer,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,1,,,,,,,,,,2020-10-07,1,Male,65,65,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,31,,71,0,,,7,0,0,Post-1st Dose,1,1,,1,1,1,2020-10-07,,4,,,82,5,60-69
27,,Female,CD,none,none,none,none,0.02,Negative,16850,Positive,,Adult,,,Post-3rd,01-Oct-21,baseline,,,21,,17-Mar-21,05-Jun-21,10-Sep-21,80,97,9.732076262,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,2022-01-05,,2021-03-17,AstraZeneca,none,.,none,none,none,2021-06-05,Pfizer,none,.,none,none,none,2021-09-10,Pfizer,none,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,61,61,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,,,80,0,,,10,0,1,Post-3rd Dose,0,1,21,1,1,1,,3,,,3,545,5,60-69
28,,Female,CD,none,none,none,none,,,2448,Positive,,Adult,,,Post-2nd,02-Jul-21,baseline,,27,,,17-Mar-21,05-Jun-21,10-Sep-21,80,97,7.803026644,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,2022-01-05,,2021-03-17,AstraZeneca,none,.,none,none,none,2021-06-05,Pfizer,none,.,none,none,none,2021-09-10,Pfizer,none,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,61,61,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,,27,80,0,,,8,0,1,Post-2nd Dose (1-8 Weeks),0,1,,1,1,1,,3,,4,,546,5,60-69
29,,Female,CD,none,none,none,none,0.02,Negative,347,Positive,,Adult,,,Post-1st,10-May-21,baseline,54,,,,17-Mar-21,05-Jun-21,10-Sep-21,80,97,5.849612923,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,2022-01-05,,2021-03-17,AstraZeneca,none,.,none,none,none,2021-06-05,Pfizer,none,.,none,none,none,2021-09-10,Pfizer,none,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,61,61,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,54,,80,0,,,6,0,1,Post-1st Dose,0,1,,1,1,1,,3,8,,,547,5,60-69
30,,Female,CD,Infliximab,none,none,Methotrexate,0.48,Negative,39669,Positive,,Adult,38,,Post-3rd,06-Oct-21,Post Vaccine covid,,,14,,01-Apr-21,27-Apr-21,22-Sep-21,26,148,10.5883127,ileocolonic,Stricturing,N/A,,Outpatient,Post Vaccine Confirmed COVID,,,,,,,2021-04-01,Pfizer,Infliximab,.,none,none,Methotrexate,2021-04-27,Pfizer,Infliximab,.,none,none,Methotrexate,2021-09-22,Pfizer,Infliximab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,,,,,,,1,,2021-08-29,1,Female,60,61,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,,26,1,,,11,0,1,Post-3rd Dose,1,1,14,0,0,0,2021-08-29,2,,,2,85,5,60-69
31,,Female,CD,Infliximab,none,none,Methotrexate,0.04,Negative,336,Positive,,Adult,-90,,Post-2nd,31-May-21,Post Vaccine covid,,34,,,01-Apr-21,27-Apr-21,22-Sep-21,26,148,5.816515745,ileocolonic,Stricturing,N/A,,Outpatient,Post Vaccine Confirmed COVID,,,,,,,2021-04-01,Pfizer,Infliximab,.,none,none,Methotrexate,2021-04-27,Pfizer,Infliximab,.,none,none,Methotrexate,2021-09-22,Pfizer,Infliximab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,1,1,,,,1,,,2021-08-29,0,Female,60,61,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,34,26,1,,,6,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2021-08-29,2,,5,,86,5,60-69
32,,Female,CD,Infliximab,none,none,Methotrexate,0.03,Negative,39,Negative,,Adult,-5,,Post-2nd,24-Aug-21,Post Vaccine covid,,119,,,01-Apr-21,27-Apr-21,22-Sep-21,26,148,3.6558396,ileocolonic,Stricturing,N/A,,Outpatient,Post Vaccine Confirmed COVID,,,,,,,2021-04-01,Pfizer,Infliximab,.,none,none,Methotrexate,2021-04-27,Pfizer,Infliximab,.,none,none,Methotrexate,2021-09-22,Pfizer,Infliximab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,,,1,,1,1,,,2021-08-29,0,Female,60,61,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,119,26,1,,,4,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,2021-08-29,2,,17,,87,5,60-69
38,,Female,UC,none,none,none,none,0.01,Negative,2803,Positive,,Adult,,,Post-1st,11-May-21,baseline,19,,,,22-Apr-21,20-May-21,10-Dec-21,28,204,7.938445551,ileocolonic,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Moderna,none,.,none,none,none,2021-05-20,Moderna,none,.,none,none,none,2021-12-10,Moderna,Adalimumab,.,none,none,Methotrexate,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,61,61,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,1,0,0,0,0,0,1,Combination Therapy,19,,28,1,,,8,0,0,Post-1st Dose,1,1,,1,0,1,,3,3,,,10,5,60-69
39,,Female,UC,none,none,none,none,0.01,Negative,3123,Positive,,Adult,,,Post-2nd,22-Sep-21,baseline,,125,,,22-Apr-21,20-May-21,10-Dec-21,28,204,8.046453291,ileocolonic,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Moderna,none,.,none,none,none,2021-05-20,Moderna,none,.,none,none,none,2021-12-10,Moderna,Adalimumab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,61,62,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,1,0,0,0,0,0,1,Combination Therapy,,125,28,1,,,8,0,0,Post-2nd Dose (8+ Weeks),1,1,,1,0,1,,3,,18,,11,5,60-69
40,,Female,UC,none,none,none,none,,,51805,Positive,,Adult,,,Post-2nd,09-Jun-21,baseline,,20,,,22-Apr-21,20-May-21,10-Dec-21,28,204,10.85524195,ileocolonic,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Moderna,none,.,none,none,none,2021-05-20,Moderna,none,.,none,none,none,2021-12-10,Moderna,Adalimumab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,61,61,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,1,0,0,0,0,0,1,Combination Therapy,,20,28,1,,,11,0,0,Post-2nd Dose (1-8 Weeks),1,1,,1,0,1,,3,,3,,12,5,60-69
59,,Female,CD,Adalimumab,none,none,none,0.02,Negative,592,Positive,,Elderly,-26,,Post-2nd,22-Jul-21,Post Vaccine covid,,53,,,18-Mar-21,30-May-21,17-Dec-21,73,201,6.382661683,ileocolonic,Stricturing,N/A,,Outpatient,Post Vaccine Confirmed COVID,,delta,,,,,2021-03-18,Pfizer,Adalimumab,.,none,none,none,2021-05-30,Pfizer,Adalimumab,.,none,none,none,2021-12-17,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,2021-08-17,0,Female,69,69,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,53,73,0,,,6,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2021-08-17,2,,8,,736,5,60-69
60,,Female,CD,Adalimumab,none,none,none,0.02,Negative,200,Positive,,Elderly,48,,Post-2nd,04-Oct-21,Post Vaccine covid,,127,,,18-Mar-21,30-May-21,17-Dec-21,73,201,5.299316867,ileocolonic,Stricturing,N/A,,Outpatient,Post Vaccine Confirmed COVID,,delta,,,,,2021-03-18,Pfizer,Adalimumab,.,none,none,none,2021-05-30,Pfizer,Adalimumab,.,none,none,none,2021-12-17,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,2021-08-17,1,Female,69,69,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,127,73,0,,,5,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,2021-08-17,2,,18,,737,5,60-69
61,,Female,CD,Adalimumab,none,none,none,0.02,Negative,28,Negative,,Elderly,-112,,Post-1st,27-Apr-21,Post Vaccine covid,40,,,,18-Mar-21,30-May-21,17-Dec-21,73,201,3.314186005,ileocolonic,Stricturing,N/A,,Outpatient,Post Vaccine Confirmed COVID,,delta,,,,,2021-03-18,Pfizer,Adalimumab,.,none,none,none,2021-05-30,Pfizer,Adalimumab,.,none,none,none,2021-12-17,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,2021-08-17,0,Female,69,69,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,40,,73,0,,,3,1,1,Post-1st Dose,1,1,,0,0,0,2021-08-17,2,6,,,738,5,60-69
80,,Female,CD,none,none,none,none,,,4130,Positive,,Adult,,,Post-2nd,26-Jul-21,baseline,,40,,,11-Mar-21,16-Jun-21,17-Dec-21,97,184,8.325960044,unknown,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-11,COVISHIELD,none,.,none,none,none,2021-06-16,COVISHIELD,none,.,none,none,none,2021-12-17,Pfizer,none,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,64,64,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,,40,97,0,,,8,0,1,Post-2nd Dose (1-8 Weeks),,,,1,1,1,,3,,6,,302,5,60-69
81,,Female,CD,none,none,none,none,0.05,Negative,463,Positive,,Adult,,,Post-2nd,10-Nov-21,baseline,,147,,,11-Mar-21,16-Jun-21,17-Dec-21,97,184,6.137294995,unknown,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-11,COVISHIELD,none,.,none,none,none,2021-06-16,COVISHIELD,none,.,none,none,none,2021-12-17,Pfizer,none,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,64,64,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,,147,97,0,,,6,0,1,Post-2nd Dose (8+ Weeks),,,,1,1,1,,3,,21,,303,5,60-69
82,,Female,CD,none,none,none,none,0.04,Negative,445,Positive,,Adult,,,Post-1st,06-May-21,baseline,56,,,,11-Mar-21,16-Jun-21,17-Dec-21,97,184,6.098523619,unknown,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-11,COVISHIELD,none,.,none,none,none,2021-06-16,COVISHIELD,none,.,none,none,none,2021-12-17,Pfizer,none,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,64,64,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,56,,97,0,,,6,0,1,Post-1st Dose,,,,1,1,1,,3,8,,,304,5,60-69
96,,Female,CD,Adalimumab,none,none,none,0.04,Negative,1081,Positive,,Elderly,,,Post-2nd,01-Sep-21,baseline,,142,,,02-Mar-21,12-Apr-21,25-Nov-21,41,227,6.986011777,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-02,Pfizer,Adalimumab,.,none,none,none,2021-04-12,Pfizer,Adalimumab,.,none,none,none,2021-11-25,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,66,67,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,142,41,1,,,7,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,20,,414,5,60-69
97,,Female,CD,Adalimumab,none,none,none,0.03,Negative,3185,Positive,,Elderly,,,Post-2nd,10-May-21,baseline,,28,,,02-Mar-21,12-Apr-21,25-Nov-21,41,227,8.066333149,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-02,Pfizer,Adalimumab,.,none,none,none,2021-04-12,Pfizer,Adalimumab,.,none,none,none,2021-11-25,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,66,66,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,28,41,1,,,8,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,415,5,60-69
98,,Male,UC,Vedolizumab,Oral Prednisone,Oral 5ASA,none,1.57,Positive,40000,Positive,,Elderly,243,,Post-3rd,16-Dec-21,Post Vaccine covid,,,14,,25-Mar-21,05-May-21,02-Dec-21,41,211,10.59663473,unknown,N/A,Pancolitis,,Outpatient,Post Vaccine Confirmed COVID,,B117(Alpha),,,,2021-05-10,2021-03-25,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,2021-05-05,Pfizer,Vedolizumab,.,Oral budesonide/Cortiment/Entocort,Oral 5ASA,none,2021-12-02,Pfizer,Ustekinumab,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,,,,,,,1,,2021-04-17,1,Male,66,67,0,1,0,0,1,1,0,Corticoteroids,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,0,1,0,0,1,0,Ustekinumab Only,,,41,1,,,11,1,0,Post-3rd Dose,1,1,14,0,0,0,2021-04-17,1,,,2,686,5,60-69
99,,Male,UC,Vedolizumab,Oral Prednisone,Oral 5ASA,none,6.63,Positive,4771,Positive,,Elderly,23,,Post-1st,10-May-21,Post Vaccine covid,46,,,,25-Mar-21,05-May-21,02-Dec-21,41,211,8.470395042,unknown,N/A,Pancolitis,,Outpatient,Post Vaccine Confirmed COVID,,B117(Alpha),,,,2021-05-10,2021-03-25,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,2021-05-05,Pfizer,Vedolizumab,.,Oral budesonide/Cortiment/Entocort,Oral 5ASA,none,2021-12-02,Pfizer,Ustekinumab,.,none,Oral 5ASA,none,,.,.,.,.,.,.,1,,,,,,,,,,2021-04-17,1,Male,66,66,0,1,0,0,1,1,0,Corticoteroids,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,0,1,0,0,1,0,Ustekinumab Only,46,,41,1,,,8,1,0,Post-1st Dose,1,1,,0,0,0,2021-04-17,1,7,,,687,5,60-69
106,,Male,CD,none,none,yes ,none,0.15,Negative,2667,Positive,,Elderly,,,Post-2nd,05-Nov-21,baseline,,139,,,26-Mar-21,19-Jun-21,19-Dec-21,85,183,7.888672028,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-26,Pfizer,none,.,none,yes ,none,2021-06-19,Pfizer,none,.,none,yes ,none,2021-12-19,Pfizer,none,.,none,yes ,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,68,69,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,139,85,0,,,8,1,1,Post-2nd Dose (8+ Weeks),1,1,,1,1,1,,3,,20,,113,5,60-69
107,,Male,CD,none,none,yes ,none,0.01,Negative,477,Positive,,Elderly,,,Post-1st,23-Apr-21,baseline,28,,,,26-Mar-21,19-Jun-21,19-Dec-21,85,183,6.166677565,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-26,Pfizer,none,.,none,yes ,none,2021-06-19,Pfizer,none,.,none,yes ,none,2021-12-19,Pfizer,none,.,none,yes ,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,68,68,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,28,,85,0,,,6,1,1,Post-1st Dose,1,1,,1,1,1,,3,4,,,114,5,60-69
108,,Male,CD,none,none,yes ,none,,,5664,Positive,,Elderly,,,Post-2nd,12-Jul-21,baseline,,23,,,26-Mar-21,19-Jun-21,19-Dec-21,85,183,8.641797355,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-26,Pfizer,none,.,none,yes ,none,2021-06-19,Pfizer,none,.,none,yes ,none,2021-12-19,Pfizer,none,.,none,yes ,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,68,68,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,23,85,0,,,9,1,1,Post-2nd Dose (1-8 Weeks),1,1,,1,1,1,,3,,3,,115,5,60-69
123,,Male,UC,Inflectra,none,none,Methotrexate,0.05,Negative,10676,Positive,,Elderly,,,Post-3rd,28-Oct-21,baseline,,,35,,26-Mar-21,05-Jun-21,23-Sep-21,71,110,9.275762877,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-03-26,Pfizer,Inflectra,.,none,none,none,2021-06-05,Pfizer,Inflectra,.,none,none,none,2021-09-23,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,66,67,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,71,0,,,9,1,0,Post-3rd Dose,1,1,35,0,0,0,,3,,,5,933,5,60-69
132,,Female,CD,Golimumab,none,none,none,1.08,Positive,43671,Positive,,Elderly,137,,Post-3rd,22-Dec-21,Post Vaccine covid,,,43,,28-Mar-21,04-Jun-21,09-Nov-21,68,158,10.6844487,ileal,,N/A,,Outpatient,Post Vaccine Confirmed COVID,,,,,,2021-12-22,2021-03-28,Pfizer,Golimumab,.,none,none,none,2021-06-04,Pfizer,Golimumab,.,none,none,none,2021-11-09,Pfizer,Golimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,2021-08-07,1,Female,65,66,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,68,0,,,11,1,1,Post-3rd Dose,1,1,43,0,0,0,2021-08-07,2,,,6,327,5,60-69
133,,Female,CD,Golimumab,none,none,none,0.03,Negative,4069,Positive,,Elderly,-44,,Post-2nd,24-Jun-21,Post Vaccine covid,,20,,,28-Mar-21,04-Jun-21,09-Nov-21,68,158,8.31102966,ileal,,N/A,,Outpatient,Post Vaccine Confirmed COVID,,,,,,2021-12-22,2021-03-28,Pfizer,Golimumab,.,none,none,none,2021-06-04,Pfizer,Golimumab,.,none,none,none,2021-11-09,Pfizer,Golimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,2021-08-07,0,Female,65,65,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,20,68,0,,,8,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2021-08-07,2,,3,,328,5,60-69
137,,Female,CD,none,none,none,none,0.02,Negative,626,Positive,,Adult,,,Post-1st,19-May-21,baseline,41,,,,08-Apr-21,26-Jun-21,,79,,6.43855133,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-08,Moderna,none,.,none,none,none,2021-06-26,Moderna,none,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,60,60,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,,41,,79,0,,,6,0,1,Post-1st Dose,1,1,,1,0,1,,,6,,,127,5,60-69
140,,Female,CD,Ustekinumab,none,none,none,0.1,Negative,12014,Positive,,Elderly,,,Post-3rd,02-Dec-21,baseline,,,28,,07-Apr-21,05-Jul-21,04-Nov-21,89,122,9.393836239,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-07,Pfizer,Ustekinumab,.,none,none,none,2021-07-05,Pfizer,Ustekinumab,.,none,none,none,2021-11-04,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,66,66,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,89,0,,,9,1,1,Post-3rd Dose,1,1,28,0,0,0,,3,,,4,838,5,60-69
141,,Female,CD,Ustekinumab,none,none,none,0.03,Negative,31280,Positive,,Elderly,,,Post-2nd,19-Jul-21,baseline,,14,,,07-Apr-21,05-Jul-21,04-Nov-21,89,122,10.35074059,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-07,Pfizer,Ustekinumab,.,none,none,none,2021-07-05,Pfizer,Ustekinumab,.,none,none,none,2021-11-04,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,66,66,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,14,89,0,,,10,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,2,,839,5,60-69
145,,Male,UC,Inflectra,none,none,none,0.02,Negative,1269,Positive,,Elderly,,,Post-3rd,08-Nov-21,baseline,,,41,,06-Apr-21,26-Jun-21,28-Sep-21,81,94,7.146299627,N/A,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-04-06,Pfizer,Inflectra,.,none,none,none,2021-06-26,Pfizer,Inflectra,.,none,none,none,2021-09-28,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,68,69,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,81,0,,,7,1,0,Post-3rd Dose,1,1,41,0,0,0,,3,,,6,254,5,60-69
146,,Male,UC,Inflectra,none,none,none,0.02,Negative,20,Negative,,Elderly,,,Post-1st,20-May-21,baseline,44,,,,06-Apr-21,26-Jun-21,28-Sep-21,81,94,3.015534901,N/A,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-04-06,Pfizer,Inflectra,.,none,none,none,2021-06-26,Pfizer,Inflectra,.,none,none,none,2021-09-28,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,68,69,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,44,,81,0,,,3,1,0,Post-1st Dose,1,1,,0,0,0,,3,6,,,255,5,60-69
147,,Male,UC,Inflectra,none,none,none,,,2338,Positive,,Elderly,,,Post-2nd,26-Jul-21,baseline,,30,,,06-Apr-21,26-Jun-21,28-Sep-21,81,94,7.757093913,N/A,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-04-06,Pfizer,Inflectra,.,none,none,none,2021-06-26,Pfizer,Inflectra,.,none,none,none,2021-09-28,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,68,69,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,30,81,0,,,8,1,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,256,5,60-69
153,,Male,CD,Inflectra,none,none,none,0.05,Negative,140,Positive,,Elderly,,,Post-1st,25-May-21,baseline,20,,,,05-May-21,22-Jun-21,07-Dec-21,48,168,4.941642423,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-05,Pfizer,Inflectra,.,none,none,none,2021-06-22,Pfizer,Inflectra,.,none,none,none,2021-12-07,Pfizer,Inflectra,.,Oral Prednisone,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,66,66,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,1,0,0,Corticoteroids,20,,48,0,,,5,1,1,Post-1st Dose,1,1,,0,0,0,,3,3,,,773,5,60-69
170,,Female,CD,Adalimumab,none,none,none,0.03,Negative,80000,Positive,,Adult,,,Post-3rd,01-Oct-21,baseline,,,13,,03-Apr-21,24-Apr-21,18-Sep-21,21,147,11.28978191,colonic,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,Adalimumab,.,none,none,none,2021-04-24,Pfizer,Adalimumab,.,none,none,none,2021-09-18,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,64,64,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,21,1,,,11,0,1,Post-3rd Dose,1,1,13,0,0,0,,3,,,2,65,5,60-69
171,,Female,CD,Adalimumab,none,none,none,0.04,Negative,23599,Positive,,Adult,,,Post-2nd,18-May-21,baseline,,24,,,03-Apr-21,24-Apr-21,18-Sep-21,21,147,10.06895114,colonic,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,Adalimumab,.,none,none,none,2021-04-24,Pfizer,Adalimumab,.,none,none,none,2021-09-18,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,64,64,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,24,21,1,,,10,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,66,5,60-69
172,,Female,CD,Adalimumab,none,none,none,0.03,Negative,4545,Positive,,Adult,,,Post-2nd,16-Aug-21,baseline,,114,,,03-Apr-21,24-Apr-21,18-Sep-21,21,147,8.421739001,colonic,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,Adalimumab,.,none,none,none,2021-04-24,Pfizer,Adalimumab,.,none,none,none,2021-09-18,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,64,64,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,114,21,1,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,16,,67,5,60-69
192,,Female,UC,none,none,Oral 5ASA,none,0.02,Negative,3889,Positive,,Adult,,,Post-2nd,22-Sep-21,baseline,,77,,,09-May-21,07-Jul-21,02-Jan-22,59,179,8.265830191,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-05-09,Pfizer,none,.,none,Oral 5ASA,none,2021-07-07,Pfizer,none,.,none,Oral 5ASA,none,2022-01-02,Pfizer,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,60,61,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,77,59,0,,,8,0,0,Post-2nd Dose (8+ Weeks),1,1,,1,1,1,,3,,11,,516,5,60-69
193,,Female,UC,none,none,Oral 5ASA,none,0.02,Negative,120,Positive,,Adult,,,Post-1st,16-Jun-21,baseline,38,,,,09-May-21,07-Jul-21,02-Jan-22,59,179,4.784152842,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-05-09,Pfizer,none,.,none,Oral 5ASA,none,2021-07-07,Pfizer,none,.,none,Oral 5ASA,none,2022-01-02,Pfizer,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,60,60,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,38,,59,0,,,5,0,0,Post-1st Dose,1,1,,1,1,1,,3,5,,,517,5,60-69
200,,Male,CD,Adalimumab,none,none,none,0.02,Negative,2125,Positive,,Adult,,,Post-3rd,12-Nov-21,baseline,,,29,,16-Apr-21,20-Jun-21,14-Oct-21,65,116,7.66129176,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-16,Pfizer,Adalimumab,.,none,none,none,2021-06-20,Pfizer,Adalimumab,.,none,none,none,2021-10-14,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,64,64,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,65,0,,,8,0,1,Post-3rd Dose,1,1,29,0,0,0,,3,,,4,270,5,60-69
201,,Male,CD,Adalimumab,none,none,none,0.02,Negative,86,Positive,,Adult,,,Post-1st,31-May-21,baseline,45,,,,16-Apr-21,20-Jun-21,14-Oct-21,65,116,4.453183829,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-16,Pfizer,Adalimumab,.,none,none,none,2021-06-20,Pfizer,Adalimumab,.,none,none,none,2021-10-14,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,64,64,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,45,,65,0,,,4,0,1,Post-1st Dose,1,1,,0,0,0,,3,6,,,271,5,60-69
202,,Male,CD,Adalimumab,none,none,none,,,642,Positive,,Adult,,,Post-2nd,29-Jul-21,baseline,,39,,,16-Apr-21,20-Jun-21,14-Oct-21,65,116,6.463965057,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-16,Pfizer,Adalimumab,.,none,none,none,2021-06-20,Pfizer,Adalimumab,.,none,none,none,2021-10-14,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,64,64,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,39,65,0,,,6,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,6,,272,5,60-69
232,,Female,UC,Infliximab,none,none,none,0.4,Negative,6932,Positive,,Adult,,,Post-3rd,01-Dec-21,baseline,,,15,,31-Mar-21,26-Apr-21,16-Nov-21,26,204,8.843932502,N/A,N/A,Proctitis,,Outpatient,Baseline Serology,,,,,,,2021-03-31,Pfizer,Infliximab,.,none,none,none,2021-04-26,Pfizer,Infliximab,.,none,none,none,2021-11-16,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,64,64,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,26,1,,,9,0,0,Post-3rd Dose,1,1,15,0,0,0,,3,,,2,520,5,60-69
233,,Female,UC,Infliximab,none,none,none,0.09,Negative,46,Negative,,Adult,,,Post-2nd,07-Sep-21,baseline,,134,,,31-Mar-21,26-Apr-21,16-Nov-21,26,204,3.824284091,N/A,N/A,Proctitis,,Outpatient,Baseline Serology,,,,,,,2021-03-31,Pfizer,Infliximab,.,none,none,none,2021-04-26,Pfizer,Infliximab,.,none,none,none,2021-11-16,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,64,64,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,134,26,1,,,4,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,19,,521,5,60-69
234,,Female,UC,Infliximab,none,none,none,0.02,Negative,522,Positive,,Adult,,,Post-2nd,20-May-21,baseline,,24,,,31-Mar-21,26-Apr-21,16-Nov-21,26,204,6.256709274,N/A,N/A,Proctitis,,Outpatient,Baseline Serology,,,,,,,2021-03-31,Pfizer,Infliximab,.,none,none,none,2021-04-26,Pfizer,Infliximab,.,none,none,none,2021-11-16,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,64,64,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,24,26,1,,,6,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,522,5,60-69
236,,Male,CD,none,none,Oral 5ASA,none,0.03,Negative,16989,Positive,,Elderly,,,Post-2nd,16-Jun-21,baseline,,13,,,29-Mar-21,03-Jun-21,06-Dec-21,66,186,9.740344899,unknown,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-29,Pfizer,none,.,none,Oral 5ASA,none,2021-06-03,Pfizer,none,.,none,Oral 5ASA,none,2021-12-06,Pfizer,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,1,,1,,,,1,,,,0,Male,68,68,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,13,66,0,,,10,1,1,Post-2nd Dose (1-8 Weeks),1,1,,1,1,1,,3,,2,,790,5,60-69
252,,Male,UC,none,none,Rectal 5ASA,none,0.06,Negative,255,Positive,,Adult,,,Post-2nd,05-Aug-21,baseline,,50,,,20-Mar-21,16-Jun-21,09-Dec-21,88,176,5.539300836,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-03-20,COVISHIELD,none,.,none,Rectal 5ASA,none,2021-06-16,COVISHIELD,none,.,none,Rectal 5ASA,none,2021-12-09,Pfizer,none,.,none,Rectal 5ASA,none,2021-12-08,Pfizer,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,62,62,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,50,88,0,,,6,0,0,Post-2nd Dose (1-8 Weeks),,,,1,1,1,,3,,7,,796,5,60-69
269,,Male,CD,Adalimumab,none,none,none,0.02,Negative,2701,Positive,,Adult,,,Post-2nd,16-Aug-21,baseline,,60,,,21-Apr-21,17-Jun-21,,57,,7.90134033,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-21,Pfizer,Adalimumab,.,none,none,none,2021-06-17,Pfizer,Adalimumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,60,60,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,60,57,0,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,9,,614,5,60-69
270,,Female,CD,Infliximab,none,none,none,0.13,Negative,7236,Positive,,Adult,,,Post-3rd,30-Nov-21,baseline,,,74,,02-Apr-21,14-May-21,17-Sep-21,42,126,8.886879124,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-02,Pfizer,Infliximab,.,none,none,none,2021-05-14,Pfizer,Infliximab,.,none,none,none,2021-09-17,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,63,63,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,42,1,,,9,0,1,Post-3rd Dose,1,1,74,0,0,0,,3,,,11,451,5,60-69
271,,Female,CD,Infliximab,none,none,none,0.08,Negative,358,Positive,,Adult,,,Post-2nd,03-Sep-21,baseline,,112,,,02-Apr-21,14-May-21,17-Sep-21,42,126,5.879974171,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-02,Pfizer,Infliximab,.,none,none,none,2021-05-14,Pfizer,Infliximab,.,none,none,none,2021-09-17,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,63,63,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,112,42,1,,,6,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,16,,452,5,60-69
272,,Male,UC,Tofacitinib,none,none,none,0.05,Negative,33873,Positive,,Adult,,,Post-2nd,20-Jul-21,baseline,,20,,,02-May-21,30-Jun-21,,59,,10.43037942,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-05-02,Moderna,Tofacitinib,.,none,none,none,2021-06-30,Moderna,Tofacitinib,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,64,64,0,0,0,1,0,0,0,Tofacitinib Only,0,0,0,1,0,0,0,Tofacitinib Only,0,0,0,1,0,0,0,Tofacitinib Only,0,0,0,0,0,0,0,,,20,59,0,,,10,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,3,,911,5,60-69
282,,Female,UC,Vedolizumab,none,none,none,,,21016,Positive,,Adult,,,Post-2nd,14-Jul-21,baseline,,23,,,20-Apr-21,21-Jun-21,12-Feb-22,62,236,9.953048848,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-04-20,Moderna,Vedolizumab,.,none,none,none,2021-06-21,Moderna,Vedolizumab,.,none,none,none,2022-02-12,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,61,61,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,0,0,0,0,0,0,No Imuunosuppressives,,23,62,0,,,10,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,1,0,,3,,3,,134,5,60-69
283,,Female,UC,Vedolizumab,none,none,none,0.68,Negative,2990,Positive,,Adult,,,Post-2nd,23-Dec-21,baseline,,185,,,20-Apr-21,21-Jun-21,12-Feb-22,62,236,8.002961775,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-04-20,Moderna,Vedolizumab,.,none,none,none,2021-06-21,Moderna,Vedolizumab,.,none,none,none,2022-02-12,,,,,,,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,61,62,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,0,0,0,0,0,0,No Imuunosuppressives,,185,62,0,,,8,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,1,0,,3,,26,,135,5,60-69
287,,Male,UC,none,none,Both oral/Rectal,none,0.05,Negative,7636,Positive,,Adult,,,Post-2nd,29-Jun-21,baseline,,19,,,22-Mar-21,10-Jun-21,15-Dec-21,80,188,8.940668472,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-03-22,AstraZeneca,none,.,none,Both oral/Rectal,none,2021-06-10,Pfizer,none,.,none,Both oral/Rectal,none,2021-12-15,Pfizer,none,.,none,Both oral/Rectal,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,61,61,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,19,80,0,,,9,0,0,Post-2nd Dose (1-8 Weeks),0,1,,1,1,1,,3,,3,,175,5,60-69
288,,Male,UC,none,none,Both oral/Rectal,none,0.05,Negative,1246,Positive,,Adult,,,Post-2nd,07-Dec-21,baseline,,180,,,22-Mar-21,10-Jun-21,15-Dec-21,80,188,7.1278542,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-03-22,AstraZeneca,none,.,none,Both oral/Rectal,none,2021-06-10,Pfizer,none,.,none,Both oral/Rectal,none,2021-12-15,Pfizer,none,.,none,Both oral/Rectal,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,61,62,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,180,80,0,,,7,0,0,Post-2nd Dose (8+ Weeks),0,1,,1,1,1,,3,,26,,176,5,60-69
302,,Male,CD,Ustekinumab,none,none,Methotrexate,0.02,Negative,1064,Positive,,Adult,,,Post-1st,19-Aug-21,baseline,23,,,,27-Jul-21,24-Aug-21,,28,,6.969978622,ileocolonic,,N/A,,Outpatient,Baseline Serology,,,,,,,2021-07-27,Pfizer,Ustekinumab,.,none,none,Methotrexate,2021-08-24,Pfizer,Ustekinumab,.,none,none,Methotrexate,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,62,62,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,0,0,0,0,0,,23,,28,1,,,7,0,1,Post-1st Dose,1,1,,0,0,0,,,3,,,589,5,60-69
303,,Male,CD,Ustekinumab,none,none,Methotrexate,0.02,Negative,40000,Positive,,Adult,,,Post-2nd,16-Sep-21,baseline,,23,,,27-Jul-21,24-Aug-21,,28,,10.59663473,ileocolonic,,N/A,,Outpatient,Baseline Serology,,,,,,,2021-07-27,Pfizer,Ustekinumab,.,none,none,Methotrexate,2021-08-24,Pfizer,Ustekinumab,.,none,none,Methotrexate,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,62,62,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,1,0,0,0,1,Combination Therapy,0,0,0,0,0,0,0,,,23,28,1,,,11,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,3,,590,5,60-69
304,,Female,CD,Renflexis/IFX,none,none,none,0.48,Negative,6233,Positive,,Adult,,,Post-3rd,04-Nov-21,baseline,,,19,,17-Mar-21,08-Jun-21,16-Oct-21,83,130,8.737596993,ileal,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-17,AstraZeneca,Renflexis/IFX,.,none,none,none,2021-06-08,Pfizer,Renflexis/IFX,.,none,none,none,2021-10-16,Pfizer,Renflexis/IFX,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,61,61,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,83,0,,,9,0,1,Post-3rd Dose,0,1,19,0,0,0,,3,,,3,181,5,60-69
305,,Female,CD,Renflexis/IFX,none,none,none,0.08,Negative,883,Positive,,Adult,,,Post-2nd,14-Sep-21,baseline,,98,,,17-Mar-21,08-Jun-21,16-Oct-21,83,130,6.783098674,ileal,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-17,AstraZeneca,Renflexis/IFX,.,none,none,none,2021-06-08,Pfizer,Renflexis/IFX,.,none,none,none,2021-10-16,Pfizer,Renflexis/IFX,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,61,61,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,98,83,0,,,7,0,1,Post-2nd Dose (8+ Weeks),0,1,,0,0,0,,3,,14,,182,5,60-69
315,,Male,UC,Vedolizumab,none,none,none,0.58,Negative,37642,Positive,,Elderly,,,Post-3rd,29-Sep-21,baseline,,,16,,03-Apr-21,25-May-21,13-Sep-21,52,111,10.53586776,N/A ,N/A,Pancolitis,none,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,Vedolizumab,.,none,none,none,2021-05-25,Pfizer,Vedolizumab,.,none,none,none,2021-09-13,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,68,68,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,,52,0,,,11,1,0,Post-3rd Dose,1,1,16,0,0,0,,3,,,2,42,5,60-69
316,,Male,UC,Vedolizumab,none,none,none,0.04,Negative,23927,Positive,,Elderly,,,Post-2nd,11-Jun-21,baseline,,17,,,03-Apr-21,25-May-21,13-Sep-21,52,111,10.08276699,N/A ,N/A,Pancolitis,none,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,Vedolizumab,.,none,none,none,2021-05-25,Pfizer,Vedolizumab,.,none,none,none,2021-09-13,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,68,68,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,17,52,0,,,10,1,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,2,,43,5,60-69
317,,Male,UC,Vedolizumab,none,none,none,0.03,Negative,368,Positive,,Elderly,,,Post-1st,11-May-21,baseline,38,,,,03-Apr-21,25-May-21,13-Sep-21,52,111,5.908082938,N/A ,N/A,Pancolitis,none,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,Vedolizumab,.,none,none,none,2021-05-25,Pfizer,Vedolizumab,.,none,none,none,2021-09-13,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,68,68,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,38,,52,0,,,6,1,0,Post-1st Dose,1,1,,0,0,0,,3,5,,,44,5,60-69
320,,Male,CD,Ustekinumab,none,none,none,0.02,Negative,30146,Positive,,Adult,,,Post-2nd,08-Oct-21,baseline,,9,,,17-Jun-21,29-Sep-21,,104,,10.31381747,colonic,unknown,N/A,none,Outpatient,Baseline Serology,,,,,,,2021-06-17,Moderna,Ustekinumab,.,none,none,none,2021-09-29,Moderna,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,1,,1,,,,1,,,,0,Male,62,62,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,,9,104,0,,,10,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,1,,690,5,60-69
333,,Female,CD,Remicade,none,none,none,0.01,Negative,4282,Positive,,Adult,,,Post-3rd,03-Nov-21,baseline,,,22,,22-Apr-21,17-Jun-21,12-Oct-21,56,117,8.362222175,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Remicade,.,none,none,none,2021-06-17,Pfizer,Remicade,.,none,none,none,2021-10-12,Pfizer,Remicade,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,59,60,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,56,0,,,8,0,1,Post-3rd Dose,1,1,22,0,0,0,,3,,,3,955,5,60-69
334,,Female,CD,Remicade,none,none,none,,,1056,Positive,,Adult,,,Post-2nd,05-Jul-21,baseline,,18,,,22-Apr-21,17-Jun-21,12-Oct-21,56,117,6.962054052,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Remicade,.,none,none,none,2021-06-17,Pfizer,Remicade,.,none,none,none,2021-10-12,Pfizer,Remicade,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,59,60,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,18,56,0,,,7,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,956,5,60-69
339,,Female,CD,Vedolizumab,none,none,none,0.09,Negative,1078,Positive,,Elderly,,,Post-2nd,22-Dec-21,baseline,,191,,,27-Mar-21,14-Jun-21,06-Jan-22,79,206,6.98323374,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-27,Pfizer,Vedolizumab,.,none,none,none,2021-06-14,Pfizer,Vedolizumab,.,none,none,none,2022-01-06,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,69,69,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,191,79,0,,,7,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,27,,530,5,60-69
340,,Female,CD,Vedolizumab,none,none,none,0.03,Negative,9143,Positive,,Elderly,,,Post-2nd,28-Jun-21,baseline,,14,,,27-Mar-21,14-Jun-21,06-Jan-22,79,206,9.12077665,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-27,Pfizer,Vedolizumab,.,none,none,none,2021-06-14,Pfizer,Vedolizumab,.,none,none,none,2022-01-06,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,69,69,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,14,79,0,,,9,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,2,,531,5,60-69
341,,Female,CD,Vedolizumab,none,none,none,0.02,Negative,211,Positive,,Elderly,,,Post-1st,03-May-21,baseline,37,,,,27-Mar-21,14-Jun-21,06-Jan-22,79,206,5.3499606,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-27,Pfizer,Vedolizumab,.,none,none,none,2021-06-14,Pfizer,Vedolizumab,.,none,none,none,2022-01-06,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,69,69,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,37,,79,0,,,5,1,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,532,5,60-69
349,,Female,CD,Inflectra,Oral budesonide/Cortiment/Entocort,none,none,,,2455,Positive,,Elderly,,,Post-2nd,26-Jul-21,New biologic/Tofacitinib start,,30,,,13-Apr-21,26-Jun-21,26-Oct-21,74,122,7.805841306,ileocolonic,fistulizng,N/A,,Outpatient,New biologic/Tofacitinib start,,,,,,,2021-04-13,Pfizer,Inflectra,.,none,none,none,2021-06-26,Pfizer,Inflectra,.,none,none,none,2021-10-26,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,69,69,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,30,74,0,,,8,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,456,5,60-69
350,,Female,CD,Ustekinumab,none,none,none,,,10406,Positive,,Adult,59,,Post-1st,05-Jul-21,Baseline to COVID,40,,,,26-May-21,05-Jul-21,,40,,9.250109012,ileocolonic,Stricturing,N/A,,Outpatient,Baseline to COVID,,,,,,,2021-05-26,Moderna,Ustekinumab,.,none,none,none,2021-07-05,Moderna,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,2021-05-07,1,Female,60,60,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,40,,40,1,,,9,0,1,Post-1st Dose,1,1,,0,0,0,2021-05-07,,6,,,33,5,60-69
351,,Female,CD,Ustekinumab,none,none,none,,,16757,Positive,,Adult,82,,Post-2nd,28-Jul-21,Baseline to COVID,,23,,,26-May-21,05-Jul-21,,40,,9.726577328,ileocolonic,Stricturing,N/A,,Outpatient,Baseline to COVID,,,,,,,2021-05-26,Moderna,Ustekinumab,.,none,none,none,2021-07-05,Moderna,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,2021-05-07,1,Female,60,60,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,,23,40,1,,,10,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2021-05-07,,,3,,34,5,60-69
353,,Female,CD,Adalimumab,none,none,none,0.14,Negative,80000,Positive,,Elderly,265,248,Post-1st,01-Oct-21,Baseline to COVID,15,,,,16-Sep-21,06-Nov-21,,51,,11.28978191,colonic,Inflamatory,N/A,,Outpatient,Baseline to COVID,,,2021-01-26,,,,2021-09-16,Pfizer,Adalimumab,.,none,none,none,2021-11-06,Pfizer,none,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,2021-01-09,1,Female,66,66,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,,15,,51,0,,,11,1,1,Post-1st Dose,1,1,,0,0,1,2021-01-09,,2,,,587,5,60-69
354,,Female,CD,Adalimumab,none,none,none,0.1,Negative,27335,Positive,,Elderly,331,314,Post-2nd,06-Dec-21,Baseline to COVID,,30,,,16-Sep-21,06-Nov-21,,51,,10.21593053,colonic,Inflamatory,N/A,,Outpatient,Baseline to COVID,,,2021-01-26,,,,2021-09-16,Pfizer,Adalimumab,.,none,none,none,2021-11-06,Pfizer,none,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,2021-01-09,1,Female,66,67,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,,,30,51,0,,,10,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,1,2021-01-09,,,4,,588,5,60-69
385,,Female,CD,Adalimumab,none,none,none,0.03,Negative,40000,Positive,,Adult,,,Post-3rd,12-Oct-21,baseline,,,17,,13-Mar-21,23-May-21,25-Sep-21,71,125,10.59663473,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-13,COVISHIELD,Adalimumab,.,none,none,none,2021-05-23,AstraZeneca,Adalimumab,.,none,none,none,2021-09-25,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,63,63,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,71,0,,,11,0,1,Post-3rd Dose,,0,17,0,0,0,,3,,,2,660,5,60-69
386,,Female,CD,Adalimumab,none,none,none,,,1897,Positive,,Adult,,,Post-2nd,05-Jul-21,baseline,,43,,,13-Mar-21,23-May-21,25-Sep-21,71,125,7.547923535,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-13,COVISHIELD,Adalimumab,.,none,none,none,2021-05-23,AstraZeneca,Adalimumab,.,none,none,none,2021-09-25,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,63,63,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,43,71,0,,,8,0,1,Post-2nd Dose (1-8 Weeks),,0,,0,0,0,,3,,6,,661,5,60-69
387,,Female,CD,Adalimumab,none,none,none,0.04,Negative,795,Positive,,Adult,,,Post-2nd,03-Sep-21,baseline,,103,,,13-Mar-21,23-May-21,25-Sep-21,71,125,6.678216321,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-13,COVISHIELD,Adalimumab,.,none,none,none,2021-05-23,AstraZeneca,Adalimumab,.,none,none,none,2021-09-25,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,63,63,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,103,71,0,,,7,0,1,Post-2nd Dose (8+ Weeks),,0,,0,0,0,,3,,15,,662,5,60-69
388,,Female,CD,Adalimumab,none,none,none,0.03,Negative,163,Positive,,Adult,,,Post-1st,03-May-21,baseline,51,,,,13-Mar-21,23-May-21,25-Sep-21,71,125,5.09436351,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-13,COVISHIELD,Adalimumab,.,none,none,none,2021-05-23,AstraZeneca,Adalimumab,.,none,none,none,2021-09-25,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,63,63,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,51,,71,0,,,5,0,1,Post-1st Dose,,0,,0,0,0,,3,7,,,663,5,60-69
392,,Male,UC,Adalimumab,none,none,none,2.38,Positive,6868,Positive,,Adult,,,Post-3rd,23-Oct-21,baseline,,,25,,16-Apr-21,15-Jun-21,28-Sep-21,60,105,8.834599101,N/A ,N/A,Unknown,,Outpatient,Baseline Serology,,,,,2022-01-07,2021-07-22,2021-04-16,Pfizer,Adalimumab,.,none,none,none,2021-06-15,Pfizer,Adalimumab,.,none,none,none,2021-09-28,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,1,Male,61,61,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,60,0,,,9,0,0,Post-3rd Dose,1,1,25,0,0,0,2021-07-22,2,,,4,508,5,60-69
393,,Male,UC,Adalimumab,none,none,none,1.75,Positive,1832,Positive,,Adult,,,Post-2nd,22-Jul-21,baseline,,37,,,16-Apr-21,15-Jun-21,28-Sep-21,60,105,7.513218129,N/A ,N/A,Unknown,,Outpatient,Baseline Serology,,,,,2022-01-07,2021-07-22,2021-04-16,Pfizer,Adalimumab,.,none,none,none,2021-06-15,Pfizer,Adalimumab,.,none,none,none,2021-09-28,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,1,Male,61,61,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,37,60,0,,,8,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2021-07-22,2,,5,,509,5,60-69
396,,Female,CD,Inflectra,none,none,none,0.09,Negative,365,Positive,,Elderly,,,Post-3rd,08-Nov-21,baseline,,,62,,27-Mar-21,10-Jun-21,07-Sep-21,75,89,5.900445149,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-27,Pfizer,Inflectra,.,none,none,none,2021-06-10,Pfizer,Inflectra,.,none,none,none,2021-09-07,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,67,68,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,75,0,,,6,1,1,Post-3rd Dose,1,1,62,0,0,0,,3,,,9,848,5,60-69
397,,Female,CD,Inflectra,none,none,none,,,1613,Positive,,Elderly,,,Post-2nd,07-Jul-21,baseline,,27,,,27-Mar-21,10-Jun-21,07-Sep-21,75,89,7.385975063,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-27,Pfizer,Inflectra,.,none,none,none,2021-06-10,Pfizer,Inflectra,.,none,none,none,2021-09-07,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,67,68,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,27,75,0,,,7,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,849,5,60-69
400,,Female,CD,Adalimumab,none,none,none,,,3685,Positive,,Elderly,,,Post-2nd,10-Jul-21,baseline,,21,,,25-Mar-21,19-Jun-21,,86,,8.212080077,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-25,Pfizer,Adalimumab,.,none,none,none,2021-06-19,Pfizer,Adalimumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,65,65,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,21,86,0,,,8,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,3,,850,5,60-69
401,,Female,CD,Adalimumab,none,none,none,0.04,Negative,135,Positive,,Elderly,,,Post-1st,24-Apr-21,baseline,30,,,,25-Mar-21,19-Jun-21,,86,,4.902307417,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-25,Pfizer,Adalimumab,.,none,none,none,2021-06-19,Pfizer,Adalimumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,65,65,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,30,,86,0,,,5,1,1,Post-1st Dose,1,1,,0,0,0,,,4,,,851,5,60-69
402,,Female,CD,Adalimumab,none,none,none,0.05,Negative,544,Positive,,Elderly,,,Post-2nd,15-Nov-21,baseline,,149,,,25-Mar-21,19-Jun-21,,86,,6.298397624,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-25,Pfizer,Adalimumab,.,none,none,none,2021-06-19,Pfizer,Adalimumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,65,66,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,149,86,0,,,6,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,21,,852,5,60-69
404,,Male,CD,Infliximab,none,none,Methotrexate,0.37,Negative,623,Positive,,Adult,,,Post-3rd,29-Oct-21,baseline,,,55,,23-Mar-21,07-Jun-21,04-Sep-21,76,89,6.434385992,ileocolonic,Perianal CD,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-23,AstraZeneca,Infliximab,.,none,none,Methotrexate,2021-06-07,Pfizer,Infliximab,.,none,none,none,2021-09-04,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,60,61,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,76,0,,,6,0,1,Post-3rd Dose,0,1,55,0,0,0,,3,,,8,343,5,60-69
405,,Male,CD,Infliximab,none,none,Methotrexate,,,137,Positive,,Adult,,,Post-2nd,29-Jul-21,baseline,,52,,,23-Mar-21,07-Jun-21,04-Sep-21,76,89,4.921439715,ileocolonic,Perianal CD,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-23,AstraZeneca,Infliximab,.,none,none,Methotrexate,2021-06-07,Pfizer,Infliximab,.,none,none,none,2021-09-04,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,60,61,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,52,76,0,,,5,0,1,Post-2nd Dose (1-8 Weeks),0,1,,0,0,0,,3,,7,,344,5,60-69
406,,Male,CD,Infliximab,none,none,none,0.02,Negative,6178,Positive,,Adult,,,Post-3rd,27-Oct-21,baseline,,,30,,23-Apr-21,19-Jun-21,27-Sep-21,57,100,8.728782246,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-23,Pfizer,Infliximab,.,none,none,none,2021-06-19,Pfizer,Infliximab,.,none,none,none,2021-09-27,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,63,63,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,57,0,,,9,0,1,Post-3rd Dose,1,1,30,0,0,0,,3,,,4,913,5,60-69
411,,Male,CD,Adalimumab,none,none,none,0.04,Negative,5102,Positive,,Adult,,,Post-3rd,07-Nov-21,baseline,,,63,,15-Mar-21,02-May-21,05-Sep-21,48,126,8.537446697,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-15,COVISHIELD,Ustekinumab,.,none,none,none,2021-05-02,COVISHIELD,Ustekinumab,.,none,none,none,2021-09-05,Pfizer,none,Ustekinumab,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,60,61,1,0,0,0,0,0,0,Anti-TNF Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,48,0,,,9,0,1,Post-3rd Dose,,,63,0,0,0,,3,,,9,705,5,60-69
412,,Male,CD,Adalimumab,none,none,none,0.03,Negative,3273,Positive,,Adult,,,Post-2nd,04-Sep-21,baseline,,125,,,15-Mar-21,02-May-21,05-Sep-21,48,126,8.093462275,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-15,COVISHIELD,Ustekinumab,.,none,none,none,2021-05-02,COVISHIELD,Ustekinumab,.,none,none,none,2021-09-05,Pfizer,none,Ustekinumab,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,60,60,1,0,0,0,0,0,0,Anti-TNF Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,125,48,0,,,8,0,1,Post-2nd Dose (8+ Weeks),,,,0,0,0,,3,,18,,706,5,60-69
413,,Male,CD,Adalimumab,none,none,none,0.03,Negative,3822,Positive,,Adult,,,Post-2nd,18-Jun-21,baseline,,47,,,15-Mar-21,02-May-21,05-Sep-21,48,126,8.248529125,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-15,COVISHIELD,Ustekinumab,.,none,none,none,2021-05-02,COVISHIELD,Ustekinumab,.,none,none,none,2021-09-05,Pfizer,none,Ustekinumab,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,60,60,1,0,0,0,0,0,0,Anti-TNF Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,47,48,0,,,8,0,1,Post-2nd Dose (1-8 Weeks),,,,0,0,0,,3,,7,,707,5,60-69
425,,Female,CD,Adalimumab,none,none,none,0.07,Negative,7864,Positive,,Elderly,,,Post-3rd,28-Oct-21,baseline,,,28,,25-Mar-21,14-Jun-21,30-Sep-21,81,108,8.969999796,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-25,Pfizer,Adalimumab,.,none,none,none,2021-06-14,Pfizer,Adalimumab,.,none,none,none,2021-09-30,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,68,69,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,81,0,,,9,1,1,Post-3rd Dose,1,1,28,0,0,0,,3,,,4,605,5,60-69
426,,Female,CD,Adalimumab,none,none,none,0.02,Negative,25,Negative,,Elderly,,,Post-1st,28-Apr-21,baseline,34,,,,25-Mar-21,14-Jun-21,30-Sep-21,81,108,3.202746443,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-25,Pfizer,Adalimumab,.,none,none,none,2021-06-14,Pfizer,Adalimumab,.,none,none,none,2021-09-30,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,68,68,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,34,,81,0,,,3,1,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,606,5,60-69
427,,Female,CD,Adalimumab,none,none,none,,,1291,Positive,,Elderly,,,Post-2nd,28-Jul-21,baseline,,44,,,25-Mar-21,14-Jun-21,30-Sep-21,81,108,7.163094929,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-25,Pfizer,Adalimumab,.,none,none,none,2021-06-14,Pfizer,Adalimumab,.,none,none,none,2021-09-30,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,68,68,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,44,81,0,,,7,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,6,,607,5,60-69
443,,Female,CD,Adalimumab,Oral Prednisone,none,none,,,7874,Positive,,Elderly,,,Post-2nd,09-Jul-21,baseline,,23,,,07-Apr-21,16-Jun-21,,70,,8.971296071,colonic,Inflamatory,N/A,none,Outpatient,Baseline Serology,,,,,,,2021-04-07,Pfizer,Adalimumab,.,none,none,none,2021-06-16,Pfizer,Adalimumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,68,68,1,0,0,0,1,0,0,Corticoteroids,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,23,70,0,,,9,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,3,,111,5,60-69
444,,Female,CD,Adalimumab,Oral Prednisone,none,none,0.04,Negative,197,Positive,,Elderly,,,Post-1st,05-May-21,baseline,28,,,,07-Apr-21,16-Jun-21,,70,,5.282695986,colonic,Inflamatory,N/A,none,Outpatient,Baseline Serology,,,,,,,2021-04-07,Pfizer,Adalimumab,.,none,none,none,2021-06-16,Pfizer,Adalimumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,68,68,1,0,0,0,1,0,0,Corticoteroids,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,28,,70,0,,,5,1,1,Post-1st Dose,1,1,,0,0,0,,,4,,,112,5,60-69
451,,Male,CD,Ustekinumab,none,none,none,,,2879,Positive,,Elderly,,,Post-2nd,08-Jul-21,baseline,,7,,,12-Apr-21,01-Jul-21,05-Jan-22,80,188,7.965267757,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-12,Pfizer,Ustekinumab,.,none,none,none,2021-07-01,Pfizer,Ustekinumab,.,none,none,none,2022-01-05,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,1,,1,,,,1,,,,0,Male,68,68,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,7,80,0,,,8,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,1,,208,5,60-69
454,,Male,CD,Ustekinumab,none,none,none,,,11516,Positive,,Elderly,,,Post-2nd,27-Jul-21,baseline,,46,,,20-Mar-21,11-Jun-21,13-Dec-21,83,185,9.351510019,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-20,Pfizer,Ustekinumab,.,none,none,none,2021-06-11,Pfizer,Ustekinumab,.,none,none,none,2021-12-13,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,66,66,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,46,83,0,,,9,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,7,,789,5,60-69
472,,Female,CD,Ustekinumab,none,none,none,0.12,Negative,28042,Positive,,Elderly,,,Post-3rd,27-Oct-21,baseline,,,30,,12-Apr-21,12-Jun-21,27-Sep-21,61,107,10.2414444,ileocolonic,fistulizing and perianal,N/A,none,Outpatient,Baseline Serology,,,,,,,2021-04-12,Pfizer,Ustekinumab,.,none,none,none,2021-06-12,Pfizer,Ustekinumab,.,none,none,none,2021-09-27,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,66,66,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,61,0,,,10,1,1,Post-3rd Dose,1,1,30,0,0,0,,3,,,4,318,5,60-69
473,,Female,CD,Ustekinumab,none,none,none,0.04,Negative,8229,Positive,,Elderly,,,Post-2nd,20-Jul-21,baseline,,38,,,12-Apr-21,12-Jun-21,27-Sep-21,61,107,9.01541978,ileocolonic,fistulizing and perianal,N/A,none,Outpatient,Baseline Serology,,,,,,,2021-04-12,Pfizer,Ustekinumab,.,none,none,none,2021-06-12,Pfizer,Ustekinumab,.,none,none,none,2021-09-27,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,66,66,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,38,61,0,,,9,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,5,,319,5,60-69
480,,Female,CD,Ustekinumab,none,none,none,0.11,Negative,36709,Positive,,Elderly,,,Post-3rd,21-Dec-21,baseline,,,27,,18-Mar-21,29-Apr-21,24-Nov-21,42,209,10.51078268,colonic,fistulizing and perianal,N/A,pouchitis,Outpatient,Baseline Serology,,,,,,,2021-03-18,Pfizer,Ustekinumab,.,none,none,none,2021-04-29,Pfizer,Ustekinumab,.,none,none,none,2021-11-24,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,68,69,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,42,1,,,11,1,1,Post-3rd Dose,1,1,27,0,0,0,,3,,,4,755,5,60-69
481,,Female,CD,Ustekinumab,none,none,none,0.28,Negative,415,Positive,,Elderly,,,Post-1st,16-Apr-21,baseline,29,,,,18-Mar-21,29-Apr-21,24-Nov-21,42,209,6.027072975,colonic,fistulizing and perianal,N/A,pouchitis,Outpatient,Baseline Serology,,,,,,,2021-03-18,Pfizer,Ustekinumab,.,none,none,none,2021-04-29,Pfizer,Ustekinumab,.,none,none,none,2021-11-24,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,68,68,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,29,,42,1,,,6,1,1,Post-1st Dose,1,1,,0,0,0,,3,4,,,756,5,60-69
482,,Female,CD,Ustekinumab,none,none,none,0.42,Negative,5937,Positive,,Elderly,,,Post-2nd,26-May-21,baseline,,27,,,18-Mar-21,29-Apr-21,24-Nov-21,42,209,8.688959234,colonic,fistulizing and perianal,N/A,pouchitis,Outpatient,Baseline Serology,,,,,,,2021-03-18,Pfizer,Ustekinumab,.,none,none,none,2021-04-29,Pfizer,Ustekinumab,.,none,none,none,2021-11-24,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,68,68,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,27,42,1,,,9,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,757,5,60-69
483,,Female,CD,Ustekinumab,none,none,none,0.08,Negative,770,Positive,,Elderly,,,Post-2nd,15-Sep-21,baseline,,139,,,18-Mar-21,29-Apr-21,24-Nov-21,42,209,6.646650221,colonic,fistulizing and perianal,N/A,pouchitis,Outpatient,Baseline Serology,,,,,,,2021-03-18,Pfizer,Ustekinumab,.,none,none,none,2021-04-29,Pfizer,Ustekinumab,.,none,none,none,2021-11-24,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,68,68,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,139,42,1,,,7,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,20,,758,5,60-69
499,,Female,CD,Adalimumab,none,none,Methotrexate,0.01,Negative,290,Positive,,Elderly,,,Post-3rd,11-Nov-21,baseline,,,59,,29-Mar-21,10-Jun-21,13-Sep-21,73,95,5.669536036,ileal,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-29,Pfizer,Adalimumab,.,none,none,Methotrexate,2021-06-10,Pfizer,Adalimumab,.,none,none,Methotrexate,2021-09-13,Pfizer,Adalimumab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,65,66,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,,73,0,,,6,1,1,Post-3rd Dose,1,1,59,0,0,0,,3,,,8,914,5,60-69
501,,Male,CD,Infliximab,none,none,none,0.03,Negative,743,Positive,,Elderly,,,Post-1st,17-May-21,baseline,56,,,,22-Mar-21,07-Jun-21,16-Dec-21,77,192,6.610022871,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-22,Moderna,Infliximab,.,none,none,none,2021-06-07,Moderna,Infliximab,.,none,none,none,2021-12-16,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,67,67,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,56,,77,0,,,7,1,1,Post-1st Dose,1,1,,0,0,0,,3,8,,,504,5,60-69
502,,Male,CD,Infliximab,none,none,none,0.03,Negative,3671,Positive,,Elderly,,,Post-2nd,29-Jun-21,baseline,,22,,,22-Mar-21,07-Jun-21,16-Dec-21,77,192,8.208164901,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-22,Moderna,Infliximab,.,none,none,none,2021-06-07,Moderna,Infliximab,.,none,none,none,2021-12-16,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,67,67,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,22,77,0,,,8,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,505,5,60-69
523,,Male,CD,Ustekinumab,none,none,none,,,28017,Positive,,Adult,,,Post-3rd,13-Jul-21,baseline,,,18,,26-Apr-21,27-May-21,25-Jun-21,31,29,10.24057032,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-26,Pfizer,Ustekinumab,.,none,none,none,2021-05-27,Pfizer,Ustekinumab,.,none,none,none,2021-06-25,Pfizer,Ustekinumab,.,none,none,none,2021-09-01,Pfizer,.,.,.,.,.,,,,,,,,,1,,,0,Male,61,61,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,31,1,,,10,0,1,Post-3rd Dose,1,1,18,0,0,0,,3,,,3,798,5,60-69
524,,Male,CD,Ustekinumab,none,none,none,0.02,Negative,8636,Positive,,Adult,,,Post-2nd,15-Jun-21,baseline,,19,,,26-Apr-21,27-May-21,25-Jun-21,31,29,9.063741108,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-26,Pfizer,Ustekinumab,.,none,none,none,2021-05-27,Pfizer,Ustekinumab,.,none,none,none,2021-06-25,Pfizer,Ustekinumab,.,none,none,none,2021-09-01,Pfizer,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,61,61,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,19,31,1,,,9,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,799,5,60-69
525,,Male,IBD-U,Inflectra,none,none,Azathioprine/Immuran,,,2449,Positive,,Adult,,,Post-2nd,15-Jul-21,baseline,,28,,,16-Mar-21,17-Jun-21,,93,,7.80351672,colonic,Inflamatory,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-03-16,AstraZeneca,Inflectra,.,none,none,Methotrexate,2021-06-17,Pfizer,Inflectra,.,none,none,Methotrexate,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,62,63,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,0,0,0,0,0,0,0,,,28,93,0,,,8,0,0,Post-2nd Dose (1-8 Weeks),0,1,,0,0,0,,,,4,,762,5,60-69
526,,Male,IBD-U,Inflectra,none,none,Azathioprine/Immuran,0.31,Negative,101,Positive,,Adult,,,Post-1st,20-Apr-21,baseline,35,,,,16-Mar-21,17-Jun-21,,93,,4.618086411,colonic,Inflamatory,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-03-16,AstraZeneca,Inflectra,.,none,none,Methotrexate,2021-06-17,Pfizer,Inflectra,.,none,none,Methotrexate,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,62,62,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,0,0,0,0,0,0,0,,35,,93,0,,,5,0,0,Post-1st Dose,0,1,,0,0,0,,,5,,,763,5,60-69
529,,Female,CD,Ustekinumab,none,none,none,0.02,Negative,20142,Positive,,Elderly,,,Post-3rd,29-Sep-21,baseline,,,28,,10-Mar-21,02-Apr-21,01-Sep-21,23,152,9.910582325,colonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-10,Pfizer,Ustekinumab,.,none,none,none,2021-04-02,Pfizer,Ustekinumab,.,none,none,none,2021-09-01,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,65,66,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,23,1,,,10,1,1,Post-3rd Dose,1,1,28,0,0,0,,3,,,4,722,5,60-69
530,,Female,CD,Ustekinumab,none,none,none,,,797,Positive,,Elderly,,,Post-2nd,12-Jul-21,baseline,,101,,,10-Mar-21,02-Apr-21,01-Sep-21,23,152,6.680854679,colonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-10,Pfizer,Ustekinumab,.,none,none,none,2021-04-02,Pfizer,Ustekinumab,.,none,none,none,2021-09-01,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,65,66,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,101,23,1,,,7,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,14,,723,5,60-69
544,,Male,UC,Infliximab,Oral Prednisone,none,none,0.06,Negative,8,Negative,,Adult,,,Post-3rd,16-Nov-21,baseline,,,42,,17-May-21,16-Jul-21,05-Oct-21,60,81,2.091864062,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-05-17,Pfizer,Infliximab,.,Oral Prednisone,none,none,2021-07-16,Moderna,Infliximab,.,Oral Prednisone,none,none,2021-10-05,Pfizer,Infliximab,.,Oral Prednisone,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,63,63,1,0,0,0,1,0,0,Corticoteroids,1,0,0,0,1,0,0,Corticoteroids,1,0,0,0,1,0,0,Corticoteroids,1,0,0,0,1,0,0,Corticoteroids,,,60,0,,,2,0,0,Post-3rd Dose,1,1,42,0,0,0,,3,,,6,919,5,60-69
545,,Male,UC,Infliximab,Oral Prednisone,none,none,0.03,Negative,4,Negative,,Adult,,,Post-2nd,17-Aug-21,baseline,,32,,,17-May-21,16-Jul-21,05-Oct-21,60,81,1.360976553,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-05-17,Pfizer,Infliximab,.,Oral Prednisone,none,none,2021-07-16,Moderna,Infliximab,.,Oral Prednisone,none,none,2021-10-05,Pfizer,Infliximab,.,Oral Prednisone,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,63,63,1,0,0,0,1,0,0,Corticoteroids,1,0,0,0,1,0,0,Corticoteroids,1,0,0,0,1,0,0,Corticoteroids,1,0,0,0,1,0,0,Corticoteroids,,32,60,0,,,1,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,5,,920,5,60-69
556,,Female,CD,Ustekinumab,none,none,none,0.01,Negative,27250,Positive,,Adult,,,Post-3rd,28-Oct-21,baseline,,,37,,16-Mar-21,13-Jun-21,21-Sep-21,89,100,10.21282348,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-16,COVISHIELD,Ustekinumab,.,none,none,none,2021-06-13,AstraZeneca,Ustekinumab,.,none,none,none,2021-09-21,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,61,61,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,89,0,,,10,0,1,Post-3rd Dose,,0,37,0,0,0,,3,,,5,108,5,60-69
557,,Female,CD,Ustekinumab,none,none,none,,,1233,Positive,,Adult,,,Post-2nd,17-Jul-21,baseline,,34,,,16-Mar-21,13-Jun-21,21-Sep-21,89,100,7.117367696,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-16,COVISHIELD,Ustekinumab,.,none,none,none,2021-06-13,AstraZeneca,Ustekinumab,.,none,none,none,2021-09-21,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,61,61,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,34,89,0,,,7,0,1,Post-2nd Dose (1-8 Weeks),,0,,0,0,0,,3,,5,,109,5,60-69
561,,Female,CD,Infliximab,none,none,none,0.02,Negative,2545,Positive,,Adult,,,Post-3rd,13-Oct-21,baseline,,,29,,22-Mar-21,27-May-21,14-Sep-21,66,110,7.841728746,colonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-22,COVISHIELD,Infliximab,.,none,none,none,2021-05-27,Pfizer,Infliximab,.,none,none,none,2021-09-14,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,60,61,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,66,0,,,8,0,1,Post-3rd Dose,,1,29,0,0,0,,3,,,4,510,5,60-69
562,,Female,CD,Infliximab,none,none,none,0.01,Negative,62,Positive,,Adult,,,Post-1st,28-Apr-21,baseline,37,,,,22-Mar-21,27-May-21,14-Sep-21,66,110,4.131961426,colonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-22,COVISHIELD,Infliximab,.,none,none,none,2021-05-27,Pfizer,Infliximab,.,none,none,none,2021-09-14,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,60,60,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,37,,66,0,,,4,0,1,Post-1st Dose,,1,,0,0,0,,3,5,,,511,5,60-69
581,,Male,CD,Ustekinumab,none,none,none,,,1423,Positive,,Elderly,,,Post-2nd,27-Jul-21,baseline,,56,,,24-Mar-21,01-Jun-21,03-Dec-21,69,185,7.260452322,ileocolonic,unknown,N/A,,Outpatient,Baseline Serology,,,,,,2021-05-06,2021-03-24,Pfizer,Ustekinumab,.,none,none,none,2021-06-01,Pfizer,Ustekinumab,.,none,none,none,2021-12-03,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,1,Male,68,69,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,56,69,0,,,7,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,2021-05-06,1,,8,,611,5,60-69
582,,Male,CD,Ustekinumab,none,none,none,0.76,Positive,107,Positive,,Elderly,,,Post-1st,06-May-21,baseline,43,,,,24-Mar-21,01-Jun-21,03-Dec-21,69,185,4.67562865,ileocolonic,unknown,N/A,,Outpatient,Baseline Serology,,,,,,2021-05-06,2021-03-24,Pfizer,Ustekinumab,.,none,none,none,2021-06-01,Pfizer,Ustekinumab,.,none,none,none,2021-12-03,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,1,Male,68,68,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,43,,69,0,,,5,1,1,Post-1st Dose,1,1,,0,0,0,2021-05-06,1,6,,,612,5,60-69
586,,Male,CD,Infliximab,none,none,none,0.08,Negative,40000,Positive,,Adult,,,Post-3rd,26-Oct-21,baseline,,,22,,03-Apr-21,19-May-21,04-Oct-21,46,138,10.59663473,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,Infliximab,.,none,none,none,2021-05-19,Pfizer,Infliximab,.,none,none,none,2021-10-04,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,61,62,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,46,0,,,11,0,1,Post-3rd Dose,1,1,22,0,0,0,,3,,,3,376,5,60-69
587,,Male,CD,Infliximab,none,none,none,,,1163,Positive,,Adult,,,Post-2nd,26-Jul-21,baseline,,68,,,03-Apr-21,19-May-21,04-Oct-21,46,138,7.058414155,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,Infliximab,.,none,none,none,2021-05-19,Pfizer,Infliximab,.,none,none,none,2021-10-04,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,61,61,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,68,46,0,,,7,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,10,,377,5,60-69
588,,Male,CD,Infliximab,none,none,none,0.02,Negative,111,Positive,,Adult,,,Post-1st,11-May-21,baseline,38,,,,03-Apr-21,19-May-21,04-Oct-21,46,138,4.705920089,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,Infliximab,.,none,none,none,2021-05-19,Pfizer,Infliximab,.,none,none,none,2021-10-04,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,61,61,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,38,,46,0,,,5,0,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,378,5,60-69
595,,Female,CD,Remicade,none,none,none,0.02,Negative,653,Positive,,Adult,,,Post-2nd,17-Sep-21,baseline,,121,,,28-Apr-21,19-May-21,29-Dec-21,21,224,6.481270804,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-28,Pfizer,Remicade,.,none,none,none,2021-05-19,Pfizer,Remicade,.,none,none,none,2021-12-29,Pfizer,Remicade,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,61,61,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,121,21,1,,,6,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,17,,623,5,60-69
614,,Male,UC,Vedolizumab,none,none,none,0.14,Negative,30,Negative,,Elderly,,,Post-1st,19-May-21,baseline,44,,,,05-Apr-21,23-Jun-21,29-Dec-21,79,189,3.391147046,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-04-05,Pfizer,Vedolizumab,.,none,none,none,2021-06-23,Pfizer,Vedolizumab,.,none,none,none,2021-12-29,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,69,69,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,44,,79,0,,,3,1,0,Post-1st Dose,1,1,,0,0,0,,3,6,,,657,5,60-69
631,,Female,CD,Vedolizumab,none,none,none,0.33,Negative,5177,Positive,,Elderly,537,,Post-2nd,21-Sep-21,covid,,226,,,31-Dec-20,07-Feb-21,07-Oct-21,38,242,8.551981017,ileal,inflamatory and upperGI ,N/A,,Outpatient,Confirmed COVID,,,,,,2021-02-25,2020-12-31,Pfizer,Vedolizumab,.,none,none,none,2021-02-07,Pfizer,Vedolizumab,.,none,none,none,2021-10-07,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,2020-04-02,1,Female,67,68,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,226,38,1,,,9,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,2020-04-02,,,32,,68,5,60-69
632,,Female,CD,Vedolizumab,none,none,none,1.34,Positive,38883,Positive,,Elderly,329,,Post-2nd,25-Feb-21,covid,,18,,,31-Dec-20,07-Feb-21,07-Oct-21,38,242,10.56830727,ileal,inflamatory and upperGI ,N/A,,Outpatient,Confirmed COVID,,,,,,2021-02-25,2020-12-31,Pfizer,Vedolizumab,.,none,none,none,2021-02-07,Pfizer,Vedolizumab,.,none,none,none,2021-10-07,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,2020-04-02,1,Female,67,67,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,18,38,1,,,11,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2020-04-02,,,3,,69,5,60-69
661,,Female,CD,Inflectra,none,none,Methotrexate,0.28,Negative,19665,Positive,,Elderly,,,Post-3rd,26-Oct-21,baseline,,,18,,11-Mar-21,22-Apr-21,08-Oct-21,42,169,9.886595685,ileal,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-11,Pfizer,Inflectra,.,none,none,none,2021-04-22,Pfizer,Inflectra,.,none,none,none,2021-10-08,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,67,68,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,42,1,,,10,1,1,Post-3rd Dose,1,1,18,0,0,0,,3,,,3,364,5,60-69
662,,Female,CD,Inflectra,none,none,Methotrexate,0.02,Negative,1077,Positive,,Elderly,,,Post-2nd,30-Apr-21,baseline,,8,,,11-Mar-21,22-Apr-21,08-Oct-21,42,169,6.98221319,ileal,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-11,Pfizer,Inflectra,.,none,none,none,2021-04-22,Pfizer,Inflectra,.,none,none,none,2021-10-08,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,1,,1,,,,1,,,,0,Female,67,67,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,8,42,1,,,7,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,1,,365,5,60-69
663,,Female,CD,Inflectra,none,none,Methotrexate,0.02,Negative,517,Positive,,Elderly,,,Post-2nd,17-Sep-21,baseline,,148,,,11-Mar-21,22-Apr-21,08-Oct-21,42,169,6.248622977,ileal,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-11,Pfizer,Inflectra,.,none,none,none,2021-04-22,Pfizer,Inflectra,.,none,none,none,2021-10-08,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,67,68,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,148,42,1,,,6,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,21,,366,5,60-69
687,,Female,CD,Remicade,none,none,none,0.07,Negative,152,Positive,,Adult,,,Post-2nd,02-Sep-21,baseline,,156,,,20-Feb-21,30-Mar-21,02-Sep-21,38,156,5.025195445,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-02-20,Pfizer,Remicade,.,none,none,none,2021-03-30,Pfizer,Remicade,.,none,none,none,2021-09-02,Pfizer,Remicade,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,62,62,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,156,38,1,,,5,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,22,,856,5,60-69
688,,Female,CD,Remicade,none,none,none,0.06,Negative,182,Positive,,Adult,,,Post-1st,30-Mar-21,baseline,38,,,,20-Feb-21,30-Mar-21,02-Sep-21,38,156,5.205653682,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-02-20,Pfizer,Remicade,.,none,none,none,2021-03-30,Pfizer,Remicade,.,none,none,none,2021-09-02,Pfizer,Remicade,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,62,62,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,38,,38,1,,,5,0,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,857,5,60-69
692,,Female,CD,Ustekinumab,none,none,none,0.05,Negative,26,Negative,,Adult,,,Post-1st,20-Apr-21,baseline,13,,,,07-Apr-21,15-Jun-21,17-Dec-21,69,185,3.250374492,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-07,Pfizer,Ustekinumab,.,none,none,none,2021-06-15,Pfizer,Adalimumab,.,none,none,none,2021-12-17,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,62,62,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,13,,69,0,,,3,0,1,Post-1st Dose,1,1,,0,0,0,,3,2,,,219,5,60-69
693,,Male,CD,Ustekinumab,none,none,none,0.02,Negative,14204,Positive,,Elderly,,,Post-2nd,19-Aug-21,baseline,,65,,,05-Apr-21,15-Jun-21,02-Dec-21,71,170,9.561257773,ileocolonic,Stricturing,N/A,ileostomy,Outpatient,Baseline Serology,,,,,,,2021-04-05,Pfizer,Ustekinumab,.,none,none,none,2021-06-15,Pfizer,Ustekinumab,.,none,none,none,2021-12-02,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,65,66,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,65,71,0,,,10,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,9,,440,5,60-69
730,,Female,CD,Ustekinumab,none,none,none,0.14,Negative,18765,Positive,,Elderly,,,Post-3rd,27-Sep-21,baseline,,,17,,25-Mar-21,04-Jun-21,10-Sep-21,71,98,9.839727395,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-25,Pfizer,Ustekinumab,.,none,none,none,2021-06-04,Pfizer,Ustekinumab,.,none,none,none,2021-09-10,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,67,67,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,71,0,,,10,1,1,Post-3rd Dose,1,1,17,0,0,0,,3,,,2,536,5,60-69
731,,Female,CD,Ustekinumab,none,none,none,0.03,Negative,4674,Positive,,Elderly,,,Post-2nd,30-Jun-21,baseline,,26,,,25-Mar-21,04-Jun-21,10-Sep-21,71,98,8.449770515,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-25,Pfizer,Ustekinumab,.,none,none,none,2021-06-04,Pfizer,Ustekinumab,.,none,none,none,2021-09-10,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,67,67,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,26,71,0,,,8,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,537,5,60-69
732,,Female,CD,Ustekinumab,none,none,none,0.02,Negative,221,Positive,,Elderly,,,Post-1st,27-Apr-21,baseline,33,,,,25-Mar-21,04-Jun-21,10-Sep-21,71,98,5.398615088,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-25,Pfizer,Ustekinumab,.,none,none,none,2021-06-04,Pfizer,Ustekinumab,.,none,none,none,2021-09-10,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,67,67,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,33,,71,0,,,5,1,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,538,5,60-69
733,,Male,UC,Infliximab,none,Rectal 5ASA,none,0.1,Negative,11555,Positive,,Adult,,,Post-3rd,15-Nov-21,baseline,,,34,,22-Apr-21,21-May-21,12-Oct-21,29,144,9.354882177,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Infliximab,.,none,Rectal 5ASA,none,2021-05-21,Pfizer,Infliximab,.,none,Rectal 5ASA,none,2021-10-12,Pfizer,Infliximab,.,none,Rectal 5ASA,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,62,63,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,,,29,1,,,9,0,0,Post-3rd Dose,1,1,34,0,0,0,,3,,,5,784,5,60-69
734,,Male,UC,Infliximab,none,Rectal 5ASA,none,0.04,Negative,6333,Positive,,Adult,,,Post-2nd,31-May-21,baseline,,10,,,22-Apr-21,21-May-21,12-Oct-21,29,144,8.753576706,N/A,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-04-22,Pfizer,Infliximab,.,none,Rectal 5ASA,none,2021-05-21,Pfizer,Infliximab,.,none,Rectal 5ASA,none,2021-10-12,Pfizer,Infliximab,.,none,Rectal 5ASA,none,,.,.,.,.,.,.,,1,,1,,,,1,,,,0,Male,62,62,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,,10,29,1,,,9,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,1,,785,5,60-69
741,,Female,CD,Ustekinumab,none,none,none,0.03,Negative,10645,Positive,,Adult,,,Post-3rd,18-Oct-21,baseline,,,14,,26-Apr-21,17-Jun-21,04-Oct-21,52,109,9.272873759,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-26,Pfizer,Ustekinumab,.,none,none,none,2021-06-17,Pfizer,Ustekinumab,.,none,none,none,2021-10-04,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,62,62,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,52,0,,,9,0,1,Post-3rd Dose,1,1,14,0,0,0,,3,,,2,888,5,60-69
742,,Female,CD,Ustekinumab,none,none,none,0.03,Negative,82,Positive,,Adult,,,Post-1st,31-May-21,baseline,35,,,,26-Apr-21,17-Jun-21,04-Oct-21,52,109,4.403054002,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-26,Pfizer,Ustekinumab,.,none,none,none,2021-06-17,Pfizer,Ustekinumab,.,none,none,none,2021-10-04,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,62,62,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,35,,52,0,,,4,0,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,889,5,60-69
743,,Female,CD,Ustekinumab,none,none,none,0.03,Negative,2231,Positive,,Adult,,,Post-2nd,16-Sep-21,baseline,,91,,,26-Apr-21,17-Jun-21,04-Oct-21,52,109,7.710205194,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-26,Pfizer,Ustekinumab,.,none,none,none,2021-06-17,Pfizer,Ustekinumab,.,none,none,none,2021-10-04,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,62,62,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,91,52,0,,,8,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,13,,890,5,60-69
756,,Female,CD,Ustekinumab,none,none,none,0.54,Negative,67229,Positive,,Elderly,,,Post-3rd,16-Nov-21,baseline,,,28,,17-Apr-21,29-Jun-21,19-Oct-21,73,112,11.11586296,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-17,Pfizer,Ustekinumab,.,none,none,none,2021-06-29,Pfizer,Ustekinumab,.,none,none,none,2021-10-19,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,65,66,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,73,0,,,11,1,1,Post-3rd Dose,1,1,28,0,0,0,,3,,,4,458,5,60-69
757,,Female,CD,Ustekinumab,none,none,none,0.23,Negative,6049,Positive,,Elderly,,,Post-1st,18-May-21,baseline,31,,,,17-Apr-21,29-Jun-21,19-Oct-21,73,112,8.707565586,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-17,Pfizer,Ustekinumab,.,none,none,none,2021-06-29,Pfizer,Ustekinumab,.,none,none,none,2021-10-19,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,65,65,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,31,,73,0,,,9,1,1,Post-1st Dose,1,1,,0,0,0,,3,4,,,459,5,60-69
758,,Female,CD,Ustekinumab,none,none,none,0.32,Negative,27416,Positive,,Elderly,,,Post-2nd,15-Sep-21,baseline,,78,,,17-Apr-21,29-Jun-21,19-Oct-21,73,112,10.21889665,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-17,Pfizer,Ustekinumab,.,none,none,none,2021-06-29,Pfizer,Ustekinumab,.,none,none,none,2021-10-19,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,65,65,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,78,73,0,,,10,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,11,,460,5,60-69
759,,Female,CD,Infliximab,none,none,Methotrexate,0.11,Negative,13551,Positive,,Adult,,,Post-3rd,14-Oct-21,baseline,,,22,,03-Apr-21,21-Jun-21,22-Sep-21,79,93,9.514193485,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,Infliximab,.,none,none,Methotrexate,2021-06-21,Pfizer,Infliximab,.,none,none,Methotrexate,2021-09-22,Pfizer,Infliximab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,60,60,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,,79,0,,,10,0,1,Post-3rd Dose,1,1,22,0,0,0,,3,,,3,28,5,60-69
760,,Female,CD,Infliximab,none,none,Methotrexate,,,1012,Positive,,Adult,,,Post-2nd,27-Jul-21,baseline,,36,,,03-Apr-21,21-Jun-21,22-Sep-21,79,93,6.91968385,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,Infliximab,.,none,none,Methotrexate,2021-06-21,Pfizer,Infliximab,.,none,none,Methotrexate,2021-09-22,Pfizer,Infliximab,.,none,none,Methotrexate,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,60,60,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,36,79,0,,,7,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,5,,29,5,60-69
761,,Female,CD,Infliximab,none,none,Methotrexate,0.03,Negative,186,Positive,,Adult,,,Post-1st,06-May-21,baseline,33,,,,03-Apr-21,21-Jun-21,22-Sep-21,79,93,5.224132468,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,Infliximab,.,none,none,Methotrexate,2021-06-21,Pfizer,Infliximab,.,none,none,Methotrexate,2021-09-22,Pfizer,Infliximab,.,none,none,Methotrexate,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,60,60,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,33,,79,0,,,5,0,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,30,5,60-69
766,,Female,CD,Ustekinumab,none,none,none,0.24,Negative,1077,Positive,,Elderly,,,Post-2nd,03-Dec-21,baseline,,176,,,27-Mar-21,10-Jun-21,12-Dec-21,75,185,6.981841822,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-27,Pfizer,Ustekinumab,.,none,none,none,2021-06-10,Pfizer,Ustekinumab,.,none,none,none,2021-12-12,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,66,66,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,176,75,0,,,7,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,25,,461,5,60-69
767,,Female,CD,Ustekinumab,none,none,none,,,15515,Positive,,Elderly,,,Post-2nd,06-Jul-21,baseline,,26,,,27-Mar-21,10-Jun-21,12-Dec-21,75,185,9.649562577,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-27,Pfizer,Ustekinumab,.,none,none,none,2021-06-10,Pfizer,Ustekinumab,.,none,none,none,2021-12-12,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,66,66,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,26,75,0,,,10,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,462,5,60-69
768,,Female,CD,Ustekinumab,none,none,none,0.06,Negative,178,Positive,,Elderly,,,Post-1st,08-May-21,baseline,42,,,,27-Mar-21,10-Jun-21,12-Dec-21,75,185,5.18234519,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-27,Pfizer,Ustekinumab,.,none,none,none,2021-06-10,Pfizer,Ustekinumab,.,none,none,none,2021-12-12,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,66,66,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,42,,75,0,,,5,1,1,Post-1st Dose,1,1,,0,0,0,,3,6,,,463,5,60-69
776,,Female,CD,Ustekinumab,none,none,none,0.18,Negative,20064,Positive,,Elderly,243,,Post-2nd,18-Aug-21,covid,,42,,,29-May-21,07-Jul-21,,39,,9.906667491,colonic,fistulizng,N/A,,Outpatient,Confirmed COVID,,,,,,,2021-05-29,Moderna,Ustekinumab,.,none,none,none,2021-07-07,Moderna,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,2020-12-18,1,Female,66,66,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,,42,39,1,,,10,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2020-12-18,,,6,,602,5,60-69
805,,Female,UC,Infliximab,none,none,none,0.04,Negative,8046,Positive,,Elderly,,,Post-3rd,22-Sep-21,baseline,,,20,,24-Mar-21,18-May-21,02-Sep-21,55,107,8.992905495,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-03-24,Pfizer,Infliximab,.,none,none,none,2021-05-18,Pfizer,Infliximab,.,none,none,none,2021-09-02,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,67,67,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,55,0,,,9,1,0,Post-3rd Dose,1,1,20,0,0,0,,3,,,3,988,5,60-69
806,,Female,UC,Infliximab,none,none,none,0.04,Negative,1497,Positive,,Elderly,,,Post-2nd,24-Aug-21,baseline,,98,,,24-Mar-21,18-May-21,02-Sep-21,55,107,7.31148555,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-03-24,Pfizer,Infliximab,.,none,none,none,2021-05-18,Pfizer,Infliximab,.,none,none,none,2021-09-02,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,67,67,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,98,55,0,,,7,1,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,14,,989,5,60-69
807,,Female,UC,Infliximab,none,none,none,0.04,Negative,959,Positive,,Elderly,,,Post-2nd,21-Jun-21,baseline,,34,,,24-Mar-21,18-May-21,02-Sep-21,55,107,6.865995345,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-03-24,Pfizer,Infliximab,.,none,none,none,2021-05-18,Pfizer,Infliximab,.,none,none,none,2021-09-02,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,67,67,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,34,55,0,,,7,1,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,5,,990,5,60-69
820,,Female,CD,Golimumab,none,none,none,0.05,Negative,8781,Positive,,Adult,,,Post-3rd,26-Oct-21,baseline,,,32,,12-Apr-21,05-May-21,24-Sep-21,23,142,9.080345575,ileocolonic,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-12,Pfizer,Golimumab,.,none,none,none,2021-05-05,Pfizer,Golimumab,.,none,none,none,2021-09-24,Pfizer,Golimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,61,62,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,23,1,,,9,0,1,Post-3rd Dose,1,1,32,0,0,0,,3,,,5,507,5,60-69
852,,Male,CD,Adalimumab,none,none,none,0.02,Negative,3631,Positive,,Elderly,-62,,Post-3rd,03-Nov-21,baseline,,,56,,03-Apr-21,25-Jun-21,08-Sep-21,83,75,8.197180746,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,Adalimumab,.,none,none,none,2021-06-25,Pfizer,Adalimumab,.,none,none,none,2021-09-08,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,2022-01-04,0,Male,66,67,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,83,0,,,8,1,1,Post-3rd Dose,1,1,56,0,0,0,2022-01-04,3,,,8,346,5,60-69
853,,Male,CD,Adalimumab,none,none,none,0.02,Negative,4172,Positive,,Elderly,-151,,Post-2nd,06-Aug-21,baseline,,42,,,03-Apr-21,25-Jun-21,08-Sep-21,83,75,8.336198754,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,Adalimumab,.,none,none,none,2021-06-25,Pfizer,Adalimumab,.,none,none,none,2021-09-08,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,2022-01-04,0,Male,66,67,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,42,83,0,,,8,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2022-01-04,3,,6,,347,5,60-69
854,,Male,CD,Adalimumab,none,none,none,0.01,Negative,78,Positive,,Elderly,-232,,Post-1st,17-May-21,baseline,44,,,,03-Apr-21,25-Jun-21,08-Sep-21,83,75,4.356708827,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,Adalimumab,.,none,none,none,2021-06-25,Pfizer,Adalimumab,.,none,none,none,2021-09-08,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,2022-01-04,0,Male,66,67,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,44,,83,0,,,4,1,1,Post-1st Dose,1,1,,0,0,0,2022-01-04,3,6,,,348,5,60-69
855,,Male,UC,Remicade,none,yes ,Azathioprine/Immuran,0.02,Negative,3465,Positive,,Adult,,,Post-2nd,16-Aug-21,baseline,,28,,,28-May-21,19-Jul-21,,52,,8.150381328,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-05-28,Pfizer,Remicade,.,none,yes ,Azathioprine/Immuran,2021-07-19,Pfizer,Remicade,.,none,yes ,Azathioprine/Immuran,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,62,62,1,0,0,0,0,1,1,Combination Therapy,1,0,0,0,0,1,1,Combination Therapy,1,0,0,0,0,1,1,Combination Therapy,0,0,0,0,0,1,0,,,28,52,0,,,8,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,4,,309,5,60-69
856,,Male,UC,Vedolizumab,none,yes ,none,,,2795,Positive,,Adult,,,Post-2nd,09-Jul-21,baseline,,34,,,17-Mar-21,05-Jun-21,10-Sep-21,80,97,7.935551607,N/A ,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-03-17,AstraZeneca,Vedolizumab,.,none,yes ,none,2021-06-05,Pfizer,Vedolizumab,.,none,yes ,none,2021-09-10,Pfizer,Vedolizumab,.,none,yes ,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,62,62,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,,34,80,0,,,8,0,0,Post-2nd Dose (1-8 Weeks),0,1,,0,0,0,,3,,5,,91,5,60-69
857,,Male,UC,Vedolizumab,none,none,none,0.02,Negative,5155,Positive,,Adult,,,Post-2nd,16-Jul-21,baseline,,76,,,07-Apr-21,01-May-21,10-Sep-21,24,132,8.547702998,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-07,Pfizer,Vedolizumab,.,none,none,none,2021-05-01,Pfizer,Vedolizumab,.,none,none,none,2021-09-10,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,64,64,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,76,24,1,,,9,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,11,,231,5,60-69
858,,Male,UC,Infliximab,none,none,none,0.03,Negative,63,Positive,,Elderly,,,Post-1st,06-May-21,baseline,42,,,,25-Mar-21,10-Jun-21,16-Nov-21,77,159,4.138361448,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-03-25,Pfizer,Infliximab,.,none,none,none,2021-06-10,Pfizer,Infliximab,.,none,none,none,2021-11-16,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,67,67,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,42,,77,0,,,4,1,0,Post-1st Dose,1,1,,0,0,0,,3,6,,,677,5,60-69
859,,Male,CD,Ustekinumab,none,none,none,0.05,Negative,20,Negative,,Adult,,,Post-1st,05-Apr-21,baseline,24,,,,12-Mar-21,19-Jun-21,24-Dec-21,99,188,2.970414466,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-12,COVISHIELD,Ustekinumab,.,none,none,none,2021-06-19,COVISHIELD,Ustekinumab,.,none,none,none,2021-12-24,Pfizer,Vedolizumab,.,Oral budesonide/Cortiment/Entocort,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,63,63,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,1,0,0,0,0,0,Vedolizumab Only,24,,99,0,,,3,0,1,Post-1st Dose,,,,0,0,0,,3,3,,,258,5,60-69
860,,Male,CD,Ustekinumab,none,none,none,0.22,Negative,356,Positive,,Adult,,,Post-2nd,09-Dec-21,baseline,,173,,,12-Mar-21,19-Jun-21,24-Dec-21,99,188,5.874649793,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-12,COVISHIELD,Ustekinumab,.,none,none,none,2021-06-19,COVISHIELD,Ustekinumab,.,none,none,none,2021-12-24,Pfizer,Vedolizumab,.,Oral budesonide/Cortiment/Entocort,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,63,64,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,173,99,0,,,6,0,1,Post-2nd Dose (8+ Weeks),,,,0,0,0,,3,,25,,259,5,60-69
861,,Male,CD,Ustekinumab,none,none,none,0.05,Negative,142,Positive,,Adult,,,Post-2nd,28-Jun-21,baseline,,9,,,12-Mar-21,19-Jun-21,24-Dec-21,99,188,4.955122584,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-12,COVISHIELD,Ustekinumab,.,none,none,none,2021-06-19,COVISHIELD,Ustekinumab,.,none,none,none,2021-12-24,Pfizer,Vedolizumab,.,Oral budesonide/Cortiment/Entocort,none,none,,.,.,.,.,.,.,,1,,1,,,,1,,,,0,Male,63,64,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,9,99,0,,,5,0,1,Post-2nd Dose (1-8 Weeks),,,,0,0,0,,3,,1,,260,5,60-69
866,,Male,UC,none,Oral Prednisone,yes ,none,0.16,Negative,667,Positive,,Elderly,,,Post-3rd,15-Nov-21,baseline,,,74,,18-Jan-21,27-Feb-21,02-Sep-21,40,187,6.503089851,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-01-18,Pfizer,none,.,Oral Prednisone,yes ,none,2021-02-27,Pfizer,none,.,Oral Prednisone,yes ,none,2021-09-02,Pfizer,none,.,Oral Prednisone,yes ,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,64,65,0,0,0,0,1,1,0,Corticoteroids,0,0,0,0,1,1,0,Corticoteroids,0,0,0,0,1,1,0,Corticoteroids,0,0,0,0,1,1,0,Corticoteroids,,,40,1,,,7,1,0,Post-3rd Dose,1,1,74,0,0,0,,3,,,11,379,5,60-69
867,,Male,UC,none,Oral Prednisone,yes ,none,0.06,Negative,5,Negative,,Adult,,,Post-2nd,15-Mar-21,baseline,,16,,,18-Jan-21,27-Feb-21,02-Sep-21,40,187,1.589235205,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-01-18,Pfizer,none,.,Oral Prednisone,yes ,none,2021-02-27,Pfizer,none,.,Oral Prednisone,yes ,none,2021-09-02,Pfizer,none,.,Oral Prednisone,yes ,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,64,64,0,0,0,0,1,1,0,Corticoteroids,0,0,0,0,1,1,0,Corticoteroids,0,0,0,0,1,1,0,Corticoteroids,0,0,0,0,1,1,0,Corticoteroids,,16,40,1,,,2,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,2,,380,5,60-69
868,,Male,UC,none,Oral Prednisone,yes ,none,,,7,Negative,,Elderly,,,Post-2nd,12-Jul-21,baseline,,135,,,18-Jan-21,27-Feb-21,02-Sep-21,40,187,1.931521412,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-01-18,Pfizer,none,.,Oral Prednisone,yes ,none,2021-02-27,Pfizer,none,.,Oral Prednisone,yes ,none,2021-09-02,Pfizer,none,.,Oral Prednisone,yes ,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,64,65,0,0,0,0,1,1,0,Corticoteroids,0,0,0,0,1,1,0,Corticoteroids,0,0,0,0,1,1,0,Corticoteroids,0,0,0,0,1,1,0,Corticoteroids,,135,40,1,,,2,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,19,,381,5,60-69
869,,Female,CD,Adalimumab,none,none,none,0.06,Negative,14324,Positive,,Elderly,,,Post-3rd,20-Dec-21,baseline,,,20,,16-Apr-21,09-May-21,30-Nov-21,23,205,9.56968475,ileal,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-16,Pfizer,Adalimumab,.,none,none,none,2021-05-09,Pfizer,Adalimumab,.,none,none,none,2021-11-30,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,66,66,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,23,1,,,10,1,1,Post-3rd Dose,1,1,20,0,0,0,,3,,,3,237,5,60-69
870,,Female,CD,Adalimumab,none,none,none,0.06,Negative,4398,Positive,,Elderly,,,Post-2nd,31-May-21,baseline,,22,,,16-Apr-21,09-May-21,30-Nov-21,23,205,8.388950645,ileal,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-16,Pfizer,Adalimumab,.,none,none,none,2021-05-09,Pfizer,Adalimumab,.,none,none,none,2021-11-30,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,66,66,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,22,23,1,,,8,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,238,5,60-69
871,,Female,CD,Adalimumab,none,none,none,0.05,Negative,434,Positive,,Elderly,,,Post-2nd,09-Sep-21,baseline,,123,,,16-Apr-21,09-May-21,30-Nov-21,23,205,6.072583598,ileal,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-16,Pfizer,Adalimumab,.,none,none,none,2021-05-09,Pfizer,Adalimumab,.,none,none,none,2021-11-30,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,66,66,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,123,23,1,,,6,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,18,,239,5,60-69
872,,Female,CD,Tofacitinib,none,none,none,0.02,Negative,813,Positive,,Elderly,,,Post-3rd,24-Nov-21,baseline,,,7,,16-Mar-21,14-Jun-21,17-Nov-21,90,156,6.700977082,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,Vedolizumab,,,,,,2021-03-16,Moderna,Tofacitinib,Vedolizumab,none,none,none,2021-06-14,Moderna,Tofacitinib,Vedolizumab,none,none,none,2021-11-17,Pfizer,Tofacitinib,Vedolizumab,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,67,67,0,1,0,1,0,0,0,Combination Therapy,0,1,0,1,0,0,0,Combination Therapy,0,1,0,1,0,0,0,Combination Therapy,0,1,0,1,0,0,0,Combination Therapy,,,90,0,,,7,1,1,Post-3rd Dose,1,1,7,0,0,0,,3,,,1,525,5,60-69
873,,Female,CD,Tofacitinib,none,none,none,,,273,Positive,,Elderly,,,Post-2nd,05-Jul-21,baseline,,21,,,16-Mar-21,14-Jun-21,17-Nov-21,90,156,5.610935924,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,Vedolizumab,,,,,,2021-03-16,Moderna,Tofacitinib,Vedolizumab,none,none,none,2021-06-14,Moderna,Tofacitinib,Vedolizumab,none,none,none,2021-11-17,Pfizer,Tofacitinib,Vedolizumab,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,67,67,0,1,0,1,0,0,0,Combination Therapy,0,1,0,1,0,0,0,Combination Therapy,0,1,0,1,0,0,0,Combination Therapy,0,1,0,1,0,0,0,Combination Therapy,,21,90,0,,,6,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,526,5,60-69
874,,Female,CD,Tofacitinib,none,none,none,0.02,Negative,7,Negative,,Elderly,,,Post-1st,10-May-21,baseline,55,,,,16-Mar-21,14-Jun-21,17-Nov-21,90,156,1.945910149,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,Vedolizumab,,,,,,2021-03-16,Moderna,Tofacitinib,Vedolizumab,none,none,none,2021-06-14,Moderna,Tofacitinib,Vedolizumab,none,none,none,2021-11-17,Pfizer,Tofacitinib,Vedolizumab,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,67,67,0,1,0,1,0,0,0,Combination Therapy,0,1,0,1,0,0,0,Combination Therapy,0,1,0,1,0,0,0,Combination Therapy,0,1,0,1,0,0,0,Combination Therapy,55,,90,0,,,2,1,1,Post-1st Dose,1,1,,0,0,0,,3,8,,,527,5,60-69
881,,Female,UC,Ustekinumab,none,Oral 5ASA,none,0.57,Negative,14068,Positive,,Adult,,,Post-3rd,24-Nov-21,baseline,,,38,,04-Apr-21,11-Jun-21,17-Oct-21,68,128,9.551679318,N/A ,N/A,Proctitis,,Outpatient,Baseline Serology,,,,,,,2021-04-04,Pfizer,Ustekinumab,.,none,Oral 5ASA,none,2021-06-11,Pfizer,Ustekinumab,.,none,Oral 5ASA,none,2021-10-17,Pfizer,Ustekinumab,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,64,64,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,,,68,0,,,10,0,0,Post-3rd Dose,1,1,38,0,0,0,,3,,,5,416,5,60-69
882,,Female,UC,Ustekinumab,none,Oral 5ASA,none,,,12090,Positive,,Adult,,,Post-2nd,05-Jul-21,baseline,,24,,,04-Apr-21,11-Jun-21,17-Oct-21,68,128,9.400100858,N/A ,N/A,Proctitis,,Outpatient,Baseline Serology,,,,,,,2021-04-04,Pfizer,Ustekinumab,.,none,Oral 5ASA,none,2021-06-11,Pfizer,Ustekinumab,.,none,Oral 5ASA,none,2021-10-17,Pfizer,Ustekinumab,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,64,64,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,,24,68,0,,,9,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,417,5,60-69
883,,Female,UC,Ustekinumab,none,Oral 5ASA,none,0.06,Negative,351,Positive,,Adult,,,Post-1st,28-May-21,baseline,54,,,,04-Apr-21,11-Jun-21,17-Oct-21,68,128,5.859931157,N/A ,N/A,Proctitis,,Outpatient,Baseline Serology,,,,,,,2021-04-04,Pfizer,Ustekinumab,.,none,Oral 5ASA,none,2021-06-11,Pfizer,Ustekinumab,.,none,Oral 5ASA,none,2021-10-17,Pfizer,Ustekinumab,.,none,Oral 5ASA,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,64,64,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,54,,68,0,,,6,0,0,Post-1st Dose,1,1,,0,0,0,,3,8,,,418,5,60-69
888,,Female,CD,Vedolizumab,none,none,none,0.02,Negative,1660,Positive,,Elderly,,,Post-2nd,12-Nov-21,baseline,,148,,,29-Mar-21,17-Jun-21,19-Dec-21,80,185,7.414693356,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-29,Pfizer,Vedolizumab,.,none,none,none,2021-06-17,Pfizer,Vedolizumab,.,none,none,none,2021-12-19,Pfizer,Adalimumab,.,none,rectal 5ASA,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,69,69,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,1,0,0,0,0,0,0,Anti-TNF Only,,148,80,0,,,7,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,21,,682,5,60-69
889,,Female,CD,Vedolizumab,none,none,none,,,25814,Positive,,Elderly,,,Post-2nd,30-Jun-21,baseline,,13,,,29-Mar-21,17-Jun-21,19-Dec-21,80,185,10.15866064,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-29,Pfizer,Vedolizumab,.,none,none,none,2021-06-17,Pfizer,Vedolizumab,.,none,none,none,2021-12-19,Pfizer,Adalimumab,.,none,rectal 5ASA,none,,.,.,.,.,.,.,,1,,1,,,,1,,,,0,Female,69,69,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,1,0,0,0,0,0,0,Anti-TNF Only,,13,80,0,,,10,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,2,,683,5,60-69
892,,Male,IBD-U,Vedolizumab,none,none,none,0.08,Negative,11244,Positive,,Adult,,,Post-2nd,22-Jul-21,baseline,,30,,,07-Apr-21,22-Jun-21,22-Nov-21,76,153,9.327616613,N/A ,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-04-07,Pfizer,Vedolizumab,.,none,none,none,2021-06-22,Pfizer,Vedolizumab,.,none,none,none,2021-11-22,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,64,64,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,30,76,0,,,9,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,869,5,60-69
893,,Male,IBD-U,Vedolizumab,none,none,none,0.09,Negative,511,Positive,,Adult,,,Post-1st,13-May-21,baseline,36,,,,07-Apr-21,22-Jun-21,22-Nov-21,76,153,6.236956502,N/A ,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-04-07,Pfizer,Vedolizumab,.,none,none,none,2021-06-22,Pfizer,Vedolizumab,.,none,none,none,2021-11-22,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,64,64,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,36,,76,0,,,6,0,0,Post-1st Dose,1,1,,0,0,0,,3,5,,,870,5,60-69
894,,Male,IBD-U,Vedolizumab,none,none,none,0.08,Negative,1991,Positive,,Adult,,,Post-2nd,09-Nov-21,baseline,,140,,,07-Apr-21,22-Jun-21,22-Nov-21,76,153,7.596291847,N/A ,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-04-07,Pfizer,Vedolizumab,.,none,none,none,2021-06-22,Pfizer,Vedolizumab,.,none,none,none,2021-11-22,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,64,64,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,140,76,0,,,8,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,20,,871,5,60-69
900,,Female,CD,none,none,none,none,,,3515,Positive,,Elderly,,,Post-2nd,07-Jul-21,baseline,,26,,,24-Mar-21,11-Jun-21,27-Dec-21,79,199,8.164880149,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-24,Pfizer,none,.,none,none,none,2021-06-11,Pfizer,none,.,none,none,none,2021-12-27,Moderna,none,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,66,66,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,,26,79,0,,,8,1,1,Post-2nd Dose (1-8 Weeks),1,1,,1,1,1,,3,,4,,494,5,60-69
901,,Female,CD,none,none,none,none,0.37,Negative,756,Positive,,Elderly,,,Post-2nd,17-Dec-21,baseline,,189,,,24-Mar-21,11-Jun-21,27-Dec-21,79,199,6.627512136,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-24,Pfizer,none,.,none,none,none,2021-06-11,Pfizer,none,.,none,none,none,2021-12-27,Moderna,none,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,66,66,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,,189,79,0,,,7,1,1,Post-2nd Dose (8+ Weeks),1,1,,1,1,1,,3,,27,,495,5,60-69
902,,Female,CD,none,none,none,none,0.02,Negative,219,Positive,,Elderly,,,Post-1st,21-Apr-21,baseline,28,,,,24-Mar-21,11-Jun-21,27-Dec-21,79,199,5.389528247,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-24,Pfizer,none,.,none,none,none,2021-06-11,Pfizer,none,.,none,none,none,2021-12-27,Moderna,none,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,66,66,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,28,,79,0,,,5,1,1,Post-1st Dose,1,1,,1,1,1,,3,4,,,496,5,60-69
916,,Female,UC,Infliximab,none,none,none,0.16,Negative,40000,Positive,,Elderly,,,Post-3rd,29-Dec-21,baseline,,,22,,12-Mar-21,07-Jun-21,07-Dec-21,87,183,10.59663473,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-03-12,Pfizer,Infliximab,.,none,none,none,2021-06-07,Pfizer,Infliximab,.,none,none,none,2021-12-07,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,67,68,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,87,0,,,11,1,0,Post-3rd Dose,1,1,22,0,0,0,,3,,,3,759,5,60-69
917,,Female,UC,Infliximab,none,none,none,0.11,Negative,15339,Positive,,Elderly,,,Post-2nd,28-Jun-21,baseline,,21,,,12-Mar-21,07-Jun-21,07-Dec-21,87,183,9.638147364,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-03-12,Pfizer,Infliximab,.,none,none,none,2021-06-07,Pfizer,Infliximab,.,none,none,none,2021-12-07,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,67,67,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,21,87,0,,,10,1,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,760,5,60-69
921,,Female,CD,Remicade,none,none,Methotrexate,0.03,Negative,0,Negative,,Adult,,,Post-1st,03-May-21,baseline,33,,,,31-Mar-21,17-Jun-21,17-Dec-21,78,183,,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-31,Pfizer,Remicade,.,none,none,Methotrexate,2021-06-17,Pfizer,Remicade,.,none,none,Methotrexate,2021-12-17,Moderna,Remicade,.,none,none,Methotrexate,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,61,61,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,33,,78,0,,,,0,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,482,5,60-69
922,,Female,CD,Remicade,none,none,Methotrexate,,,74,Positive,,Adult,,,Post-2nd,26-Jul-21,baseline,,39,,,31-Mar-21,17-Jun-21,17-Dec-21,78,183,4.308110952,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-31,Pfizer,Remicade,.,none,none,Methotrexate,2021-06-17,Pfizer,Remicade,.,none,none,Methotrexate,2021-12-17,Moderna,Remicade,.,none,none,Methotrexate,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,61,61,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,39,78,0,,,4,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,6,,483,5,60-69
937,,Male,CD,Ustekinumab,none,none,none,,,2181,Positive,,Adult,,,Post-2nd,27-Jul-21,baseline,,38,,,16-Mar-21,19-Jun-21,,95,,7.687309487,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-16,AstraZeneca,Ustekinumab,.,none,none,none,2021-06-19,AstraZeneca,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,62,62,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,,38,95,0,,,8,0,1,Post-2nd Dose (1-8 Weeks),0,0,,0,0,0,,,,5,,139,5,60-69
938,,Male,CD,Ustekinumab,none,none,none,0.2,Negative,1345,Positive,,Adult,,,Post-2nd,16-Nov-21,baseline,,150,,,16-Mar-21,19-Jun-21,,95,,7.20407494,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-16,AstraZeneca,Ustekinumab,.,none,none,none,2021-06-19,AstraZeneca,Ustekinumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,62,63,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,0,0,0,0,0,,,150,95,0,,,7,0,1,Post-2nd Dose (8+ Weeks),0,0,,0,0,0,,,,21,,140,5,60-69
949,,Female,UC,Vedolizumab,none,none,none,0.01,Negative,4176,Positive,,Adult,,,Post-2nd,18-May-21,baseline,,8,,,18-Apr-21,10-May-21,,22,,8.337061236,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-18,Pfizer,Vedolizumab,.,none,none,none,2021-05-10,Pfizer,Vedolizumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,1,,1,,,,1,,,,0,Female,60,60,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,0,0,0,0,0,0,,,8,22,1,,,8,0,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,1,,426,5,60-69
950,,Female,UC,Vedolizumab,none,none,none,0.02,Negative,2128,Positive,,Adult,,,Post-2nd,15-Sep-21,baseline,,128,,,18-Apr-21,10-May-21,,22,,7.66270286,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-18,Pfizer,Vedolizumab,.,none,none,none,2021-05-10,Pfizer,Vedolizumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,60,60,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,0,0,0,0,0,0,,,128,22,1,,,8,0,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,18,,427,5,60-69
964,,Male,CD,Ustekinumab,none,none,none,0.03,Negative,780,Positive,,Adult,,,Post-1st,20-May-21,baseline,38,,,,12-Apr-21,13-Jun-21,14-Dec-21,62,184,6.658652688,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-12,Pfizer,Ustekinumab,.,none,none,none,2021-06-13,Pfizer,Ustekinumab,.,none,none,none,2021-12-14,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,60,60,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,38,,62,0,,,7,0,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,804,5,60-69
965,,Male,CD,Ustekinumab,none,none,none,,,3302,Positive,,Adult,,,Post-2nd,29-Jul-21,baseline,,46,,,12-Apr-21,13-Jun-21,14-Dec-21,62,184,8.10213219,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-12,Pfizer,Ustekinumab,.,none,none,none,2021-06-13,Pfizer,Ustekinumab,.,none,none,none,2021-12-14,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,60,60,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,46,62,0,,,8,0,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,7,,805,5,60-69
971,,Male,CD,Remicade,none,none,Azathioprine/Immuran,0.05,Negative,11062,Positive,,Elderly,,,Post-3rd,23-Sep-21,baseline,,,20,,17-Mar-21,27-May-21,03-Sep-21,71,99,9.31130725,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-17,Moderna,Remicade,.,none,none,Azathioprine/Immuran,2021-05-27,Moderna,Remicade,.,none,none,Azathioprine/Immuran,2021-09-03,Moderna,Remicade,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,66,66,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,,71,0,,,9,1,1,Post-3rd Dose,1,1,20,0,0,0,,3,,,3,99,5,60-69
972,,Male,CD,Remicade,none,none,Azathioprine/Immuran,0.02,Negative,197,Positive,,Elderly,,,Post-1st,21-Apr-21,baseline,35,,,,17-Mar-21,27-May-21,03-Sep-21,71,99,5.281171208,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-17,Moderna,Remicade,.,none,none,Azathioprine/Immuran,2021-05-27,Moderna,Remicade,.,none,none,Azathioprine/Immuran,2021-09-03,Moderna,Remicade,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,66,66,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,35,,71,0,,,5,1,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,100,5,60-69
973,,Male,CD,Remicade,none,none,Azathioprine/Immuran,,,1775,Positive,,Elderly,,,Post-2nd,23-Jul-21,baseline,,57,,,17-Mar-21,27-May-21,03-Sep-21,71,99,7.481612038,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-17,Moderna,Remicade,.,none,none,Azathioprine/Immuran,2021-05-27,Moderna,Remicade,.,none,none,Azathioprine/Immuran,2021-09-03,Moderna,Remicade,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,66,66,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,,57,71,0,,,7,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,8,,101,5,60-69
976,,Female,CD,Infliximab,none,none,none,0.02,Negative,4381,Positive,,Elderly,,,Post-2nd,27-Aug-21,baseline,,51,,,10-Jun-21,07-Jul-21,,27,,8.385055113,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-06-10,Pfizer,Infliximab,.,none,none,none,2021-07-07,Pfizer,Infliximab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,67,67,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,51,27,1,,,8,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,7,,240,5,60-69
986,,Female,CD,Adalimumab,none,none,none,0.02,Negative,1286,Positive,,Adult,,,Post-2nd,06-Oct-21,baseline,,133,,,12-Apr-21,26-May-21,,44,,7.159602898,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-12,Pfizer,Adalimumab,.,none,none,none,2021-05-26,Pfizer,Adalimumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,63,64,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,133,44,0,,,7,0,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,19,,221,5,60-69
987,,Female,CD,Adalimumab,none,none,none,0.03,Negative,821,Positive,,Adult,,,Post-1st,18-May-21,baseline,36,,,,12-Apr-21,26-May-21,,44,,6.710523109,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-12,Pfizer,Adalimumab,.,none,none,none,2021-05-26,Pfizer,Adalimumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,63,63,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,36,,44,0,,,7,0,1,Post-1st Dose,1,1,,0,0,0,,,5,,,222,5,60-69
989,,Male,UC,Ustekinumab,Oral Prednisone,none,none,0.23,Negative,3824,Positive,,Elderly,,,Post-3rd,06-Nov-21,baseline,,,52,,31-Mar-21,13-Jun-21,15-Sep-21,74,94,8.249130723,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-03-31,Pfizer,Ustekinumab,Infliximab,Oral Prednisone,none,none,2021-06-13,Pfizer,Ustekinumab,none,none,none,none,2021-09-15,Pfizer,Ustekinumab,none,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,65,65,0,0,1,0,1,0,0,Corticoteroids,1,0,1,0,1,0,0,Corticoteroids,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,74,0,,,8,1,0,Post-3rd Dose,1,1,52,0,0,0,,3,,,7,48,5,60-69
990,,Male,UC,Ustekinumab,Oral Prednisone,none,none,0.01,Negative,42,Negative,,Elderly,,,Post-1st,09-May-21,baseline,39,,,,31-Mar-21,13-Jun-21,15-Sep-21,74,94,3.740047741,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-03-31,Pfizer,Ustekinumab,Infliximab,Oral Prednisone,none,none,2021-06-13,Pfizer,Ustekinumab,none,none,none,none,2021-09-15,Pfizer,Ustekinumab,none,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,65,65,0,0,1,0,1,0,0,Corticoteroids,1,0,1,0,1,0,0,Corticoteroids,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,39,,74,0,,,4,0,0,Post-1st Dose,1,1,,0,0,0,,3,6,,,49,5,60-69
991,,Male,UC,Ustekinumab,Oral Prednisone,none,none,0.01,Negative,1405,Positive,,Elderly,,,Post-2nd,19-Aug-21,baseline,,67,,,31-Mar-21,13-Jun-21,15-Sep-21,74,94,7.247579036,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-03-31,Pfizer,Ustekinumab,Infliximab,Oral Prednisone,none,none,2021-06-13,Pfizer,Ustekinumab,none,none,none,none,2021-09-15,Pfizer,Ustekinumab,none,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,65,65,0,0,1,0,1,0,0,Corticoteroids,1,0,1,0,1,0,0,Corticoteroids,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,67,74,0,,,7,1,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,10,,50,5,60-69
36,,Male,UC,Renflexis/IFX,none,none,none,0.69,Negative,4141,Positive,,Elderly,,,Post-3rd,23-Nov-21,baseline,,,12,,12-Mar-21,03-Jun-21,11-Nov-21,83,161,8.328644285,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-03-12,Pfizer,Renflexis/IFX,.,none,none,none,2021-06-03,Pfizer,Renflexis/IFX,.,none,none,none,2021-11-11,Pfizer,Renflexis/IFX,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,72,73,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,83,0,,,8,1,0,Post-3rd Dose,1,1,12,0,0,0,,3,,,2,948,6,70+
37,,Male,UC,Renflexis/IFX,none,none,none,0.06,Negative,57,Positive,,Elderly,,,Post-1st,29-Apr-21,baseline,48,,,,12-Mar-21,03-Jun-21,11-Nov-21,83,161,4.048300624,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-03-12,Pfizer,Renflexis/IFX,.,none,none,none,2021-06-03,Pfizer,Renflexis/IFX,.,none,none,none,2021-11-11,Pfizer,Renflexis/IFX,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,72,72,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,48,,83,0,,,4,1,0,Post-1st Dose,1,1,,0,0,0,,3,7,,,949,6,70+
56,,Male,CD,Adalimumab,Oral Prednisone,none,Azathioprine/Immuran,0.03,Negative,183,Positive,,Elderly,,,Post-3rd,02-Dec-21,baseline,,,30,,06-Apr-21,28-Jun-21,02-Nov-21,83,127,5.211124155,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-06,Moderna,Adalimumab,none,none,none,Azathioprine/Immuran,2021-06-28,Moderna,Adalimumab,none,Oral Prednisone,none,Azathioprine/Immuran,2021-11-02,Pfizer,Adalimumab,.,Oral Prednisone,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,72,73,1,0,0,0,1,0,1,Corticoteroids,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,1,0,1,Corticoteroids,1,0,0,0,1,0,1,Corticoteroids,,,83,0,,,5,1,1,Post-3rd Dose,1,1,30,0,0,0,,3,,,4,188,6,70+
57,,Male,CD,Adalimumab,Oral Prednisone,none,Azathioprine/Immuran,0.04,Negative,6,Negative,,Elderly,,,Post-1st,31-May-21,baseline,55,,,,06-Apr-21,28-Jun-21,02-Nov-21,83,127,1.740466175,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-06,Moderna,Adalimumab,none,none,none,Azathioprine/Immuran,2021-06-28,Moderna,Adalimumab,none,Oral Prednisone,none,Azathioprine/Immuran,2021-11-02,Pfizer,Adalimumab,.,Oral Prednisone,none,Azathioprine/Immuran,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,72,72,1,0,0,0,1,0,1,Corticoteroids,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,1,0,1,Corticoteroids,1,0,0,0,1,0,1,Corticoteroids,55,,83,0,,,2,1,1,Post-1st Dose,1,1,,0,0,0,,3,8,,,189,6,70+
58,,Male,CD,Adalimumab,Oral Prednisone,none,Azathioprine/Immuran,0.05,Negative,16,Negative,,Elderly,,,Post-2nd,25-Aug-21,baseline,,58,,,06-Apr-21,28-Jun-21,02-Nov-21,83,127,2.747270914,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-06,Moderna,Adalimumab,none,none,none,Azathioprine/Immuran,2021-06-28,Moderna,Adalimumab,none,Oral Prednisone,none,Azathioprine/Immuran,2021-11-02,Pfizer,Adalimumab,.,Oral Prednisone,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,72,72,1,0,0,0,1,0,1,Corticoteroids,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,1,0,1,Corticoteroids,1,0,0,0,1,0,1,Corticoteroids,,58,83,0,,,3,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,8,,190,6,70+
63,,Male,UC,none,none,Oral 5ASA,none,0.07,Negative,1885,Positive,,Elderly,,,Post-2nd,09-Sep-21,baseline,,132,,,07-Apr-21,30-Apr-21,21-Oct-21,23,174,7.541470876,N/A,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-04-07,Pfizer,none,.,none,Oral 5ASA,none,2021-04-30,Pfizer,none,.,none,Oral 5ASA,none,2021-10-21,Pfizer,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,74,74,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,132,23,1,,,8,1,0,Post-2nd Dose (8+ Weeks),1,1,,1,1,1,,3,,19,,393,6,70+
64,,Male,UC,none,none,Oral 5ASA,none,0.07,Negative,9370,Positive,,Elderly,,,Post-2nd,17-May-21,baseline,,17,,,07-Apr-21,30-Apr-21,21-Oct-21,23,174,9.145257703,N/A,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-04-07,Pfizer,none,.,none,Oral 5ASA,none,2021-04-30,Pfizer,none,.,none,Oral 5ASA,none,2021-10-21,Pfizer,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,74,74,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,17,23,1,,,9,1,0,Post-2nd Dose (1-8 Weeks),1,1,,1,1,1,,3,,2,,394,6,70+
65,,Female,CD,none,none,Oral 5ASA,none,,,3709,Positive,,Elderly,,,Post-2nd,02-Jul-21,Suspected COVID-19/Symptomatic,,18,,,26-Mar-21,14-Jun-21,14-Dec-21,80,183,8.21843669,ileocolonic,Inflamatory,N/A,,Outpatient,Suspected COVID-19/Symptomatic,,,,,,,2021-03-26,Pfizer,none,.,none,Oral 5ASA,none,2021-06-14,Pfizer,none,.,none,Oral 5ASA,none,2021-12-14,Pfizer,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,70,70,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,18,80,0,,,8,1,1,Post-2nd Dose (1-8 Weeks),1,1,,1,1,1,,3,,3,,288,6,70+
66,,Female,CD,none,none,Oral 5ASA,none,0.03,Negative,1342,Positive,,Elderly,,,Post-2nd,17-Nov-21,Suspected COVID-19/Symptomatic,,156,,,26-Mar-21,14-Jun-21,14-Dec-21,80,183,7.202214336,ileocolonic,Inflamatory,N/A,,Outpatient,Suspected COVID-19/Symptomatic,,,,,,,2021-03-26,Pfizer,none,.,none,Oral 5ASA,none,2021-06-14,Pfizer,none,.,none,Oral 5ASA,none,2021-12-14,Pfizer,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,70,70,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,156,80,0,,,7,1,1,Post-2nd Dose (8+ Weeks),1,1,,1,1,1,,3,,22,,289,6,70+
67,,Female,CD,none,none,Oral 5ASA,none,0.01,Negative,613,Positive,,Elderly,,,Post-1st,18-May-21,Suspected COVID-19/Symptomatic,53,,,,26-Mar-21,14-Jun-21,14-Dec-21,80,183,6.41787542,ileocolonic,Inflamatory,N/A,,Outpatient,Suspected COVID-19/Symptomatic,,,,,,,2021-03-26,Pfizer,none,.,none,Oral 5ASA,none,2021-06-14,Pfizer,none,.,none,Oral 5ASA,none,2021-12-14,Pfizer,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,70,70,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,53,,80,0,,,6,1,1,Post-1st Dose,1,1,,1,1,1,,3,8,,,290,6,70+
86,,Female,CD,Vedolizumab,none,Oral 5ASA,none,0.05,Negative,74,Positive,,Elderly,,,Post-1st,29-Apr-21,baseline,46,,,,14-Mar-21,10-Jun-21,24-Dec-21,88,197,4.298645026,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-14,Pfizer,Vedolizumab,.,none,none,none,2021-06-10,Pfizer,Vedolizumab,.,none,none,none,2021-12-24,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,74,74,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,46,,88,0,,,4,1,1,Post-1st Dose,1,1,,0,0,0,,3,7,,,341,6,70+
87,,Female,CD,Vedolizumab,none,Oral 5ASA,none,0.12,Negative,4997,Positive,,Elderly,,,Post-2nd,12-Nov-21,baseline,,155,,,14-Mar-21,10-Jun-21,24-Dec-21,88,197,8.516653046,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-14,Pfizer,Vedolizumab,.,none,none,none,2021-06-10,Pfizer,Vedolizumab,.,none,none,none,2021-12-24,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,74,74,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,155,88,0,,,9,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,22,,342,6,70+
91,,Female,UC,Adalimumab,none,none,Methotrexate,0.05,Negative,82,Positive,,Elderly,,,Post-2nd,08-Dec-21,baseline,,163,,,07-Apr-21,28-Jun-21,,82,,4.406719247,N/A,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-07,Pfizer,Adalimumab,.,none,none,Methotrexate,2021-06-28,Pfizer,Adalimumab,.,none,none,Methotrexate,,,,,,,,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,73,73,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,0,0,0,0,0,0,0,,,163,82,0,,,4,1,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,23,,73,6,70+
100,,Female,UC,Adalimumab,none,none,none,0.02,Negative,482,Positive,,Elderly,-137,,Post-2nd,09-Aug-21,baseline,,61,,,14-Apr-21,09-Jun-21,24-Sep-21,56,107,6.178151561,N/A,N/A,Proctitis,,Outpatient,Baseline Serology,,,,,,,2021-04-14,Pfizer,Adalimumab,.,none,none,none,2021-06-09,Pfizer,Adalimumab,.,none,none,none,2021-09-24,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,2021-12-24,0,Female,72,72,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,61,56,0,,,6,1,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,2021-12-24,3,,9,,183,6,70+
101,,Female,UC,Adalimumab,none,none,none,0.02,Negative,516,Positive,,Elderly,-232,,Post-1st,06-May-21,baseline,22,,,,14-Apr-21,09-Jun-21,24-Sep-21,56,107,6.245331271,N/A,N/A,Proctitis,,Outpatient,Baseline Serology,,,,,,,2021-04-14,Pfizer,Adalimumab,.,none,none,none,2021-06-09,Pfizer,Adalimumab,.,none,none,none,2021-09-24,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,2021-12-24,0,Female,72,72,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,22,,56,0,,,6,1,0,Post-1st Dose,1,1,,0,0,0,2021-12-24,3,3,,,184,6,70+
148,,Male,CD,Vedolizumab,none,none,none,,,70,Positive,,Elderly,,,Post-1st,12-Jun-21,baseline,47,,,,26-Apr-21,24-Jun-21,,59,,4.254193263,ileocolonic,fistulizng,N/A,,,Baseline Serology,,,,,,,2021-04-26,Moderna,Vedolizumab,.,none,none,none,2021-06-24,Moderna,Vedolizumab,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,70,70,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,0,0,0,0,0,0,,47,,59,0,,,4,1,1,Post-1st Dose,1,1,,0,0,0,,,7,,,457,6,70+
176,,Male,CD,Adalimumab,none,none,none,0.02,Negative,1648,Positive,,Elderly,,,Post-2nd,22-Jun-21,baseline,,49,,,03-Mar-21,04-May-21,04-Dec-21,62,214,7.407135655,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-03,Pfizer,Adalimumab,.,none,none,none,2021-05-04,Pfizer,Adalimumab,.,none,none,none,2021-12-04,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,78,78,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,49,62,0,,,7,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,7,,615,6,70+
240,,Male,CD,Ustekinumab,none,none,none,,,14678,Positive,,Elderly,,,Post-2nd,29-Jul-21,baseline,,49,,,25-Mar-21,10-Jun-21,10-Dec-21,77,183,9.594105053,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-25,Pfizer,Ustekinumab,.,none,none,none,2021-06-10,Pfizer,Ustekinumab,.,none,none,none,2021-12-10,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,71,72,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,49,77,0,,,10,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,7,,730,6,70+
279,,Male,CD,none,none,Oral 5ASA,none,0.04,Negative,6816,Positive,,Elderly,,,Post-3rd,13-Dec-21,baseline,,,38,,30-Mar-21,05-May-21,05-Nov-21,36,184,8.82704274,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-30,Pfizer,none,.,none,none,none,2021-05-05,Pfizer,none,.,none,none,none,2021-11-05,Pfizer,none,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,72,73,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,,,36,1,,,9,1,1,Post-3rd Dose,1,1,38,1,1,1,,3,,,5,372,6,70+
280,,Male,CD,none,none,Oral 5ASA,none,0.03,Negative,361,Positive,,Elderly,,,Post-2nd,30-Sep-21,baseline,,148,,,30-Mar-21,05-May-21,05-Nov-21,36,184,5.889431822,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-30,Pfizer,none,.,none,none,none,2021-05-05,Pfizer,none,.,none,none,none,2021-11-05,Pfizer,none,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,72,73,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,,148,36,1,,,6,1,1,Post-2nd Dose (8+ Weeks),1,1,,1,1,1,,3,,21,,373,6,70+
284,,Male,CD,Infliximab,none,none,none,0.03,Negative,0,Negative,,Elderly,,,Post-2nd,22-Jun-21,baseline,,52,,,02-Apr-21,01-May-21,02-Sep-21,29,124,,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-02,Pfizer,Infliximab,.,none,none,none,2021-05-01,Pfizer,Infliximab,.,none,none,none,2021-09-02,Pfizer,Infliximab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,73,73,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,52,29,1,,,-2,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,7,,119,6,70+
289,,Male,CD,Inflectra,none,Rectal 5ASA,none,0.06,Negative,37,Negative,,Elderly,,,Post-2nd,30-Nov-21,baseline,,139,,,15-May-21,14-Jul-21,,60,,3.621670704,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-15,Pfizer,Inflectra,none,none,none,Methotrexate,2021-07-14,Pfizer,Inflectra,none,none,none,Methotrexate,,,,,,,,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,71,71,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,0,0,0,0,0,0,0,,,139,60,0,,,4,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,20,,156,6,70+
290,,Male,CD,Inflectra,none,Rectal 5ASA,none,0.02,Negative,2,Negative,,Elderly,,,Post-1st,15-Jun-21,baseline,31,,,,15-May-21,14-Jul-21,,60,,0.693147181,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-05-15,Pfizer,Inflectra,none,none,none,Methotrexate,2021-07-14,Pfizer,Inflectra,none,none,none,Methotrexate,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,71,71,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,0,1,Combination Therapy,1,0,0,0,0,0,1,Combination Therapy,0,0,0,0,0,0,0,,31,,60,0,,,1,1,1,Post-1st Dose,1,1,,0,0,0,,,4,,,157,6,70+
313,,Female,CD,Inflectra,none,none,none,0.1,Negative,1864,Positive,,Elderly,,,Post-2nd,15-Sep-21,baseline,,63,,,26-Apr-21,14-Jul-21,,79,,7.53026538,,,,,Outpatient,Baseline Serology,,,,,,,2021-04-26,Moderna,Inflectra,.,none,none,none,2021-07-14,Moderna,Inflectra,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,74,74,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,63,79,0,,,8,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,9,,921,6,70+
439,,Male,CD,Vedolizumab,none,none,none,0.32,Negative,33233,Positive,,Elderly,,,Post-3rd,13-Dec-21,baseline,,,28,,24-Mar-21,13-May-21,15-Nov-21,50,186,10.41129563,ileocolonic,Inflamatory,N/A,none,Outpatient,Baseline Serology,,,,,,,2021-03-24,Pfizer,Vedolizumab,.,none,none,none,2021-05-13,Pfizer,Vedolizumab,.,none,none,none,2021-11-15,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,70,71,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,,50,0,,,10,1,1,Post-3rd Dose,1,1,28,0,0,0,,3,,,4,714,6,70+
440,,Male,CD,Vedolizumab,none,none,none,0.4,Negative,1286,Positive,,Elderly,,,Post-2nd,13-Oct-21,baseline,,153,,,24-Mar-21,13-May-21,15-Nov-21,50,186,7.159602898,ileocolonic,Inflamatory,N/A,none,Outpatient,Baseline Serology,,,,,,,2021-03-24,Pfizer,Vedolizumab,.,none,none,none,2021-05-13,Pfizer,Vedolizumab,.,none,none,none,2021-11-15,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,70,70,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,153,50,0,,,7,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,22,,715,6,70+
441,,Male,CD,Vedolizumab,none,none,none,0.01,Negative,774,Positive,,Elderly,,,Post-1st,26-Apr-21,baseline,33,,,,24-Mar-21,13-May-21,15-Nov-21,50,186,6.651313442,ileocolonic,Inflamatory,N/A,none,Outpatient,Baseline Serology,,,,,,,2021-03-24,Pfizer,Vedolizumab,.,none,none,none,2021-05-13,Pfizer,Vedolizumab,.,none,none,none,2021-11-15,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,70,70,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,33,,50,0,,,7,1,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,716,6,70+
442,,Male,CD,Vedolizumab,none,none,none,0.02,Negative,2690,Positive,,Elderly,,,Post-2nd,21-Jun-21,baseline,,39,,,24-Mar-21,13-May-21,15-Nov-21,50,186,7.897370819,ileocolonic,Inflamatory,N/A,none,Outpatient,Baseline Serology,,,,,,,2021-03-24,Pfizer,Vedolizumab,.,none,none,none,2021-05-13,Pfizer,Vedolizumab,.,none,none,none,2021-11-15,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,70,70,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,39,50,0,,,8,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,6,,717,6,70+
457,,Male,CD,Ustekinumab,none,Rectal 5ASA,none,0.01,Negative,5019,Positive,,Elderly,,,Post-2nd,26-May-21,baseline,,40,,,09-Mar-21,16-Apr-21,16-Oct-21,38,183,8.521065684,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-09,Pfizer,Ustekinumab,.,none,Rectal 5ASA,none,2021-04-16,Pfizer,Ustekinumab,.,none,Rectal 5ASA,none,2021-10-16,Pfizer,Ustekinumab,.,none,Rectal 5ASA,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,78,78,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,,40,38,1,,,9,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,6,,833,6,70+
458,,Male,CD,Ustekinumab,none,Rectal 5ASA,none,0.01,Negative,186,Positive,,Elderly,,,Post-1st,14-Apr-21,baseline,36,,,,09-Mar-21,16-Apr-21,16-Oct-21,38,183,5.225746674,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-09,Pfizer,Ustekinumab,.,none,Rectal 5ASA,none,2021-04-16,Pfizer,Ustekinumab,.,none,Rectal 5ASA,none,2021-10-16,Pfizer,Ustekinumab,.,none,Rectal 5ASA,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,78,78,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,36,,38,1,,,5,1,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,834,6,70+
459,,Male,CD,Ustekinumab,none,Rectal 5ASA,none,0.06,Negative,593,Positive,,Elderly,,,Post-2nd,01-Sep-21,baseline,,138,,,09-Mar-21,16-Apr-21,16-Oct-21,38,183,6.384350873,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-09,Pfizer,Ustekinumab,.,none,Rectal 5ASA,none,2021-04-16,Pfizer,Ustekinumab,.,none,Rectal 5ASA,none,2021-10-16,Pfizer,Ustekinumab,.,none,Rectal 5ASA,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,78,78,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,0,0,1,0,0,1,0,Ustekinumab Only,,138,38,1,,,6,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,20,,835,6,70+
460,,Male,CD,Ustekinumab,none,none,none,0.09,Negative,11702,Positive,,Elderly,,,Post-2nd,27-May-21,baseline,,50,,,25-Feb-21,07-Apr-21,19-Oct-21,41,195,9.367549228,colonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-02-25,Pfizer,Ustekinumab,.,none,none,none,2021-04-07,Pfizer,Ustekinumab,.,none,none,none,2021-10-19,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,75,75,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,50,41,1,,,9,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,7,,88,6,70+
461,,Male,CD,Ustekinumab,none,none,none,0.09,Negative,1961,Positive,,Elderly,,,Post-2nd,30-Aug-21,baseline,,145,,,25-Feb-21,07-Apr-21,19-Oct-21,41,195,7.581413783,colonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-02-25,Pfizer,Ustekinumab,.,none,none,none,2021-04-07,Pfizer,Ustekinumab,.,none,none,none,2021-10-19,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,75,76,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,145,41,1,,,8,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,21,,89,6,70+
462,,Male,CD,Ustekinumab,none,none,none,0.11,Negative,597,Positive,,Elderly,,,Post-1st,05-Apr-21,baseline,39,,,,25-Feb-21,07-Apr-21,19-Oct-21,41,195,6.391582049,colonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-02-25,Pfizer,Ustekinumab,.,none,none,none,2021-04-07,Pfizer,Ustekinumab,.,none,none,none,2021-10-19,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,75,75,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,39,,41,1,,,6,1,1,Post-1st Dose,1,1,,0,0,0,,3,6,,,90,6,70+
466,,Male,CD,Vedolizumab,none,Oral 5ASA,none,0.39,Negative,1330,Positive,,Elderly,,,Post-2nd,26-May-21,baseline,,32,,,14-Mar-21,24-Apr-21,15-Oct-21,41,174,7.192708632,ileal,,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-14,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,2021-04-24,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,2021-10-15,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,79,79,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,,32,41,1,,,7,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,5,,966,6,70+
468,,Female,UC,none,none,Oral 5ASA,none,,,330,Positive,,Elderly,,,Post-2nd,15-Jul-21,baseline,,37,,,26-Mar-21,08-Jun-21,07-Dec-21,74,182,5.797879798,N/A ,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-03-26,Pfizer,none,.,none,Oral 5ASA,none,2021-06-08,Pfizer,none,.,none,Oral 5ASA,none,2021-12-07,Pfizer,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,74,74,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,37,74,0,,,6,1,0,Post-2nd Dose (1-8 Weeks),1,1,,1,1,1,,3,,5,,854,6,70+
469,,Female,UC,none,none,Oral 5ASA,none,0.04,Negative,17,Negative,,Elderly,,,Post-1st,29-Apr-21,baseline,34,,,,26-Mar-21,08-Jun-21,07-Dec-21,74,182,2.839078464,N/A ,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-03-26,Pfizer,none,.,none,Oral 5ASA,none,2021-06-08,Pfizer,none,.,none,Oral 5ASA,none,2021-12-07,Pfizer,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,74,74,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,34,,74,0,,,3,1,0,Post-1st Dose,1,1,,1,1,1,,3,5,,,855,6,70+
508,,Male,CD,Ustekinumab,none,none,none,0.02,Negative,24881,Positive,,Elderly,,,Post-3rd,14-Oct-21,baseline,,,28,,19-Mar-21,07-May-21,16-Sep-21,49,132,10.1218517,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-19,Moderna,Ustekinumab,.,none,none,none,2021-05-07,Moderna,Ustekinumab,.,none,none,none,2021-09-16,Moderna,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,72,72,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,49,0,,,10,1,1,Post-3rd Dose,1,1,28,0,0,0,,3,,,4,21,6,70+
509,,Male,CD,Ustekinumab,none,none,none,0.03,Negative,754,Positive,,Elderly,,,Post-2nd,14-Sep-21,baseline,,130,,,19-Mar-21,07-May-21,16-Sep-21,49,132,6.624994411,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-19,Moderna,Ustekinumab,.,none,none,none,2021-05-07,Moderna,Ustekinumab,.,none,none,none,2021-09-16,Moderna,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,72,72,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,130,49,0,,,7,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,19,,22,6,70+
510,,Male,CD,Ustekinumab,none,none,none,0.02,Negative,87,Positive,,Elderly,,,Post-1st,29-Apr-21,baseline,41,,,,19-Mar-21,07-May-21,16-Sep-21,49,132,4.469350463,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-19,Moderna,Ustekinumab,.,none,none,none,2021-05-07,Moderna,Ustekinumab,.,none,none,none,2021-09-16,Moderna,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,72,72,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,41,,49,0,,,4,1,1,Post-1st Dose,1,1,,0,0,0,,3,6,,,23,6,70+
511,,Male,CD,Ustekinumab,none,none,none,0.03,Negative,1561,Positive,,Elderly,,,Post-2nd,23-Jun-21,baseline,,47,,,19-Mar-21,07-May-21,16-Sep-21,49,132,7.352889718,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-19,Moderna,Ustekinumab,.,none,none,none,2021-05-07,Moderna,Ustekinumab,.,none,none,none,2021-09-16,Moderna,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,72,72,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,47,49,0,,,7,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,7,,24,6,70+
520,,Male,CD,Infliximab,none,none,none,0.05,Negative,13,Negative,,Elderly,,,Post-2nd,22-Sep-21,baseline,,126,,,21-Apr-21,19-May-21,22-Oct-21,28,156,2.557227311,ileocolonic,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-21,Moderna,Renflexis/IFX,none,Oral Prednisone,none,none,2021-05-19,Moderna,Renflexis/IFX,none,none,none,none,2021-10-22,Moderna,Renflexis/IFX,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,71,71,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,1,0,0,Corticoteroids,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,126,28,1,,,3,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,18,,155,6,70+
575,,Male,IBD-U,Ustekinumab,none,none,none,0.04,Negative,12,Negative,,Elderly,,,Post-1st,23-Apr-21,baseline,35,,,,19-Mar-21,30-Apr-21,23-Oct-21,42,176,2.509599262,ileal,Inflamatory,Pancolitis,both,Outpatient,Baseline Serology,,,,,,,2021-03-19,Pfizer,Ustekinumab,.,none,none,none,2021-04-30,Pfizer,Ustekinumab,.,none,none,none,2021-10-23,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,70,70,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,35,,42,1,,,3,1,0,Post-1st Dose,1,1,,0,0,0,,3,5,,,293,6,70+
591,,Female,CD,Ustekinumab,none,none,none,0.02,Negative,24982,Positive,,Elderly,,,Post-3rd,16-Nov-21,baseline,,,27,,16-Mar-21,09-Apr-21,20-Oct-21,24,194,10.12589483,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-16,Pfizer,Ustekinumab,.,none,none,none,2021-04-09,Pfizer,Ustekinumab,.,none,none,none,2021-10-20,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,73,74,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,24,1,,,10,1,1,Post-3rd Dose,1,1,27,0,0,0,,3,,,4,163,6,70+
592,,Female,CD,Ustekinumab,none,none,none,0.01,Negative,459,Positive,,Elderly,,,Post-1st,13-Apr-21,baseline,28,,,,16-Mar-21,09-Apr-21,20-Oct-21,24,194,6.127960292,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-16,Pfizer,Ustekinumab,.,none,none,none,2021-04-09,Pfizer,Ustekinumab,.,none,none,none,2021-10-20,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,73,74,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,28,,24,1,,,6,1,1,Post-1st Dose,1,1,,0,0,0,,3,4,,,164,6,70+
593,,Female,CD,Ustekinumab,none,none,none,0.01,Negative,1122,Positive,,Elderly,,,Post-2nd,20-Jul-21,baseline,,102,,,16-Mar-21,09-Apr-21,20-Oct-21,24,194,7.022511516,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-16,Pfizer,Ustekinumab,.,none,none,none,2021-04-09,Pfizer,Ustekinumab,.,none,none,none,2021-10-20,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,73,74,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,102,24,1,,,7,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,15,,165,6,70+
594,,Female,CD,Ustekinumab,none,none,none,0.01,Negative,2133,Positive,,Elderly,,,Post-2nd,04-May-21,baseline,,25,,,16-Mar-21,09-Apr-21,20-Oct-21,24,194,7.665144062,ileal,fistulizng,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-16,Pfizer,Ustekinumab,.,none,none,none,2021-04-09,Pfizer,Ustekinumab,.,none,none,none,2021-10-20,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,73,74,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,25,24,1,,,8,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,166,6,70+
736,,Male,CD,Ustekinumab,none,none,none,2.64,Positive,32231,Positive,,Elderly,282,,Post-3rd,05-Nov-21,covid,,,21,,23-Mar-21,08-Jun-21,15-Oct-21,77,129,10.38069641,ileal,Stricturing,N/A,,Outpatient,Confirmed COVID,,,,,,2021-04-20,2021-03-23,Pfizer,Ustekinumab,.,none,none,none,2021-06-08,Pfizer,Ustekinumab,.,none,none,none,2021-10-15,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,2021-01-27,1,Male,74,74,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,,77,0,,,10,1,1,Post-3rd Dose,1,1,21,0,0,0,2021-01-27,,,,3,320,6,70+
737,,Male,CD,Ustekinumab,none,none,none,6.73,Positive,14619,Positive,,Elderly,83,,Post-1st,20-Apr-21,covid,28,,,,23-Mar-21,08-Jun-21,15-Oct-21,77,129,9.590084172,ileal,Stricturing,N/A,,Outpatient,Confirmed COVID,,,,,,2021-04-20,2021-03-23,Pfizer,Ustekinumab,.,none,none,none,2021-06-08,Pfizer,Ustekinumab,.,none,none,none,2021-10-15,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,2021-01-27,1,Male,74,74,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,28,,77,0,,,10,1,1,Post-1st Dose,1,1,,0,0,0,2021-01-27,,4,,,321,6,70+
738,,Male,CD,Ustekinumab,none,none,none,3.29,Positive,20380,Positive,,Elderly,174,,Post-2nd,20-Jul-21,covid,,42,,,23-Mar-21,08-Jun-21,15-Oct-21,77,129,9.922314214,ileal,Stricturing,N/A,,Outpatient,Confirmed COVID,,,,,,2021-04-20,2021-03-23,Pfizer,Ustekinumab,.,none,none,none,2021-06-08,Pfizer,Ustekinumab,.,none,none,none,2021-10-15,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,2021-01-27,1,Male,74,74,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,42,77,0,,,10,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,2021-01-27,,,6,,322,6,70+
778,,Male,CD,none,none,none,Azathioprine/Immuran,0.01,Negative,18000,Positive,,Elderly,,,Post-3rd,01-Nov-21,baseline,,,14,,05-Mar-21,12-Apr-21,18-Oct-21,38,189,9.798115926,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-05,Pfizer,none,.,none,none,Azathioprine/Immuran,2021-04-12,Pfizer,none,.,none,none,Azathioprine/Immuran,2021-10-18,Pfizer,none,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,75,76,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,,,38,1,,,10,1,1,Post-3rd Dose,1,1,14,0,0,0,,3,,,2,349,6,70+
779,,Male,CD,none,none,none,Azathioprine/Immuran,0.01,Negative,69,Positive,,Elderly,,,Post-1st,12-Apr-21,baseline,38,,,,05-Mar-21,12-Apr-21,18-Oct-21,38,189,4.232656178,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-05,Pfizer,none,.,none,none,Azathioprine/Immuran,2021-04-12,Pfizer,none,.,none,none,Azathioprine/Immuran,2021-10-18,Pfizer,none,.,none,none,Azathioprine/Immuran,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,75,75,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,0,0,0,0,0,0,1,Immunomodulator Only,38,,38,1,,,4,1,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,350,6,70+
780,,Male,CD,Inflectra,none,none,none,0.04,Negative,1736,Positive,,Elderly,,,Post-2nd,20-May-21,baseline,,21,,,21-Mar-21,29-Apr-21,,39,,7.459396497,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-21,Pfizer,Inflectra,.,none,none,none,2021-04-29,Pfizer,Inflectra,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,75,75,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,21,39,1,,,7,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,,,3,,311,6,70+
781,,Male,CD,Inflectra,none,none,none,0.18,Negative,86,Positive,,Elderly,,,Post-2nd,17-Dec-21,baseline,,232,,,21-Mar-21,29-Apr-21,,39,,4.453183829,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-21,Pfizer,Inflectra,.,none,none,none,2021-04-29,Pfizer,Inflectra,.,none,none,none,,,,,,,,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,75,75,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,,232,39,1,,,4,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,,,33,,312,6,70+
782,,Male,CD,Inflectra,none,none,none,0.05,Negative,499,Positive,,Elderly,,,Post-1st,19-Apr-21,baseline,29,,,,21-Mar-21,29-Apr-21,,39,,6.212004713,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-21,Pfizer,Inflectra,.,none,none,none,2021-04-29,Pfizer,Inflectra,.,none,none,none,,,,,,,,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,75,75,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,0,0,0,0,0,0,0,,29,,39,1,,,6,1,1,Post-1st Dose,1,1,,0,0,0,,,4,,,313,6,70+
783,,Male,UC,none,Oral budesonide/Cortiment/Entocort,Oral 5ASA,none,0.04,Negative,7896,Positive,,Elderly,,,Post-3rd,03-Nov-21,baseline,,,41,,27-Feb-21,08-Apr-21,23-Sep-21,40,168,8.974098916,N/A ,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-02-27,Pfizer,none,.,Oral budesonide/Cortiment/Entocort,Oral 5ASA,none,2021-04-08,Pfizer,none,.,Oral budesonide/Cortiment/Entocort,Oral 5ASA,none,2021-09-23,Pfizer,Vedolizumab,.,Oral budesonide/Cortiment/Entocort,Oral 5ASA,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,74,75,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,1,0,0,0,1,0,Vedolizumab Only,,,40,1,,,9,1,0,Post-3rd Dose,1,1,41,1,0,1,,3,,,6,691,6,70+
784,,Male,UC,none,Oral budesonide/Cortiment/Entocort,Oral 5ASA,none,0.02,Negative,946,Positive,,Elderly,,,Post-2nd,25-May-21,baseline,,47,,,27-Feb-21,08-Apr-21,23-Sep-21,40,168,6.851925394,N/A ,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-02-27,Pfizer,none,.,Oral budesonide/Cortiment/Entocort,Oral 5ASA,none,2021-04-08,Pfizer,none,.,Oral budesonide/Cortiment/Entocort,Oral 5ASA,none,2021-09-23,Pfizer,Vedolizumab,.,Oral budesonide/Cortiment/Entocort,Oral 5ASA,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,74,75,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,1,0,0,0,1,0,Vedolizumab Only,,47,40,1,,,7,1,0,Post-2nd Dose (1-8 Weeks),1,1,,1,0,1,,3,,7,,692,6,70+
785,,Male,UC,none,Oral budesonide/Cortiment/Entocort,Oral 5ASA,none,0.01,Negative,82,Positive,,Elderly,,,Post-1st,05-Apr-21,baseline,37,,,,27-Feb-21,08-Apr-21,23-Sep-21,40,168,4.404277244,N/A ,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-02-27,Pfizer,none,.,Oral budesonide/Cortiment/Entocort,Oral 5ASA,none,2021-04-08,Pfizer,none,.,Oral budesonide/Cortiment/Entocort,Oral 5ASA,none,2021-09-23,Pfizer,Vedolizumab,.,Oral budesonide/Cortiment/Entocort,Oral 5ASA,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,74,74,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,1,0,0,0,1,0,Vedolizumab Only,37,,40,1,,,4,1,0,Post-1st Dose,1,1,,1,0,1,,3,5,,,693,6,70+
786,,Male,UC,none,Oral budesonide/Cortiment/Entocort,Oral 5ASA,none,0.01,Negative,171,Positive,,Elderly,,,Post-2nd,30-Aug-21,baseline,,144,,,27-Feb-21,08-Apr-21,23-Sep-21,40,168,5.138735297,N/A ,N/A,Unknown,,Outpatient,Baseline Serology,,,,,,,2021-02-27,Pfizer,none,.,Oral budesonide/Cortiment/Entocort,Oral 5ASA,none,2021-04-08,Pfizer,none,.,Oral budesonide/Cortiment/Entocort,Oral 5ASA,none,2021-09-23,Pfizer,Vedolizumab,.,Oral budesonide/Cortiment/Entocort,Oral 5ASA,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,74,75,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,1,0,0,0,1,0,Vedolizumab Only,,144,40,1,,,5,1,0,Post-2nd Dose (8+ Weeks),1,1,,1,0,1,,3,,21,,694,6,70+
789,,Female,CD,Vedolizumab,none,none,none,0.02,Negative,57,Positive,,Elderly,,,Post-1st,13-Apr-21,baseline,43,,,,01-Mar-21,10-Apr-21,25-Oct-21,40,198,4.037774211,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-01,Pfizer,Vedolizumab,.,none,none,none,2021-04-10,Pfizer,Vedolizumab,.,none,none,none,2021-10-25,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,78,78,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,43,,40,1,,,4,1,1,Post-1st Dose,1,1,,0,0,0,,3,6,,,488,6,70+
790,,Female,CD,Vedolizumab,none,none,none,0.02,Negative,3011,Positive,,Elderly,,,Post-2nd,08-Jun-21,baseline,,59,,,01-Mar-21,10-Apr-21,25-Oct-21,40,198,8.010060739,ileocolonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-01,Pfizer,Vedolizumab,.,none,none,none,2021-04-10,Pfizer,Vedolizumab,.,none,none,none,2021-10-25,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,78,78,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,59,40,1,,,8,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,8,,489,6,70+
795,,Male,CD,Vedolizumab,none,Oral 5ASA,none,0.06,Negative,3592,Positive,,Elderly,,,Post-3rd,29-Oct-21,baseline,,,56,,12-Mar-21,16-Apr-21,03-Sep-21,35,140,8.186464429,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-12,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,2021-04-16,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,2021-09-03,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,75,75,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,,,35,1,,,8,1,1,Post-3rd Dose,1,1,56,0,0,0,,3,,,8,428,6,70+
796,,Male,CD,Vedolizumab,none,Oral 5ASA,none,0.06,Negative,609,Positive,,Elderly,,,Post-1st,09-Apr-21,baseline,28,,,,12-Mar-21,16-Apr-21,03-Sep-21,35,140,6.412474867,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-12,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,2021-04-16,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,2021-09-03,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,75,75,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,28,,35,1,,,6,1,1,Post-1st Dose,1,1,,0,0,0,,3,4,,,429,6,70+
797,,Male,CD,Vedolizumab,none,Oral 5ASA,none,0.06,Negative,1769,Positive,,Elderly,,,Post-2nd,12-May-21,baseline,,26,,,12-Mar-21,16-Apr-21,03-Sep-21,35,140,7.478395785,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-12,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,2021-04-16,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,2021-09-03,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,75,75,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,,26,35,1,,,7,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,430,6,70+
798,,Male,CD,Vedolizumab,none,Oral 5ASA,none,0.07,Negative,684,Positive,,Elderly,,,Post-2nd,03-Sep-21,baseline,,140,,,12-Mar-21,16-Apr-21,03-Sep-21,35,140,6.528542542,ileocolonic,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-12,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,2021-04-16,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,2021-09-03,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,75,75,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,,140,35,1,,,7,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,20,,431,6,70+
808,,Female,CD,Ustekinumab,none,none,none,0.05,Negative,9369,Positive,,Elderly,,,Post-1st,30-Apr-21,baseline,29,,,,01-Apr-21,24-Apr-21,23-Nov-21,23,213,9.145182993,ileal,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-01,Pfizer,Ustekinumab,.,none,none,none,2021-04-24,Pfizer,Ustekinumab,.,none,none,none,2021-11-23,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,76,76,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,29,,23,1,,,9,1,1,Post-1st Dose,1,1,,0,0,0,,3,4,,,658,6,70+
809,,Female,CD,Ustekinumab,none,none,none,0.38,Negative,720,Positive,,Elderly,,,Post-2nd,23-Oct-21,baseline,,182,,,01-Apr-21,24-Apr-21,23-Nov-21,23,213,6.579667792,ileal,unknown,N/A,,Outpatient,Baseline Serology,,,,,,,2021-04-01,Pfizer,Ustekinumab,.,none,none,none,2021-04-24,Pfizer,Ustekinumab,.,none,none,none,2021-11-23,Pfizer,Ustekinumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,76,77,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,0,0,1,0,0,0,0,Ustekinumab Only,,182,23,1,,,7,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,26,,659,6,70+
816,,Male,CD,none,none,none,none,0.35,Negative,5455,Positive,,Elderly,,,Post-3rd,30-Dec-21,baseline,,,68,,07-Mar-21,14-Apr-21,23-Oct-21,38,192,8.604342892,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-07,Pfizer,none,.,none,none,none,2021-04-14,Pfizer,none,.,none,none,none,2021-10-23,Pfizer,none,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,76,77,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,,,38,1,,,9,1,1,Post-3rd Dose,1,1,68,1,1,1,,3,,,10,61,6,70+
817,,Male,CD,none,none,none,none,0.03,Negative,128,Positive,,Elderly,,,Post-1st,12-Apr-21,baseline,36,,,,07-Mar-21,14-Apr-21,23-Oct-21,38,192,4.854371272,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-07,Pfizer,none,.,none,none,none,2021-04-14,Pfizer,none,.,none,none,none,2021-10-23,Pfizer,none,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,76,76,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,36,,38,1,,,5,1,1,Post-1st Dose,1,1,,1,1,1,,3,5,,,62,6,70+
818,,Male,CD,none,none,none,none,0.05,Negative,995,Positive,,Elderly,,,Post-2nd,03-Sep-21,baseline,,142,,,07-Mar-21,14-Apr-21,23-Oct-21,38,192,6.902742737,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-07,Pfizer,none,.,none,none,none,2021-04-14,Pfizer,none,.,none,none,none,2021-10-23,Pfizer,none,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,76,76,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,,142,38,1,,,7,1,1,Post-2nd Dose (8+ Weeks),1,1,,1,1,1,,3,,20,,63,6,70+
819,,Male,CD,none,none,none,none,0.02,Negative,5756,Positive,,Elderly,,,Post-2nd,06-May-21,baseline,,22,,,07-Mar-21,14-Apr-21,23-Oct-21,38,192,8.657928573,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-07,Pfizer,none,.,none,none,none,2021-04-14,Pfizer,none,.,none,none,none,2021-10-23,Pfizer,none,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,76,76,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,,22,38,1,,,9,1,1,Post-2nd Dose (1-8 Weeks),1,1,,1,1,1,,3,,3,,64,6,70+
827,,Male,UC,none,none,Oral 5ASA,none,0.06,Negative,12938,Positive,,Elderly,,,Post-3rd,22-Dec-21,baseline,,,17,,26-Mar-21,05-Jun-21,05-Dec-21,71,183,9.46788535,N/A ,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-03-26,Pfizer,none,.,none,Oral 5ASA,none,2021-06-05,Pfizer,none,.,none,Oral 5ASA,none,2021-12-05,Pfizer,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,70,71,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,,71,0,,,9,1,0,Post-3rd Dose,1,1,17,1,1,1,,3,,,2,708,6,70+
828,,Male,UC,none,none,Oral 5ASA,none,0.03,Negative,3246,Positive,,Elderly,,,Post-2nd,21-Jun-21,baseline,,16,,,26-Mar-21,05-Jun-21,05-Dec-21,71,183,8.085178748,N/A ,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-03-26,Pfizer,none,.,none,Oral 5ASA,none,2021-06-05,Pfizer,none,.,none,Oral 5ASA,none,2021-12-05,Pfizer,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,70,70,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,16,71,0,,,8,1,0,Post-2nd Dose (1-8 Weeks),1,1,,1,1,1,,3,,2,,709,6,70+
829,,Male,UC,none,none,Oral 5ASA,none,0.02,Negative,789,Positive,,Elderly,,,Post-2nd,01-Oct-21,baseline,,118,,,26-Mar-21,05-Jun-21,05-Dec-21,71,183,6.670512803,N/A ,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-03-26,Pfizer,none,.,none,Oral 5ASA,none,2021-06-05,Pfizer,none,.,none,Oral 5ASA,none,2021-12-05,Pfizer,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,70,70,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,,118,71,0,,,7,1,0,Post-2nd Dose (8+ Weeks),1,1,,1,1,1,,3,,17,,710,6,70+
830,,Male,UC,none,none,Oral 5ASA,none,0.03,Negative,22,Negative,,Elderly,,,Post-1st,24-Apr-21,baseline,29,,,,26-Mar-21,05-Jun-21,05-Dec-21,71,183,3.068052935,N/A ,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-03-26,Pfizer,none,.,none,Oral 5ASA,none,2021-06-05,Pfizer,none,.,none,Oral 5ASA,none,2021-12-05,Pfizer,none,.,none,Oral 5ASA,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,70,70,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,0,0,0,0,0,1,0,No Imuunosuppressives,29,,71,0,,,3,1,0,Post-1st Dose,1,1,,1,1,1,,3,4,,,711,6,70+
875,,Male,CD,Vedolizumab,none,none,none,0.02,Negative,3010,Positive,,Elderly,,,Post-3rd,25-Oct-21,baseline,,,43,,23-Mar-21,17-May-21,12-Sep-21,55,118,8.00972858,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-23,Pfizer,Vedolizumab,.,none,none,none,2021-05-17,Pfizer,Vedolizumab,.,none,none,none,2021-09-12,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,71,72,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,,55,0,,,8,1,1,Post-3rd Dose,1,1,43,0,0,0,,3,,,6,929,6,70+
876,,Male,CD,Vedolizumab,none,none,none,0.02,Negative,43,Negative,,Elderly,,,Post-1st,07-May-21,baseline,45,,,,23-Mar-21,17-May-21,12-Sep-21,55,118,3.751854253,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-23,Pfizer,Vedolizumab,.,none,none,none,2021-05-17,Pfizer,Vedolizumab,.,none,none,none,2021-09-12,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,71,71,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,45,,55,0,,,4,1,1,Post-1st Dose,1,1,,0,0,0,,3,6,,,930,6,70+
877,,Male,CD,Vedolizumab,none,none,none,0.02,Negative,2917,Positive,,Elderly,,,Post-2nd,08-Jun-21,baseline,,22,,,23-Mar-21,17-May-21,12-Sep-21,55,118,7.978242404,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-23,Pfizer,Vedolizumab,.,none,none,none,2021-05-17,Pfizer,Vedolizumab,.,none,none,none,2021-09-12,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,71,71,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,22,55,0,,,8,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,931,6,70+
884,,Female,CD,Vedolizumab,Oral Prednisone,none,none,0.02,Negative,19256,Positive,,Elderly,,,Post-3rd,02-Nov-21,New biologic/Tofacitinib start,,,28,,18-Mar-21,22-Apr-21,05-Oct-21,35,166,9.865572786,colonic,Inflamatory,N/A,,Outpatient,New biologic/Tofacitinib start,,,,,,,2021-03-18,Pfizer,Vedolizumab,.,Oral Prednisone,Oral 5ASA,Methotrexate,2021-04-22,Pfizer,Vedolizumab,.,none,Oral 5ASA,Methotrexate,2021-10-05,Pfizer,Vedolizumab,.,none,Oral 5ASA,Methotrexate,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,78,78,0,1,0,0,1,0,0,Corticoteroids,0,1,0,0,1,1,1,Corticoteroids,0,1,0,0,0,1,1,Combination Therapy,0,1,0,0,0,1,1,Combination Therapy,,,35,1,,,10,1,1,Post-3rd Dose,1,1,28,0,0,0,,3,,,4,624,6,70+
885,,Female,CD,Vedolizumab,Oral Prednisone,none,none,0.02,Negative,1511,Positive,,Elderly,,,Post-2nd,22-Jul-21,New biologic/Tofacitinib start,,91,,,18-Mar-21,22-Apr-21,05-Oct-21,35,166,7.320725487,colonic,Inflamatory,N/A,,Outpatient,New biologic/Tofacitinib start,,,,,,,2021-03-18,Pfizer,Vedolizumab,.,Oral Prednisone,Oral 5ASA,Methotrexate,2021-04-22,Pfizer,Vedolizumab,.,none,Oral 5ASA,Methotrexate,2021-10-05,Pfizer,Vedolizumab,.,none,Oral 5ASA,Methotrexate,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,78,78,0,1,0,0,1,0,0,Corticoteroids,0,1,0,0,1,1,1,Corticoteroids,0,1,0,0,0,1,1,Combination Therapy,0,1,0,0,0,1,1,Combination Therapy,,91,35,1,,,7,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,13,,625,6,70+
886,,Female,CD,Vedolizumab,Oral Prednisone,none,none,0.02,Negative,675,Positive,,Elderly,,,Post-1st,19-Apr-21,New biologic/Tofacitinib start,32,,,,18-Mar-21,22-Apr-21,05-Oct-21,35,166,6.514564532,colonic,Inflamatory,N/A,,Outpatient,New biologic/Tofacitinib start,,,,,,,2021-03-18,Pfizer,Vedolizumab,.,Oral Prednisone,Oral 5ASA,Methotrexate,2021-04-22,Pfizer,Vedolizumab,.,none,Oral 5ASA,Methotrexate,2021-10-05,Pfizer,Vedolizumab,.,none,Oral 5ASA,Methotrexate,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,78,78,0,1,0,0,1,0,0,Corticoteroids,0,1,0,0,1,1,1,Corticoteroids,0,1,0,0,0,1,1,Combination Therapy,0,1,0,0,0,1,1,Combination Therapy,32,,35,1,,,7,1,1,Post-1st Dose,1,1,,0,0,0,,3,5,,,626,6,70+
890,,Female,CD,Adalimumab,none,none,none,0.07,Negative,4818,Positive,,Elderly,,,Post-3rd,04-Nov-21,baseline,,,29,,23-Mar-21,10-Jun-21,06-Oct-21,79,118,8.480134938,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,Vedolizumab,,,,,,2021-03-23,Pfizer,Adalimumab,Vedolizumab,none,none,none,2021-06-10,Pfizer,Adalimumab,Vedolizumab,none,none,none,2021-10-06,Pfizer,Adalimumab,Vedolizumab,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,72,73,1,1,0,0,0,0,0,Combination Therapy,1,1,0,0,0,0,0,Combination Therapy,1,1,0,0,0,0,0,Combination Therapy,1,1,0,0,0,0,0,Combination Therapy,,,79,0,,,8,1,1,Post-3rd Dose,1,1,29,0,0,0,,3,,,4,769,6,70+
891,,Female,CD,Adalimumab,none,none,none,0.02,Negative,27,Negative,,Elderly,,,Post-1st,12-May-21,baseline,50,,,,23-Mar-21,10-Jun-21,06-Oct-21,79,118,3.306886702,ileocolonic,Stricturing,N/A,,Outpatient,Baseline Serology,Vedolizumab,,,,,,2021-03-23,Pfizer,Adalimumab,Vedolizumab,none,none,none,2021-06-10,Pfizer,Adalimumab,Vedolizumab,none,none,none,2021-10-06,Pfizer,Adalimumab,Vedolizumab,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Female,72,72,1,1,0,0,0,0,0,Combination Therapy,1,1,0,0,0,0,0,Combination Therapy,1,1,0,0,0,0,0,Combination Therapy,1,1,0,0,0,0,0,Combination Therapy,50,,79,0,,,3,1,1,Post-1st Dose,1,1,,0,0,0,,3,7,,,770,6,70+
912,,Male,UC,Infliximab,none,Oral 5ASA,none,0.05,Negative,18195,Positive,,Elderly,,,Post-2nd,26-May-21,baseline,,12,,,16-Mar-21,14-May-21,01-Oct-21,59,140,9.808907606,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-03-16,Pfizer,Infliximab,.,none,Oral 5ASA,none,2021-05-14,Pfizer,Infliximab,.,none,Oral 5ASA,none,2021-10-01,Pfizer,Infliximab,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,1,,1,,,,1,,,,0,Male,70,70,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,,12,59,0,,,10,1,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,2,,764,6,70+
913,,Male,UC,Infliximab,none,Oral 5ASA,none,0.04,Negative,2020,Positive,,Elderly,,,Post-2nd,15-Sep-21,baseline,,124,,,16-Mar-21,14-May-21,01-Oct-21,59,140,7.610605235,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-03-16,Pfizer,Infliximab,.,none,Oral 5ASA,none,2021-05-14,Pfizer,Infliximab,.,none,Oral 5ASA,none,2021-10-01,Pfizer,Infliximab,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,70,71,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,1,0,0,0,0,1,0,Anti-TNF Only,,124,59,0,,,8,1,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,18,,765,6,70+
977,,Male,UC,Vedolizumab,none,none,none,0.01,Negative,1210,Positive,,Elderly,,,Post-3rd,04-Nov-21,baseline,,,59,,03-Apr-21,28-Apr-21,06-Sep-21,25,131,7.09845828,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,Vedolizumab,.,none,none,none,2021-04-28,Pfizer,Vedolizumab,.,none,none,none,2021-09-06,Pfizer,Inflectra,.,Oral Prednisone,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,70,70,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,1,0,0,0,1,0,0,Corticoteroids,,,25,1,,,7,1,0,Post-3rd Dose,1,1,59,0,0,0,,3,,,8,358,6,70+
978,,Male,UC,Vedolizumab,none,none,none,0.02,Negative,5423,Positive,,Elderly,,,Post-2nd,21-May-21,baseline,,23,,,03-Apr-21,28-Apr-21,06-Sep-21,25,131,8.598478204,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,Vedolizumab,.,none,none,none,2021-04-28,Pfizer,Vedolizumab,.,none,none,none,2021-09-06,Pfizer,Inflectra,.,Oral Prednisone,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,70,70,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,1,0,0,0,1,0,0,Corticoteroids,,23,25,1,,,9,1,0,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,3,,359,6,70+
979,,Male,UC,Vedolizumab,none,none,none,0.02,Negative,214,Positive,,Elderly,,,Post-2nd,09-Sep-21,baseline,,134,,,03-Apr-21,28-Apr-21,06-Sep-21,25,131,5.364105107,N/A ,N/A,Pancolitis,,Outpatient,Baseline Serology,,,,,,,2021-04-03,Pfizer,Vedolizumab,.,none,none,none,2021-04-28,Pfizer,Vedolizumab,.,none,none,none,2021-09-06,Pfizer,Inflectra,.,Oral Prednisone,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,70,70,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,1,0,0,0,1,0,0,Corticoteroids,,134,25,1,,,5,1,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,19,,360,6,70+
10,,Female,CD,none,Oral budesonide/Cortiment/Entocort,none,none,0.05,Negative,1873,Positive,,Elderly,,,Post-3rd,09-Dec-21,baseline,,,52,,13-Mar-21,21-Apr-21,18-Oct-21,39,180,7.535243311,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-13,Pfizer,none,.,Oral budesonide/Cortiment/Entocort,none,none,2021-04-21,Pfizer,none,.,Oral budesonide/Cortiment/Entocort,none,none,2021-10-18,Pfizer,none,.,Oral budesonide/Cortiment/Entocort,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,84,85,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,,,39,1,,,8,1,1,Post-3rd Dose,1,1,52,1,1,1,,3,,,7,801,6,70+
11,,Female,CD,none,Oral budesonide/Cortiment/Entocort,none,none,0.04,Negative,162,Positive,,Elderly,,,Post-2nd,14-Oct-21,baseline,,176,,,13-Mar-21,21-Apr-21,18-Oct-21,39,180,5.086361005,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-13,Pfizer,none,.,Oral budesonide/Cortiment/Entocort,none,none,2021-04-21,Pfizer,none,.,Oral budesonide/Cortiment/Entocort,none,none,2021-10-18,Pfizer,none,.,Oral budesonide/Cortiment/Entocort,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,84,84,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,,176,39,1,,,5,1,1,Post-2nd Dose (8+ Weeks),1,1,,1,1,1,,3,,25,,802,6,70+
12,,Female,CD,none,Oral budesonide/Cortiment/Entocort,none,none,0.04,Negative,713,Positive,,Elderly,,,Post-2nd,20-May-21,baseline,,29,,,13-Mar-21,21-Apr-21,18-Oct-21,39,180,6.56948142,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-13,Pfizer,none,.,Oral budesonide/Cortiment/Entocort,none,none,2021-04-21,Pfizer,none,.,Oral budesonide/Cortiment/Entocort,none,none,2021-10-18,Pfizer,none,.,Oral budesonide/Cortiment/Entocort,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,84,84,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,0,0,0,0,0,0,0,No Imuunosuppressives,,29,39,1,,,7,1,1,Post-2nd Dose (1-8 Weeks),1,1,,1,1,1,,3,,4,,803,6,70+
249,,Male,CD,Inflectra,none,none,none,0.06,Negative,3119,Positive,,Elderly,,,Post-3rd,28-Sep-21,baseline,,,33,,01-Mar-21,09-Apr-21,26-Aug-21,39,139,8.045363897,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-01,Pfizer,Inflectra,.,none,none,none,2021-04-09,Pfizer,Inflectra,.,none,none,none,2021-08-26,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,79,80,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,39,1,,,8,1,1,Post-3rd Dose,1,1,33,0,0,0,,3,,,5,419,6,70+
250,,Male,CD,Inflectra,none,none,none,0.02,Negative,108,Positive,,Elderly,,,Post-2nd,07-Jun-21,baseline,,59,,,01-Mar-21,09-Apr-21,26-Aug-21,39,139,4.681204872,colonic,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-01,Pfizer,Inflectra,.,none,none,none,2021-04-09,Pfizer,Inflectra,.,none,none,none,2021-08-26,Pfizer,Inflectra,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,79,80,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,59,39,1,,,5,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,8,,420,6,70+
467,,Male,CD,Vedolizumab,none,Oral 5ASA,none,0.24,Negative,206,Positive,,Elderly,,,Post-2nd,24-Aug-21,baseline,,122,,,14-Mar-21,24-Apr-21,15-Oct-21,41,174,5.327390614,ileal,,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-14,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,2021-04-24,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,2021-10-15,Pfizer,Vedolizumab,.,none,Oral 5ASA,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,79,80,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,0,1,0,0,0,1,0,Vedolizumab Only,,122,41,1,,,5,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,17,,967,6,70+
479,,Male,CD,Vedolizumab,Oral Prednisone,none,none,0.16,Negative,2,Negative,,Elderly,,,Post-2nd,20-Aug-21,baseline,,125,,,11-Mar-21,17-Apr-21,11-Sep-21,37,147,0.587786665,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,Golimumab,,,,,,2021-03-11,Pfizer,Vedolizumab,Golimumab,Oral Prednisone,none,none,2021-04-17,Pfizer,Vedolizumab,Golimumab,Oral Prednisone,none,none,2021-09-11,Pfizer,Vedolizumab,Golimumab,Oral Prednisone,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Male,84,84,1,1,0,0,1,0,0,Corticoteroids,1,1,0,0,1,0,0,Corticoteroids,1,1,0,0,1,0,0,Corticoteroids,1,1,0,0,1,0,0,Corticoteroids,,125,37,1,,,1,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,18,,816,6,70+
627,,Male,CD,Adalimumab,none,none,none,0.03,Negative,622,Positive,,Elderly,,,Post-3rd,15-Dec-21,baseline,,,69,,28-Feb-21,13-Apr-21,07-Oct-21,44,177,6.432779308,ileal,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-02-28,Pfizer,Adalimumab,.,none,none,none,2021-04-13,Pfizer,Adalimumab,.,none,none,none,2021-10-07,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Male,83,84,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,,44,0,,,6,1,1,Post-3rd Dose,1,1,69,0,0,0,,3,,,10,498,6,70+
628,,Male,CD,Adalimumab,none,none,none,,,618,Positive,,Elderly,,,Post-2nd,12-May-21,baseline,,29,,,28-Feb-21,13-Apr-21,07-Oct-21,44,177,6.426650257,ileal,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-02-28,Pfizer,Adalimumab,.,none,none,none,2021-04-13,Pfizer,Adalimumab,.,none,none,none,2021-10-07,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Male,83,83,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,29,44,0,,,6,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,4,,499,6,70+
629,,Male,CD,Adalimumab,none,none,none,0.03,Negative,45,Negative,,Elderly,,,Post-1st,31-Mar-21,baseline,31,,,,28-Feb-21,13-Apr-21,07-Oct-21,44,177,3.799973502,ileal,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-02-28,Pfizer,Adalimumab,.,none,none,none,2021-04-13,Pfizer,Adalimumab,.,none,none,none,2021-10-07,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,1,,,,,,,,,,,0,Male,83,83,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,31,,44,0,,,4,1,1,Post-1st Dose,1,1,,0,0,0,,3,4,,,500,6,70+
630,,Male,CD,Adalimumab,none,none,none,0.03,Negative,37,Negative,,Elderly,,,Post-2nd,27-Aug-21,baseline,,136,,,28-Feb-21,13-Apr-21,07-Oct-21,44,177,3.605497845,ileal,fistulizing and perianal,N/A,,Outpatient,Baseline Serology,,,,,,,2021-02-28,Pfizer,Adalimumab,.,none,none,none,2021-04-13,Pfizer,Adalimumab,.,none,none,none,2021-10-07,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,83,84,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,136,44,0,,,4,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,19,,501,6,70+
664,,Female,CD,Vedolizumab,none,none,none,0.08,Negative,2601,Positive,,Elderly,,,Post-3rd,30-Oct-21,baseline,,,24,,11-Mar-21,03-Apr-21,06-Oct-21,23,186,7.863651265,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-11,Pfizer,Vedolizumab,.,none,none,none,2021-04-03,Pfizer,Vedolizumab,.,none,none,none,2021-10-06,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,,,,,1,,,0,Female,81,82,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,,23,1,,,8,1,1,Post-3rd Dose,1,1,24,0,0,0,,3,,,3,397,6,70+
665,,Female,CD,Vedolizumab,none,none,none,0.09,Negative,883,Positive,,Elderly,,,Post-2nd,11-May-21,baseline,,38,,,11-Mar-21,03-Apr-21,06-Oct-21,23,186,6.783211944,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-11,Pfizer,Vedolizumab,.,none,none,none,2021-04-03,Pfizer,Vedolizumab,.,none,none,none,2021-10-06,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,1,1,,,,1,,,,0,Female,81,81,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,38,23,1,,,7,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,5,,398,6,70+
666,,Female,CD,Vedolizumab,none,none,none,0.08,Negative,422,Positive,,Elderly,,,Post-2nd,31-Aug-21,baseline,,150,,,11-Mar-21,03-Apr-21,06-Oct-21,23,186,6.044768319,ileal,Inflamatory,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-11,Pfizer,Vedolizumab,.,none,none,none,2021-04-03,Pfizer,Vedolizumab,.,none,none,none,2021-10-06,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,81,81,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,150,23,1,,,6,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,21,,399,6,70+
930,,Female,CD,Adalimumab,none,none,none,0.01,Negative,95,Positive,,Elderly,,,Post-2nd,26-Apr-21,baseline,,73,,,15-Jan-21,12-Feb-21,27-Sep-21,28,227,4.549657476,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-01-15,Pfizer,Adalimumab,.,none,none,none,2021-02-12,Pfizer,Adalimumab,.,none,none,none,2021-09-27,Pfizer,Adalimumab,.,none,none,none,,.,.,.,.,.,.,,,,,1,,1,1,,,,0,Female,83,83,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,1,0,0,0,0,0,0,Anti-TNF Only,,73,28,1,,,5,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,10,,306,6,70+
931,,Male,CD,Vedolizumab,Oral budesonide/Cortiment/Entocort,none,none,0.13,Negative,3316,Positive,,Elderly,,,Post-2nd,21-Apr-21,baseline,,9,,,03-Mar-21,12-Apr-21,13-Oct-21,40,184,8.106393882,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-03,Pfizer,Vedolizumab,.,none,none,none,2021-04-12,Pfizer,Vedolizumab,.,Oral budesonide/Cortiment/Entocort,none,none,2021-10-13,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,1,,1,,,,1,,,,0,Male,79,80,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,9,40,1,,,8,1,1,Post-2nd Dose (1-8 Weeks),1,1,,0,0,0,,3,,1,,684,6,70+
932,,Male,CD,Vedolizumab,Oral budesonide/Cortiment/Entocort,none,none,0.13,Negative,99,Positive,,Elderly,,,Post-2nd,07-Oct-21,baseline,,178,,,03-Mar-21,12-Apr-21,13-Oct-21,40,184,4.597138014,ileal,Stricturing,N/A,,Outpatient,Baseline Serology,,,,,,,2021-03-03,Pfizer,Vedolizumab,.,none,none,none,2021-04-12,Pfizer,Vedolizumab,.,Oral budesonide/Cortiment/Entocort,none,none,2021-10-13,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Male,79,80,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,178,40,1,,,5,1,1,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,25,,685,6,70+
992,,Female,UC,Vedolizumab,none,none,none,0.03,Negative,1165,Positive,,Elderly,,,Post-2nd,20-Aug-21,baseline,,126,,,05-Mar-21,16-Apr-21,23-Sep-21,42,160,7.060648025,N/A ,N/A,Left Sided Colitis,,Outpatient,Baseline Serology,,,,,,,2021-03-05,Pfizer,Vedolizumab,.,none,none,none,2021-04-16,Pfizer,Vedolizumab,.,none,none,none,2021-09-23,Pfizer,Vedolizumab,.,none,none,none,,.,.,.,.,.,.,,,,,,1,1,1,,,,0,Female,81,81,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,0,1,0,0,0,0,0,Vedolizumab Only,,126,42,1,,,7,1,0,Post-2nd Dose (8+ Weeks),1,1,,0,0,0,,3,,18,,844,6,70+
993,,Male,CD,Vedolizumab,Oral budesonide/Cortiment/Entocort,none,none,4.97,Positive,12789,Positive,,Adult,39,,Pre-1st,26-May-21,covid,,,,,01-Jun-21,20-Jul-21,,49,,9.456340705,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
994,,Female,UC,none,none,Oral 5ASA,none,7.63,Positive,6488,Positive,,Adult,28,,Pre-1st,27-May-21,covid,,,,,28-May-21,08-Jul-21,,41,,8.777709596,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
995,,Female,UC,none,none,Oral 5ASA,none,0.87,Negative,78,Positive,,Adult,38,,Pre-1st,15-Jun-21,covid,,,,,16-Jun-21,03-Sep-21,,79,,4.356708827,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
996,,Female,CD,Adalimumab,none,none,none,2.65,Positive,640,Positive,,Adult,30,,Pre-1st,06-Apr-21,Baseline to COVID,,,,,22-Apr-21,27-May-21,27-Sep-21,35,123,6.461468176,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
997,,Male,UC,Inflectra,none,none,none,0.03,Negative,0,Negative,,Adult,,,Pre-1st,09-Apr-21,baseline,,,,,22-Apr-21,17-Jun-21,15-Sep-21,56,90,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
998,,Female,CD,Ustekinumab,none,none,none,4.11,Positive,74,Positive,,Adult,18,,Pre-1st,25-May-21,Baseline to COVID,,,,,26-May-21,05-Jul-21,,40,,4.304065093,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
999,,Female,CD,Adalimumab,none,none,none,6.82,Positive,3430,Positive,,Elderly,40,,Pre-1st,18-Feb-21,Baseline to COVID,,,,,16-Sep-21,06-Nov-21,,51,,8.14031554,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1000,,Female,UC,none,none,Both oral/Rectal,none,0.2,Negative,566,Positive,,Adult,203,,Pre-1st,15-Mar-21,covid,,,,,15-Apr-21,13-Jun-21,,59,,6.338594078,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1001,,Male,CD,Ustekinumab,none,none,none,0.03,Negative,2,Negative,,Adult,123,,Pre-1st,10-Feb-21,covid,,,,,31-Mar-21,11-Jun-21,02-Sep-21,72,83,0.693147181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1002,,Female,CD,Adalimumab,unknown,none,unkknown,0.4,Negative,34,Negative,,Adult,142,,Pre-1st,25-Feb-21,covid,,,,,16-Apr-21,06-Jun-21,,51,,3.526360525,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1003,,Female,CD,Infliximab,none,none,none,7.35,Positive,754,Positive,,Adult,25,,Pre-1st,09-Dec-20,covid,,,,,06-Jul-21,28-Sep-21,,84,,6.625392368,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1004,,Male,CD,Adalimumab,none,none,none,0.02,Negative,2,Negative,,Adult,238,,Pre-1st,18-Jan-21,covid,,,,,08-Apr-21,09-Jun-21,08-Dec-21,62,182,0.693147181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1005,,Female,CD,Adalimumab,none,none,none,2.02,Positive,243,Positive,,Adult,101,,Pre-1st,26-Feb-21,covid,,,,,22-Apr-21,20-Jun-21,,59,,5.493061443,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1006,,Male,UC,Vedolizumab,none,none,Methotrexate,0.83,Negative,983,Positive,,Adult,119,,Pre-1st,24-Mar-21,covid,,,,,23-May-21,03-Jul-21,,41,,6.89060912,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1007,,Female,CD,Adalimumab,none,none,none,0.03,Negative,3,Negative,,Adult,,,Pre-1st,01-Mar-21,baseline,,,,,13-Mar-21,23-May-21,25-Sep-21,71,125,1.098612289,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1008,,Male,UC,Adalimumab,none,none,none,2.88,Positive,7,Negative,,Adult,,,Pre-1st,14-Dec-20,baseline,,,,,16-Apr-21,15-Jun-21,28-Sep-21,60,105,1.945910149,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1009,,Female,CD,Infliximab,none,none,none,2.93,Positive,195,Positive,,Adult,37,,Pre-1st,06-Jan-21,covid,,,,,18-Apr-21,21-May-21,30-Sep-21,33,132,5.272999559,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1010,,Female,CD,Infliximab,none,none,none,1.37,Negative,117,Positive,,Adult,71,,Pre-1st,09-Feb-21,covid,,,,,18-Apr-21,21-May-21,30-Sep-21,33,132,4.762173935,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1011,,Male,CD,Inflectra,none,none,Methotrexate,,,1,Negative,,Adult,,,Pre-1st,14-Jul-21,baseline,,,,,16-Sep-21,14-Oct-21,,28,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1012,,Male,CD,Infliximab,none,none,none,0.02,Negative,3,Negative,,Adult,,,Pre-1st,16-Mar-21,baseline,,,,,23-Apr-21,19-Jun-21,27-Sep-21,57,100,1.098612289,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1013,,Female,CD,Adalimumab,none,none,none,0.58,Negative,23,Negative,,Adult,159,,Pre-1st,13-May-21,covid,,,,,04-Jun-21,03-Jul-21,,29,,3.135494216,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1014,,Female,UC,none,none,Both oral/Rectal,none,0.05,Negative,0,Negative,,Adult,83,,Pre-1st,18-Dec-20,covid,,,,,02-May-21,28-Jun-21,,57,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1015,,Male,CD,Infliximab,none,none,Methotrexate,0.22,Negative,148,Positive,,Adult,57,,Pre-1st,26-Jan-21,covid,,,,,21-Apr-21,11-Jun-21,08-Sep-21,51,89,4.997212274,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1016,,Female,UC,Adalimumab,none,none,none,1.51,Positive,450,Positive,,Adult,73,,Pre-1st,04-Feb-21,covid,,,,,26-Apr-21,26-Jun-21,14-Dec-21,61,171,6.109247583,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1017,,Female,UC,none,none,Oral 5ASA,none,4.65,Positive,1672,Positive,,Adult,78,,Pre-1st,01-Feb-21,covid,,,,,16-Apr-21,08-May-21,07-Oct-21,22,152,7.421775794,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1018,,Female,CD,Vedolizumab,none,none,Methotrexate,0.03,Negative,7,Negative,,Adult,,,Pre-1st,30-Dec-20,baseline,,,,,10-Apr-21,13-Jun-21,,64,,1.945910149,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1019,,Female,CD,Adalimumab,none,none,none,0.05,Negative,1,Negative,,Adult,,,Pre-1st,23-Mar-21,baseline,,,,,17-Apr-21,27-Sep-21,,163,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1020,,Male,UC,Vedolizumab,none,none,none,0.02,Negative,1,Negative,,Adult,,,Pre-1st,07-Apr-21,baseline,,,,,16-May-21,30-Jun-21,,45,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1021,,Female,UC,Inflectra,none,none,Methotrexate,0.02,Negative,2,Negative,,Adult,,,Pre-1st,15-Apr-21,baseline,,,,,26-Apr-21,25-Jun-21,20-Dec-21,60,178,0.693147181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1022,,Male,CD,Ustekinumab,none,none,none,2.92,Positive,980,Positive,,Adult,60,,Pre-1st,08-Apr-21,covid,,,,,04-Apr-21,07-Jun-21,,64,,6.887552572,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1023,,Male,CD,Remicade,none,none,Methotrexate,0.02,Negative,4,Negative,,Adult,,,Pre-1st,23-Jul-21,baseline,,,,,28-Aug-21,20-Sep-21,,23,,1.386294361,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1024,,Male,CD,Infliximab,none,none,none,0.03,Negative,4,Negative,,Adult,,,Pre-1st,19-Mar-21,baseline,,,,,11-Apr-21,27-Jun-21,28-Sep-21,77,93,1.386294361,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1025,,Female,CD,Inflectra,none,none,Methotrexate,0.02,Negative,5,Negative,,Adult,,,Pre-1st,09-Mar-21,baseline,,,,,08-Apr-21,06-May-21,04-Sep-21,28,121,1.609437912,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1026,,Male,CD,Ustekinumab,none,none,none,0.03,Negative,7,Negative,,Adult,,,Pre-1st,15-Apr-21,baseline,,,,,21-Apr-21,24-Jun-21,01-Oct-21,64,99,1.945910149,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1027,,Male,CD,Remicade,none,Oral 5ASA,Azathioprine/Immuran,0.76,Negative,1,Negative,,Adult,,,Pre-1st,12-Mar-21,baseline,,,,,10-Apr-21,11-Jun-21,19-Nov-21,62,161,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1028,,Female,CD,Adalimumab,none,none,Methotrexate,0.02,Negative,2,Negative,,Elderly,,,Pre-1st,08-Mar-21,baseline,,,,,29-Mar-21,10-Jun-21,13-Sep-21,73,95,0.693147181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1029,,Male,UC,Infliximab,none,none,none,0.02,Negative,3,Negative,,Adult,,,Pre-1st,04-Mar-21,baseline,,,,,15-May-21,08-Jul-21,,54,,1.098612289,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1030,,Male,CD,Ustekinumab,none,none,none,0.02,Negative,5,Negative,,Elderly,,,Pre-1st,05-Mar-21,baseline,,,,,19-Mar-21,07-May-21,16-Sep-21,49,132,1.609437912,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1031,,Female,CD,Ustekinumab,none,none,Methotrexate,0.03,Negative,2,Negative,,Adult,,,Pre-1st,03-Mar-21,baseline,,,,,15-Apr-21,19-Jun-21,30-Sep-21,65,103,0.693147181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1032,,Male,CD,Ustekinumab,none,none,none,0.03,Negative,3,Negative,,Adult,,,Pre-1st,09-Mar-21,baseline,,,,,13-Apr-21,27-May-21,12-Nov-21,44,169,1.098612289,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1033,,Female,UC,Ustekinumab,none,none,Methotrexate,0.04,Negative,1,Negative,,Adult,,,Pre-1st,01-Mar-21,baseline,,,,,02-Apr-21,15-May-21,05-Oct-21,43,143,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1034,,Male,CD,Vedolizumab,none,none,none,0.23,Negative,47,Negative,,Adult,263,,Pre-1st,08-Jan-21,covid,,,,,10-Jun-21,15-Jul-21,,35,,3.850147602,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1035,,Female,CD,Ustekinumab,none,none,none,0.04,Negative,2,Negative,,Adult,,,Pre-1st,02-Mar-21,baseline,,,,,30-Mar-21,09-Jun-21,27-Dec-21,71,201,0.693147181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1036,,Female,CD,Ustekinumab,none,none,none,0.1,Negative,2,Negative,,Adult,,,Pre-1st,01-Mar-21,baseline,,,,,03-May-21,30-May-21,02-Oct-21,27,125,0.693147181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1037,,Female,CD,Ustekinumab,none,none,none,4.09,Positive,406,Positive,,Adult,23,,Pre-1st,15-Apr-21,Baseline to COVID,,,,,18-Apr-21,01-Jun-21,07-Sep-21,44,98,6.00635316,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1038,,Female,CD,Infliximab,none,none,Methotrexate,0.02,Negative,1,Negative,,Adult,,,Pre-1st,16-Mar-21,baseline,,,,,09-Apr-21,02-May-21,22-Sep-21,23,143,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1039,,Female,CD,Infliximab,none,none,none,0.02,Negative,6,Negative,,Adult,,,Pre-1st,30-Mar-21,baseline,,,,,08-Apr-21,11-Jun-21,17-Sep-21,64,98,1.791759469,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1040,,Female,CD,Infliximab,none,none,none,0.04,Negative,2,Negative,,Adult,,,Pre-1st,05-Mar-21,baseline,,,,,22-Apr-21,14-May-21,05-Oct-21,22,144,0.693147181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1041,,Female,CD,Ustekinumab,none,none,none,,,,,,Adult,,,Pre-1st,16-Aug-21,baseline,,,,,12-Oct-21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1042,,Female,CD,Infliximab,none,none,Methotrexate,1.51,Positive,1163,Positive,,Adult,110,,Pre-1st,15-Jan-21,covid,,,,,19-Apr-21,13-Jun-21,08-Oct-21,55,117,7.058758153,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1043,,Female,CD,Infliximab,none,none,Methotrexate,1.23,Negative,900,Positive,,Adult,159,,Pre-1st,05-Mar-21,covid,,,,,19-Apr-21,13-Jun-21,08-Oct-21,55,117,6.802394763,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1044,,Female,CD,Ustekinumab,none,none,none,1.56,Positive,1,Negative,,Adult,,,Pre-1st,09-Jan-21,baseline,,,,,01-Sep-21,29-Sep-21,,28,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1045,,Female,CD,Ustekinumab,none,none,none,,,0,Negative,,Adult,,,Pre-1st,09-Jul-21,baseline,,,,,01-Sep-21,29-Sep-21,,28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1046,,Female,CD,Inflectra,none,none,Methotrexate,0.03,Negative,2,Negative,,Adult,,,Pre-1st,16-Mar-21,baseline,,,,,22-Apr-21,16-Jun-21,09-Sep-21,55,85,0.693147181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1047,,Female,CD,Ustekinumab,none,none,none,0.03,Negative,3,Negative,,Adult,,,Pre-1st,01-Apr-21,baseline,,,,,25-Apr-21,17-May-21,,22,,1.098612289,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1048,,Male,CD,Ustekinumab,none,none,none,2.77,Positive,4,Negative,,Adult,,,Pre-1st,23-Mar-21,baseline,,,,,09-Apr-21,10-May-21,03-Sep-21,31,116,1.386294361,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1049,,Male,UC,Infliximab,none,none,none,0.03,Negative,1,Negative,,Elderly,,,Pre-1st,12-Mar-21,baseline,,,,,28-Mar-21,24-Apr-21,,27,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1050,,Female,CD,Remicade,none,none,Azathioprine/Immuran,0.01,Negative,1,Negative,,Adult,,,Pre-1st,17-Apr-21,baseline,,,,,06-May-21,04-Jul-21,,59,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1051,,Female,CD,Adalimumab,none,none,Methotrexate,0.61,Negative,12,Negative,,Adult,43,,Pre-1st,05-Feb-21,covid,,,,,30-Apr-21,16-Jun-21,27-Sep-21,47,103,2.48490665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1052,,Male,UC,Remicade,none,none,none,0.04,Negative,3,Negative,,Adult,,,Pre-1st,01-Apr-21,baseline,,,,,26-Apr-21,01-Jun-21,28-Sep-21,36,119,1.098612289,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1053,,Female,CD,Adalimumab,none,none,Methotrexate,0.02,Negative,3,Negative,,Adult,,,Pre-1st,07-Apr-21,baseline,,,,,09-Apr-21,17-Jun-21,,69,,1.098612289,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1054,,Female,CD,Remicade,none,none,Azathioprine/Immuran,0.04,Negative,2,Negative,,Adult,,,Pre-1st,22-Apr-21,baseline,,,,,27-Apr-21,21-Jun-21,,55,,0.693147181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1055,,Male,CD,Vedolizumab,none,none,none,0.1,Negative,4,Negative,,Adult,,,Pre-1st,08-Mar-21,baseline,,,,,30-Mar-21,11-Jun-21,,73,,1.386294361,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1056,,Female,UC,Infliximab,none,none,none,0.03,Negative,14,Negative,,Adult,,,Pre-1st,08-Mar-21,baseline,,,,,03-Apr-21,06-May-21,02-Sep-21,33,119,2.63905733,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1057,,Male,CD,Ustekinumab,none,none,none,0.02,Negative,1,Negative,,Adult,,,Pre-1st,03-Mar-21,baseline,,,,,01-Apr-21,21-Jun-21,,81,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1058,,Male,UC,Infliximab,none,Oral 5ASA,Methotrexate,0.03,Negative,2,Negative,,Adult,,,Pre-1st,05-Mar-21,baseline,,,,,12-May-21,07-Jul-21,,56,,0.693147181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1059,,Male,CD,Infliximab,none,none,none,0.06,Negative,0,Negative,,Adult,,,Pre-1st,05-Mar-21,baseline,,,,,15-Apr-21,23-Jun-21,14-Sep-21,69,83,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1060,,Male,CD,Adalimumab,none,none,none,0.8,Negative,2,Negative,,Adult,,,Pre-1st,29-Mar-21,baseline,,,,,13-Apr-21,16-Jun-21,29-Sep-21,64,105,0.693147181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1061,,Male,CD,Infliximab,none,none,Azathioprine/Immuran,0.47,Negative,56,Positive,,Adult,93,,Pre-1st,06-Apr-21,covid,,,,,18-May-21,02-Jul-21,,45,,4.025351691,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1062,,Female,UC,Inflectra,none,none,none,0.03,Negative,7,Negative,,Adult,,,Pre-1st,09-Mar-21,baseline,,,,,09-Apr-21,03-May-21,28-Sep-21,24,148,1.945910149,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1063,,Male,UC,Remicade,none,none,none,0.81,Negative,90,Positive,,Adult,164,,Pre-1st,28-Jan-21,covid,,,,,06-May-21,02-Jul-21,,57,,4.49980967,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1064,,Male,CD,Vedolizumab,none,none,none,0.05,Negative,7,Negative,,Adult,,,Pre-1st,03-Mar-21,baseline,,,,,10-Apr-21,19-Jun-21,,70,,1.945910149,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1065,,Female,CD,Vedolizumab,none,none,none,0.16,Negative,4,Negative,,Adult,,,Pre-1st,24-Mar-21,baseline,,,,,06-Oct-21,,,,,1.386294361,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1066,,Female,CD,Vedolizumab,none,none,none,0.17,Negative,4,Negative,,Adult,,,Pre-1st,14-Jul-21,baseline,,,,,06-Oct-21,,,,,1.386294361,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1067,,Female,CD,Ustekinumab,none,none,none,6.71,Positive,1494,Positive,,Adult,52,,Pre-1st,14-May-21,Baseline to COVID,,,,,07-Jul-21,,,,,7.309212366,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1068,,Male,CD,Ustekinumab,none,none,none,0.03,Negative,6,Negative,,Adult,,,Pre-1st,13-Apr-21,baseline,,,,,15-Apr-21,18-May-21,,33,,1.791759469,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1069,,Male,UC,Inflectra,none,none,none,0.01,Negative,1,Negative,,Adult,,,Pre-1st,26-Mar-21,baseline,,,,,29-Apr-21,09-Jun-21,26-Sep-21,41,109,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1070,,Female,CD,Vedolizumab,none,none,none,0.42,Negative,1,Negative,,Adult,,,Pre-1st,16-Mar-21,baseline,,,,,03-Apr-21,24-Jun-21,29-Sep-21,82,97,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1071,,Male,CD,Inflectra,none,none,none,0.03,Negative,1,Negative,,Adult,,,Pre-1st,03-May-21,baseline,,,,,03-May-21,28-Jun-21,,56,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1072,,Female,CD,Ustekinumab,none,none,none,0.02,Negative,0,Negative,,Adult,,,Pre-1st,13-Apr-21,baseline,,,,,10-May-21,02-Jul-21,,53,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1073,,Male,CD,Ustekinumab,none,none,none,0.03,Negative,2,Negative,,Adult,,,Pre-1st,16-Apr-21,baseline,,,,,12-Apr-21,22-May-21,,40,,0.693147181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1074,,Female,UC,Infliximab,none,none,Methotrexate,0.02,Negative,2,Negative,,Adult,,,Pre-1st,01-Mar-21,baseline,,,,,10-Apr-21,09-Jun-21,04-Oct-21,60,117,0.693147181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1075,,Male,CD,Infliximab,none,none,none,4.12,Positive,182,Positive,,Adult,12,,Pre-1st,18-Jan-21,covid,,,,,22-Apr-21,26-Jul-21,,95,,5.204006687,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1076,,Male,CD,Infliximab,none,none,none,1.35,Negative,342,Positive,,Adult,68,,Pre-1st,15-Mar-21,covid,,,,,22-Apr-21,26-Jul-21,,95,,5.834810737,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1077,,Female,UC,Vedolizumab,none,none,none,0.03,Negative,11,Negative,,Adult,,,Pre-1st,08-Mar-21,baseline,,,,,10-Apr-21,15-Jun-21,,66,,2.397895273,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1078,,Female,CD,Adalimumab,none,none,none,0.48,Negative,109,Positive,,Adult,103,,Pre-1st,12-Mar-21,covid,,,,,21-Apr-21,25-Jun-21,,65,,4.691347882,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1079,,Female,CD,Ustekinumab,none,none,none,0.07,Negative,1,Negative,,Adult,,,Pre-1st,06-Apr-21,baseline,,,,,02-Apr-21,28-May-21,,56,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1080,,Female,CD,Remicade,none,none,none,0.03,Negative,0,Negative,,Adult,,,Pre-1st,17-Mar-21,baseline,,,,,24-Apr-21,12-Jun-21,,49,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1081,,Male,CD,Ustekinumab,none,none,none,0.04,Negative,0,Negative,,Adult,,,Pre-1st,25-Mar-21,baseline,,,,,10-Apr-21,11-Jun-21,,62,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1082,,Male,UC,Vedolizumab,none,none,none,0.35,Negative,344,Positive,,Adult,215,,Pre-1st,22-Feb-21,covid,,,,,28-Jul-21,28-Aug-21,,31,,5.840641657,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1083,,Male,CD,Infliximab,none,none,Azathioprine/Immuran,0.03,Negative,0,Negative,,Adult,,,Pre-1st,03-Apr-21,baseline,,,,,12-May-21,08-Jul-21,,57,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1084,,Male,CD,Infliximab,none,none,none,0.03,Negative,0,Negative,,Adult,-28,,Pre-1st,14-Mar-21,Baseline to COVID,,,,,19-May-21,01-Aug-21,,74,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1085,,Female,CD,Ustekinumab,none,none,none,0.02,Negative,0,Negative,,Adult,,,Pre-1st,12-Mar-21,baseline,,,,,09-Apr-21,12-May-21,23-Sep-21,33,134,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1086,,Male,CD,Infliximab,none,none,none,0.05,Negative,3,Negative,,Adult,,,Pre-1st,16-Mar-21,baseline,,,,,20-Apr-21,25-Jun-21,,66,,1.098612289,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1087,,Male,CD,Adalimumab,none,none,none,6.3,Positive,9005,Positive,,Adult,51,,Pre-1st,10-Feb-21,covid,,,,,11-Apr-21,17-Jun-21,,67,,9.105535258,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1088,,Male,UC,Tofacitinib,Oral budesonide/Cortiment/Entocort,none,none,3.77,Positive,816,Positive,,Adult,75,,Pre-1st,16-Feb-21,covid,,,,,22-Apr-21,15-Jun-21,,54,,6.704414355,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1089,,Male,CD,Ustekinumab,none,none,none,0.02,Negative,0,Negative,,Elderly,,,Pre-1st,24-Mar-21,baseline,,,,,05-Apr-21,15-Jun-21,,71,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1090,,Male,CD,Inflectra,none,none,Azathioprine/Immuran,0.04,Negative,4,Negative,,Adult,,,Pre-1st,19-Mar-21,baseline,,,,,04-Jun-21,04-Jul-21,,30,,1.386294361,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1091,,Female,UC,Vedolizumab,none,Oral 5ASA,none,5.88,Positive,564,Positive,,Adult,19,,Pre-1st,13-Feb-21,covid,,,,,07-Sep-21,,,,,6.335054251,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1092,,Male,CD,Adalimumab,none,none,none,0.32,Negative,8,Negative,,Adult,121,,Pre-1st,15-Mar-21,covid,,,,,20-Apr-21,16-Jun-21,,57,,2.079441542,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1093,,Female,CD,Adalimumab,none,none,none,0.13,Negative,0,Negative,,Adult,,,Pre-1st,15-Apr-21,baseline,,,,,18-Apr-21,28-May-21,22-Sep-21,40,117,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1094,,Female,UC,Remicade,none,none,none,0.07,Negative,2,Negative,,Adult,,,Pre-1st,02-Mar-21,Post Vaccine covid,,,,,30-Apr-21,29-Sep-21,,152,,0.693147181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1095,,Female,CD,Vedolizumab,none,none,Azathioprine/Immuran,2.07,Positive,1271,Positive,,Adult,100,,Pre-1st,30-Apr-21,covid,,,,,26-May-21,29-Jun-21,,34,,7.147559271,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1096,,Female,UC,none,none,none,Azathioprine/Immuran,0.03,Negative,4,Negative,,Adult,,,Pre-1st,01-Mar-21,baseline,,,,,03-Mar-21,21-Apr-21,22-Sep-21,49,154,1.386294361,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1097,,Male,UC,other,none,Oral 5ASA,none,0.09,Negative,322,Positive,,Adult,209,,Pre-1st,10-Feb-21,covid,,,,,18-Feb-21,30-Mar-21,03-Dec-21,40,248,5.774551546,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1098,,Female,CD,Adalimumab,none,none,none,0.02,Negative,2,Negative,,Adult,,,Pre-1st,02-Mar-21,baseline,,,,,29-Mar-21,26-Apr-21,14-Sep-21,28,141,0.693147181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1099,,Female,UC,none,none,Oral 5ASA,none,0.93,Negative,1333,Positive,,Adult,93,,Pre-1st,08-Mar-21,covid,,,,,29-Aug-21,01-Oct-21,,33,,7.19518732,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1100,,Female,CD,Ustekinumab,none,none,none,0.02,Negative,3,Negative,,Elderly,,,Pre-1st,14-Mar-21,baseline,,,,,25-Mar-21,04-Jun-21,10-Sep-21,71,98,1.098612289,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1101,,Male,CD,Remicade,none,none,none,0.41,Negative,112,Positive,,Adult,100,,Pre-1st,13-Mar-21,covid,,,,,10-Jun-21,04-Jul-21,,24,,4.718498871,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1102,,Male,UC,Infliximab,none,Rectal 5ASA,none,0.02,Negative,4,Negative,,Adult,,,Pre-1st,12-Apr-21,baseline,,,,,22-Apr-21,21-May-21,12-Oct-21,29,144,1.386294361,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1103,,Female,CD,Vedolizumab,none,none,none,0.02,Negative,5,Negative,,Adult,,,Pre-1st,25-Mar-21,baseline,,,,,06-Apr-21,10-Jun-21,,65,,1.609437912,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1104,,Male,CD,Ustekinumab,none,none,none,7.39,Positive,671,Positive,,Elderly,22,,Pre-1st,18-Feb-21,covid,,,,,23-Mar-21,08-Jun-21,15-Oct-21,77,129,6.508769137,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1105,,Male,UC,none,none,none,Azathioprine/Immuran,6.44,Positive,714,Positive,,Adult,49,,Pre-1st,01-Apr-21,covid,,,,,01-May-21,10-Jul-21,,70,,6.570882962,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1106,,Female,CD,Adalimumab,none,none,none,0.02,Negative,2,Negative,,Adult,,,Pre-1st,16-Mar-21,baseline,,,,,11-Apr-21,08-Jun-21,,58,,0.693147181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1107,,Female,CD,Ustekinumab,none,none,none,0.03,Negative,2,Negative,,Adult,,,Pre-1st,10-Mar-21,baseline,,,,,26-Apr-21,17-Jun-21,04-Oct-21,52,109,0.693147181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1108,,Male,CD,Infliximab,none,none,none,0.02,Negative,0,Negative,,Adult,,,Pre-1st,26-Mar-21,baseline,,,,,14-Apr-21,30-Jun-21,16-Nov-21,77,139,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1109,,Female,CD,Infliximab,none,none,Methotrexate,0.03,Negative,1,Negative,,Adult,,,Pre-1st,16-Mar-21,baseline,,,,,03-Apr-21,21-Jun-21,22-Sep-21,79,93,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1110,,Male,CD,Vedolizumab,none,none,none,0.01,Negative,10,Negative,,Adult,,,Pre-1st,12-Mar-21,baseline,,,,,22-Apr-21,22-Jun-21,,61,,2.302585093,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1111,,Male,CD,Infliximab,none,none,none,0.06,Negative,1,Negative,,Elderly,,,Pre-1st,16-Mar-21,baseline,,,,,23-Mar-21,06-May-21,,44,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1112,,Male,UC,Ustekinumab,none,none,none,0.02,Negative,3,Negative,,Adult,,,Pre-1st,13-Mar-21,baseline,,,,,08-Apr-21,20-Jun-21,,73,,1.098612289,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1113,,Male,CD,Ustekinumab,none,none,none,0.02,Negative,2,Negative,,Adult,,,Pre-1st,08-Mar-21,baseline,,,,,22-Apr-21,15-Jun-21,29-Oct-21,54,136,0.693147181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1114,,Female,CD,Ustekinumab,none,none,none,0.17,Negative,2,Negative,,Elderly,,,Pre-1st,25-Mar-21,baseline,,,,,27-Mar-21,10-Jun-21,08-Dec-21,75,181,0.693147181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1115,,Male,UC,Infliximab,none,none,none,0.02,Negative,2,Negative,,Adult,,,Pre-1st,02-Mar-21,baseline,,,,,10-Apr-21,10-Jun-21,22-Sep-21,61,104,0.693147181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1116,,Male,CD,Ustekinumab,none,none,Azathioprine/Immuran,0.03,Negative,1,Negative,,Adult,,,Pre-1st,25-Mar-21,baseline,,,,,06-Apr-21,13-Jun-21,31-Oct-21,68,140,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1117,,Male,CD,Infliximab,none,none,Azathioprine/Immuran,4.21,Positive,965,Positive,,Adult,113,,Pre-1st,26-Feb-21,covid,,,,,16-Jul-21,12-Aug-21,,27,,6.872128101,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1118,,Male,CD,Ustekinumab,none,none,Azathioprine/Immuran,0.07,Negative,2,Negative,,Adult,,,Pre-1st,23-Mar-21,Suspected COVID-19/Symptomatic,,,,,10-Apr-21,03-Jun-21,27-Sep-21,54,116,0.693147181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1119,,Male,CD,Ustekinumab,none,none,none,0.05,Negative,1,Negative,,Adult,,,Pre-1st,19-Apr-21,baseline,,,,,22-Apr-21,21-Jun-21,,60,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1120,,Male,CD,Ustekinumab,none,none,none,0.02,Negative,2,Negative,,Adult,,,Pre-1st,09-Mar-21,baseline,,,,,08-Jul-21,12-Aug-21,07-Oct-21,35,56,0.693147181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1121,,Male,CD,Infliximab,none,none,Azathioprine/Immuran,0.09,Negative,5,Negative,,Adult,,,Pre-1st,07-Apr-21,baseline,,,,,13-Apr-21,07-May-21,13-Sep-21,24,129,1.609437912,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1122,,Female,CD,Vedolizumab,none,none,none,0.02,Negative,1,Negative,,Adult,,,Pre-1st,29-Mar-21,baseline,,,,,20-Apr-21,23-Jul-21,,94,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1123,,Female,CD,Golimumab,none,none,none,0.04,Negative,3,Negative,,Adult,,,Pre-1st,07-Mar-21,baseline,,,,,12-Apr-21,05-May-21,24-Sep-21,23,142,1.098612289,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1124,,Male,CD,Remicade,none,none,none,0.03,Negative,3,Negative,,Adult,,,Pre-1st,31-Mar-21,baseline,,,,,14-Apr-21,13-Jun-21,,60,,1.098612289,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1125,,Female,CD,Ustekinumab,none,none,none,0.05,Negative,3,Negative,,Adult,,,Pre-1st,30-Mar-21,baseline,,,,,13-Apr-21,22-Jun-21,02-Sep-21,70,72,1.098612289,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1126,,Male,CD,Ustekinumab,none,none,none,0.08,Negative,2,Negative,,Adult,,,Pre-1st,09-Apr-21,baseline,,,,,09-May-21,08-Jul-21,22-Oct-21,60,106,0.693147181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1127,,Male,CD,Ustekinumab,none,none,none,0.02,Negative,5,Negative,,Adult,,,Pre-1st,10-Mar-21,baseline,,,,,06-Apr-21,16-May-21,08-Oct-21,40,145,1.609437912,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1128,,Male,UC,Remicade,none,yes ,Azathioprine/Immuran,0.02,Negative,1,Negative,,Adult,,,Pre-1st,15-Mar-21,baseline,,,,,28-May-21,19-Jul-21,,52,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1129,,Female,UC,Infliximab,none,none,none,0.38,Negative,324,Positive,,Adult,124,,Pre-1st,25-Mar-21,covid,,,,,22-Sep-21,,,,,5.780743516,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1130,,Male,CD,Ustekinumab,Oral Prednisone,none,Methotrexate,0.02,Negative,180,Positive,,Adult,,,Pre-1st,23-Mar-21,baseline,,,,,09-Apr-21,06-May-21,08-Sep-21,27,125,5.192956851,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1131,,Male,CD,Infliximab,none,none,Azathioprine/Immuran,5.05,Positive,53,Positive,,Adult,,,Pre-1st,06-May-21,covid,,,,,26-May-21,08-Jul-21,,43,,3.970291914,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1132,,Female,CD,Adalimumab,none,none,none,1.82,Positive,139,Positive,,Adult,31,,Pre-1st,19-Apr-21,covid,,,,,28-Apr-21,19-May-21,,21,,4.934473933,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1133,,Female,CD,Inflectra,none,none,Azathioprine/Immuran,5.78,Positive,93,Positive,,Adult,55,,Pre-1st,30-Mar-21,covid,,,,,09-Apr-21,04-May-21,,25,,4.532599493,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1134,,Male,CD,Ustekinumab,none,none,none,0.02,Negative,17054,Positive,,Adult,,,Post-4th,06-Oct-21,baseline,,,,25-Jun-21,01-Sep-21,26-Apr-21,27-May-21,31,29,9.744140059,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,